FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Peinado, RD
   Olivier, DS
   Eberle, RJ
   de Moraes, FR
   Amaral, MS
   Arni, RK
   Coronado, MA
AF Peinado, Rafaela dos S.
   Olivier, Danilo S.
   Eberle, Raphael J.
   de Moraes, Fabio R.
   Amaral, Marcos S.
   Arni, Raghuvir K.
   Coronado, Monika A.
TI Binding studies of a putative C. pseudotuberculosis target protein from
   Vitamin B-12 Metabolism
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; FUNCTIONAL-CHARACTERIZATION;
   COBALAMIN VITAMIN-B-12; SECONDARY STRUCTURE; METHYLTRANSFERASE; SURAMIN;
   METHIONINE; BIOSYNTHESIS; PARAMETERS; RESIDUES
AB Vitamin B-12 acts as a cofactor for various metabolic reactions important in living organisms. The Vitamin B-12 biosynthesis is restricted to prokaryotes, which means, all eukaryotic organisms must acquire this molecule through diet. This study presents the investigation of Vitamin B-12 metabolism and the characterization of precorrin-4 C(11)-methyltransferase (CobM), an enzyme involved in the biosynthesis of Vitamin B-12 in Corynebacterium pseudotuberculosis. The analysis of the C. pseudotuberculosis genome identified two Vitamin B-12-dependent pathways, which can be strongly affected by a disrupted vitamin metabolism. Molecular dynamics, circular dichroism, and NMR-STD experiments identified regions in CobM that undergo conformational changes after s-adenosyl-L-methionine binding to promote the interaction of precorrin-4, a Vitamin B(12 )precursor. The binding of s-adenosyl-L-methionine was examined along with the competitive binding of adenine, dATP, and suramin. Based on fluorescence spectroscopy experiments the dissociation constant for the four ligands and the target protein could be determined; SAM (1.4 +/- 0.7 mu M), adenine (17.8 +/- 1.5 mu M), dATP (15.8 +/- 2.0 mu M), and Suramin (6.3 +/- 1.1 mu M). The results provide rich information for future investigations of potential drug targets within the C. pseudotuberculosis's Vitamin B12 metabolism and related pathways to reduce the pathogen's virulence in its hosts.
C1 [Peinado, Rafaela dos S.; Olivier, Danilo S.; Eberle, Raphael J.; de Moraes, Fabio R.; Arni, Raghuvir K.; Coronado, Monika A.] Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, Inst Biociencias Letras & Ciencias Exatas Ibilce, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Amaral, Marcos S.] Univ Fed Mato Grosso do Sul, Inst Phys, BR-79090700 Campo Grande, MS, Brazil.
RP Arni, RK; Coronado, MA (corresponding author), Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, Inst Biociencias Letras & Ciencias Exatas Ibilce, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM raghuvir.arni@unesp.br; monikacoronado@gmail.com
RI Arni, Raghuvir K/B-2222-2013; de Moraes, Fabio R/B-8331-2017; Olivier,
   Danilo/M-7566-2016; Serrou do Amaral, Marcos/I-6927-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; de Moraes, Fabio
   R/0000-0002-0425-0352; Olivier, Danilo/0000-0003-1269-3783; Serrou do
   Amaral, Marcos/0000-0001-8101-6933
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2, 150444/2017-6];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2015/13765-0, 2015/18868-2, 2016/08104-8, 2016/12904-0, 2009/53989-4];
   FundectFundect [23/200.307/2014]; CAPESCAPES; PROPe UNESP
FX This research was supported by grants from CNPq [Grant numbers
   435913/2016-6, 401270/2014-9, 307338/2014-2, 150444/2017-6], FAPESP
   [Grant numbers 2015/13765-0, 2015/18868-2, 2016/08104-8; 2016/12904-0;
   2009/53989-4], Fundect [23/200.307/2014], CAPES and PROPe UNESP.
CR Ahumada M, 2017, ANALYST, V142, P2067, DOI 10.1039/c7an00288b
   Ayers J. L., 1997, J AM VET MED ASSOC, V171, P1251
   Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828
   BERGERAT A, 1990, NUCLEIC ACIDS RES, V18, P4369, DOI 10.1093/nar/18.15.4369
   BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989
   BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Coronado MA, 2018, ANTIVIR RES, V160, P118, DOI 10.1016/j.antiviral.2018.10.019
   Costa LRR, 1998, VET MICROBIOL, V62, P135, DOI 10.1016/S0378-1135(98)00202-8
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   DeLano W.L., 2002, CCP4 NEWSLETTER PROT, V40, P82, DOI DOI 10.1038/S41598-017-03842-2
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Eswar N., 2007, CURR PROTOC BIOINFOR, V15, P1
   Fini C, 1996, BIOCHEM MOL MED, V58, P37, DOI 10.1006/bmme.1996.0030
   Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200
   Frank S, 2007, J BIOL CHEM, V282, P23957, DOI 10.1074/jbc.M703827200
   Frisch D.J.F. M.J., 2009, GAUSSIAN 09 REVISION
   Gopinath K, 2013, FUTURE MICROBIOL, V8, P1405, DOI 10.2217/fmb.13.113
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301
   Klug G, 2014, MOL MICROBIOL, V91, P635, DOI 10.1111/mmi.12490
   Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Maravic G, 2003, J MOL BIOL, V332, P99, DOI 10.1016/S0022-2836(03)00863-5
   Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7
   Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200
   Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
   MIDDAUGH CR, 1992, BIOCHEMISTRY-US, V31, P9016, DOI 10.1021/bi00152a044
   Monteiro RQ, 2004, INT J BIOCHEM CELL B, V36, P2077, DOI 10.1016/j.biocel.2004.03.007
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003
   Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485
   Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031
   Qin J, 2014, FEBS J, V281, P1948, DOI 10.1111/febs.12744
   Raux E, 2000, CELL MOL LIFE SCI, V57, P1880, DOI 10.1007/PL00000670
   Raux E, 1999, BIOORG CHEM, V27, P100, DOI 10.1006/bioo.1998.1125
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Roessner CA, 2005, J BIOL CHEM, V280, P16748, DOI 10.1074/jbc.M501805200
   ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993
   Ruiz JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018551
   Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08
   Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07
   Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711
   Schubert HL, 1998, NAT STRUCT BIOL, V5, P585, DOI 10.1038/846
   Shaikh SMT, 2007, DYES PIGMENTS, V73, P211, DOI 10.1016/j.dyepig.2005.11.008
   Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8
   Trott O., 2009, J COMPUT CHEM, V31, pNA461, DOI DOI https://doi.org/10.1002/jcc.21334
   Wang GK, 2015, COLLOID SURFACE B, V135, P261, DOI 10.1016/j.colsurfb.2015.07.063
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F
   WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725
   Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599
NR 58
TC 1
Z9 1
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 23
PY 2019
VL 9
AR 6350
DI 10.1038/s41598-019-42935-y
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HU3YE
UT WOS:000465210300003
PM 31015525
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Eberle, RJ
   Coronado, MA
   Peinado, RS
   de Moraes, FR
   Olivier, D
   Dreyer, T
   Lopes, DD
   da Luz, BSR
   Azevedo, V
   Arni, RK
AF Eberle, Raphael J.
   Coronado, Monika A.
   Peinado, Rafaela S.
   de Moraes, Fabio R.
   Olivier, Danilo
   Dreyer, Thiago
   Lopes, Debora de Oliveira
   Rosa da Luz, Brenda Silva
   Azevedo, Vasco
   Arni, Raghuvir K.
TI The polyanions heparin and suramin impede binding of free adenine to a
   DNA glycosylase from C. pseudotuberculosis
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Corynebacterium pseudotuberculosis; MutY; Adenine; Polyanions;
   Competition
ID ESCHERICHIA-COLI MUTY; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; STRUCTURAL
   BASIS; CASEOUS-LYMPHADENITIS; REPAIR; RECOGNITION; DOMAIN; PATHOGENESIS;
   INHIBITION; MUTATIONS
AB Currently no effective treatment is available to combat infections caused by Corynebacterium pseudotuberculosis in livestock. Survival of this Gram-positive bacterium in rapidly-growing pathogens in hostile environments is strongly dependent on the existence of a robust DNA repair system to prevent DNA mutations and contribute to bacterial colonization and virulence. The adenine/guanine-specific DNA glycosylase (MutY) is evolutionarily conserved and has been well characterized due to its central role in the prevention of mutagenesis and DNA repair.
   The aim of this study was the characterization of the target protein interaction with free adenine, suramin, and heparin, as well as the binding competition characterization between the molecules.
   The dissociation constant for free adenine interaction with Corynebacterium pseudotuberculosis MutY (Cp-MutY) was determined, 86 +/- 2.5 mu M. NMR competition experiments demonstrated, that the polyanions heparin and suramin compete with adenine for the protein active site. The determined dissociation constant for the heparin/Cp-MutY interaction was 5.9 +/- 1.0 mu M and for suramin was 16 +/- 1.5 mu M. Docking of both polyanions with Cp-MutY revealed a possible mode of interaction and indicates that these molecules can interfere with the protein interaction with damaged DNA or prevent the binding of the adenine base in the enzyme active site. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Eberle, Raphael J.; Coronado, Monika A.; Peinado, Rafaela S.; de Moraes, Fabio R.; Olivier, Danilo; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Inst Biociencias Letras & Ciencias Exatas Ibilce, Dept Phys, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Dreyer, Thiago] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.
   [Lopes, Debora de Oliveira] Univ Fed Sao Joao Del Rei CCO, Mol Biol Lab, Ave Sebastiao Goncalves Coelho 400, BR-35501296 Divinopolis, MG, Brazil.
   [Rosa da Luz, Brenda Silva; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Ave Antonio Carlos,6627 Pampulha,CP 486, BR-31270901 Belo Horizonte, MG, Brazil.
RP Eberle, RJ; Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias Letras & Ciencias Exatas Ibilce, Dept Phys, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM eberleraphael@gmail.com; fabio.moraes@unesp.br; debora@ufsj.edu.br;
   vasco@icb.ufmg.br; raghuvir.arni@unesp.br
RI Olivier, Danilo/M-7566-2016; Azevedo, Vasco A.C/F-4315-2011; de Moraes,
   Fabio R/B-8331-2017; Azevedo, Vasco A/B-1556-2019; Arni, Raghuvir
   K/B-2222-2013; Lopes, Debora de Oliveira/L-3601-2016
OI Olivier, Danilo/0000-0003-1269-3783; Azevedo, Vasco
   A.C/0000-0002-4775-2280; de Moraes, Fabio R/0000-0002-0425-0352;
   Azevedo, Vasco A/0000-0002-4775-2280; Arni, Raghuvir
   K/0000-0003-2460-1145; Lopes, Debora de Oliveira/0000-0002-8559-8552;
   Silva Rosa da Luz, Brenda/0000-0001-5208-7994; Dreyer,
   Thiago/0000-0002-2780-1428
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13765-0, 2015/18868-2,
   2016/08104-8, 2016/12904-0, 2009/53989-4]; CAPESCAPES; PROPe UNESP
FX The authors wish to thank Prof. Marcos R. M. Fontes for the use of the
   ITC equipment. This research was supported by grants from CNPq [Grant
   numbers 435913/2016-6, 401270/2014-9, 307338/2014-2], FAPESP [Grant
   numbers 2015/13765-0, 2015/18868-2, 2016/08104-8; 2016/12904-0;
   2009/53989-4], CAPES and PROPe UNESP.
CR Ahumada M, 2017, ANALYST, V142, P2067, DOI 10.1039/c7an00288b
   Ainalem ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092692
   Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828
   AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448
   Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003
   Chaves-Moreira D, 2017, J CELL BIOCHEM, V118, P726, DOI 10.1002/jcb.25678
   CHEN JZ, 1990, NUCLEIC ACIDS RES, V18, P3255, DOI 10.1093/nar/18.11.3255
   Chepanoske CL, 1999, NUCLEIC ACIDS RES, V27, P3197, DOI 10.1093/nar/27.15.3197
   Chmiel NH, 2001, NUCLEIC ACIDS RES, V29, P553, DOI 10.1093/nar/29.2.553
   COMPER WD, 1981, HEPARIN RELATED POLY, V7
   Dalvit C, 2002, J AM CHEM SOC, V124, P7702, DOI 10.1021/ja020174b
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   de Faria RC, 2016, INFECT GENET EVOL, V44, P318, DOI 10.1016/j.meegid.2016.07.028
   Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969
   Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Drohat AC, 2002, NAT STRUCT BIOL, V9, P659, DOI 10.1038/nsb829
   Eberle RJ, 2015, BBA-GEN SUBJECTS, V1850, P393, DOI 10.1016/j.bbagen.2014.11.014
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Ellenbecker M, 2014, ANTIMICROB AGENTS CH, V58, P7405, DOI 10.1128/AAC.03595-14
   EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353
   Eswar N., 2007, CURR PROTOC BIOINFOR, V15, P1
   Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306
   Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168
   Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194
   JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301
   Jones LS, 2004, MOL CELL PROTEOMICS, V3, P746, DOI 10.1074/mcp.R400008-MCP200
   Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221
   Li L, 2003, NUCLEIC ACIDS RES, V31, P3038, DOI 10.1093/nar/gkg434
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Manetti F, 2000, CURR PHARM DESIGN, V6, P1897, DOI 10.2174/1381612003398528
   MARTIN SA, 1986, BIOCHIM BIOPHYS ACTA, V867, P67, DOI 10.1016/0167-4781(86)90030-8
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022
   MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   ONO K, 1988, EUR J BIOCHEM, V172, P349, DOI 10.1111/j.1432-1033.1988.tb13893.x
   Resende BC, 2011, GENE, V482, P1, DOI 10.1016/j.gene.2011.03.008
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   Shaikh SMT, 2007, DYES PIGMENTS, V73, P211, DOI 10.1016/j.dyepig.2005.11.008
   Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wang GK, 2015, COLLOID SURFACE B, V135, P261, DOI 10.1016/j.colsurfb.2015.07.063
   Wang L, 2017, J BIOL CHEM, V292, P5007, DOI 10.1074/jbc.M116.757039
   Wang YS, 2004, MAGN RESON CHEM, V42, P485, DOI 10.1002/mrc.1381
   WASYLEWSKI Z, 1992, EUR J BIOCHEM, V206, P235, DOI 10.1111/j.1432-1033.1992.tb16921.x
   Widlak P, 2006, APOPTOSIS, V11, P1331, DOI 10.1007/s10495-006-6983-0
   Williamson LH, 2001, VET CLIN N AM-FOOD A, V17, P359, DOI 10.1016/S0749-0720(15)30033-5
   Wright PM, 1999, J BIOL CHEM, V274, P29011, DOI 10.1074/jbc.274.41.29011
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
NR 56
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAR 15
PY 2019
VL 125
BP 459
EP 468
DI 10.1016/j.ijbiomac.2018.12.067
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA HK8EK
UT WOS:000458222000049
PM 30529553
DA 2020-12-01
ER

PT J
AU Batista, MN
   Braga, ACS
   Campos, GRF
   Souza, MM
   de Matos, RPA
   Lopes, TZ
   Candido, NM
   Lima, MLD
   Machado, FC
   de Andrade, STQ
   Bittar, C
   Nogueira, ML
   Carneiro, BM
   Mariutti, RB
   Arni, RK
   Calmon, MF
   Rahal, P
AF Batista, Mariana N.
   Braga, Ana Claudia S.
   Fernandes Campos, Guilherme Rodrigues
   Souza, Marcos Michel
   Adum de Matos, Renata Prandini
   Lopes, Tairine Zara
   Candido, Natalia Maria
   Duarte Lima, Maria Leticia
   Machado, Francielly Cristina
   Queiroz de Andrade, Stephane Tereza
   Bittar, Cintia
   Nogueira, Mauricio L.
   Carneiro, Bruno M.
   Mariutti, Ricardo B.
   Arni, Raghuvir Krishnaswamy
   Calmon, Marilia Freitas
   Rahal, Paula
TI Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika
   Virus
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; berberin; emodin; Vero E6 cells
ID POLYGONUM-CUSPIDATUM; ALOE-EMODIN; ANTIVIRAL ACTIVITY; IN-VITRO; ORAL
   BIOAVAILABILITY; BERBERINE CHLORIDE; MAJOR COMPONENT; NANOPARTICLES;
   VIVO; PHARMACOKINETICS
AB Zika virus (ZIKV) has been associated with serious health conditions, and an intense search to discover different ways to prevent and treat ZIKV infection is underway. Berberine and emodin possess several pharmacological properties and have been shown to be particularly effective against the entry and replication of several viruses. We show that emodin and berberine trigger a virucidal effect on ZIKV. When the virus was exposed to 160 mu M of berberine, a reduction of 77.6% in the infectivity was observed; when emodin was used (40 mu M), this reduction was approximately 83.3%. Dynamic light scattering data showed that both compounds significantly reduce the hydrodynamic radius of virus particle in solution. We report here that berberine and emodin, two natural compounds, have strong virucidal effect in Zika virus.
C1 [Batista, Mariana N.; Braga, Ana Claudia S.; Fernandes Campos, Guilherme Rodrigues; Souza, Marcos Michel; Adum de Matos, Renata Prandini; Lopes, Tairine Zara; Candido, Natalia Maria; Duarte Lima, Maria Leticia; Machado, Francielly Cristina; Queiroz de Andrade, Stephane Tereza; Bittar, Cintia; Carneiro, Bruno M.; Calmon, Marilia Freitas; Rahal, Paula] Sao Paulo State Univ, UNESP, Lab Genom Studies, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Nogueira, Mauricio L.] FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Carneiro, Bruno M.] Univ Fed Mato Grosso, Inst Exact & Nat Sci, BR-78060900 Rondonopolis, MG, Brazil.
   [Mariutti, Ricardo B.; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ, UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Calmon, MF (corresponding author), Sao Paulo State Univ, UNESP, Lab Genom Studies, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM batista_m.n@hotmail.com; anabragga@gmail.com;
   guilhermecampos07@gmail.com; marcosmichel@gmail.com;
   renatapram@hotmail.com; tairinezlopes@gmail.com; naty_candido@ig.com.br;
   mle.lima94@gmail.com; francielly.cristinam@gmail.com; teph94@gmail.com;
   cibittar@gmail.com; mnogueira@famerp.br; brunocopo@yahoo.com.br;
   ricardomariutti@yahoo.com.br; arni@ibilce.unesp.br; macal131@gmail.com;
   rahalp@yahoo.com.br
RI Bittar, Cintia/A-5042-2015; Arni, Raghuvir K/B-2222-2013; Calmon,
   Marilia Freitas/H-3150-2012; Candido, Natalia M./H-5703-2013; Carneiro,
   Bruno/P-2415-2019; de Matos, Renata Prandini Adum/O-6766-2019; Nogueira,
   Mauricio L/B-7599-2012; Rahal, Paula/D-3871-2012
OI Bittar, Cintia/0000-0002-2048-4589; Arni, Raghuvir
   K/0000-0003-2460-1145; Calmon, Marilia Freitas/0000-0001-5203-0103;
   Nogueira, Mauricio L/0000-0003-1102-2419; Carneiro,
   Bruno/0000-0002-2355-7907; Rahal, Paula/0000-0001-5693-6148; Rodrigues
   Fernandes Campos, Guilherme/0000-0003-1118-8486; Zara Lopes,
   Tairine/0000-0002-0336-4067
FU Sao Paulo Research Foundation (FAPESP), BrazilFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2014/22198-0]
FX This research was funding by the Sao Paulo Research Foundation (FAPESP),
   Brazil Grant number 2014/22198-0.
CR Ahmed T, 2015, PHARMACOL REP, V67, P970, DOI 10.1016/j.pharep.2015.03.002
   Alam Z, 2015, ANTIVIR RES, V114, P86, DOI 10.1016/j.antiviral.2014.12.003
   Alves DS, 2004, BIOCHEM PHARMACOL, V68, P549, DOI 10.1016/j.bcp.2004.04.012
   Battu SK, 2010, AAPS PHARMSCITECH, V11, P1466, DOI 10.1208/s12249-010-9520-y
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chin LW, 2010, ARCH VIROL, V155, P1933, DOI 10.1007/s00705-010-0779-9
   da Cunha Antonio R, 2017, Biophys Rev, V9, P729, DOI 10.1007/s12551-017-0323-1
   Dang SS, 2009, WORLD J GASTROENTERO, V15, P5669, DOI 10.3748/wjg.15.5669
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong XX, 2016, PHYTOTHER RES, V30, P1207, DOI 10.1002/ptr.5631
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duan HG, 2009, DRUG DEVELOP RES, V70, P363, DOI 10.1002/ddr.20312
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freag MS, 2016, INT J NANOMED, V11, P4799, DOI 10.2147/IJN.S111736
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085
   Hsiang CY, 2008, BRIT J PHARMACOL, V155, P227, DOI 10.1038/bjp.2008.242
   Imenshahidi M, 2016, PHYTOTHER RES, V30, P1745, DOI 10.1002/ptr.5693
   Lee MH, 2011, J AGR FOOD CHEM, V59, P9135, DOI 10.1021/jf201577f
   Li L, 2016, MICROBIOL RES, V186, P139, DOI 10.1016/j.micres.2016.03.008
   Li SW, 2014, EUR J PHARMACOL, V738, P125, DOI 10.1016/j.ejphar.2014.05.028
   Lin CW, 2008, INT J ANTIMICROB AG, V32, P355, DOI 10.1016/j.ijantimicag.2008.04.018
   Liu HY, 2016, PHARM RES-DORDR, V33, P217, DOI 10.1007/s11095-015-1781-4
   Liu Z, 2015, J HUAZHONG U SCI-MED, V35, P916, DOI 10.1007/s11596-015-1528-9
   Liu Z, 2013, MOLECULES, V18, P11842, DOI 10.3390/molecules181011842
   Lu YC, 2006, J CHEM ENG DATA, V51, P642, DOI 10.1021/je0504360
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mischitelli M, 2016, CELL PHYSIOL BIOCHEM, V40, P91, DOI 10.1159/000452527
   Naqvi S, 2010, INDIAN J BIOCHEM BIO, V47, P161
   Pund S, 2014, PHYTOMEDICINE, V21, P307, DOI 10.1016/j.phymed.2013.09.013
   Rad SZK, 2017, IRAN J BASIC MED SCI, V20, P516, DOI 10.22038/IJBMS.2017.8676
   SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x
   Schwarz S, 2011, ANTIVIR RES, V90, P64, DOI 10.1016/j.antiviral.2011.02.008
   Shia CS, 2010, J PHARM SCI-US, V99, P2185, DOI 10.1002/jps.21978
   SYDISKIS RJ, 1991, ANTIMICROB AGENTS CH, V35, P2463, DOI 10.1128/AAC.35.12.2463
   Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683
   Tan XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077969
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wang B, 2015, J MATER CHEM B, V3, P3840, DOI 10.1039/c5tb00065c
   Wang JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498
   Wang TC, 2012, INT J NANOMED, V7, P2325, DOI 10.2147/IJN.S31029
   Wu Y, 2011, CHIN J INTEGR MED, V17, P444, DOI 10.1007/s11655-011-0640-3
   Xiong HR, 2011, J ETHNOPHARMACOL, V133, P718, DOI 10.1016/j.jep.2010.10.059
   Xue M, 2013, INT J NANOMED, V8, P4677, DOI 10.2147/IJN.S51262
   Yang YC, 2003, J AGR FOOD CHEM, V51, P7629, DOI 10.1021/jf034727t
   Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330
   Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013
   Yiu CY, 2014, MOLECULES, V19, P1258, DOI 10.3390/molecules19011258
   Zhu JX, 2013, DRUG DEV IND PHARM, V39, P499, DOI 10.3109/03639045.2012.683875
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 55
TC 11
Z9 12
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JAN
PY 2019
VL 11
IS 1
AR 49
DI 10.3390/v11010049
PG 10
WC Virology
SC Virology
GA HM0IW
UT WOS:000459132000048
PM 30641880
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Eberle, RJ
   Bleffert, N
   Feuerstein, S
   Olivier, DS
   de Moraes, FR
   Willbold, D
   Arni, RK
AF Coronado, Monika Aparecida
   Eberle, Raphael Josef
   Bleffert, Nicole
   Feuerstein, Sophie
   Olivier, Danilo Silva
   de Moraes, Fabio Rogerio
   Willbold, Dieter
   Arni, Raghuvir Krishnaswamy
TI Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a
   lead compound for NS2B/NS3 proteinase inhibition
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; NS2B/NS3 proteinase; Suramin; Inhibitor; Lead compound
ID NS2B-NS3 PROTEASE; DENGUE VIRUS; CRYSTAL-STRUCTURE; BINDING; DYNAMICS;
   LIGAND; NMR; IDENTIFICATION; REPLICATION; PARAMETERS
AB Zika virus infection is the focus of much research due to the medical and social repercussions. Due the role of the viral NS2B/NS3 proteinase in maturation of the viral proteins, it had become an attractive antiviral target. Numerous investigations on viral epidemiology, structure and function analysis, vaccines, and therapeutic drugs have been conducted around the world. At present, no approved vaccine or even drugs have been reported. Thus, there is an urgent need to develop therapeutic agents to cure this epidemic disease. In the present study, we identified the polyanion suramin, an approved antiparasitic drug with antiviral properties, as a potential inhibitor of Zika virus complex NS2B/NS3 proteinase with IC50 of 47 mu M. Using fluorescence spectroscopy results we could determine a k(d) value of 28 mu M and had shown that the ligand does not affect the thermal stability of the protein. STD NMR spectroscopy experiments and molecular docking followed by molecular dynamics simulation identified the binding epitopes of the molecule and shows the mode of interaction, respectively. The computational analysis showed that suramin block the Ser135 residue and interact with the catalytically histidine residue.
C1 [Coronado, Monika Aparecida; Eberle, Raphael Josef; Olivier, Danilo Silva; de Moraes, Fabio Rogerio; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista, UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Bleffert, Nicole; Feuerstein, Sophie; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, Julich, Germany.
   [Bleffert, Nicole; Feuerstein, Sophie; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Univ Str, Dusseldorf, Germany.
RP Coronado, MA; Arni, RK (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas Ibilce, Dept Fis,Ctr Multiusuario Inovacao Biomol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM monikacoronado@gmail.com; arni@sjrp.unesp.br
RI Arni, Raghuvir K/B-2222-2013; de Moraes, Fabio R/B-8331-2017; Olivier,
   Danilo/M-7566-2016; Willbold, Dieter/A-6280-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; de Moraes, Fabio
   R/0000-0002-0425-0352; Olivier, Danilo/0000-0003-1269-3783; Willbold,
   Dieter/0000-0002-0065-7366
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13765-0, 2015/18868-2,
   2016/08104-8, 2016/12904-0, 2009/53989-4]; CAPESCAPES; PROPe UNESP
FX The authors want to thank you Professor Dr. Marcos R. de Mattos Fontes
   for providing access to the fluorescence machine, Prof. Dr. Marcos S. do
   Amaral for providing time on his computer cluster to run MD simulations,
   Dr. Dayane dos Santos Alvarez to support the DSC experiments and Dr.
   Melanie Schwarten. This research was supported by grants from CNPq
   [Grant numbers 435913/2016-6, 401270/2014-9, 307338/2014-2], FAPESP
   [Grant numbers 2015/13765-0, 2015/18868-2, 2016/08104-8; 2016/12904-0;
   2009/53989-4], CAPES and PROPe UNESP.
CR Ahumada M, 2017, ANALYST, V142, P2067, DOI 10.1039/c7an00288b
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Centers for Disease Control and Prevention, 2018, WORLD MAP AR RISK ZI
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Ehrlich P., 1904, BERL KLIN WCHNSCHR, V41, P329
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015
   Frisch D.J.F. M.J., 2009, GAUSSIAN 09 REVISION
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nguyen H, 2013, J CHEM THEORY COMPUT, V9, P2020, DOI 10.1021/ct3010485
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Shaikh SMT, 2007, DYES PIGMENTS, V73, P211, DOI 10.1016/j.dyepig.2005.11.008
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Trott O., 2009, J COMPUT CHEM, V31, pNA461, DOI DOI https://doi.org/10.1002/jcc.21334
   Wang GK, 2015, COLLOID SURFACE B, V135, P261, DOI 10.1016/j.colsurfb.2015.07.063
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   WASYLEWSKI Z, 1992, EUR J BIOCHEM, V206, P235, DOI 10.1111/j.1432-1033.1992.tb16921.x
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 49
TC 8
Z9 8
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD DEC
PY 2018
VL 160
BP 118
EP 125
DI 10.1016/j.antiviral.2018.10.019
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HC6UA
UT WOS:000451936000014
PM 30393012
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Olivier, DD
   Eberle, RJ
   do Amaral, MS
   Arni, RK
AF Coronado, Monika Aparecida
   Olivier, Danilo da Silva
   Eberle, Raphael Josef
   do Amaral, Marcos Serrou
   Arni, Raghuvir Krishnaswamy
TI Modeling and molecular dynamics indicate that snake venom phospholipase
   B-like enzymes are Ntn-hydrolases
SO TOXICON
LA English
DT Review
DE Snake venom phospholipase B; Crotalus adamanteus; Ntn-hydrolase;
   Molecular modeling; Molecular dynamics
ID LIPOLYTIC ACYL-HYDROLASE; CRYSTAL-STRUCTURE; PROTEIN; PREDICTION;
   ACCURACY; ADULT
AB Phospholipase-B-like (SVPLB-like) enzymes are present in relatively small amounts in a number of venoms, however, their biological function and mechanisms of action are un-clear. A three-dimensional model of the SVPLB-like enzyme from Crotalus adamanteus was generated by homology modeling based on the crystal structures of bovine Ntn-hydrolyases and the modeled protein possesses conserved domains characteristic of Ntn-hydrolases. Molecular dynamics simulations indicate that activation by autocatalytic cleavage results in the removal of 25 amino acids which increases accessibility to the active site. SVPLB-like enzymes possess a highly reactive cysteine and are hence amidases that to belong to the N-terminal nucleophile (Ntn) hydrolase family. The Ntn-hydrolases (N-terminal nucleophile) form a superfamily of diverse enzymes that are activated auto catalytically; wherein the N-terminal catalytic nucleophile is implicated in the cleavage of the amide bond.
C1 [Coronado, Monika Aparecida; Olivier, Danilo da Silva; Eberle, Raphael Josef; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista, Dept Phys, Multiuser Ctr Biomol Innovat, UNESP,Ibilce, Sao Jose Do Rio Preto, SP, Brazil.
   [do Amaral, Marcos Serrou] Univ Fed Mato Grosso do Sul, Inst Phys, Campo Grande, MS, Brazil.
RP Coronado, MA (corresponding author), Univ Estadual Paulista, Dept Phys, Multiuser Ctr Biomol Innovat, UNESP,Ibilce, Sao Jose Do Rio Preto, SP, Brazil.; Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias Letras & Ciencias Exatas Ibilce, Dept Fis, Ctr Multiusuario Inovacao Biomol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM monikacoronado@gmail.com; raghuvir.arni@unesp.br
RI Olivier, Danilo/M-7566-2016; Arni, Raghuvir K/B-2222-2013; Serrou do
   Amaral, Marcos/I-6927-2012
OI Olivier, Danilo/0000-0003-1269-3783; Arni, Raghuvir
   K/0000-0003-2460-1145; Serrou do Amaral, Marcos/0000-0001-8101-6933;
   Coronado, Monika/0000-0002-6518-6497
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13765-0, 2015/18868-2,
   2016/08104-8, 2016/12904-0, 2009/53989-4]; FUNDECTFundect
   [23/200.307/2014]; CAPESCAPES; PROPe UNESP
FX This work is supported by grants from CNPq [Grant numbers 435913/2016-6,
   401270/2014-9, 307338/2014-2], FAPESP [Grant numbers 2015/13765-0,
   2015/18868-2, 2016/08104-8; 2016/12904-0; 2009/53989-4], FUNDECT
   [23/200.307/2014], CAPES and PROPe UNESP.
CR ACKERMANN EJ, 1995, BBA-LIPID LIPID MET, V1259, P125, DOI 10.1016/0005-2760(95)00143-Z
   Aird SD, 2017, GENOME BIOL EVOL, V9, P2640, DOI 10.1093/gbe/evx199
   Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790
   Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   BERNHEIMER AW, 1987, TOXICON, V25, P547, DOI 10.1016/0041-0101(87)90290-X
   Bokhove M, 2010, STRUCTURE, V18, P301, DOI 10.1016/j.str.2010.01.005
   BOLL W, 1993, J BIOL CHEM, V268, P12901
   BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0
   Case D.A., 2017, AMBER
   Chatrath ST, 2011, J PROTEOME RES, V10, P739, DOI 10.1021/pr1008916
   Coronado M. A., 2016, SNAKE VENOMS ENVENOM
   Coronado M.A., 2014, VENOM GENOMICS PROTE
   Danpaiboon W, 2014, TOXINS, V6, P1526, DOI 10.3390/toxins6051526
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   DAWSON RMC, 1958, BIOCHEM J, V70, P559, DOI 10.1042/bj0700559
   DOERY HM, 1964, BIOCHEM J, V92, P599, DOI 10.1042/bj0920599
   DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   GALLIARD T, 1971, EUR J BIOCHEM, V21, P90, DOI 10.1111/j.1432-1033.1971.tb01444.x
   Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Kim JK, 2006, P NATL ACAD SCI USA, V103, P1732, DOI 10.1073/pnas.0507862103
   Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0
   Kovalchuk SI, 2016, TOXINS, V8, DOI 10.3390/toxins8040105
   Lakomek K, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-56
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Margres MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-531
   MATSUDA H, 1979, BIOCHIM BIOPHYS ACTA, V573, P155, DOI 10.1016/0005-2760(79)90182-6
   Matsumoto Y, 2013, FEBS J, V280, P3780, DOI 10.1111/febs.12366
   Nauze M, 2002, J BIOL CHEM, V277, P44093, DOI 10.1074/jbc.M205761200
   Ohler M, 2010, J PROTEOME RES, V9, P2422, DOI 10.1021/pr901128x
   Oliveira I. S., 2018, J PROTEOMICS S, V1874-3919, P30066
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pla D, 2018, J PROTEOMICS, V174, P71, DOI 10.1016/j.jprot.2017.12.020
   Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134
   Repo H, 2014, PROTEINS, V82, P300, DOI 10.1002/prot.24388
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008
   Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213
   TAKASAKI C, 1982, BIOCHEM J, V203, P269, DOI 10.1042/bj2030269
   Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110
   WEBB B, 2014, CURR PROTOC BIOINFOR, V47, P5, DOI [DOI 10.1002/0471250953.BI0506S47, 10.1002/0471250953.bi0506s47]
   Wiezel G. A, 2015, TOXICON, V359-368
NR 48
TC 1
Z9 1
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD OCT
PY 2018
VL 153
BP 106
EP 113
DI 10.1016/j.toxicon.2018.08.014
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA GW6ZW
UT WOS:000447114600015
PM 30179630
OA Green Published
DA 2020-12-01
ER

PT J
AU Eberle, RJ
   Kawai, LA
   de Moraes, FR
   Tasic, L
   Arni, RK
   Coronado, MA
AF Eberle, Raphael J.
   Kawai, Liege A.
   de Moraes, Fabio R.
   Tasic, Ljubica
   Arni, Raghuvir K.
   Coronado, Monika A.
TI Biochemical and biophysical characterization of a mycoredoxin protein
   glutaredoxin A1 from Corynebacterium pseudotuberculosis
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Corynebacterium pseudotuberculosis; Glutaredoxin; NMR; CD spectroscopy;
   Inhibitors
ID TRANSFER DIFFERENCE NMR; MYCOBACTERIUM-TUBERCULOSIS; CITRUS FLAVONOIDS;
   CIS-PROLINE; THIOREDOXIN; MYCOTHIOL; THIOL; SPECTROSCOPY; HESPERIDIN;
   MECHANISM
AB Glutaredoxin A1 from Corynebacterium pseudotuberculosis was shown to be a mycoredoxin protein. In this study, we established a process to overexpress and purify glutaredoxin A1. The aim of this study was the investigation of the Glutaredoxin A1 from C pseudotuberculosis behavior under different redox environments and the identification of lead molecules, which can be used for specific inhibitor development for this protein family. A quantitative assay was performed measuring the rate of insulin reduction spectrophotometrically at 640 nm through turbidity formation from the precipitation of the free insulin. Glutaredoxin A1, at 5 mu M concentration, accelerated the reduction process of 0.2 mM insulin and 1 mM DTT. The pH optimum of the reaction was 7.4. In the presence of DTT and ESH the glutaredoxin A1 presents similar activity, and its activity is reduced by 50% in the presence of GSH. Additional function for ESH in the redox metabolism of C. pseudotuberculosis is suggested. A combined STD and Chemical Shift - NMR approach was employed to study the effects of potential inhibitors on the structure of glutaredoxin A1 from Corynebacterium pseudotuberculosis. The inhibitory potential of four ligands (heparin, suramin, hesperetin - Hst, and hesperidin - Hsp) against glutaredoxin A1 is discussed. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Eberle, Raphael J.; Kawai, Liege A.; de Moraes, Fabio R.; Arni, Raghuvir K.; Coronado, Monika A.] UNESP, Ibilce, Dept Phys, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Tasic, Ljubica] Univ Estadual Campinas, Inst Chem, BR-13083970 Campinas, SP, Brazil.
RP Coronado, MA (corresponding author), UNESP, Ibilce, Dept Phys, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM eberleraphael@gmail.com; liegekawai@gmail.com; fabiom@ibilce.unesp.br;
   ljubica@iqm.unicamp.br; arni@sjrp.unesp.br; monikacoronado@gmail.com
RI de Moraes, Fabio R/B-8331-2017; Arni, Raghuvir K/B-2222-2013; Tasic,
   Ljubica/C-3760-2013; Arni, Raghuvir K/N-9338-2018
OI de Moraes, Fabio R/0000-0002-0425-0352; Arni, Raghuvir
   K/0000-0003-2460-1145; Tasic, Ljubica/0000-0003-2930-7332; Arni,
   Raghuvir K/0000-0003-2460-1145; Eberle, Raphael/0000-0002-8763-3884
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [435913/2016-6, 401270/2014-9, 307338/2014-2]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/13765-0, 2015/18868-2,
   2016/08104-8, 2016/12904-0, 2009/53989-4]; CAPESCAPES; PROPe UNESP
FX This research was supported by grants from CNPq [Grant numbers
   435913/2016-6, 401270/2014-9, 307338/2014-2], FAPESP [Grant numbers
   2015/13765-0, 2015/18868-2, 2016/08104-8; 2016/12904-0; 2009/53989-4],
   CAPES and PROPe UNESP.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1
   Angulo J, 2008, CHEMBIOCHEM, V9, P2225, DOI 10.1002/cbic.200800361
   AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568
   Berndt C, 2015, CHEM SCI, V6, P7049, DOI 10.1039/c5sc01501d
   Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x
   Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200
   Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x
   Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Charbonnier JB, 1999, PROTEIN SCI, V8, P96
   Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114
   COMPER WD, 1981, HEPARIN RELATED POLY, V7
   Ding F, 2012, J AGR FOOD CHEM, V60, P7218, DOI 10.1021/jf300424w
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Eswar N., 2007, CURR PROTOC BIOINFOR, V15, P1
   Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333
   Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107
   Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074
   GENGHOF DS, 1970, J BACTERIOL, V103, P475, DOI 10.1128/JB.103.2.475-478.1970
   Grimsley Gerald R, 2004, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0301s33
   HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321
   HOLMGREN A, 1979, J BIOL CHEM, V254, P3672
   Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y
   Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044
   Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7
   KRAUSE G, 1991, J BIOL CHEM, V266, P4056
   Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493
   Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003
   Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007
   Manetti F, 2000, CURR PHARM DESIGN, V6, P1897, DOI 10.2174/1381612003398528
   Manthey JA, 2001, CURR MED CHEM, V8, P135, DOI 10.2174/0929867013373723
   MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X
   Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Nathaniel C, 2003, BIOCHEM J, V372, P241, DOI 10.1042/BJ20021765
   NEWTON GL, 1995, EUR J BIOCHEM, V230, P821
   Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996
   Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n
   Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h
   PATON MW, 1994, AUST VET J, V71, P47, DOI 10.1111/j.1751-0813.1994.tb06152.x
   Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185
   Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661
   Rahlfs S, 2001, J BIOL CHEM, V276, P37133, DOI 10.1074/jbc.M105524200
   Ratnaparkhi A, 2015, J BIOMOL STRUCT DYN, V33, P1866, DOI 10.1080/07391102.2014.975746
   Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002
   Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x
   Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14
   Sreerama N, 2004, METHOD ENZYMOL, V383, P318
   Tasic L, 2016, CITRUS FRUITS
   Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030
   Yu J, 2005, J AGR FOOD CHEM, V53, P2009, DOI 10.1021/jf0484632
NR 55
TC 2
Z9 2
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2018
VL 107
BP 1999
EP 2007
DI 10.1016/j.ijbiomac.2017.10.063
PN B
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA FU7WB
UT WOS:000424062300071
PM 29042280
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Caruso, IP
   Panwalkar, V
   Coronado, MA
   Dingley, AJ
   Cornelio, ML
   Willbold, D
   Arni, RK
   Eberle, RJ
AF Caruso, Icaro P.
   Panwalkar, Vineet
   Coronado, Monika A.
   Dingley, Andrew J.
   Cornelio, Marinonio L.
   Willbold, Dieter
   Arni, Raghuvir K.
   Eberle, Raphael J.
TI Structure and interaction of Corynebacterium pseudotuberculosis cold
   shock protein A with Y-box single-stranded DNA fragment
SO FEBS JOURNAL
LA English
DT Article
DE cold shock protein; Corynebacterium pseudotuberculosis; NMR
   spectroscopy; structure determination; Y-box binding
ID SOLUTION NMR STRUCTURE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS;
   CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; BINDING SURFACE;
   CHEMICAL-SHIFTS; BS-CSPB; IDENTIFICATION; STABILITY
AB Cold shock proteins (Csps) function to preserve cell viability at low temperatures by binding to nucleic acids and consequently control gene expression. The mesophilic bacterium Corynebacterium pseudotuberculosis is the causative agent of caseous lymphadenitis in animals, and infection in livestock is a considerable economic burden worldwide. In this report, the structure of cold shock protein A from Cp (Cp-CspA) and biochemical analysis of its temperature-dependent interaction with a Y-box ssDNA motif is presented. The Cp-CspA structure contains five beta-strands making up a beta-barrel fold with 11 hydrophobic core residues and two salt bridges that confers it with a melting temperature of similar to 54 degrees C that is similar to mesophilic Bs-CspB. Chemical shift perturbations analysis revealed that residues in the nucleic acid-binding motifs (RNP 1 and 2) and loop 3 are involved in binding to the Y-box fragment either by direct interaction or by conformational rearrangements remote from the binding region. Fluorescence quenching experiments of Cp-CspA showed that the dissociation constants for Y-box ssDNA binding is nanomolar and the binding affinity decreased as the temperature increased, indicating that the interaction is enthalpically driven and the hydrogen bonds and van der Waals forces are important contributions for complex stabilization. The Y31 of Cp-CspA is a particular occurrence among Csps from mesophilic bacteria that provide a possible explanation for the higher binding affinity to ssDNA than that observed for Bs-CspB. Anisotropy measurements indicated that the reduction in molecular mobility of Cp-CspA upon Y-box binding is characterized by a cooperative process.
C1 [Caruso, Icaro P.; Coronado, Monika A.; Cornelio, Marinonio L.; Arni, Raghuvir K.; Eberle, Raphael J.] UNESP, IBILCE, Multiuser Ctr Biomol Innovat CMIB, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   [Panwalkar, Vineet; Dingley, Andrew J.; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, Julich, Germany.
   [Panwalkar, Vineet; Dingley, Andrew J.; Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, Univ Str, Dusseldorf, Germany.
RP Arni, RK; Eberle, RJ (corresponding author), UNESP, IBILCE, Multiuser Ctr Biomol Innovat CMIB, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br; eberleraphael@gmail.com
RI Arni, Raghuvir K/B-2222-2013; Cornelio, Marinonio Lopes/AAC-9215-2020;
   Dingley, Andrew/G-6427-2013; Arni, Raghuvir K/N-9338-2018; Panwalkar,
   Vineet/H-9852-2018; Caruso, Icaro/M-8647-2017
OI Arni, Raghuvir K/0000-0003-2460-1145; Dingley,
   Andrew/0000-0002-6838-5803; Arni, Raghuvir K/0000-0003-2460-1145;
   Panwalkar, Vineet/0000-0003-1621-1606; Caruso,
   Icaro/0000-0003-4464-0520; Eberle, Raphael/0000-0002-8763-3884
FU CAPES scholarshipCAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP)
FX The author IPC gratefully acknowledges CAPES scholarship, Science
   without Borders (SwB) from CNPq, financial support received from FAPESP,
   and Prof. Dr. Alexandre Suma de Araujo for the access to the Calix
   cluster for performing the MD simulations (FAPESP 2010/18169-3). The
   authors thank access to the Julich-Dusseldorf Biomolecular NMR Center
   that is jointly run by the Forschungszentrum Julich and Heinrich Heine
   University Dusseldorf, and also NMR laboratory of Multiuser Center for
   Biomolecular Innovation (2009/53989-4) IBILCE/UNESP. The authors also
   thank the PROPe UNESP.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Beckett D, 2011, METHOD ENZYMOL, P1, DOI 10.1016/B978-0-12-381268-1.00001-X
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Bernard A, 2011, PROTEINS, V79, P1525, DOI 10.1002/prot.22980
   Biswas-Fiss EE, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-10
   BRANDI A, 1994, BIOCHIMIE, V76, P1090, DOI 10.1016/0300-9084(94)90035-3
   Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406
   Cooper A., 2000, PROTEIN LIGAND INTER
   Coronado MA, 2017, PROTEIN PEPTIDE LETT, V24, P358, DOI 10.2174/0929866524666170207153808
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164
   Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0
   Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620
   Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4
   Hubbard S, 1993, NACCESS COMPUTER PRO
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jiang WN, 1997, J BIOL CHEM, V272, P196
   Jin B, 2014, BIOCHEM BIOPH RES CO, V451, P402, DOI 10.1016/j.bbrc.2014.07.127
   JONES PG, 1992, J BACTERIOL, V174, P5798, DOI 10.1128/jb.174.18.5798-5802.1992
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kremer W, 2001, EUR J BIOCHEM, V268, P2527, DOI 10.1046/j.1432-1327.2001.02127.x
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907
   Lee J, 2013, BIOCHEMISTRY-US, V52, P2492, DOI 10.1021/bi301641b
   Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279
   Lindae A, 2015, PROTEIN EXPRES PURIF, V112, P15, DOI 10.1016/j.pep.2015.04.006
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299
   Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0
   Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601
   MAKHATADZE GI, 1994, PROTEIN SCI, V3, P2144, DOI 10.1002/pro.5560031127
   Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058
   Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x
   Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Morgan HP, 2009, ACTA CRYSTALLOGR F, V65, P1240, DOI 10.1107/S1744309109033788
   Morgan HP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm040
   Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602
   Nelson D.L., 2013, LEHNINGER PRINCIPLES
   NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114
   NICHOLSON LK, 1992, BIOCHEMISTRY-US, V31, P5253, DOI 10.1021/bi00138a003
   Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   PATON MW, 1994, AUST VET J, V71, P47, DOI 10.1111/j.1751-0813.1994.tb06152.x
   Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185
   Perl D, 2000, NAT STRUCT BIOL, V7, P380
   Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691
   Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119
   SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0
   SCHNUCHEL A, 1993, NATURE, V364, P169, DOI 10.1038/364169a0
   SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x
   SHAW MK, 1967, J BACTERIOL, V94, P157, DOI 10.1128/JB.94.1.157-164.1967
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004
   van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   Zeeb M, 2003, PROTEIN SCI, V12, P112, DOI 10.1110/ps.0219703
   Zeeb M, 2006, NUCLEIC ACIDS RES, V34, P4561, DOI 10.1093/nar/gkl376
NR 72
TC 4
Z9 4
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD JAN
PY 2018
VL 285
IS 2
BP 372
EP 390
DI 10.1111/febs.14350
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FT8QF
UT WOS:000423416700012
PM 29197185
OA Bronze
DA 2020-12-01
ER

PT J
AU Mariutti, RB
   Chaves-Moreira, D
   Vuitika, L
   Caruso, IP
   Coronado, MA
   Azevedo, VA
   Murakami, MT
   Veiga, SS
   Arni, RK
AF Mariutti, Ricardo Barros
   Chaves-Moreira, Daniele
   Vuitika, Larissa
   Caruso, Icaro Putinhon
   Coronado, Monika A.
   Azevedo, Vasco A.
   Murakami, Mario T.
   Veiga, Silvio Sanches
   Arni, Raghuvir K.
TI Bacterial and Arachnid Sphingomyelinases D: Comparison of Biophysical
   and Pathological Activities
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE SPHINGOMYELINASE D; CATALYSIS; HEMOLYSIS; DERMONECROSIS
ID D DERMONECROTIC TOXIN; PHOSPHOLIPASE-D-GENE;
   CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; ARCANOBACTERIUM-HAEMOLYTICUM;
   FUNCTIONAL-CHARACTERIZATION; MEMBRANE PHOSPHOLIPIDS; SPIDER; VENOM;
   CLONING; IDENTIFICATION
AB Sphingomyelinases D have only been identified in arachnid venoms, Corynebacteria, Arcanobacterium, Photobacterium and in the fungi Aspergillus and Coccidioides. The arachnid and bacterial enzymes share very low sequence identity and do not contain the HKD sequence motif characteristic of the phospholipase D superfamily, however, molecular modeling and circular dichroism of SMases D from Loxosceles intermedia and Corynebacterium pseudotuberculosis indicate similar folds. The phospholipase, hemolytic and necrotic activities and mice vessel permeabilities were compared and both enzymes possess the ability to hydrolyze phospholipids and also promote similar pathological reactions in the host suggesting the existence of a common underlying mechanism in tissue disruption. J. Cell. Biochem. 118:2053-2063, 2017. (c) 2016 Wiley Periodicals, Inc.
C1 [Mariutti, Ricardo Barros; Caruso, Icaro Putinhon; Coronado, Monika A.; Arni, Raghuvir K.] UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   [Chaves-Moreira, Daniele; Vuitika, Larissa; Veiga, Silvio Sanches] UFPR, Dept Cell Biol, Curitiba, PR, Brazil.
   [Azevedo, Vasco A.] Univ Fed Minas Gerais, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   [Murakami, Mario T.] LNBio, Brazilian Biosci Natl Lab, Campinas, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
EM arni@unesp.ibilce.br
RI Murakami, Mario T/F-5640-2016; Caruso, Icaro P./M-8647-2017; Vuitika,
   Larissa/L-4664-2016; Azevedo, Vasco A.C/F-4315-2011; Veiga, Silvio
   Sanches/C-2194-2013; Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir
   K/N-9338-2018; Azevedo, Vasco A/B-1556-2019
OI Murakami, Mario T/0000-0002-0405-8010; Caruso, Icaro
   P./0000-0003-4464-0520; Azevedo, Vasco A.C/0000-0002-4775-2280; Veiga,
   Silvio Sanches/0000-0002-9691-1225; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; Azevedo,
   Vasco A/0000-0002-4775-2280; Moreira, Daniele/0000-0001-6562-8817;
   mariutti, ricardo/0000-0001-6720-4655
FU FINEPCiencia Tecnologia e Inovacao (FINEP); CAPES/PNPDCAPES;
   CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); FUNDACAO ARAUCARIAFundacao Araucaria
FX Grant sponsor: FINEP; Grant sponsor: CAPES/PNPD; Grant sponsor: CNPq;
   Grant sponsor: FAPESP; Grant sponsor: FUNDACAO ARAUCARIA.
CR Appel M. H., 2005, ISJ - Invertebrate Survival Journal, V2, P152
   Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007
   Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274
   Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005
   Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D, 2014, VENOM GENOMICS PROTE, P120
   Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811
   CUEVAS WA, 1993, INFECT IMMUN, V61, P4310, DOI 10.1128/IAI.61.10.4310-4316.1993
   da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002
   da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   Dias-Lopes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079240
   Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1
   Fiser A, 2010, METHODS MOL BIOL, V673, P73, DOI 10.1007/978-1-60761-842-3_6
   Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356
   Gertsch WJ, 1967, B AM MUS NAT HIST, V136, P119
   Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023
   Heringdorf DMZ, 2002, BBA-MOL CELL BIOL L, V1582, P178, DOI 10.1016/S1388-1981(02)00154-3
   HODGSON ALM, 1992, INFECT IMMUN, V60, P2900, DOI 10.1128/IAI.60.7.2900-2905.1992
   Hodgson ALM, 1999, VACCINE, V17, P802, DOI 10.1016/S0264-410X(98)00264-3
   HODGSON ALM, 1990, J BACTERIOL, V172, P1256, DOI 10.1128/jb.172.3.1256-1261.1990
   Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011
   Lajoie DM, 2015, TOXICON, V108, P176, DOI 10.1016/j.toxicon.2015.10.008
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   LIPSKY BA, 1982, REV INFECT DIS, V4, P1220
   MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N
   MCNAMARA PJ, 1994, MOL MICROBIOL, V12, P921, DOI 10.1111/j.1365-2958.1994.tb01080.x
   Nairn M.E., 1977, P ANN C AUST VET ASS, P159
   Ospedal KZ, 2002, INT J EXP PATHOL, V83, P287, DOI 10.1046/j.1365-2613.2002.00241.x
   QUINN PJ, 1994, CLIN VET MICROBIOLOG, P648
   Rivas AJ, 2015, INFECT IMMUN, V83, P1246, DOI 10.1128/IAI.02608-14
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Simmons CP, 1998, INFECT IMMUN, V66, P474, DOI 10.1128/IAI.66.2.474-479.1998
   Sistema de informacAo de agravo de notificacoes (SINAN), 2016, CAS AC AR BRAS
   SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079
   Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003
   Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006
   Tarazi YH, 2016, J INFECT DEV COUNTR, V10, P506, DOI 10.3855/jidc.7023
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Vuitika L, 2016, BBA-MOL CELL BIOL L, V1861, P970, DOI 10.1016/j.bbalip.2016.05.009
   Vuitika L, 2013, J CELL BIOCHEM, V114, P2479, DOI 10.1002/jcb.24594
   Ward KE, 2013, J LIPID RES, V54, P636, DOI 10.1194/jlr.M031088
   Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 47
TC 3
Z9 3
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD AUG
PY 2017
VL 118
IS 8
BP 2053
EP 2063
DI 10.1002/jcb.25781
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EX2JR
UT WOS:000403053000013
PM 27808444
DA 2020-12-01
ER

PT J
AU Chaves-Moreira, D
   de Moraes, FR
   Caruso, IP
   Chaim, OM
   Senff-Ribeiro, A
   Ullah, A
   da Silva, LS
   Chahine, J
   Arni, RK
   Veiga, SS
AF Chaves-Moreira, Daniele
   de Moraes, Fabio Rogerio
   Caruso, Icaro Putinhon
   Chaim, Olga Meiri
   Senff-Ribeiro, Andrea
   Ullah, Anwar
   da Silva, Luciane Sussuchi
   Chahine, Jorge
   Arni, Raghuvir K.
   Veiga, Silvio Sanches
TI Potential Implications for Designing Drugs Against the Brown Spider
   Venom Phospholipase-D
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE BROWN SPIDER; LOXOSCELES INTERMEDIA; VENOM PHOSPHOLIPASE-D; RECOMBINANT
   TOXIN; INHIBITOR
ID LOXOSCELES-INTERMEDIA VENOM; DERMONECROTIC TOXIN;
   FUNCTIONAL-CHARACTERIZATION; SPHINGOMYELINASES-D; STRUCTURAL INSIGHTS;
   CATALYTIC MECHANISM; NMR-SPECTROSCOPY; CLONING; LIGAND; IDENTIFICATION
AB Loxoscelism refers to the clinical symptoms that develop after brown spider bites. Brown spider venoms contain several phospholipase-D isoforms, which are the main toxins responsible for both the cutaneous and systemic effects of loxoscelism. Understanding of the phospholipase-D catalytic mechanism is crucial for the development of specific treatment that could reverse the toxic effects caused by the spider bite. Based on enzymatic, biological, structural, and thermodynamic tests, we show some features suitable for designing drugs against loxoscelism. Firstly, through molecular docking andmolecular dynamics predictions, we found three differentmolecules (Suramin, Vu0155056, and Vu0359595) that were able to bind the enzyme's catalytic site and interact with catalytically important residues (His12 or His47) and with the Mg2+ co-factor. The binding promoted a decrease in the recombinant brown spider venom phospholipase-D (LiRecDT1) enzymatic activity. Furthermore, the presence of the inhibitors reduced the hemolytic, dermonecrotic, and inflammatory activities of the venom toxin in biological assays. Altogether, these results indicate the mode of action of three different LiRecDT1 inhibitors, which were able to prevent the venom toxic effects. This strengthen the idea of the importance of designing a specific drug to treat the serious clinical symptoms caused by the brown spider bite, a public health problem in several parts of the world, and until now without specific treatment. (C) 2016 Wiley Periodicals, Inc.
C1 [Chaves-Moreira, Daniele; Chaim, Olga Meiri; Senff-Ribeiro, Andrea; Veiga, Silvio Sanches] Univ Fed Parana, Dept Cell Biol, Curitiba, PR, Brazil.
   [de Moraes, Fabio Rogerio; Caruso, Icaro Putinhon; Ullah, Anwar; da Silva, Luciane Sussuchi; Chahine, Jorge; Arni, Raghuvir K.] Paulista State Univ UNESP, Multiuser Ctr Biomol Innovat, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   [Ullah, Anwar] COMSATS Inst Informat Technol, Dept Biosci, Pk Rd, Islamabad 45550, Pakistan.
RP Veiga, SS (corresponding author), Univ Fed Parana, Dept Cell Biol, Curitiba, PR, Brazil.
EM veigass@ufpr.br
RI Caruso, Icaro P./M-8647-2017; Arni, Raghuvir K/N-9338-2018; Veiga,
   Silvio Sanches/C-2194-2013; Ullah, Anwar/B-1720-2013; Senff-Ribeiro,
   Andrea/D-6246-2018; Senff-Ribeiro, Andrea/K-8745-2019; Arni, Raghuvir
   K/B-2222-2013; de Moraes, Fabio R/B-8331-2017; Chaim, Olga
   Meiri/Y-7559-2019; Sussuchi da Silva, Luciane/A-8833-2019
OI Caruso, Icaro P./0000-0003-4464-0520; Arni, Raghuvir
   K/0000-0003-2460-1145; Veiga, Silvio Sanches/0000-0002-9691-1225; Ullah,
   Anwar/0000-0003-3793-7393; Senff-Ribeiro, Andrea/0000-0002-7967-6307;
   Senff-Ribeiro, Andrea/0000-0002-7967-6307; Arni, Raghuvir
   K/0000-0003-2460-1145; de Moraes, Fabio R/0000-0002-0425-0352; Chaim,
   Olga Meiri/0000-0002-3854-3292; Chahine, Jorge/0000-0002-6474-0337;
   Sussuchi da Silva, Luciane/0000-0002-7470-4655; Moreira,
   Daniele/0000-0001-6562-8817
FU CAPES (TOXINO and PNPD); CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); FUNDAScaO ARAUCaRIA
FX This research was supported by funds from CAPES (TOXINO and PNPD), CNPq,
   FAPESP, and FUNDAScaO ARAUCaRIA. We are also grateful to the Center for
   Scientific Computing (NCC/ Grid UNESP) of the Sao Paulo State University
   (UNESP) and the Production and Research Center of Immunobiological
   (CPPI) of the Parana State Health Secretary (SESA- PR), and especially
   to the veterinarians Bruno Antunes and Dr.Joao Carlos Minozzo, who
   helped us with the animal experiments. We are also grateful to Professor
   Dr. David Mitchell from the Department of Biochemistry, UFPR, for his
   useful contribution on enzymatic kinetics analysis and discussion.
CR Angulo J, 2010, CHEM-EUR J, V16, P7803, DOI 10.1002/chem.200903528
   Appel M. H., 2005, ISJ - Invertebrate Survival Journal, V2, P152
   Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007
   Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x
   Boularot A, 2007, J MED CHEM, V50, P10, DOI 10.1021/jm060910c
   Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005
   Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D, 2014, VENOM GENOMICS PROTE, P1
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   Cooper A., 2000, PROTEIN LIGAND INTER
   Coronado MA, 2015, CURR PROTEIN PEPT SC, V16, P768, DOI 10.2174/1389203716666150505231625
   da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002
   da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   Ganesan R, 2014, BIOCHIM BIOPHYS ACTA, V1851, P261
   Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023
   Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a
   Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028
   Horta CCR, 2013, J INVEST DERMATOL, V133, P1682, DOI 10.1038/jid.2013.40
   Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1
   Janowski PA, 2016, PROTEIN SCI, V25, P87, DOI 10.1002/pro.2713
   Lajoie DM, 2015, J BIOL CHEM, V290, P10994, DOI 10.1074/jbc.M115.636951
   Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w
   Lindae A, 2015, PROTEIN EXPRES PURIF, V112, P15, DOI 10.1016/j.pep.2015.04.006
   Lipparini F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454683
   Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703
   Malaque CMS, 2016, LOXOSCELES LOXOSCE 3, P419
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200
   McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573
   Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058
   Morris GM, 2008, CURR PROTOC BIOINFOR, V14, P1
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312
   Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Peterson ME, 2006, CLIN TECH SMALL AN P, V21, P191, DOI 10.1053/j.ctsap.2006.10.004
   Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573
   Platinick NI, 2013, AM MUSEUM NATURAL HI, V14, P5
   Privalov P L, 1986, Methods Enzymol, V131, P4
   Rusakov AA, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821352
   Scalmani G, 2011, J CHEM PHYS, V134
   Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t
   Senff-Ribeiro A, 2008, BIOTECHNOL ADV, V26, P210, DOI 10.1016/j.biotechadv.2007.12.003
   Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006
   Tsujishita H, 1997, J MED CHEM, V40, P362, DOI 10.1021/jm9606103
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Vieira DS, 2009, BIOORG CHEM, V37, P41, DOI 10.1016/j.bioorg.2009.01.002
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
NR 54
TC 13
Z9 13
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR
PY 2017
VL 118
IS 4
BP 726
EP 738
DI 10.1002/jcb.25678
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EP5LO
UT WOS:000397420300008
PM 27563734
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Caruso, IP
   de Oliveira, VM
   Contessoto, VG
   Leite, VBP
   Kawai, LA
   Arni, RK
   Eberle, RJ
AF Coronado, Monika A.
   Caruso, Icaro P.
   de Oliveira, Vinicius M.
   Contessoto, Vinicius G.
   Leite, Vitor B. P.
   Kawai, Liege A.
   Arni, Raghuvir K.
   Eberle, Raphael J.
TI Cold Shock Protein A from Corynebacterium pseudotuberculosis: Role of
   Electrostatic Forces in the Stability of the Secondary Structure
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Cold shock protein; C. pseudotuberculosis; ion binding; histidine; pH;
   secondary structure
ID SINGLE-STRANDED-DNA; SOLUTION NMR STRUCTURE; PH MOLECULAR-DYNAMICS;
   ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CONSTANT-PH; BACILLUS-SUBTILIS;
   CSPA; BINDING; IDENTIFICATION
AB The conformational stability of the Cold shock protein A (CspA) from C. pseudotuberculosis (Cp), a nucleic acid binding protein in function of pH and salt concentration was examined by using differential scanning calorimetry and CD spectroscopy in combination with computational analysis to identify the specify amino acids undergoing change. Our approach identified a sodiumbinding site in CpCspA and at pH 8.0 a significant reduction in the beta-sheet content was observed which resulted in a decrease of the protein thermal stability. The computational analyses identified His30 and His65 as the amino acids with the largest charge shifts at different pHs. His30/His65 are part of the extensive hydrogen bonding network and along with the ion-binding site are essential for the conformational stability of CspA.
C1 [Coronado, Monika A.; Kawai, Liege A.; Arni, Raghuvir K.; Eberle, Raphael J.] Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Coronado, Monika A.; Caruso, Icaro P.; de Oliveira, Vinicius M.; Contessoto, Vinicius G.; Leite, Vitor B. P.; Kawai, Liege A.; Arni, Raghuvir K.; Eberle, Raphael J.] Univ Estadual Paulista UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Eberle, RJ (corresponding author), Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM eberleraphael@gmail.co
RI Arni, Raghuvir K/N-9338-2018; Caruso, Icaro P./M-8647-2017; Arni,
   Raghuvir K/B-2222-2013; Contessoto, Vinicius/K-7960-2019; Martins de
   Oliveira, Vinicius/T-2407-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Caruso, Icaro
   P./0000-0003-4464-0520; Arni, Raghuvir K/0000-0003-2460-1145;
   Contessoto, Vinicius/0000-0002-1891-9563; Martins de Oliveira,
   Vinicius/0000-0003-0927-3825; Eberle, Raphael/0000-0002-8763-3884
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [442352/2014-0, 2532/002/14-PROPe/CDC]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); CAPESCAPES; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/08104-8,
   2014/06862-7]
FX This research was supported by grants from the CNPq (Science without
   Frontiers), FAPESP and CAPES. The authors want to thanks the PROPe
   UNESP. The authors would like to thank Sidney Jurado de Carvalho and
   Leandro Cristante de Oliveira for the helpful discussions. RJE is funded
   by FAPESP (2016/08104-8), VBPL was funded by FAPESP (2014/06862-7) and
   CNPq (Grants 442352/2014-0, 2532/002/14-PROPe/CDC). We also thank the
   Center of Scientific Computing (NCC/GridUNESP) of Sao Paulo State
   University (UNESP) for computational resources.
CR ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337
   AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3
   Baptista AM, 2002, J CHEM PHYS, V117, P4184, DOI 10.1063/1.1497164
   BRANDI A, 1994, BIOCHIMIE, V76, P1090, DOI 10.1016/0300-9084(94)90035-3
   Cavicchioli R, 2000, EXTREMOPHILES, V4, P321, DOI 10.1007/s007920070001
   CHATTERJEE S, 1993, J BIOCHEM, V114, P663, DOI 10.1093/oxfordjournals.jbchem.a124234
   Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693
   Contessoto VG, 2016, J CHEM THEORY COMPUT, V12, P3270, DOI 10.1021/acs.jctc.6b00399
   Contessoto VG, 2013, PROTEINS, V81, P1727, DOI 10.1002/prot.24309
   Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137
   D'Auria G, 2010, BIOCHEM BIOPH RES CO, V402, P693, DOI 10.1016/j.bbrc.2010.10.086
   de Mendonca MR, 2014, PROTEINS, V82, P119, DOI 10.1002/prot.24381
   Dominy BN, 2002, J MOL BIOL, V319, P541, DOI 10.1016/S0022-2836(02)00259-0
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Fersht A, 1984, ENZYME STRUCTURE MEC
   Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211
   Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620
   Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4
   Huang L, 2012, PROTEIN SCI, V21, P677, DOI 10.1002/pro.2053
   Jiang WN, 1997, J BIOL CHEM, V272, P196
   Jin B, 2014, BIOCHEM BIOPH RES CO, V451, P402, DOI 10.1016/j.bbrc.2014.07.127
   JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987
   JONES PG, 1992, J BACTERIOL, V174, P5798, DOI 10.1128/jb.174.18.5798-5802.1992
   KARSHIKOV AD, 1989, EUR BIOPHYS J BIOPHY, V17, P287
   Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037
   Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930
   Kremer W, 2001, EUR J BIOCHEM, V268, P2527, DOI 10.1046/j.1432-1327.2001.02127.x
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085
   LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907
   Lindae A, 2015, PROTEIN EXPRES PURIF, V112, P15, DOI 10.1016/j.pep.2015.04.006
   Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0
   Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601
   MAKHATADZE GI, 1994, PROTEIN SCI, V3, P2144, DOI 10.1002/pro.5560031127
   Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139
   Morgan HP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm040
   Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602
   NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114
   PATON MW, 1994, AUST VET J, V71, P47, DOI 10.1111/j.1751-0813.1994.tb06152.x
   Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185
   Perl D, 2000, NAT STRUCT BIOL, V7, P380
   Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229
   Record MT, 1998, ADV PROTEIN CHEM, V51, P281
   Sanchez-Ruiz JM, 2007, BIOPHYS CHEM, V126, P43, DOI 10.1016/j.bpc.2006.05.021
   SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119
   SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0
   Schindler T, 1998, PROTEINS, V30, P401, DOI 10.1002/(SICI)1097-0134(19980301)30:4<401::AID-PROT7>3.0.CO;2-L
   SCHNUCHEL A, 1993, NATURE, V364, P169, DOI 10.1038/364169a0
   SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x
   Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327
   Sreerama N, 2004, METHOD ENZYMOL, V383, P318
   STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.physchem.38.1.463
   Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806
   Tzul FO, 2015, P NATL ACAD SCI USA, V112, pE259, DOI 10.1073/pnas.1410424112
   Ullner M, 1996, J CHEM PHYS, V105, P2056, DOI 10.1063/1.472046
   VONHIPPEL PH, 1964, SCIENCE, V145, P577, DOI 10.1126/science.145.3632.577
   Wassenberg D, 1999, J MOL BIOL, V289, P187, DOI 10.1006/jmbi.1999.2772
   Webb B., 2006, CURR PROTOC BIOINFOR, V15, DOI DOI 10.1002/0471250953.BI0506S15
   Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193
   Zhao L, 2015, INT J MOL SCI, V16, P8454, DOI 10.3390/ijms16048454
NR 63
TC 9
Z9 10
U1 2
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PY 2017
VL 24
IS 4
BP 358
EP 367
DI 10.2174/0929866524666170207153808
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU8EX
UT WOS:000401271400011
PM 28176661
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Hildebrand, D
   Simas, R
   Coronado, MA
   Kwiatkowski, M
   Schluter, H
   Arni, R
   Spencer, P
   Betzel, C
AF Georgieva, Dessislava
   Hildebrand, Diana
   Simas, Rodrigo
   Coronado, Monika A.
   Kwiatkowski, Marcel
   Schlueter, Hartmut
   Arni, Raghuvir
   Spencer, Patrick
   Betzel, Christian
TI Protein Profile Analysis of Two Australian Snake Venoms by
   OneDimensional Gel Electrophoresis and MS/MS Experiments
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Article
DE Proteome; Snake venom; Pseudechis butleri; Pseudechis colletti; protein
   profile analysis.
ID PSEUDECHIS SPP. VENOMS; PHYLOGENETIC ANALYSIS; TOXIN SEQUENCES; COLLETTS
   SNAKE; BLACK; METALLOPROTEINASE; EVOLUTION; ANTIVENOMS; EFFICACY;
   NEUROTOXIN
AB The Pseudechis colletti and Pseudechis butleri venoms were analyzed by 1-D gel electrophoresis, followed by mass spectrometric analysis of tryptic peptides obtained from the protein bands. Both venoms contain highly potent pharmacologically active components, which were assigned to the following protein families: basic and acidic phospholipases A(2) (PLA(2)s), L-amino acid oxidases (LAAOs), P-III metalloproteinases (P-III SVMPs), 5'nucleotidases (5'-NTDs), cysteine-rich secretory proteins (CRISPs), venom nerve growth factors (VNGFs) and post-synaptic neurotoxins. Considerable predominance of PLA(2)s over other toxins is a characteristic feature of both venoms. The major differences in the venom compositions are the higher concentration of SVMPs and CRISPs in the P. butleri venom, as well as the presence of post-synaptic neurotoxins. Furthermore, the analysis revealed a high concentration of proteins with myotoxic, coagulopathic and apoptotic activities. PLA(2)s are responsible for the myotoxic and anticoagulant effects observed in patients after envenomation (4). The other protein families, encountered in the two venoms, probably contribute to the major symptoms described for these venoms. These results explain the observed clinical effects of the black snake envenomation. The analyzed venoms contain group P-III metalloproteinases of medical importance with the potency to be used for diagnostic purposes of von Willebrand factor (vWF) disease, for regulation of vWF in thrombosis and haemostasis, for studying the function of the complement system in host defense and in the pathogenesis of diseases. Comparison of venomic data showed similarities in the major venom components of snakes from the genus Pseudechis, resulting in common clinical effects of envenomation, and demonstrating close relationships between venom toxins of Elapidae snakes.
C1 [Georgieva, Dessislava; Simas, Rodrigo; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Build 22a,Notkestr 85, D-22603 Hamburg, Germany.
   [Hildebrand, Diana; Kwiatkowski, Marcel; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf UKE, Inst Clin Chem, Martinistr 52, D-20246 Hamburg, Germany.
   [Simas, Rodrigo] Univ Fed Parana, Rua 15 Novembro,1299, BR-80060000 Curitiba, Parana, Brazil.
   [Coronado, Monika A.; Arni, Raghuvir] IBILCE UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, R Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Spencer, Patrick] Inst Pesquisas Energet & Nucl, Ctr Biotechnol, Ave Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Build 22a,Notkestr 85, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Betzel, Christian/G-8105-2018; Kwiatkowski, Marcel/M-3384-2016; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013
OI Betzel, Christian/0000-0002-3879-5019; Kwiatkowski,
   Marcel/0000-0002-5804-6031; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Spencer, Patrick/0000-0001-8949-7735;
   Simas, Rodrigo/0000-0003-0682-2446
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; FAPESP/CNPq/CAPESNational Council for Scientific and
   Technological Development (CNPq)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP)CAPES; PROBRAL; Alexander von Humboldt
   FoundationAlexander von Humboldt Foundation [3.3-BUL/1073481 STP]
FX This research was financed by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1, 26-1) and
   FAPESP/CNPq/CAPES, PROBRAL. Dessislava Georgieva thanks the Alexander
   von Humboldt Foundation for grant 3.3-BUL/1073481 STP. The authors thank
   the venom suppliers in Australia for kindly providing the venom samples.
CR BERNHEIMER AW, 1987, TOXICON, V25, P547, DOI 10.1016/0041-0101(87)90290-X
   Betzel C, 1999, CELL MOL LIFE SCI, V56, P384, DOI 10.1007/s000180050440
   Calvete JJ, 2009, J PROTEOMICS, V72, P227, DOI 10.1016/j.jprot.2009.01.005
   Calvete JJ, 2009, J PROTEOMICS, V72, P121, DOI 10.1016/j.jprot.2009.01.018
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Earl STH, 2012, TOXICON, V59, P456, DOI 10.1016/j.toxicon.2010.12.010
   FAURE G, 1991, BIOCHEMISTRY-US, V30, P8074, DOI 10.1021/bi00246a028
   Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1
   Georgieva D, 2011, J PROTEOME RES, V10, P2440, DOI 10.1021/pr101248e
   Georgieva D, 2010, J PROTEOME RES, V9, P2302, DOI 10.1021/pr901042p
   Guan HH, 2010, J STRUCT BIOL, V169, P294, DOI 10.1016/j.jsb.2009.11.009
   Gutierrez J. M., 2014, J PROTEOMICS, DOI [10.1016/j.prot.2014.02.021, DOI 10.1016/J.PROT.2014.02.021]
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008
   Hart A, 2008, TOXICON, V52, P647, DOI 10.1016/j.toxicon.2008.07.013
   Hart AJ, 2013, TOXICOL LETT, V219, P262, DOI 10.1016/j.toxlet.2013.03.026
   Hart AJ, 2013, TOXICON, V63, P112, DOI 10.1016/j.toxicon.2012.12.002
   Hart AJ, 2011, MUSCLE NERVE, V43, P552, DOI 10.1002/mus.21916
   Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003
   Ito M, 2001, BIOCHEMISTRY-US, V40, P4503, DOI 10.1021/bi0022700
   Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   Kuch U, 2005, NATURWISSENSCHAFTEN, V92, P121, DOI 10.1007/s00114-004-0602-0
   Kumar JR, 2008, BIOCHIMIE, V90, P1545, DOI 10.1016/j.biochi.2008.05.018
   Kuruppu S, 2005, BIOCHEM PHARMACOL, V70, P794, DOI 10.1016/j.bcp.2005.06.003
   Lane J, 2011, TOXICON, V58, P239, DOI 10.1016/j.toxicon.2011.05.020
   Gutierrez JM, 2013, TOXICON, V62, P27, DOI 10.1016/j.toxicon.2012.09.006
   Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023
   MEBS D, 1980, EXPERIENTIA, V36, P868, DOI 10.1007/BF01978620
   OKEEFE MC, 1988, J BIOL CHEM, V263, P12690
   Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204
   Pia D., 2017, J PROTEOMICS, V150, P201
   Ramasamy S, 2005, CLIN EXP PHARMACOL P, V32, P7, DOI 10.1111/j.1440-1681.2005.04151.x
   Ramasamy S, 2004, TOXICON, V44, P837, DOI 10.1016/j.toxicon.2004.08.005
   Sun QY, 2010, TOXICON, V56, P1459, DOI 10.1016/j.toxicon.2010.08.013
   Trummal K, 2011, TOXICON, V58, P363, DOI 10.1016/j.toxicon.2011.07.005
   Vogel CW, 2010, TOXICON, V56, P1198, DOI 10.1016/j.toxicon.2010.04.007
   Wuster W, 2005, MOL PHYLOGENET EVOL, V34, P1, DOI 10.1016/j.ympev.2004.08.018
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
NR 43
TC 1
Z9 1
U1 1
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2017
VL 24
IS 17
BP 1892
EP 1908
DI 10.2174/0929867324666170601073148
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA EZ8ST
UT WOS:000404998700012
PM 28571558
DA 2020-12-01
ER

PT J
AU Bhat, SK
   Joshi, MB
   Ullah, A
   Masood, R
   Biligiri, SG
   Arni, RK
   Satyamoorthy, K
AF Bhat, Shreesha K.
   Joshi, Manjunath B.
   Ullah, Anwar
   Masood, Rehana
   Biligiri, Setlur G.
   Arni, Raghuvir K.
   Satyamoorthy, Kapaettu
TI Serine proteinases from Bothrops snake venom activates PI3K/Akt mediated
   angiogenesis
SO TOXICON
LA English
DT Article
DE Serine proteinases; Bothrops; Venom; Blood coagulation; Angiogenesis;
   Therapeutic applications
ID THROMBIN-LIKE ENZYME; ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION;
   IN-VITRO; PROTEASE; PURIFICATION; ALTERNATUS; INTEGRIN; SEQUENCE;
   PEPTIDE
AB The discovery of rapid acting and powerful angiogenic proteins are of significant interest in the treatment of various human disorders associated with insufficient angiogenesis such as ischemia, menorrhagia and delayed wound healing. Snake venoms consist of a mixture of bioactive proteins and polypeptides and are rich sources of pharmacologically important molecules. Serine proteinases are one of the abundant proteins present in Bothrops snake venoms and possess multiple biological functions including the regulation of the blood coagulation cascade. In this study, serine proteinases from Bothrops atrox (B. atrox) and Bothrops brazili (B. brazili) that modulate angiogenesis were purified and characterized. Molecular size exclusion chromatography, affinity chromatography followed by ion exchange chromatography of the serine proteinases indicated molecular masses of around 32 kDa. Serine proteinases from both the species exhibited diverse catalytic activities such as the ability to induce amidolytic, fibrino-genolytic, gelatinolytic activities and also coagulated plasma with a minimal coagulation concentration of 2.4 mu g/mL. Serine proteinases facilitated the sprouting of human umbilical vein endothelial cells (HUVEC) in three-dimensional culture systems and induced tubule formation in monolayer culture systems. Serine proteinase stimulated Akt(ser473) and eNOS(ser1177) phosphorylation in endothelial cells and addition of PI3K inhibitor LY294002 abrogated the effects of serine proteinases on sprout formation of endothelial cells in 3D collagen gels, suggesting that serine proteinase facilitated angiogenesis was mediated by PI3K/eNOS signaling axis. We also show in agarose plug assays using a mouse model, serine proteinases from Bothrops venoms significantly enhanced neovascularization. Our data suggests pro-angiogenic activity by the serine proteinases from B. atrox and B. brazili venom and further studies are warranted to explore the therapeutic applications. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Bhat, Shreesha K.; Joshi, Manjunath B.; Satyamoorthy, Kapaettu] Manipal Univ, Sch Life Sci, Manipal 576104, Karnataka, India.
   [Ullah, Anwar; Masood, Rehana; Arni, Raghuvir K.] IBILCE UNESP, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Biligiri, Setlur G.] Jagadale Ind, Juggat Pharma, Bangalore, Karnataka, India.
RP Satyamoorthy, K (corresponding author), Manipal Univ, Sch Life Sci, Manipal 576104, Karnataka, India.
EM ksatyamoorthy@manipal.edu
RI Ullah, Anwar/B-1720-2013; Joshi, Manjunath B/G-2052-2012; Arni, Raghuvir
   K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145;
   Arni, Raghuvir K/0000-0003-2460-1145; Joshi,
   Manjunath/0000-0002-1310-5480
FU Department of Biotechnology, Government of IndiaDepartment of
   Biotechnology (DBT) India [DBT/In-Bz/2013-16/08]; CAPES Toxinologia
   [1214/2011]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/13765-0]; MCTI/CNPq/DBT [401388/2013-1]
FX The project was funded by Department of Biotechnology, Government of
   India under Indo-Brazil joint call for proposal (DBT/In-Bz/2013-16/08)
   and by grants from CAPES Toxinologia 1214/2011, FAPESP 2015/13765-0,
   MCTI/CNPq/DBT 401388/2013-1. The authors thank Mrs. Veena, Ms. Shobha,
   Mr. Gangadhar and Mr. Manoj for technical assistance.
CR Bazaa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010124
   Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007
   Patino AC, 2013, TOXICON, V63, P32, DOI 10.1016/j.toxicon.2012.11.010
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x
   Chung CH, 2004, BLOOD, V103, P2105, DOI 10.1182/blood-2003-07-2483
   Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4
   Costa JD, 2010, TOXICON, V55, P1365, DOI 10.1016/j.toxicon.2010.02.014
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   de Oliveira LMF, 2013, TOXICON, V76, P282, DOI 10.1016/j.toxicon.2013.10.016
   Folkman J, 1984, BIOL ENDOTHELIAL CEL, P412
   Ghorbanpur M, 2009, J VENOM ANIM TOXINS, V15, P411, DOI 10.1590/S1678-91992009000300005
   GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211
   Halfon S., 1998, HDB PROTEOLYTIC ENZY, P12
   Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003
   Liu SQ, 2008, TOXICON, V52, P760, DOI 10.1016/j.toxicon.2008.08.012
   Lu QM, 2000, TOXICON, V38, P1225, DOI 10.1016/S0041-0101(99)00222-6
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   McDiarmid RW, 1999, SNAKE SPECIES WORLD, V1, P511
   Menaldo DL, 2012, BIOCHIMIE, V94, P2545, DOI 10.1016/j.biochi.2012.07.007
   Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200
   Mukherjee AK, 2013, BBA-GEN SUBJECTS, V1830, P3476, DOI 10.1016/j.bbagen.2013.02.007
   Noel A, 2004, J CLIN PATHOL, V57, P577, DOI 10.1136/jcp.2003.014472
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622
   Perez AV, 2008, BRAZ J MED BIOL RES, V41, P12, DOI 10.1590/S0100-879X2006005000189
   Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08
   Ponce-Soto LA, 2007, PROTEIN J, V26, P387, DOI 10.1007/s10930-007-9078-z
   Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507
   Ramos OHP, 2007, ARCH BIOCHEM BIOPHYS, V461, P1, DOI 10.1016/j.abb.2007.02.021
   Ribatti D, 2011, INT J DEV BIOL, V55, P343, DOI 10.1387/ijdb.103211dr
   Said SS, 2013, J VASC RES, V50, P35, DOI 10.1159/000345108
   Sant' Ana C.D., 2008, COMP BIOCH PHYSL A, V151, P443
   SERRANO SMT, 1993, TOXICON, V31, P471, DOI 10.1016/0041-0101(93)90182-I
   Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020
   Serrano SMT, 2013, TOXICON, V62, P19, DOI 10.1016/j.toxicon.2012.09.003
   Sheu JR, 1997, BBA-GEN SUBJECTS, V1336, P445, DOI 10.1016/S0304-4165(97)00057-3
   Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002
   Stocker K., 1976, Methods Enzymol, V45, P214
   Tan NH, 2010, COMP BIOCHEM PHYS C, V151, P131, DOI 10.1016/j.cbpc.2009.09.002
   Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200
   THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949
   Tsopanoglou NE, 2004, SEMIN THROMB HEMOST, V30, P63
   Vaiyapuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009687
   van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17
   Vieira DF, 2004, ACTA BIOCH BIOPH SIN, V36, P798, DOI 10.1093/abbs/36.12.798
   Vyas Vivek Kumar, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P156, DOI 10.1016/S2221-1691(13)60042-8
   Weijers E.M., 2013, ANGIOGENESIS VASCULA, P85
   Yip HK, 2013, INT J CARDIOL, V168, P226, DOI 10.1016/j.ijcard.2012.09.090
   Zaqueo KD, 2016, COMP BIOCHEM PHYS A, V195, P15, DOI 10.1016/j.cbpa.2016.01.021
   Zaqueo KD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/595186
NR 52
TC 12
Z9 13
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 15
PY 2016
VL 124
BP 63
EP 72
DI 10.1016/j.toxicon.2016.11.001
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA EF7OJ
UT WOS:000390518600008
PM 27816537
OA Green Published
DA 2020-12-01
ER

PT J
AU Vuitika, L
   Chaves-Moreira, D
   Caruso, I
   Lima, MA
   Matsubara, FH
   Murakami, MT
   Takahashi, HK
   Toledo, MS
   Coronado, MA
   Nader, HB
   Senff-Ribeiro, A
   Chaim, OM
   Arni, RK
   Veiga, SS
AF Vuitika, L.
   Chaves-Moreira, D.
   Caruso, I.
   Lima, M. A.
   Matsubara, F. H.
   Murakami, M. T.
   Takahashi, H. K.
   Toledo, M. S.
   Coronado, M. A.
   Nader, H. B.
   Senff-Ribeiro, A.
   Chaim, O. M.
   Arni, R. K.
   Veiga, S. S.
TI Active site mapping of Loxosceles phospholipases D: Biochemical and
   biological features
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE Brown spider venom; Phospholipase D; Site-directed mutagenesis; Activity
   modulation
ID BROWN SPIDER VENOM; D DERMONECROTIC TOXIN; FUNCTIONAL-CHARACTERIZATION;
   SPHINGOMYELINASES-D; INTERMEDIA VENOM; HETEROLOGOUS EXPRESSION;
   MOLECULAR-CLONING; MEMBRANE PHOSPHOLIPIDS; CATALYTIC MECHANISM; D
   ISOFORMS
AB Brown spider phospholipases D from Loxosceles venoms are among the most widely studied toxins since they induce dermonecrosis, triggering inflammatory responses, increase vascular permeability, cause hemolysis, and renal failure. The catalytic (H12 and H47) and metal-ion binding (E32 and D34) residues in Loxosceles intermedia phospholipase D (LiRecDT1) were mutated to understand their roles in the observed activities. All mutants were identified using whole venom serum antibodies and a specific antibody to wild-type LiRecDT1, they were also analyzed by circular dichroism (CD) and differential scanning calorimetry (DSC). The phospholipase D activities of H12A, H47A, H12A-H47A, E32, D34 and E32A-D34A, such as vascular permeability, dermonecrosis, and hemolytic effects were inhibited. The mutant Y228A was equally detrimental to biochemical and biological effects of phospholipase D, suggesting an essential role of this residue in substrate recognition and binding. On the other hand, the mutant C53A-C201A reduced the enzyme's ability to hydrolyze phospholipids and promote dermonecrosis, hemolytic, and vascular effects. These results provide the basis understanding the importance of specific residues in the observed activities and contribute to the design of synthetic and specific inhibitors for Brown spider venom phospholipases D. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Vuitika, L.; Chaves-Moreira, D.; Matsubara, F. H.; Senff-Ribeiro, A.; Chaim, O. M.; Veiga, S. S.] Fed Univ Parana UFPR, Dept Cell Biol, Curitiba, Parana, Brazil.
   [Caruso, I.; Coronado, M. A.; Arni, R. K.] Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Lima, M. A.; Takahashi, H. K.; Toledo, M. S.; Nader, H. B.] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Sao Paulo, SP, Brazil.
   [Murakami, M. T.] Natl Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
RP Veiga, SS (corresponding author), Univ Fed Parana, Dept Cell Biol, BR-81531990 Curitiba, Parana, Brazil.
EM veigass@ufpr.br
RI Chaim, Olga/H-5179-2012; Murakami, Mario T/F-5640-2016; Chaim, Olga
   Meiri/Y-7559-2019; Vuitika, Larissa/L-4664-2016; Senff-Ribeiro,
   Andrea/D-6246-2018; Caruso, Icaro/M-8647-2017; Arni,
   Raghuvir/N-9338-2018
OI Chaim, Olga/0000-0002-3854-3292; Murakami, Mario T/0000-0002-0405-8010;
   Chaim, Olga Meiri/0000-0002-3854-3292; NADER,
   HELENA/0000-0002-7569-2166; Senff-Ribeiro, Andrea/0000-0002-7967-6307;
   Toledo, Marcos/0000-0002-6605-0874; Caruso, Icaro/0000-0003-4464-0520;
   Moreira, Daniele/0000-0001-6562-8817; Arni, Raghuvir/0000-0003-2460-1145
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); FA-PR; SETI-PR
FX The present study was supported by grants from CAPES, CNPq, FAPESP,
   FA-PR, and SETI-PR. We are also grateful to Veterinarians Bruno Antunes,
   BVSc, and Joao Carlos Minozzo, PhD, from the Production and Research
   Center of Immunobiology (CPPI) of the Parana State Health Secretary
   (SESA-PR) for their help during dermonecrosis experiments.
CR Adamek DH, 2005, J MOL BIOL, V346, P307, DOI 10.1016/j.jmb.2004.11.046
   Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007
   Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399
   Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D., 2014, BROWN SPIDER VENOM I, P1
   Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   Chen X, 2012, GENE, V495, P170, DOI [10.1016/j.gene.2011.12.051, 10.1016/j.biocel.2011.10.013]
   Coronado MA, 2015, CURR PROTEIN PEPT SC
   da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363
   da Silveira RB, 2007, TOXICON, V49, P758, DOI 10.1016/j.toxicon.2006.11.024
   da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002
   da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008
   de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   Dias-Lopes C, 2014, VACCINE, V32, P2086, DOI 10.1016/j.vaccine.2014.02.012
   Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4
   Ferrer VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002206
   Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023
   Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a
   Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028
   Kalapothakis E, 2007, TOXICON, V50, P938, DOI 10.1016/j.toxicon.2007.07.001
   Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011
   Lajoie DM, 2015, J BIOL CHEM, V290, P10994, DOI 10.1074/jbc.M115.636951
   Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Lindae A, 2015, PROTEIN EXPRES PURIF, V112, P15, DOI 10.1016/j.pep.2015.04.006
   Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188
   Luciano MN, 2004, J HISTOCHEM CYTOCHEM, V52, P455, DOI 10.1177/002215540405200404
   Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002
   Matsubara FH, 2013, TOXICON, V71, P147, DOI 10.1016/j.toxicon.2013.05.014
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Paludo KS, 2006, TOXICON, V47, P844, DOI 10.1016/j.toxicon.2006.02.006
   Paludo KS, 2009, COMP BIOCHEM PHYS C, V149, P323, DOI 10.1016/j.cbpc.2008.08.009
   Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013
   Ribeiro ROS, 2007, TOXICON, V50, P1162, DOI 10.1016/j.toxicon.2007.08.001
   Scott Shaun P, 2002, Hum Mutat, V20, P323, DOI 10.1002/humu.9068
   SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0
   Such DR, 2015, TOXICON, V108, P154, DOI 10.1016/j.toxicon.2015.09.041
   Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006
   Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003
   Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Vuitika L, 2013, J CELL BIOCHEM, V114, P2479, DOI 10.1002/jcb.24594
   Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375
   Zobel-Thropp PA, 2010, TOXICON, V55, P1274, DOI 10.1016/j.toxicon.2010.01.019
NR 52
TC 13
Z9 13
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 0006-3002
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD SEP
PY 2016
VL 1861
IS 9
BP 970
EP 979
DI 10.1016/j.bbalip.2016.05.009
PN A
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DT5OY
UT WOS:000381533700002
PM 27233517
DA 2020-12-01
ER

PT J
AU Mariutti, RB
   Ullah, A
   Araujo, GC
   Murakami, MT
   Arni, RK
AF Mariutti, Ricardo Barros
   Ullah, Anwar
   Araujo, Gabriela Campos
   Murakami, Mario Tyago
   Arni, Raghuvir Krishnaswamy
TI Tyrosine binding and promiscuity in the arginine repressor from the
   pathogenic bacterium Corynebacterium pseudotuberculosis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Arginine repressor; Corynebacterium pseudotuberculosis; Crystal
   structure; Promiscuity; Tyrosine
ID C-TERMINAL DOMAIN; ESCHERICHIA-COLI; CLAVULANIC ACID;
   STREPTOMYCES-CLAVULIGERUS; MYCOBACTERIUM-TUBERCULOSIS;
   BACILLUS-STEAROTHERMOPHILUS; ARGR GENE; BIOSYNTHESIS; PROTEINS;
   ORNITHINE
AB The arginine repressor (ArgR) regulates arginine biosynthesis in a number of microorganisms and consists of two domains interlinked by a short peptide; the N-terminal domain is involved in DNA binding and the C-terminal domain binds arginine and forms a hexamer made-up of a dimer of trimers. The crystal structure of the C-terminal domain of ArgR from the pathogenic Corynebacterium pseudo tuberculosis determined at 1.9 angstrom resolution contains a tightly bound tyrosine at the arginine-binding site indicating hitherto unobserved promiscuity. Structural analysis of the binding pocket displays clear molecular adaptations to accommodate tyrosine binding suggesting the possible existence of an alternative regulatory process in this pathogenic bacterium. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Mariutti, Ricardo Barros; Ullah, Anwar; Arni, Raghuvir Krishnaswamy] IBILCE UNESP, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Ullah, Anwar] COMSATS Inst Informat Technol, Dept Biosci, Park Rd, Islamabad 45550, Pakistan.
   [Araujo, Gabriela Campos; Arni, Raghuvir Krishnaswamy] IBILCE UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Murakami, Mario Tyago] Natl Ctr Res Energy & Mat CNPEM, Biosci Natl Lab LNBio, BR-13083100 Campinas, SP, Brazil.
RP Mariutti, RB (corresponding author), IBILCE UNESP, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.; Arni, RK (corresponding author), IBILCE UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM mariutti@ibilce.unesp.br; arni@sjrp.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; Ullah,
   Anwar/B-1720-2013; Murakami, Mario T/F-5640-2016
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Ullah, Anwar/0000-0003-3793-7393; Murakami, Mario
   T/0000-0002-0405-8010; mariutti, ricardo/0000-0001-6720-4655
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); FAPESP (Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   PNPD/CAPES (Microbiology/UNESP); FAPESP fellowshipFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil) and FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). Ricardo Mariutti
   is the recipient of a fellowship from PNPD/CAPES (Microbiology/UNESP)
   and Anwar Ullah was supported by a FAPESP fellowship.
CR BURKE M, 1994, MOL MICROBIOL, V13, P609, DOI 10.1111/j.1365-2958.1994.tb00455.x
   CHARLIER D, 1988, J MOL BIOL, V204, P867, DOI 10.1016/0022-2836(88)90047-2
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cherney LT, 2008, ACTA CRYSTALLOGR D, V64, P950, DOI 10.1107/S0907444908021513
   Cherney LT, 2009, J MOL BIOL, V388, P85, DOI 10.1016/j.jmb.2009.02.053
   CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986
   de la Fuente A, 2004, J BACTERIOL, V186, P6501, DOI 10.1128/JB.186.19.6501-6507.2004
   Dimova D, 2000, MOL GEN GENET, V263, P119, DOI 10.1007/s004380050038
   Dion M, 1997, MOL MICROBIOL, V25, P385, DOI 10.1046/j.1365-2958.1997.4781845.x
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007
   Garnett JA, 2007, ACTA CRYSTALLOGR F, V63, P918, DOI 10.1107/S1744309107049391
   GRANDORI R, 1995, J MOL BIOL, V254, P150, DOI 10.1006/jmbi.1995.0607
   Holtham CAM, 1999, J MOL BIOL, V289, P707
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larsen R, 2004, J BACTERIOL, V186, P1147, DOI 10.1128/JB.186.4.1147-1157.2004
   Lee SY, 2010, APPL MICROBIOL BIOT, V86, P235, DOI 10.1007/s00253-009-2264-5
   LIM D, 1987, P NATL ACAD SCI USA, V84, P6697, DOI 10.1073/pnas.84.19.6697
   Linares DM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-23
   Lu GJ, 2007, ACTA CRYSTALLOGR F, V63, P936, DOI 10.1107/S1744309107046374
   LUDOVICE M, 1992, J BACTERIOL, V174, P4606, DOI 10.1128/JB.174.14.4606-4613.1992
   MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994
   Makarova K. S., 2001, GENOME BIOL, V2, P00131
   Mayer AF, 1996, APPL MICROBIOL BIOT, V45, P41, DOI 10.1007/s002530050646
   Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981
   Morin A, 2003, J MOL BIOL, V332, P537, DOI 10.1016/S0022-2836(03)00951-3
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Ni JP, 1999, NAT STRUCT BIOL, V6, P427
   RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x
   ROMERO J, 1986, APPL ENVIRON MICROB, V52, P892, DOI 10.1128/AEM.52.4.892-897.1986
   Sakanyan V, 1996, MICROBIOL-SGM, V142, P99, DOI 10.1099/13500872-142-1-99
   Samalikova M, 2005, RAPID COMMUN MASS SP, V19, P2549, DOI 10.1002/rcm.2094
   Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002
   Strawn R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000801
   TIAN GL, 1994, J MOL BIOL, V235, P221, DOI 10.1016/S0022-2836(05)80028-2
   VALENTINE BP, 1993, J CHEM SOC CHEM COMM, P1210, DOI 10.1039/c39930001210
   VanDuyne GD, 1996, J MOL BIOL, V256, P377, DOI 10.1006/jmbi.1996.0093
   Yu YH, 2002, BIOTECHNOL BIOENG, V79, P23, DOI 10.1002/bit.10271
NR 40
TC 1
Z9 1
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 8
PY 2016
VL 475
IS 4
BP 350
EP 355
DI 10.1016/j.bbrc.2016.05.091
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DP6AO
UT WOS:000378579500008
PM 27233609
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Santana-Jorge, KTO
   Santos, TM
   Tartaglia, NR
   Aguiar, EL
   Souza, RFS
   Mariutti, RB
   Eberle, RJ
   Arni, RK
   Portela, RW
   Meyer, R
   Azevedo, V
AF Santana-Jorge, Karina T. O.
   Santos, Tulio M.
   Tartaglia, Natayme R.
   Aguiar, Edgar L.
   Souza, Renata F. S.
   Mariutti, Ricardo B.
   Eberle, Raphael J.
   Arni, Raghuvir K.
   Portela, Ricardo W.
   Meyer, Roberto
   Azevedo, Vasco
TI Putative virulence factors of Corynebacterium pseudotuberculosis FRC41:
   vaccine potential and protein expression
SO MICROBIAL CELL FACTORIES
LA English
DT Article
DE Corynebacterium pseudotuberculosis; Pathogenicity and virulence; Vaccine
   potential; Epitope prediction; Protein expression; Protein purification
ID NECROSIS-FACTOR-ALPHA; CASEOUS-LYMPHADENITIS; GAMMA-INTERFERON;
   PREDICTION; IDENTIFICATION; SURVIVAL; DESIGN; STRATEGIES; INFECTION;
   DISCOVERY
AB Background: Corynebacterium pseudotuberculosis, a facultative intracellular bacterial pathogen, is the etiological agent of caseous lymphadenitis (CLA), an infectious disease that affects sheep and goats and it is responsible for significant economic losses. The disease is characterized mainly by bacteria-induced caseous necrosis in lymphatic glands. New vaccines are needed for reliable control and management of CLA. Thus, the putative virulence factors SpaC, SodC, NanH, and PknG from C. pseudotuberculosis FRC41 may represent new target proteins for vaccine development and pathogenicity studies.
   Results: SpaC, PknG and NanH presented better vaccine potential than SodC after in silico analyses. A total of 136 B and T cell epitopes were predicted from the four putative virulence factors. A cluster analysis was performed to evaluate the redundancy degree among the sequences of the predicted epitopes; 57 clusters were formed, most of them (34) were single clusters. Two clusters from PknG and one from SpaC grouped epitopes for B and T-cell (MHC I and II). These epitopes can thus potentially stimulate a complete immune response (humoral and cellular) against C. pseudotuberculosis. Several other clusters, including two from NanH, grouped B-cell epitopes with either MHC I or II epitopes. The four target proteins were expressed in Escherichia coli. A purification protocol was developed for PknG expression.
   Conclusions: In silico analyses show that the putative virulence factors SpaC, PknG and NanH present good potential for CLA vaccine development. Target proteins were successfully expressed in E. coli. A protocol for PknG purification is described.
C1 [Santana-Jorge, Karina T. O.; Santos, Tulio M.; Tartaglia, Natayme R.; Aguiar, Edgar L.; Souza, Renata F. S.; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Santos, Tulio M.] Uniclon Biotecnol, Belo Horizonte, MG, Brazil.
   [Mariutti, Ricardo B.; Eberle, Raphael J.; Arni, Raghuvir K.] Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Portela, Ricardo W.; Meyer, Roberto] Univ Fed Bahia, Inst Ciencias Saude, Lab Imunol & Biol Mol, Salvador, BA, Brazil.
RP Azevedo, V (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM vasco@icb.ufmg.br
RI Arni, Raghuvir K/B-2222-2013; Portela, Ricardo Wagner Dias/W-1794-2019;
   Azevedo, Vasco A/B-1556-2019; Arni, Raghuvir K/N-9338-2018; Portela,
   RW/H-5638-2013; Azevedo, Vasco A.C/F-4315-2011
OI Arni, Raghuvir K/0000-0003-2460-1145; Portela, Ricardo Wagner
   Dias/0000-0001-9095-776X; Azevedo, Vasco A/0000-0002-4775-2280; Arni,
   Raghuvir K/0000-0003-2460-1145; Portela, RW/0000-0001-9095-776X;
   Azevedo, Vasco A.C/0000-0002-4775-2280; Eberle,
   Raphael/0000-0002-8763-3884; mariutti, ricardo/0000-0001-6720-4655
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG); FAPESB
FX This study was supported by CAPES, CNPq, FAPEMIG, and FAPESB.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Arnon R, 2006, FEBS J, V273, P33
   Baird GJ, 2007, J COMP PATHOL, V137, P179, DOI 10.1016/j.jcpa.2007.07.002
   BASTOS BL, 2012, J CLIN CELL IMMUNOL, V4, P5, DOI DOI 10.4172/2155-9899.S4-005
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247
   Chakraborty Sajib, 2010, In Silico Biology, V10, P235, DOI 10.3233/ISB-2010-0435
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   Chou PY, 1989, PREDICTION PROTEIN S, P549
   De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Dudek NL, 2010, CURR PHARM DESIGN, V16, P3149
   Dussurget O, 2001, INFECT IMMUN, V69, P529, DOI 10.1128/IAI.69.1.529-533.2001
   El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2
   EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985
   Fontaine MC, 2008, SMALL RUMINANT RES, V76, P42, DOI 10.1016/j.smallrumres.2007.12.025
   Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   Goodswen SJ, 2013, BRIEF BIOINFORM, V14, P753, DOI 10.1093/bib/bbs066
   Grimm SK, 2013, CURR OPIN BIOTECH, V24, P1078, DOI 10.1016/j.copbio.2013.02.015
   Guimaraes AD, 2011, IIOAB J, V2, P33
   JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Kaufmann SHE, 1999, IMMUNOL LETT, V65, P81, DOI 10.1016/S0165-2478(98)00128-X
   Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2
   Kim S, 2010, J BIOCHEM, V147, P523, DOI 10.1093/jb/mvp198
   Kimura K, 2013, INFECT IMMUN, V81, P3825, DOI 10.1128/IAI.00570-13
   Krachler AM, 2013, VIRULENCE, V4, P284, DOI 10.4161/viru.24606
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lan DTB, 1998, MICROBIOL IMMUNOL, V42, P863, DOI 10.1111/j.1348-0421.1998.tb02362.x
   Lan DTB, 1999, J VET MED SCI, V61, P1203
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   Oreiby AF, 2015, SMALL RUMINANT RES, V123, P160, DOI 10.1016/j.smallrumres.2014.11.013
   Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001
   RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293
   Rogers EA, 2011, ADV EXP MED BIOL, V715, P91, DOI 10.1007/978-94-007-0940-9_6
   Saha Sudipto, 2007, V409, P387, DOI 10.1007/978-1-60327-118-9_29
   Saida F, 2006, CURR PROTEIN PEPT SC, V7, P47, DOI 10.2174/138920306775474095
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Sugiki T, 2014, EXPERT OPIN DRUG DIS, P1
   Trivedi S, 2006, GENET MOL RES, V5, P816
   Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282
   Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002
   White A, 1964, PRINCIPLES BIOCH
   Windsor PA, 2011, VET CLIN N AM-FOOD A, V27, P193, DOI 10.1016/j.cvfa.2010.10.019
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
NR 57
TC 13
Z9 14
U1 2
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2859
J9 MICROB CELL FACT
JI Microb. Cell. Fact.
PD MAY 16
PY 2016
VL 15
AR 83
DI 10.1186/s12934-016-0479-6
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DM0ZQ
UT WOS:000376075100002
PM 27184574
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Chaim, OM
   Brown, JH
   Vuitika, L
   Chaves-Moreira, D
   Caruso, IP
   Lima, MA
   Matsubara, FH
   Murakami, MT
   Takahashi, HK
   Toledo, MS
   Coronado, MA
   Nader, HB
   Senff-Ribeiro, A
   Arni, RK
   Veiga, SS
AF Chaim, Olga Meiri
   Brown, Joan Heller
   Vuitika, Larissa
   Chaves-Moreira, Daniele
   Caruso, Icaro Putinhon
   Lima, Marcelo Andrade
   Matsubara, Fernando Hitomi
   Murakami, Mario Tyago
   Takahashi, Helio Kiyoshi
   Toledo, Marcos Sergio
   Coronado, Monika Aparecida
   Nader, Helena Bonciani
   Senff-Ribeiro, Andrea
   Arni, Raghuvir Krishnaswamy
   Veiga, Silvio Sanches
TI Active site mapping of Loxosceles phospholipases D: biochemical and
   biological features
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Chaim, Olga Meiri; Brown, Joan Heller] Univ Calif San Diego, Pharmacol, San Diego, CA 92103 USA.
   [Chaim, Olga Meiri; Vuitika, Larissa; Chaves-Moreira, Daniele; Matsubara, Fernando Hitomi; Senff-Ribeiro, Andrea; Veiga, Silvio Sanches] Univ Fed Parana, Cell Biol, Curitiba, Parana, Brazil.
   [Caruso, Icaro Putinhon; Coronado, Monika Aparecida; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ, Phys, Sao Jose Do Rio Preto, Brazil.
   [Lima, Marcelo Andrade; Takahashi, Helio Kiyoshi; Toledo, Marcos Sergio; Nader, Helena Bonciani] Univ Fed Sao Paulo, Biochem, Sao Paulo, Brazil.
   [Murakami, Mario Tyago] Natl Ctr Res Energy & Mat CPEM, Campinas, SP, Brazil.
RI Vuitika, Larissa/L-4664-2016; Senff-Ribeiro, Andrea/K-8745-2019; Arni,
   Raghuvir K/B-2222-2013; Takahashi, Helio/J-1725-2012; Caruso, Icaro
   P./M-8647-2017; Arni, Raghuvir K/N-9338-2018; Chaim, Olga/H-5179-2012;
   Chaim, Olga Meiri/Y-7559-2019; Veiga, Silvio Sanches/C-2194-2013;
   Senff-Ribeiro, Andrea/D-6246-2018; de Toledo, Marcos Sergio/M-7185-2019
OI Senff-Ribeiro, Andrea/0000-0002-7967-6307; Arni, Raghuvir
   K/0000-0003-2460-1145; Caruso, Icaro P./0000-0003-4464-0520; Arni,
   Raghuvir K/0000-0003-2460-1145; Chaim, Olga/0000-0002-3854-3292; Chaim,
   Olga Meiri/0000-0002-3854-3292; Veiga, Silvio
   Sanches/0000-0002-9691-1225; Senff-Ribeiro, Andrea/0000-0002-7967-6307;
   de Toledo, Marcos Sergio/0000-0002-6605-0874
FU Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Araucaria Foundation
   in Support of the Scientific and Technological Development of the State
   of Parana (FA-PR); Science, Technology and Higher Education of the State
   of Parana (SETI-PR)
FX Coordination for the Improvement of Higher Education Personnel (CAPES),
   National Council for Scientific and Technological Development (CNPq),
   Sao Paulo Research Foundation (FAPESP), Araucaria Foundation in Support
   of the Scientific and Technological Development of the State of Parana
   (FA-PR), and Secretary of Science, Technology and Higher Education of
   the State of Parana (SETI-PR).
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA lb51
PG 4
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444005209
DA 2020-12-01
ER

PT J
AU Mariutti, RB
   Caruso, IP
   Ullah, A
   De Morais, FR
   Rehders, D
   Arni, RK
AF Mariutti, R. B.
   Caruso, I. P.
   Ullah, A.
   De Morais, F. R.
   Rehders, D.
   Arni, R. K.
TI Functional expression, monodispersity and conformational changes in the
   SBMV virus viral VPg on binding TFE
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE VPg; Viral genome-linked protein; Expression; Purification
ID GENOME-LINKED PROTEIN; PHOSPHODIESTER LINKAGE; MOSAIC-VIRUS; RNA;
   LIGAND; NMR
AB Southern bean mosaic virus (SBMV) RNA purified from infected plants was used for cloning the viral genome-linked protein (VPg) and was subsequently expressed in Escherichia coli. Circular dichroism (CD), dynamic light scattering (DLS) and saturation transfer difference (STD) by nuclear magnetic resonance (NMR) measurements were employed to determine the degree of monodispersity and to investigate the conformational changes in the absence and presence of trifluoroethanol (TFE) which indicated increased helical content with increasing concentration of TFE. 8-Anilino-1-naphthalenesulfonic acid (ANS) was used as a probe to compare the unfolding regions of the protein before and after addition of TFE. The results indicated that although the TFE concentration influences VPg folding, it does not play a role in nucleotide binding and that the local solvent hydrophobicity causes significant conformational changes. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mariutti, R. B.; Ullah, A.; Arni, R. K.] IBILCE UNESP, Multiuser Ctr Biomol Innovat, Sao Paulo, Brazil.
   [Caruso, I. P.; De Morais, F. R.; Arni, R. K.] IBILCE UNESP, Dept Phys, Sao Paulo, Brazil.
   [Rehders, D.] Univ Hamburg, Lab Struct Biol Infect & Inflammat, Hamburg, Germany.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Ullah, Anwar/B-1720-2013; Caruso, Icaro P./M-8647-2017; de Moraes, Fabio
   R/B-8331-2017; Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir
   K/B-2222-2013
OI Ullah, Anwar/0000-0003-3793-7393; Caruso, Icaro P./0000-0003-4464-0520;
   de Moraes, Fabio R/0000-0002-0425-0352; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; mariutti,
   ricardo/0000-0001-6720-4655
FU PROPe-UNESP; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); CAPES (Brazil)CAPES
FX This research was supported by grants from PROPe-UNESP, CNPq, FAPESP and
   CAPES (Brazil).
CR Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003
   AMBROS V, 1978, J BIOL CHEM, V253, P5263
   Anindya R, 2005, VIROLOGY, V336, P154, DOI 10.1016/j.virol.2005.03.024
   Gerber K, 2001, J VIROL, V75, P10969, DOI 10.1128/JVI.75.22.10969-10978.2001
   Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003
   Grzela R, 2008, J BIOL CHEM, V283, P213, DOI 10.1074/jbc.M705666200
   Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23
   JAEGLE M, 1987, J GEN VIROL, V68, P627, DOI 10.1099/0022-1317-68-3-627
   Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010
   Kim J., 2015, BIOCHEM BIOPH RES CO, V459, P610
   KITAMURA N, 1980, CELL, V21, P295, DOI 10.1016/0092-8674(80)90137-3
   KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233
   Moreira Andreia E., 2002, Fitopatologia Brasileira, V27, P292, DOI 10.1590/S0100-41582002000300009
   Nakashima N, 2006, J INVERTEBR PATHOL, V92, P100, DOI 10.1016/j.jip.2006.03.003
   Olspert A, 2011, FEBS LETT, V585, P2979, DOI 10.1016/j.febslet.2011.08.009
   Olspert A, 2011, J GEN VIROL, V92, P445, DOI 10.1099/vir.0.026476-0
   Pellecchia M, 2008, NAT REV DRUG DISCOV, V7, P738, DOI 10.1038/nrd2606
   Puustinen P, 2004, J BIOL CHEM, V279, P38103, DOI 10.1074/jbc.M402910200
   Rantalainen KI, 2008, VIROLOGY, V377, P280, DOI 10.1016/j.virol.2008.04.025
   Sadowy E, 2001, ADV VIRUS RES, V57, P185, DOI 10.1016/S0065-3527(01)57004-9
   Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006
NR 26
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2016
VL 83
BP 178
EP 184
DI 10.1016/j.ijbiomac.2015.11.026
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DC4OP
UT WOS:000369200500021
PM 26592780
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Ullah, A
   Mariutti, RB
   Masood, R
   Caruso, IP
   Costa, GHG
   de Freita, CM
   Santos, CR
   Zanphorlin, LM
   Mutton, MJR
   Murakami, MT
   Arni, RK
AF Ullah, Anwar
   Mariutti, Ricardo Barros
   Masood, Rehana
   Caruso, Icaro Putinhon
   Gravatim Costa, Gustavo Henrique
   de Freita, Cristhyane Millena
   Santos, Camila Ramos
   Zanphorlin, Leticia Maria
   Rossini Mutton, Marcia Justino
   Murakami, Mario Tyago
   Arni, Raghuvir Krishnaswamy
TI Crystal structure of mature 2S albumin from Moringa oleifera seeds
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Moringa oleifera seeds; 2S albumin; Flocculating activity; Crystal
   structure
ID STORAGE PROTEIN; PRECURSORS; HOMOLOGY; CLEAVAGE; EXTRACT
AB 2S albumins, the seed storage proteins, are the primary sources of carbon and nitrogen and are involved in plant defense. The mature form of Moringa olezfera (M. oleifera), a chitin binding protein isoform 3-1 (mMo-CBP3-1) a thermostable antifungal, antibacterial, flocculating 2S albumin is widely used for the treatment of water and is potentially interesting for the development of both antifungal drugs and transgenic crops. The crystal structure of mMo-CBP3-1 determined at 1.7 angstrom resolution demonstrated that it is comprised of two proteolytically processed cc-helical chains, stabilized by four disulfide bridges that is stable, resistant to pH changes and has a melting temperature (T-M) of approximately 98 degrees C. The surface arginines and the polyglutamine motif are the key structural factors for the observed flocculating, antibacterial and antifungal activities. This represents the first crystal structure of a 2S albumin and the model of the pro-protein indicates the structural changes that occur upon formation of mMo-CBP3-1 and determines the structural motif and charge distribution patterns for the diverse observed activities. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ullah, Anwar; Mariutti, Ricardo Barros; Masood, Rehana; Caruso, Icaro Putinhon; Arni, Raghuvir Krishnaswamy] IBILCE UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Gravatim Costa, Gustavo Henrique; de Freita, Cristhyane Millena; Rossini Mutton, Marcia Justino] FCAV UNESP, Dept Tecnol, Sao Paulo, Brazil.
   [Santos, Camila Ramos; Murakami, Mario Tyago] Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
   [Zanphorlin, Leticia Maria] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Bioethanol Sci & Technol Lab CTBE, Campinas, SP, Brazil.
RP Arni, RK (corresponding author), IBILCE UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
EM anwar.ms90@yahoo.com; ami@sjrp.unesp.br
RI Ullah, Anwar/B-1720-2013; Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir
   K/B-2222-2013; Caruso, Icaro P./M-8647-2017; Costa, Gustavo/C-4101-2014;
   Murakami, Mario T/C-2087-2012; Murakami, Mario T/F-5640-2016; Santos,
   Camila/F-7095-2013
OI Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145;
   Arni, Raghuvir K/0000-0003-2460-1145; Caruso, Icaro
   P./0000-0003-4464-0520; Murakami, Mario T/0000-0002-0405-8010; Santos,
   Camila/0000-0003-0652-4211; mariutti, ricardo/0000-0001-6720-4655
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); FAPESP (Brazil)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPES (Brazil)CAPES
FX This work was supported by grants from CNPq, FAPESP and CAPES (Brazil).
CR Al-Said MS, 2012, J FOOD SCI, V77, pT124, DOI 10.1111/j.1750-3841.2012.02698.x
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427
   BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023
   DHONDT K, 1993, J BIOL CHEM, V268, P20884
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Freire J.E., 2015, PLOS ONE, V10
   GASSENSCHMIDT U, 1995, BBA-GEN SUBJECTS, V1243, P477, DOI 10.1016/0304-4165(94)00176-X
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068
   Costa GHG, 2014, FOOD SCI TECH-BRAZIL, V34, P204, DOI 10.1590/S0101-20612014000100029
   Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378
   HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x
   HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D
   Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x
   Hu Z, 1983, YUNNAN ZHIWU YANJIU, V5, P207
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Jahn S.A.A., 1981, TRADITIONAL WATER PU, V117, P47
   Jahn S.A.A., 1986, PUBL GERMAN AGENCY T, V191, P71
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Katre UV, 2008, INT J BIOL MACROMOL, V42, P203, DOI 10.1016/j.ijbiomac.2007.10.024
   Krzvianiak A., 1997, NAHRUNG, V42, P201
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leone A, 2015, INT J MOL SCI, V16, P18923, DOI 10.3390/ijms160818923
   Li DF, 2008, J STRUCT BIOL, V162, P50, DOI 10.1016/j.jsb.2007.12.007
   Mahajan SG, 2007, J IMMUNOTOXICOL, V4, P287, DOI 10.1080/15476910701680137
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   NIRASAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1202, P277, DOI 10.1016/0167-4838(93)90016-K
   ONADERRA M, 1994, EUR J BIOCHEM, V225, P609, DOI 10.1111/j.1432-1033.1994.00609.x
   Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y
   Pantoja-Uceda D, 2003, BIOCHEMISTRY-US, V42, P13839, DOI 10.1021/bi0352217
   Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047
   PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4
   Rico M, 1996, BIOCHEMISTRY-US, V35, P15672, DOI 10.1021/bi961748q
   SCOTT MP, 1992, P NATL ACAD SCI USA, V89, P658, DOI 10.1073/pnas.89.2.658
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945
   VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797
NR 41
TC 22
Z9 22
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 4
PY 2015
VL 468
IS 1-2
BP 365
EP 371
DI 10.1016/j.bbrc.2015.10.087
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY2LS
UT WOS:000366240800059
PM 26505799
DA 2020-12-01
ER

PT J
AU Viala, VL
   Hildebrand, D
   Fucase, TM
   Sciani, JM
   Prezotto-Neto, JP
   Riedner, M
   Sanches, L
   Nishimura, PJ
   Oguiura, N
   Pimenta, DC
   Schluter, H
   Betzel, C
   Arni, RK
   Spencer, PJ
AF Viala, Vincent Louis
   Hildebrand, Diana
   Fucase, Tamara Mieco
   Sciani, Juliana Mozer
   Prezotto-Neto, Jose Pedro
   Riedner, Maria
   Sanches, Leonardo
   Nishimura, Paula Juliana
   Oguiura, Nancy
   Pimenta, Daniel Carvalho
   Schlueter, Hartmut
   Betzel, Christian
   Arni, Raghuvir Krishnaswami
   Spencer, Patrick Jack
TI Proteomic analysis of the rare Uracoan rattlesnake Crotalus vegrandis
   venom: Evidence of a broad arsenal of toxins
SO TOXICON
LA English
DT Article
DE Crotalus vegrandis; Peptide; Uracoan rattlesnake; Toxin; Venom;
   Proteomics
ID BRADYKININ-POTENTIATING PEPTIDES; SMALL BASIC MYOTOXIN; AMINO-ACID
   OXIDASE; C-TYPE LECTIN; PHOSPHOLIPASE A(2); CRYSTAL-STRUCTURE;
   DURISSUS-RURUIMA; SNAKE VENOMICS; PROTEINS; PURIFICATION
AB The investigation of venoms has many clinical, pharmacological, ecological and evolutionary outcomes. The Crotalus spp. venom can cause hemorrhage, neurotoxicity, myotoxicity, coagulopathy and hypotension. Although neurotoxicity and hemorrhage usually does not occur for the same species, the rare Venezuelan species Crotalus vegrandis presents both characteristic. Different from the other species it has a restricted ecological niche and geographical distribution. Nevertheless, it has a raising medical importance as this rattlesnake population is increasing. Few works describe its neurotoxic and hemorrhagic features, but other toxins might play an important role in envenomation. We combined proteomic methods to identify for the first time the main components of it venom: 2D SDS-PAGE and gel-filtration chromatography for protein mixture decomplexation; LC-MS2 of low molecular mass fractions and tryptic peptides; bioinformatic identification of toxin families and specific protein species based on unique peptide analysis and sequence database enriched with species-specific venom gland transcripts; and finally polyclonal anti-crotamine Western-blotting. Our results point to a broad arsenal of toxins in C. vegrandis venom: PIII and PII metalloproteases, crotoxin subunits, other phospholipases, isoforms of serine proteases and lectins, L-amino-acid oxidase, nerve growth factor, as well as other less abundant toxins. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Viala, Vincent Louis; Fucase, Tamara Mieco; Prezotto-Neto, Jose Pedro; Nishimura, Paula Juliana; Spencer, Patrick Jack] IPEN, Ctr Biotecnol, BR-05508000 Sao Paulo, SP, Brazil.
   [Hildebrand, Diana; Schlueter, Hartmut] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, D-20246 Hamburg, Germany.
   [Sciani, Juliana Mozer; Pimenta, Daniel Carvalho] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, SP, Brazil.
   [Riedner, Maria] Univ Hamburg, Massenspektrometrie, Inst Organ Chem, D-20146 Hamburg, Germany.
   [Sanches, Leonardo; Oguiura, Nancy] Inst Butantan, Lab Especial Ecol & Evolucao, BR-05503900 Sao Paulo, SP, Brazil.
   [Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany.
   [Arni, Raghuvir Krishnaswami] UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Spencer, PJ (corresponding author), IPEN, Ctr Biotecnol, Av Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
EM pspencer@ipen.br
RI Sciani, Juliana Mozer/B-6990-2012; Arni, Raghuvir K/B-2222-2013;
   Sanches, Leonardo/O-6706-2016; Betzel, Christian/G-8105-2018; Oguiura,
   Nancy/N-6861-2014; Viala, Vincent L/C-9924-2014; Arni, Raghuvir
   K/N-9338-2018; Pimenta, Daniel C/B-4361-2008; Riedner, Maria/W-5546-2019
OI Sciani, Juliana Mozer/0000-0001-7213-206X; Arni, Raghuvir
   K/0000-0003-2460-1145; Betzel, Christian/0000-0002-3879-5019; Oguiura,
   Nancy/0000-0002-1924-5302; Arni, Raghuvir K/0000-0003-2460-1145;
   Pimenta, Daniel C/0000-0003-2406-0860; Spencer,
   Patrick/0000-0001-8949-7735; Viala, Vincent/0000-0003-2267-9985
FU FAPESP (SP, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2010/08585-8, 2009/10305-8]; CAPES/DAAD (Brazil/Germany)CAPES
   [364/11]
FX We would like to acknowledge Mr. Joaquin Sanchez and Ms. Adelina Jara
   from the Brenesia scientific journal of the Museo Nacional de Costa Rica
   for providing valuable literature used in this manuscript; the
   Biotechnology Center at the Butantan Institute for DNA sequencing; grant
   and scholarship from FAPESP (SP, Brazil) (2010/08585-8 and 2009/10305-8)
   and CAPES/DAAD no 364/11 (Brazil/Germany research program).
CR Aguilar I, 2001, BBA-PROTEIN STRUCT M, V1548, P57, DOI 10.1016/S0167-4838(01)00217-5
   Aguilar I, 2007, TOXICON, V50, P214, DOI 10.1016/j.toxicon.2007.03.012
   Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790
   da Silva JAA, 2011, TOXICON, V57, P162, DOI 10.1016/j.toxicon.2010.06.027
   Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001
   Ausubel FM, 2000, CURRENT PROTOCOLS MO
   AZEVEDOMARQUES MM, 2003, ANIMAIS PECONHENTOS, P91, DOI DOI 10.1016/J.TTBDIS.2014.03.010
   Azofeifa-Cordero G, 2008, TOXICON, V52, P302, DOI 10.1016/j.toxicon.2008.05.023
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   Barnwal B, 2013, BIOCHEM J, V455, P239, DOI 10.1042/BJ20130599
   Barrabin H., 1978, TOXINS ANIMALS PLANT, P113
   BARRIO A, 1961, ACTA PHYSIOL LAT AM, V11, P224
   BERNHEIMER AW, 1986, TOXICON, V24, P841, DOI 10.1016/0041-0101(86)90109-1
   BERNHEIMER AW, 1987, TOXICON, V25, P547, DOI 10.1016/0041-0101(87)90290-X
   BJARNASON JB, 1983, J BIOL CHEM, V258, P2566
   BOBER MA, 1988, TOXICON, V26, P665, DOI 10.1016/0041-0101(88)90248-6
   BON C, 1982, TOXICON, V20, P105, DOI 10.1016/0041-0101(82)90173-8
   Calvete J.J., 2010, SNAKE VENOMICS CENTR, P528
   Calvete JJ, 2014, TOXINS, V6, P3388, DOI 10.3390/toxins6123388
   Calvete JJ, 2013, TOXICON, V75, P44, DOI 10.1016/j.toxicon.2013.03.020
   Calvete JJ, 2012, J PROTEOME RES, V11, P1382, DOI 10.1021/pr201021d
   Camargo ACM, 2012, TOXICON, V59, P516, DOI 10.1016/j.toxicon.2011.07.013
   Campbell J.A., 2004, VENOMOUS REPTILES W
   Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039
   Chatrath S.T., 2011, IDENTIFICATION NOVEL, P739
   Ching ATC, 2006, FEBS LETT, V580, P4417, DOI 10.1016/j.febslet.2006.07.010
   Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011
   Costa BA, 2014, J PHYS CHEM B, V118, P5471, DOI 10.1021/jp411886u
   CUSHMAN DW, 1991, HYPERTENSION, V17, P589, DOI 10.1161/01.HYP.17.4.589
   Damico DCS, 2005, BBA-GEN SUBJECTS, V1726, P75, DOI 10.1016/j.bbagen.2005.05.022
   De Sousa Leonardo, 2005, Invest. clín, V46, P229
   DEGN LL, 1991, TOXICON, V29, P973, DOI 10.1016/0041-0101(91)90080-B
   Dhananjaya BL, 2010, CELL BIOCHEM FUNCT, V28, P171, DOI 10.1002/cbf.1637
   DOERY HM, 1964, BIOCHEM J, V92, P599, DOI 10.1042/bj0920599
   DOSSANTOS MC, 1993, TOXICON, V31, P1459, DOI 10.1016/0041-0101(93)90211-Z
   Du X.-Y., 2009, HDB VENOMS TOXINS RE, P521
   ENG J, 1992, J BIOL CHEM, V267, P7402
   FERREIRA SH, 1965, EXPERIENTIA, V21, P347, DOI 10.1007/BF02144709
   Furman BL, 2012, TOXICON, V59, P464, DOI 10.1016/j.toxicon.2010.12.016
   Cavalcante WLG, 2015, TOXICON, V96, P46, DOI 10.1016/j.toxicon.2015.01.006
   Georgieva D, 2010, J PROTEOME RES, V9, P2302, DOI 10.1021/pr901042p
   Georgieva D, 2008, EXPERT REV PROTEOMIC, V5, P787, DOI 10.1586/14789450.5.6.787
   Girón María E., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P147, DOI 10.1590/S0036-46652005000300006
   GLENN JL, 1994, COMP BIOCHEM PHYS C, V107, P337, DOI 10.1016/1367-8280(94)90059-0
   Gomes CL, 2007, BIOCHEM PHARMACOL, V74, P1350, DOI 10.1016/j.bcp.2007.07.014
   GONCALVES J. MOURA, 1950, AN ACAD BRASIL CIENC, V22, P141
   GONCALVES JM, 1947, ARCH BIOCHEM, V13, P253
   Graham RLJ, 2005, BIOCHEM BIOPH RES CO, V338, P1587, DOI 10.1016/j.bbrc.2005.10.130
   Guarnieri MC, 2009, J VENOM ANIM TOXINS, V15, P745, DOI 10.1590/S1678-91992009000400012
   GUBENSEK F, 1978, PERIOD BIOL, V80, P101
   Gutierrez J. M., 2009, Handbook of venoms and toxins of reptiles, P491
   Hahn BS, 1996, J BIOCHEM-TOKYO, V119, P835, DOI 10.1093/oxfordjournals.jbchem.a021319
   Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219
   Harvey AL, 2012, TOXICON, V59, P433, DOI 10.1016/j.toxicon.2011.09.016
   Huang KF, 2004, BIOCHEM J, V378, P399, DOI 10.1042/BJ20031507
   Irwin DM, 2012, GEN COMP ENDOCR, V175, P27, DOI 10.1016/j.ygcen.2011.11.025
   Jiao HM, 2005, ACTA BIOCH BIOPH SIN, V37, P835, DOI 10.1111/j.1745-7270.2005.00119.x
   Vargas LJ, 2013, TOXICON, V64, P1, DOI 10.1016/j.toxicon.2012.11.027
   Jones P, 2014, BIOINFORMATICS
   KAISER II, 1987, TOXICON, V25, P1113, DOI 10.1016/0041-0101(87)90268-6
   Kerkis I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675985
   Klauber L.M., 1997, RATTLESNAKES THEIR H, V1
   Kostiza T, 1996, TOXICON, V34, P787, DOI 10.1016/0041-0101(96)00023-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433
   Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196
   Mackessy SP, 2008, BIOL RATTLESNAKES
   Mackessy SP, 2010, TOXICON, V55, P1463, DOI 10.1016/j.toxicon.2010.02.028
   Margres MJ, 2014, J PROTEOMICS, V96, P145, DOI 10.1016/j.jprot.2013.11.001
   Gutierrez JM, 2014, J PROTEOMICS, V105, P340, DOI 10.1016/j.jprot.2014.02.021
   Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004
   MARKLAND FS, 1983, J TOXICOL-TOXIN REV, V2, P119, DOI 10.3109/15569548309012695
   MARKLAND FS, 1982, P NATL ACAD SCI-BIOL, V79, P1688, DOI 10.1073/pnas.79.6.1688
   Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035
   Masuda S, 1997, BIOCHEM BIOPH RES CO, V235, P59, DOI 10.1006/bbrc.1997.6728
   McCleary R.J.R., 2012, TOXICON, P1
   Melani R.D., 2015, EUPA OPEN PROTEOM
   Menin L, 2008, TOXICON, V51, P1288, DOI 10.1016/j.toxicon.2008.02.019
   Mitra J, 2014, TOXICON, V88, P1, DOI 10.1016/j.toxicon.2014.06.004
   MOCHCAMORALES J, 1990, TOXICON, V28, P299, DOI 10.1016/0041-0101(90)90065-F
   Munawar A, 2014, TOXINS, V6, P850, DOI 10.3390/toxins6030850
   Murakami MT, 2003, BIOCHEM BIOPH RES CO, V310, P478, DOI 10.1016/j.bbrc.2003.09.032
   Navarro J, 2004, REV FAC MED, V27, P106
   Castro EN, 2013, J PROTEOMICS, V87, P103, DOI 10.1016/j.jprot.2013.05.024
   Oguiura N, 2005, TOXICON, V46, P363, DOI 10.1016/j.toxicon.2005.06.009
   Oguiura N, 2000, TOXICON, V38, P443, DOI 10.1016/S0041-0101(99)00157-9
   Oguiura N, 2011, J ANTIBIOT, V64, P327, DOI 10.1038/ja.2011.10
   Peigneur S, 2012, MOL PHARMACOL, V82, P90, DOI 10.1124/mol.112.078188
   Peng LL, 2013, METALLOMICS, V5, P920, DOI 10.1039/c3mt00031a
   Peng L, 2011, BIOCHIMIE, V93, P1601, DOI 10.1016/j.biochi.2011.05.027
   Perez AV, 2008, BRAZ J MED BIOL RES, V41, P12, DOI 10.1590/S0100-879X2006005000189
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pifano C. Felix, 1996, Brenesia, V45-46, P169
   Pifano F., 1995, REV FAC MED, V18, P194
   Pimenta DC, 2007, PEPTIDES, V28, P2403, DOI 10.1016/j.peptides.2007.10.005
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   Pulido-Mendez M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P555
   Rioli V, 2008, FEBS J, V275, P2442, DOI 10.1111/j.1742-4658.2008.06389.x
   Rodriguez-Acosta A., 1995, QUE HACER FRENTE ACC
   Rodriguez-Acosta Alexis, 1998, Natural Toxins, V6, P15, DOI 10.1002/(SICI)1522-7189(199802)6:1<15::AID-NT2>3.0.CO;2-S
   Rokyta DR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-394
   Romero-Vargas FF, 2010, COMP BIOCHEM PHYS C, V151, P66, DOI 10.1016/j.cbpc.2009.08.011
   Santoro ML, 2009, TOXICON, V54, P499, DOI 10.1016/j.toxicon.2009.05.016
   Saviola AJ, 2015, J PROTEOMICS, V121, P28, DOI 10.1016/j.jprot.2015.03.015
   Scannone H., 1978, TOXINS ANIMAL PLANT
   SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928
   Serrano SMT, 2013, TOXICON, V62, P19, DOI 10.1016/j.toxicon.2012.09.003
   Slotta KH, 1938, NATURE, V142, P213, DOI 10.1038/142213a0
   Sunagar K, 2014, J PROTEOMICS, V99, P68, DOI [10.1016/j.jprot.2014.01.013, 10.1016]
   Tavares NAC, 2008, TOXICON, V52, P897, DOI 10.1016/j.toxicon.2008.08.022
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Toyama MH, 2006, TOXICON, V47, P47, DOI 10.1016/j.toxicon.2005.09.008
   Viala VL, 2014, J PROTEOMICS, V110, P32, DOI 10.1016/j.jprot.2014.07.030
   Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290
   Yamane ES, 2013, BIOCHIMIE, V95, P231, DOI 10.1016/j.biochi.2012.09.019
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
   Yamazaki Y, 2003, ARCH BIOCHEM BIOPHYS, V412, P133, DOI 10.1016/S0003-9861(03)00028-6
   Yonamine CM, 2009, TOXICON, V54, P110, DOI 10.1016/j.toxicon.2009.03.022
   Yoshida-Kanashiro Erika, 2003, Rev Cubana Med Trop, V55, P38
NR 119
TC 9
Z9 9
U1 0
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 1
PY 2015
VL 107
SI SI
BP 234
EP 251
DI 10.1016/j.toxicon.2015.09.023
PN B
PG 18
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CY6SR
UT WOS:000366539600008
PM 26403864
OA Bronze
DA 2020-12-01
ER

PT J
AU Viala, VL
   Hildebrand, D
   Trusch, M
   Fucase, TM
   Sciani, JM
   Pimenta, DC
   Arni, RK
   Schluter, H
   Betzel, C
   Mirtschin, P
   Dunstan, N
   Spencer, PJ
AF Viala, Vincent Louis
   Hildebrand, Diana
   Trusch, Maria
   Fucase, Tamara Mieco
   Sciani, Juliana Mozer
   Pimenta, Daniel Carvalho
   Arni, Raghuvir K.
   Schlueter, Hartmut
   Betzel, Christian
   Mirtschin, Peter
   Dunstan, Nathan
   Spencer, Patrick Jack
TI Venomics of the Australian eastern brown snake (Pseudonaja textilis):
   Detection of new venom proteins and splicing variants
SO TOXICON
LA English
DT Article
DE Pseudonaja textilis; Transcriptome; Proteome; Toxin; Splicing variant
ID AMINO-ACID-SEQUENCES; PROTHROMBIN ACTIVATOR; GLAND TRANSCRIPTOME;
   MOLECULAR-CLONING; COBRA VENOM; KING COBRA; FACTOR-V;
   STRUCTURAL-CHARACTERIZATION; PRESYNAPTIC NEUROTOXIN; ANTIMICROBIAL
   ACTIVITY
AB The eastern brown snake is the predominant cause of snakebites in mainland Australia. Its venom induces defibrination coagulopathy, renal failure and microangiopathic hemolytic anemia. Cardiovascular collapse has been described as an early cause of death in patients, but, so far, the mechanisms involved have not been fully identified. In the present work, we analysed the venome of Pseudonaja textilis by combining high throughput proteomics and transcriptomics, aiming to further characterize the components of this venom. The combination of these techniques in the analysis and identification of toxins, venom proteins and putative toxins allowed the sequence description and the identification of the following: prothrombinase coagulation factors, neurotoxic textilotoxin phospholipase A(2) (PLA(2)) subunits and "acidic PLA(2)", three-finger toxins (3FTx) and the Kunitz-type protease inhibitor textilinin, venom metalloproteinase, C-type lectins, cysteine rich secretory proteins, calreticulin, dipeptidase 2, as well as evidences of Heloderma lizard peptides. Deep data-mining analysis revealed the secretion of a new transcript variant of venom coagulation factor 5a and the existence of a splicing variant of PLA(2) modifying the UTR and signal peptide from a same mature protein. The transcriptome revealed the diversity of transcripts and mutations, and also indicates that splicing variants can be an important source of toxin variation. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Viala, Vincent Louis; Fucase, Tamara Mieco; Spencer, Patrick Jack] IPEN, Ctr Biotecnol, BR-05508000 Sao Paulo, SP, Brazil.
   [Hildebrand, Diana; Schlueter, Hartmut] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, D-20246 Hamburg, Germany.
   [Trusch, Maria; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany.
   [Sciani, Juliana Mozer; Pimenta, Daniel Carvalho] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, SP, Brazil.
   [Arni, Raghuvir K.] UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Mirtschin, Peter; Dunstan, Nathan] Venom Supplies Pty Ltd, Tanunda, SA 5352, Australia.
RP Spencer, PJ (corresponding author), IPEN, Ctr Biotecnol, Av Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
EM pspencer@ipen.br
RI Riedner, Maria/W-5546-2019; Pimenta, Daniel C/B-4361-2008; Sciani,
   Juliana Mozer/B-6990-2012; Arni, Raghuvir K/N-9338-2018; Viala, Vincent
   L/C-9924-2014; Betzel, Christian/G-8105-2018; Arni, Raghuvir
   K/B-2222-2013
OI Pimenta, Daniel C/0000-0003-2406-0860; Sciani, Juliana
   Mozer/0000-0001-7213-206X; Arni, Raghuvir K/0000-0003-2460-1145; Betzel,
   Christian/0000-0002-3879-5019; Arni, Raghuvir K/0000-0003-2460-1145;
   Spencer, Patrick/0000-0001-8949-7735; Viala, Vincent/0000-0003-2267-9985
FU FAPESP (Sao Paulo, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2009/10305-8]; CAPES/DAAD (Brazil/Germany)CAPES [364/11]
FX We are thankful to Dr. David Williams (Australian Venom Research Unit,
   University of Melbourne, Australia) for the critical review and
   important contributions to the manuscript. Scholarship and research
   grant were from FAPESP no 2009/10305-8 (Sao Paulo, Brazil) and
   CAPES/DAAD no 364/11 (Brazil/Germany). We acknowledge Dr. Maisa
   Splendore Della Casa (Instituto Butantan, Sao Paulo, Brazil) for kindly
   providing the anti-jararhagin antibodies.
CR Abreu PA, 2006, TOXICON, V48, P690, DOI 10.1016/j.toxicon.2006.08.006
   ADACHI H, 1993, BIOCHIM BIOPHYS ACTA, V1163, P42, DOI 10.1016/0167-4838(93)90276-W
   Aquilina JA, 2009, PROTEINS, V75, P478, DOI 10.1002/prot.22259
   Armugam A, 2004, ARCH BIOCHEM BIOPHYS, V421, P10, DOI 10.1016/j.abb.2003.09.045
   Barber CM, 2012, TOXICOL LETT, V210, P318, DOI 10.1016/j.toxlet.2012.02.001
   Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363
   Birrell GW, 2006, MOL CELL PROTEOMICS, V5, P379, DOI 10.1074/mcp.M500270-MCP200
   Bos MHA, 2010, TOXINS, V2, P1554, DOI 10.3390/toxins2061554
   Bos MHA, 2009, BLOOD, V114, P686, DOI 10.1182/blood-2009-02-202663
   Calvete JJ, 2013, TOXICON, V75, P44, DOI 10.1016/j.toxicon.2013.03.020
   Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x
   Chatrath ST, 2011, J PROTEOME RES, V10, P739, DOI 10.1021/pr1008916
   Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996
   Cheng AC, 2012, J BIOL CHEM, V287, P15739, DOI 10.1074/jbc.M111.323063
   Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8
   Doley R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-146
   Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885
   Du XY, 2002, J BIOL CHEM, V277, P35124, DOI 10.1074/jbc.M204372200
   Earl STH, 2012, TOXICON, V59, P456, DOI 10.1016/j.toxicon.2010.12.010
   Earl STH, 2011, BIOCHIMIE, V93, P519, DOI 10.1016/j.biochi.2010.11.006
   EunHwaChung, 2002, International Journal of Industrial Entomology, V4, P43
   Faiz MA, 1996, COMP BIOCHEM PHYS B, V113, P199, DOI 10.1016/0305-0491(95)02050-0
   Filippovich I, 2005, BRIT J HAEMATOL, V131, P237, DOI 10.1111/j.1365-2141.2005.05744.x
   Filippovich I, 2002, BRIT J HAEMATOL, V119, P376, DOI 10.1046/j.1365-2141.2002.03878.x
   FRITZINGER DC, 1994, P NATL ACAD SCI USA, V91, P12775, DOI 10.1073/pnas.91.26.12775
   Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200
   Fry BG, 2010, MOL CELL PROTEOMICS, V9, P2369, DOI 10.1074/mcp.M110.001370
   Furman BL, 2012, TOXICON, V59, P464, DOI 10.1016/j.toxicon.2010.12.016
   Gasparello-Clemente E, 2002, TOXICON, V40, P1617, DOI 10.1016/S0041-0101(02)00180-0
   Georgieva D, 2011, J PROTEOME RES, V10, P2440, DOI 10.1021/pr101248e
   Gong NL, 1999, EUR J BIOCHEM, V265, P982, DOI 10.1046/j.1432-1327.1999.00800.x
   Gong NL, 2000, FEBS LETT, V473, P303, DOI 10.1016/S0014-5793(00)01549-0
   Gong NL, 2001, BIOCHEM J, V358, P647, DOI 10.1042/0264-6021:3580647
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   GUTIERREZ JM, 1981, TOXICON, V19, P493, DOI 10.1016/0041-0101(81)90007-6
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Harrison RA, 2007, GENE, V392, P22, DOI 10.1016/j.gene.2006.10.026
   Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569
   Hegde R.P., 2009, HDB VENOMS TOXINS RE, P521
   HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677
   Henschen-Edman AH, 1999, THROMB HAEMOSTASIS, V81, P81
   Heyborne W.H., 2009, HDB VENOMS TOXINS RE, P521
   Hisada M, 2005, BIOCHEM BIOPH RES CO, V330, P1048, DOI 10.1016/j.bbrc.2005.03.087
   Irwin DM, 2012, GEN COMP ENDOCR, V175, P27, DOI 10.1016/j.ygcen.2011.11.025
   ITOH N, 1987, J BIOL CHEM, V262, P3132
   Jackson TNW, 2013, TOXINS, V5, P2621, DOI 10.3390/toxins5122621
   JOUBERT FJ, 1977, BIOCHIM BIOPHYS ACTA, V493, P216, DOI 10.1016/0005-2795(77)90275-6
   Judge RK, 2006, TOXICOL APPL PHARM, V213, P117, DOI 10.1016/j.taap.2005.09.010
   Kemparaju K., 2009, HDB VENOMS TOXINS RE, P521
   Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kini RM, 2001, THROMB HAEMOSTASIS, V86, P710
   Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101
   KUWABARA K, 1995, J BIOL CHEM, V270, P8179, DOI 10.1074/jbc.270.14.8179
   Kwok HF, 2008, PEPTIDES, V29, P65, DOI 10.1016/j.peptides.2007.10.025
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006
   Le TNM, 2005, THROMB HAEMOSTASIS, V93, P420, DOI 10.1160/TH040-11-0707
   LIN W-W, 1987, Proceedings of the National Science Council Republic of China Part B Life Sciences, V11, P155
   Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624
   Madrigal M, 2012, J PROTEOMICS, V77, P280, DOI 10.1016/j.jprot.2012.09.003
   MANN KG, 1990, BLOOD, V76, P1
   Margres MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-531
   Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004
   MASCI PP, 1988, BIOCHEM INT, V17, P825
   Masci PP, 2000, BLOOD COAGUL FIBRIN, V11, P385, DOI 10.1097/00001721-200006000-00011
   Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228
   Mirtschin PJ, 1998, AUST VET J, V76, P195, DOI 10.1111/j.1751-0813.1998.tb10128.x
   Mirtschin PJ, 2002, TOXICON, V40, P1581, DOI 10.1016/S0041-0101(02)00175-7
   Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243
   MOCHCAMORALES J, 1990, TOXICON, V28, P299, DOI 10.1016/0041-0101(90)90065-F
   MORRISSETTE J, 1995, BIOPHYS J, V68, P2280, DOI 10.1016/S0006-3495(95)80410-8
   Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318
   Castro EN, 2013, J PROTEOMICS, V87, P103, DOI 10.1016/j.jprot.2013.05.024
   Ogawa Y, 2006, COMP BIOCHEM PHYS B, V145, P35, DOI 10.1016/j.cbpb.2006.05.013
   Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307
   OmPraba G, 2010, J PROTEOME RES, V9, P1882, DOI 10.1021/pr901044x
   Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115
   Paiva O, 2014, J PROTEOMICS, V110, P209, DOI 10.1016/j.jprot.2014.07.019
   PEARSON JA, 1993, BIOCHIM BIOPHYS ACTA, V1161, P223, DOI 10.1016/0167-4838(93)90217-F
   Pung YF, 2005, J BIOL CHEM, V280, P13137, DOI 10.1074/jbc.M414137200
   Rao VS, 2003, BLOOD, V102, P1347, DOI 10.1182/blood-2002-12-3839
   Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611
   Reyes-Velasco J, 2015, MOL BIOL EVOL, V32, P173, DOI 10.1093/molbev/msu294
   Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312
   SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121
   Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279
   Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696
   St Pierre L, 2008, CELL MOL LIFE SCI, V65, P4039, DOI 10.1007/s00018-008-8573-5
   St Pierre L, 2007, CELL MOL LIFE SCI, V64, P2829, DOI 10.1007/s00018-007-7352-z
   St Pierre L, 2005, CELL MOL LIFE SCI, V62, P2679, DOI 10.1007/s00018-005-5384-9
   St Pierre L, 2007, J PROTEOME RES, V6, P3093, DOI 10.1021/pr0701613
   St Pierre L, 2006, BIOCHIMIE, V88, P1923, DOI 10.1016/j.biochi.2006.06.014
   Sunagar K, 2013, TOXINS, V5, P2172, DOI 10.3390/toxins5112172
   Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005
   TIBBALLS J, 1991, ANAESTH INTENS CARE, V19, P338, DOI 10.1177/0310057X9101900304
   TIBBALLS J, 1992, ANAESTH INTENS CARE, V20, P28, DOI 10.1177/0310057X9202000105
   Torres AM, 2003, J BIOL CHEM, V278, P40097, DOI 10.1074/jbc.M305322200
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tsueshita T, 2004, PEPTIDES, V25, P65, DOI 10.1016/j.peptides.2003.11.010
   TYLER MI, 1987, EUR J BIOCHEM, V166, P139, DOI 10.1111/j.1432-1033.1987.tb13493.x
   UTAISINCHAROEN P, 1993, J BIOL CHEM, V268, P21975
   Utkin YN, 2013, TOXICON, V62, P50, DOI 10.1016/j.toxicon.2012.09.007
   Viala VL, 2014, J PROTEOMICS, V110, P32, DOI 10.1016/j.jprot.2014.07.030
   Vink S, 2012, TOXICON, V59, P434, DOI 10.1016/j.toxicon.2010.12.001
   Vogel CW, 2010, TOXICON, V56, P1198, DOI 10.1016/j.toxicon.2010.04.007
   Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110
   Vonk FJ, 2011, BIOESSAYS, V33, P269, DOI 10.1002/bies.201000117
   Wang Zengjun, 2007, Soc Reprod Fertil Suppl, V65, P535
   Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195
   Welton RE, 2005, TOXICON, V46, P328, DOI 10.1016/j.toxicon.2005.05.001
   White J., 2009, HDB VENOMS TOXINS RE, P521
   World Health Organization, 2007, RAB ENV NEGL PUBL HL
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
   Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567
   Zha HG, 2001, TOXICON, V39, P1887, DOI 10.1016/S0041-0101(01)00172-6
NR 118
TC 13
Z9 13
U1 4
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 1
PY 2015
VL 107
SI SI
BP 252
EP 265
DI 10.1016/j.toxicon.2015.06.005
PN B
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA CY6SR
UT WOS:000366539600009
PM 26079951
DA 2020-12-01
ER

PT J
AU Mariutti, RB
   Souza, TACB
   Ullah, A
   Caruso, IP
   de Moraes, FR
   Zanphorlin, LM
   Tartaglia, NR
   Seyffert, N
   Azevedo, VA
   Le Loir, Y
   Murakami, MT
   Arni, RK
AF Mariutti, Ricardo B.
   Souza, Tatiana A. C. B.
   Ullah, Anwar
   Caruso, Icaro P.
   de Moraes, Fabio R.
   Zanphorlin, Leticia M.
   Tartaglia, Natayme R.
   Seyffert, Nubia
   Azevedo, Vasco A.
   Le Loir, Yves
   Murakami, Mario T.
   Arni, Raghuvir K.
TI Crystal structure of Staphylococcus aureus exfoliative toxin D-like
   protein: Structural basis for the high specificity of exfoliative toxins
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Exfoliative toxin D-like protein; Staphylococcus aureus; Crystal
   structure; Toxin-mediated staphylococcal syndromes
ID SCALDED-SKIN SYNDROME; MOLECULAR SIMULATION; CIRCULAR-DICHROISM; BULLOUS
   IMPETIGO; SERINE-PROTEASE; DESMOGLEIN-1; SUPERANTIGEN; REFINEMENT;
   CLEAVAGE; MASTITIS
AB Exfoliative toxins are serine proteases secreted by Staphylococcus aureus that are associated with toxin-mediated staphylococcal syndromes. To date, four different serotypes of exfoliative toxins have been identified and 3 of them (ETA, ETB, and ETD) are linked to human infection. Among these toxins, only the ETD structure remained unknown, limiting our understanding of the structural determinants for the functional differentiation between these toxins. We recently identified an ETD-like protein associated to S. aureus strains involved in mild mastitis in sheep. The crystal structure of this ETD-like protein was determined at 1.95 angstrom resolution and the structural analysis provide insights into the oligomerization, stability and specificity and enabled a comprehensive structural comparison with ETA and ETB. Despite the highly conserved molecular architecture, significant differences in the composition of the loops and in both the N- and C-terminal alpha-helices seem to define ETD-like specificity. Molecular dynamics simulations indicate that these regions defining ET specificity present different degrees of flexibility and may undergo conformational changes upon substrate recognition and binding. DLS and AUC experiments indicated that the ETD-like is monomeric in solution whereas it is present as a dimer in the asymmetric unit indicating that oligomerization is not related to functional differentiation among these toxins. Differential scanning calorimetry and circular dichroism assays demonstrated an endothermic transition centered at 52 degrees C, and an exothermic aggregation in temperatures up to 64 degrees C. All these together provide insights about the mode of action of a toxin often secreted in syndromes that are not associated with either ETA or ETB. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Mariutti, Ricardo B.; Ullah, Anwar; Caruso, Icaro P.; de Moraes, Fabio R.; Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, Multi User Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Souza, Tatiana A. C. B.] FIOCRUZ PR, Carlos Chagas Inst, Curitiba, Parana, Brazil.
   [Zanphorlin, Leticia M.] Natl Ctr Res Energy & Mat, Bioethanol Sci & Technol Lab CTBE, BR-13083970 Campinas, SP, Brazil.
   [Tartaglia, Natayme R.; Seyffert, Nubia; Azevedo, Vasco A.] Univ Fed Minas Gerais, Inst Biol Sci, Cellular & Mol Genet Lab, BR-270901 Belo Horizonte, MG, Brazil.
   [Le Loir, Yves] INRA, STLO UMR1253, Sci & Technol Lait & Aeuf, F-35042 Rennes, France.
   [Tartaglia, Natayme R.; Le Loir, Yves] Agrocampus Ouest, STLO UMR1253, F-35042 Rennes, France.
   [Murakami, Mario T.] Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/C-2087-2012; de Moraes, Fabio R/B-8331-2017; Azevedo,
   Vasco A/B-1556-2019; Murakami, Mario T/F-5640-2016; Azevedo, Vasco
   A.C/F-4315-2011; Arni, Raghuvir K/B-2222-2013; Seyffert,
   Nubia/N-6410-2014; Arni, Raghuvir K/N-9338-2018; Caruso, Icaro
   P./M-8647-2017; Ullah, Anwar/B-1720-2013
OI de Moraes, Fabio R/0000-0002-0425-0352; Azevedo, Vasco
   A/0000-0002-4775-2280; Murakami, Mario T/0000-0002-0405-8010; Azevedo,
   Vasco A.C/0000-0002-4775-2280; Arni, Raghuvir K/0000-0003-2460-1145;
   Seyffert, Nubia/0000-0002-2193-6508; Arni, Raghuvir
   K/0000-0003-2460-1145; Caruso, Icaro P./0000-0003-4464-0520; Ullah,
   Anwar/0000-0003-3793-7393; Le Loir, Yves/0000-0002-0355-1065; mariutti,
   ricardo/0000-0001-6720-4655
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Amagai M, 2000, NAT MED, V6, P1275
   Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x
   BAILEY CJ, 1982, BIOCHEM J, V203, P775, DOI 10.1042/bj2030775
   Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003
   Benson P., MEDSCAPE
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Borges JC, 2011, CURR MED CHEM, V18, P1276
   Bukowski M, 2010, TOXINS, V2, P1148, DOI 10.3390/toxins2051148
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Cavarelli J, 1997, STRUCTURE, V5, P813, DOI 10.1016/S0969-2126(97)00235-9
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   DEAZAVEDO JCS, 1988, METHOD ENZYMOL, V165, P32
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356
   Hanakawa Y, 2004, J BIOL CHEM, V279, P5268, DOI 10.1074/jbc.M311087200
   Hanakawa Y, 2003, J INVEST DERMATOL, V121, P383, DOI 10.1046/j.1523-1747.2003.12362.x
   Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   Le Marechal C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027354
   Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6
   Le Marechal C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-35
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nishifuji K, 2008, J DERMATOL SCI, V49, P21, DOI 10.1016/j.jdermsci.2007.05.007
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Papageorgiou AC, 2000, PROTEIN SCI, V9, P610
   PERONA JJ, 1995, PROTEIN SCI, V4, P337
   Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011
   PIEMONT Y, 1986, FEMS MICROBIOL LETT, V36, P245, DOI 10.1016/0378-1097(86)90320-4
   Prevost G, 2003, CURR OPIN INFECT DIS, V16, P71, DOI 10.1097/00001432-200304000-00002
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vath GM, 1999, BIOCHEMISTRY-US, V38, P10239, DOI 10.1021/bi990721e
   Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f
   Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002
   Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje
   Yamasaki O, 2006, CLIN MICROBIOL INFEC, V12, P585, DOI 10.1111/j.1469-0691.2006.01410.x
   Yamasaki O, 2005, J CLIN MICROBIOL, V43, P1890, DOI 10.1128/JCM.43.4.1890-1893.2005
NR 43
TC 3
Z9 3
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 6
PY 2015
VL 467
IS 1
BP 171
EP 177
DI 10.1016/j.bbrc.2015.08.083
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU7JQ
UT WOS:000363712900028
PM 26299923
OA Green Published
DA 2020-12-01
ER

PT J
AU Lindae, A
   Eberle, RJ
   Caruso, IP
   Coronado, MA
   de Moraes, FR
   Azevedo, V
   Arni, RK
AF Lindae, Antje
   Eberle, Raphael J.
   Caruso, Icaro P.
   Coronado, Monika A.
   de Moraes, Fabio R.
   Azevedo, Vasco
   Arni, Raghuvir K.
TI Expression, purification and characterization of cold shock protein A of
   Corynebacterium pseudotuberculosis
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE C. pseudotuberculosis; Cold shock protein; Spectroscopic methods;
   Secondary structure; Folding and refolding proteins
ID STRANDED-DNA TEMPLATES; ESCHERICHIA-COLI; CIRCULAR-DICHROISM;
   BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; BINDING-PROTEINS; CSPA; GENES;
   IDENTIFICATION; LYMPHADENITIS
AB The gram-positive bacterium Corynebacterium pseudotuberculosis is the causative agent of different diseases that cause dramatically reduced yields of wool and milk, and results in weight loss, carcass condemnation and also death mainly in sheep, equids, cattle and goats and therefore globally results in considerable economical loss. Cold shock proteins are conserved in many bacteria and eukaryotic cells and they help to restore normal cell functions after cold shock in which some appear to have specific functions at normal growth temperature as well.
   Cold shock protein A from C pseudotuberculosis was expressed in Escherichia coli and purified. The thermal unfolding/refolding process characterized by circular dichroism, differential scanning calorimetry and NMR spectroscopy techniques indicated that the refolding process was almost completely reversible. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Lindae, Antje; Eberle, Raphael J.; Caruso, Icaro P.; Coronado, Monika A.; de Moraes, Fabio R.; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Ctr Multiusuario Inovacao Biomol, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Azevedo, Vasco] Univ Fed Minas Gerais, Lab Genet Celular & Mol, Inst Ciencias Biol, BR-270901 Belo Horizonte, MG, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Ctr Multiusuario Inovacao Biomol, Dept Fis, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI de Moraes, Fabio R/B-8331-2017; Azevedo, Vasco A.C/F-4315-2011; Arni,
   Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; Azevedo, Vasco
   A/B-1556-2019; Caruso, Icaro P./M-8647-2017
OI de Moraes, Fabio R/0000-0002-0425-0352; Azevedo, Vasco
   A.C/0000-0002-4775-2280; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Azevedo, Vasco A/0000-0002-4775-2280;
   Caruso, Icaro P./0000-0003-4464-0520; Eberle,
   Raphael/0000-0002-8763-3884
FU CNPq (Science without Frontiers); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPESCAPES
FX This research was supported by grants from the CNPq (Science without
   Frontiers), FAPESP, and CAPES. The authors want to thanks the PROPe
   UNESP.
CR AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   BRANDI A, 1994, BIOCHIMIE, V76, P1090, DOI 10.1016/0300-9084(94)90035-3
   Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564
   Cooper A., 2000, PROTEIN LIGAND INTER
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Grimsley GR, 2004, CURR PROTOC PROTEIN
   Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0
   Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620
   Huang L, 2012, PROTEIN SCI, V21, P677, DOI 10.1002/pro.2053
   Jiang WN, 1997, J BIOL CHEM, V272, P196
   JONES PG, 1992, J BACTERIOL, V174, P5798, DOI 10.1128/jb.174.18.5798-5802.1992
   Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315
   Kim WS, 2007, J MICROBIOL BIOTECHN, V17, P1353
   Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LATEANA A, 1991, P NATL ACAD SCI USA, V88, P10907, DOI 10.1073/pnas.88.23.10907
   LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8
   Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0
   Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601
   Max KEA, 2007, J MOL BIOL, V369, P1087, DOI 10.1016/j.jmb.2007.04.016
   Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Morgan HP, 2009, ACTA CRYSTALLOGR F, V65, P1240, DOI 10.1107/S1744309109033788
   Morgan HP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm040
   Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602
   PATON MW, 1994, AUST VET J, V71, P47, DOI 10.1111/j.1751-0813.1994.tb06152.x
   Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185
   SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119
   Schindelin H., 1993, NATURE
   Schindler T, 1996, BIOCHEMISTRY-US, V35, P16833, DOI 10.1021/bi962090j
   SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663
   Schnuchel A., 1993, NATURE
   Sreerama N, 2004, METHOD ENZYMOL, V383, P318
   Thieringer HA, 1998, BIOESSAYS, V20, P49
   WOLFFE AP, 1992, NEW BIOL, V4, P290
NR 36
TC 12
Z9 12
U1 1
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD AUG
PY 2015
VL 112
BP 15
EP 20
DI 10.1016/j.pep.2015.04.006
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA CJ5ZG
UT WOS:000355572200003
PM 25907380
DA 2020-12-01
ER

PT J
AU Stuqui, B
   de Paula-Silva, M
   Carlos, CP
   Ullah, A
   Arni, RK
   Gil, CD
   Oliani, SM
AF Stuqui, Bruna
   de Paula-Silva, Marina
   Carlos, Carla Patricia
   Ullah, Anwar
   Arni, Raghuvir Krishnaswamy
   Gil, Cristiane Damas
   Oliani, Sonia Maria
TI Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic
   Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49
   Phospholipase A(2) in a Rat Model
SO PLOS ONE
LA English
DT Article
ID ASPER SNAKE-VENOM; MAST-CELLS; MYOTOXIN-II; ADHESION MOLECULES;
   HEPARIN-BINDING; EXPRESSION; RELEASE; EDEMA; PROTEIN; INJURY
AB Annexin A1 (AnxA1) is an endogenous glucocorticoid regulated protein that modulates antiinflammatory process and its therapeutic potential has recently been recognized in a range of systemic inflammatory disorders. The effect of the N-terminal peptide Ac2-26 of AnxA1 on the toxic activities of Bothrops moojeni crude venom (CV) and its myotoxin II (MjTX-II) were evaluated using a peritonitis rat model. Peritonitis was induced by the intraperitoneal injection of either CV or MjTX-II, a Lys-49 phospholipase A2. Fifteen minutes after the injection, the rats were treated with either Ac2-26 or PBS. Four hours later, the CV and MjTX-II-induced peritonitis were characterized by neutrophilia (in the peritoneal exudate, blood and mesentery) and increased number of mesenteric degranulated mast cells and macrophages. At 24 hours post-injection, the local inflammatory response was attenuated in the CV-induced peritonitis while the MjTX-II group exhibited neutrophilia (peritoneal exudates and blood). Ac2-26 treatment prevented the influx of neutrophils in MjTX-II-induced peritonitis and diminished the proportion of mesenteric degranulated mast cells and macrophages in CV-induced peritonitis. Additionally, CV and MjTX-II promoted increased levels of IL-1 beta and IL-6 in the peritoneal exudates which were significantly reduced after Ac2-26 treatment. At 4 and 24 hours, the endogenous expression of AnxA1 was upregulated in the mesenteric neutrophils (CV and MjTX-II groups) and mast cells (CV group). In the kidneys, CV and MjTX-II administrations were associated with an increased number of macrophages and morphological alterations in the juxtamedullary nephrons in proximal and distal tubules. Ac2-26 promoted significant recovery of the juxtamedullary structures, decreased the number of macrophages and diminished the AnxA1 in epithelial cells from distal tubules and renal capsules. Our results show that Ac2-26 treatment significantly attenuates local and systemic inflammatory processes and indicate this peptide as a potential target for the development of new therapeutic strategies for the snakebite envenomation treatment.
C1 [Stuqui, Bruna; de Paula-Silva, Marina; Carlos, Carla Patricia; Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.
   [Ullah, Anwar; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Paulo, Brazil.
   [Gil, Cristiane Damas] Sao Paulo Fed Univ UNIFESP, Dept Morphol & Genet, Sao Paulo, Brazil.
RP Oliani, SM (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.
EM smoliani@ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Silva, Marina/P-7857-2017; Arni, Raghuvir
   K/N-9338-2018; Gil, Cristiane Damas/E-1187-2012; Oliani, Sonia
   Maria/E-3476-2012; Ullah, Anwar/B-1720-2013; Carlos, Carla P/K-1403-2014
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Gil, Cristiane Damas/0000-0001-6979-4126; Oliani,
   Sonia Maria/0000-0003-0918-2130; Ullah, Anwar/0000-0003-3793-7393;
   Carlos, Carla P/0000-0003-0516-4533
FU State of Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); National Council for
   Scientific and Technological Development (CNPq), BrazilNational Council
   for Scientific and Technological Development (CNPq)
FX This work was supported by the State of Sao Paulo Research Foundation
   (FAPESP) and by the National Council for Scientific and Technological
   Development (CNPq), Brazil. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ajuebor MN, 1999, J IMMUNOL, V162, P1685
   [Anonymous], 1999, MAN DIAGN TRAT AC AN
   ANTUNES E, 1990, BRIT J PHARMACOL, V101, P986, DOI 10.1111/j.1476-5381.1990.tb14193.x
   Araujo LP, 2010, AM J NEPHROL, V31, P527, DOI 10.1159/000309756
   Araujo LP, 2012, INFLAMM RES, V61, P189, DOI 10.1007/s00011-011-0400-z
   Araujo SD, 2007, INFLAMM RES, V56, P409, DOI 10.1007/s00011-007-7054-x
   ASSAKURA MT, 1985, TOXICON, V23, P691, DOI 10.1016/0041-0101(85)90374-5
   Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473
   Boer-Lima PA, 1999, AM J TROP MED HYG, V61, P698, DOI 10.4269/ajtmh.1999.61.698
   Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587
   Carneiro AS, 2008, TOXICON, V52, P619, DOI 10.1016/j.toxicon.2008.07.012
   Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738
   COLEMAN JW, 1981, BIOCHEM J, V198, P615, DOI 10.1042/bj1980615
   Collares-Buzato CB, 2002, TOXICOL APPL PHARM, V181, P124, DOI 10.1006/taap.2002.9404
   da Silva PS, 2011, MOL VIS, V17, P1310
   Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410
   de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015
   dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858
   ENNIS M, 1980, BRIT J PHARMACOL, V70, P329, DOI 10.1111/j.1476-5381.1980.tb07940.x
   Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4
   Fernandes CM, 2006, TOXICON, V47, P549, DOI 10.1016/j.toxicon.2006.01.009
   Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342
   Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010
   Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030
   Guido BC, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-10
   GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211
   GUTIERREZ JM, 1986, REV BIOL TROP, V34, P209
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   ITO NMK, 1989, RES VET SCI, V46, P192, DOI 10.1016/S0034-5288(18)31144-5
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2
   Kanashiro MM, 2002, BIOCHEM PHARMACOL, V64, P1179, DOI 10.1016/S0006-2952(02)01288-1
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   Kumar V., 2010, ROBBINS COTRAN PATOL
   Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X
   Landucci ECT, 2000, BIOCHEM PHARMACOL, V59, P1289, DOI 10.1016/S0006-2952(00)00248-3
   Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007
   Maria DA, 2003, TOXICON, V42, P579, DOI 10.1016/S0041-0101(03)00237-X
   Markoff A, 2005, AM J PHYSIOL-RENAL, V289, pF949, DOI 10.1152/ajprenal.00089.2005
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877
   MOLITORIS BA, 1991, AM J PHYSIOL, V260, pF769
   Moreira V, 2008, TOXICON, V52, P428, DOI 10.1016/j.toxicon.2008.06.012
   MORENO JJ, 1992, AGENTS ACTIONS, V36, P258
   Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101
   Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041
   Nascimento NG, 2010, TOXICON, V55, P343, DOI 10.1016/j.toxicon.2009.08.009
   Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006
   Oliani SM, 2008, INFLAMM RES, V57, P450, DOI 10.1007/s00011-008-7222-7
   Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3
   PALLER MS, 1994, J MEMBRANE BIOL, V142, P127
   Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552
   Polli-Lopes AC, 2013, INT J CLIN EXP PATHO, V6, P13
   Santos NA, 2008, TOXICON, V52, P908, DOI 10.1016/j.toxicon.2008.08.020
   Saude Md, 2011, AC AN PEC SERPENTES2
   SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6
   Sena AAS, 2006, CLIN EXP ALLERGY, V36, P1260, DOI 10.1111/j.1365-2222.2006.02570.x
   Sgrignolli LR, 2011, NEPHRON CLIN PRACT, V119, pC131, DOI 10.1159/000324228
   Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639
   Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5
   Soerensen B., 1990, ANIMAIS PECONHENTOS, P138
   Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje
   VORONOV E, 1999, J VENOM ANIM TOXINS, V5, P5, DOI DOI 10.1590/S0104-79301999000100002
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000
   Zamuner SR, 2005, TOXICON, V46, P806, DOI 10.1016/j.toxicon.2005.08.011
NR 69
TC 12
Z9 14
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2015
VL 10
IS 7
AR e0130803
DI 10.1371/journal.pone.0130803
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1DQ
UT WOS:000358157600050
PM 26147724
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Eberle, RJ
   Coronado, MA
   Caruso, IP
   Lopes, DO
   Miyoshi, A
   Azevedo, V
   Arni, RK
AF Eberle, Raphael J.
   Coronado, Monika A.
   Caruso, Icaro P.
   Lopes, Debora O.
   Miyoshi, Anderson
   Azevedo, Vasco
   Arni, Raghuvir K.
TI Chemical and thermal influence of the [4Fe-4S](2+) cluster of
   A/G-specific adenine glycosylase from Corynebacterium pseudotuberculosis
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE C. pseudotuberculosis; MutY; [4Fe-4S](2+) cluster; DNA repair;
   Spectroscopic method; Secondary and tertiary structure
ID IRON-SULFUR CLUSTERS; DNA-REPAIR; CASEOUS-LYMPHADENITIS;
   CIRCULAR-DICHROISM; PROTEIN; FERREDOXIN; BASE; MICROBIOLOGY;
   PATHOGENESIS; RECOGNITION
AB The gram-positive bacteria Corynebacterium pseudotuberculosis, the causative agent of caseous lymphadenitis in livestock significantly reduces productivity and often causes death. The adenine/guanine-specific DNA glycosylase (MutY) prevents mutations in the DNA of the pathogen and a unique feature of the MutY protein family is the [4Fe-4S](2+) cluster that interlinks two protein subdomains. MutY from C. pseudotuberculosis was expressed in E. coli and purified, the CD experiments indicate a high content of alpha-helices and random coiled secondary structure and a typical near-UV CD fingerprint for the [4Fe-4S](2+) cluster. EDTA and copper sulfate possess a strong destabilizing effect on the [4Fe-4S](2+) cluster. UV-vis and fluorescence spectroscopy results demonstrate that between pH 3.0 and 4.0 the integrity of the [4Fe-4S](2+) cluster is destroyed. To investigate the thermal stability of the protein differential scanning calorimetry and fluorescence spectroscopy were used and the T-m was determined to be 45 degrees C. The analysis presented provides information concerning the protein stability under different physio-chemical conditions. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Eberle, Raphael J.; Coronado, Monika A.; Caruso, Icaro P.; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Lopes, Debora O.] Fed Univ Sao Joao Del Rei CCO, Mol Biol Lab, BR-35501296 Divinopolis, MG, Brazil.
   [Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, BR-270901 Belo Horizonte, MG, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Arni, Raghuvir K/N-9338-2018; Azevedo, Vasco A/B-1556-2019; Azevedo,
   Vasco A.C/F-4315-2011; lopes, debora/L-3601-2016; Arni, Raghuvir
   K/B-2222-2013; Caruso, Icaro P./M-8647-2017
OI Arni, Raghuvir K/0000-0003-2460-1145; Azevedo, Vasco
   A/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; lopes,
   debora/0000-0002-8559-8552; Arni, Raghuvir K/0000-0003-2460-1145;
   Caruso, Icaro P./0000-0003-4464-0520; Eberle,
   Raphael/0000-0002-8763-3884
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This research was supported by grants from the CNPq (Science without
   Frontiers), FAPESP, CAPES and FAPEMIG.
CR AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251
   Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448
   Bowers EM, 2007, BBA-PROTEINS PROTEOM, V1774, P1500, DOI 10.1016/j.bbapap.2007.10.007
   Bregenzer Thomas, 1997, Clin Microbiol Infect, V3, P696, DOI 10.1111/j.1469-0691.1997.tb00482.x
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Constantinescu D, 2007, ANGEW CHEM INT EDIT, V46, P8887, DOI 10.1002/anie.200702295
   CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049
   Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969
   Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056
   Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166
   EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353
   Eswar N., 2007, CURR PROTOC BIOINFOR, V15, P1
   Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125
   Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168
   Higgins CL, 2002, BBA-PROTEINS PROTEOM, V1599, P82, DOI 10.1016/S1570-9639(02)00405-3
   JOHNSON MK, 1994, ENCY INORGANIC CHEM
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leal SS, 2008, BBA-PROTEINS PROTEOM, V1784, P1596, DOI 10.1016/j.bbapap.2008.05.001
   Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106
   Manuel RC, 2004, J BIOL CHEM, V279, P46930, DOI 10.1074/jbc.M403944200
   Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658
   McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002
   Messick TE, 2002, BIOCHEMISTRY-US, V41, P3931, DOI 10.1021/bi012035x
   MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992
   Moczygemba C, 2001, PROTEIN SCI, V10, P1539, DOI 10.1110/ps.49401
   Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2
   Ossa DMH, 2011, PROCESS BIOCHEM, V46, P1335, DOI 10.1016/j.procbio.2011.03.001
   Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185
   Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t
   Resende BC, 2011, GENE, V482, P1, DOI 10.1016/j.gene.2011.03.008
   Ryle MJ, 1996, J BIOL CHEM, V271, P1551, DOI 10.1074/jbc.271.3.1551
   Sreerama N, 2004, METHOD ENZYMOL, V383, P318
   SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035
   TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L
   Williamson LH, 2001, VET CLIN N AM-FOOD A, V17, P359, DOI 10.1016/S0749-0720(15)30033-5
   Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11
NR 40
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD FEB
PY 2015
VL 1850
IS 2
BP 393
EP 400
DI 10.1016/j.bbagen.2014.11.014
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ5JF
UT WOS:000348256800015
PM 25445713
OA Bronze
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Ullah, A
   da Silva, LS
   Chaves-Moreira, D
   Vuitika, L
   Chaim, OM
   Veiga, SS
   Chahine, J
   Murakami, MT
   Arni, RK
AF Coronado, M. A.
   Ullah, A.
   da Silva, L. S.
   Chaves-Moreira, D.
   Vuitika, L.
   Chaim, O. M.
   Veiga, S. S.
   Chahine, J.
   Murakami, M. T.
   Arni, R. K.
TI Structural Insights into Substrate Binding of Brown Spider Venom Class
   II Phospholipases D
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Loxoscele; myo-inositol-1-phosphate; phospholipase D; sphingomyelin
ID DERMONECROTIC TOXIN; SPHINGOMYELINASES-D; TOOLS; ACID
AB Phospholipases D (PLDs), the major dermonecrotic factors from brown spider venoms, trigger a range of biological reactions both in vitro and in vivo. Despite their clinical relevance in loxoscelism, structural data is restricted to the apo-form of these enzymes, which has been instrumental in understanding the functional differences between the class I and II spider PLDs. The crystal structures of the native class II PLD from Loxosceles intermedia complexed with myo-inositol 1-phosphate and the inactive mutant H12A complexed with fatty acids indicate the existence of a strong ligand-dependent conformation change of the highly conserved aromatic residues, Tyr 223 and Trp225 indicating their roles in substrate binding. These results provided insights into the structural determinants for substrate recognition and binding by class II PLDs.
C1 [Coronado, M. A.; Ullah, A.; da Silva, L. S.; Chahine, J.; Arni, R. K.] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Chaves-Moreira, D.; Vuitika, L.; Chaim, O. M.; Veiga, S. S.] Univ Fed Parana UFPR, Dept Biol Celular, BR-80060000 Curitiba, Parana, Brazil.
   [Murakami, M. T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, BR-13083970 Campinas, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013; Ullah,
   Anwar/B-1720-2013; Arni, Raghuvir K/N-9338-2018; Chaim,
   Olga/H-5179-2012; Veiga, Silvio Sanches/C-2194-2013; Chaim, Olga
   Meiri/Y-7559-2019; Murakami, Mario T/F-5640-2016; Vuitika,
   Larissa/L-4664-2016; Chaves-Moreira, daniele/L-5133-2015; Sussuchi da
   Silva, Luciane/A-8833-2019
OI Arni, Raghuvir K/0000-0003-2460-1145; Ullah, Anwar/0000-0003-3793-7393;
   Arni, Raghuvir K/0000-0003-2460-1145; Chaim, Olga/0000-0002-3854-3292;
   Veiga, Silvio Sanches/0000-0002-9691-1225; Chaim, Olga
   Meiri/0000-0002-3854-3292; Murakami, Mario T/0000-0002-0405-8010;
   Moreira, Daniele/0000-0001-6562-8817; Chahine,
   Jorge/0000-0002-6474-0337; Sussuchi da Silva,
   Luciane/0000-0002-7470-4655
FU PROPe/UNESP; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)
FX This research was supported by funds from PROPe/UNESP, CAPES, CNPq and
   FAPESP. We are also grateful to the Center for Scientific Computing
   (NCC/GridUNESP) of the Sao Paulo State University (UNESP).
CR Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4
   Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217
   Case D. A., 2010, AMBER 11
   Cerutti DS, 2010, J CHEM THEORY COMPUT, V6, P443, DOI 10.1021/ct900522g
   Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Frisch M J, 2009, GAUSSIAN 09 REVISION
   Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023
   Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372
   MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   van Meeteren D.M., 2013, PLOS ONE, V8
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
NR 29
TC 9
Z9 9
U1 0
U2 12
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PY 2015
VL 16
IS 8
BP 768
EP 774
DI 10.2174/1389203716666150505231625
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CQ6EL
UT WOS:000360697100009
PM 25961401
DA 2020-12-01
ER

PT J
AU Santana, VS
   Mariutti, RB
   Eberle, RJ
   Ullah, A
   Caruso, IP
   Arni, RK
AF Santana, Vinicius S.
   Mariutti, Ricardo B.
   Eberle, Raphael J.
   Ullah, Anwar
   Caruso, Icaro P.
   Arni, Raghuvir K.
TI Preparation and Characterization of Monomodal Grapevine Virus A Capsid
   Protein
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Capsid protein; CD spectroscopy; dynamic light scattering; grapevine
   virus A; protein characterization; secondary structure
ID SERIAL FEMTOSECOND CRYSTALLOGRAPHY; POTEXVIRUS COAT PROTEIN; PAPAYA
   MOSAIC-VIRUS; ESCHERICHIA-COLI; CIRCULAR-DICHROISM; PLANT-VIRUSES;
   PURIFICATION; EXPRESSION; GENOME; GENUS
AB Grapevine virus A (GVA), a flexible filament of approximately 800 nm in length is composed of capsid subunits that spontaneously assembles around a positive sense genomic RNA. In addition to encapsidation, plant viruses capsid proteins (CPs) participate in other processes throughout infection and GVA CP is involved in cell-to-cell translocation of the virus. A protocol was developed to obtain low-molecular weight GVA-CP that is not prone to aggregation and spontaneous assembly and this was characterized by circular dichroism and dynamic light scattering. These results indicate the suitably of GVA-CP for X-ray crystallographic and NMR studies that should lead to the elucidation of the first three-dimensional structure of a flexible filamentous virus from the Betaflexiviridae family.
C1 [Santana, Vinicius S.; Mariutti, Ricardo B.; Eberle, Raphael J.; Ullah, Anwar; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Caruso, Icaro P.; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Caruso, Icaro P./M-8647-2017; Arni, Raghuvir K/N-9338-2018; Arni,
   Raghuvir K/B-2222-2013; Ullah, Anwar/B-1720-2013
OI Caruso, Icaro P./0000-0003-4464-0520; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; Ullah,
   Anwar/0000-0003-3793-7393; Eberle, Raphael/0000-0002-8763-3884;
   mariutti, ricardo/0000-0001-6720-4655
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; PROPe-UNESP
FX This work was supported by grants from FAPESP, CNPq, CAPES and
   PROPe-UNESP.
CR Boll John F., 2008, V451, P21, DOI 10.1007/978-1-59745-102-4_2
   Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Callaway A, 2001, ANNU REV PHYTOPATHOL, V39, P419, DOI 10.1146/annurev.phyto.39.1.419
   Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x
   Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750
   Gagne MEL, 2008, FEBS J, V275, P1474, DOI 10.1111/j.1742-4658.2008.06306.x
   Galiakparov N, 2003, VIROLOGY, V306, P42, DOI 10.1016/S0042-6822(02)00019-3
   HWANG DJ, 1994, P NATL ACAD SCI USA, V91, P9067, DOI 10.1073/pnas.91.19.9067
   Jacob T, 2002, VIRUS RES, V86, P133, DOI 10.1016/S0168-1702(02)00057-6
   Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/nmeth.1867, 10.1038/NMETH.1867]
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kegel WK, 2006, BIOPHYS J, V91, P1501, DOI 10.1529/biophysj.105.072603
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lecours K, 2006, PROTEIN EXPRES PURIF, V47, P273, DOI 10.1016/j.pep.2005.10.013
   Martelli GP, 1997, ARCH VIROL, V142, P1929
   Martelli GP, 2006, OPTIONS MEDITERRAN B, V55
   MCDONALD JG, 1976, VIROLOGY, V69, P327, DOI 10.1016/0042-6822(76)90220-8
   Minafra A, 1997, ARCH VIROL, V142, P417, DOI 10.1007/s007050050088
   Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663
   Serra-Negra JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080075
   Shanmugam G, 2005, J GEN VIROL, V86, P2371, DOI 10.1099/vir.0.81055-0
   Sreerama N, 2004, METHOD ENZYMOL, V383, P318
   Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x
   Voloudakis AE, 2004, ARCH VIROL, V149, P699, DOI 10.1007/s00705-003-0247-x
   Yang SQ, 2012, J MOL BIOL, V422, P263, DOI 10.1016/j.jmb.2012.05.032
   Yusibov V, 1996, J GEN VIROL, V77, P567, DOI 10.1099/0022-1317-77-4-567
   ZHAO XX, 1995, VIROLOGY, V207, P486, DOI 10.1006/viro.1995.1108
NR 28
TC 0
Z9 0
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PY 2015
VL 22
IS 8
BP 712
EP 718
DI 10.2174/0929866522666150625111607
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CM8GU
UT WOS:000357937700006
PM 26112976
DA 2020-12-01
ER

PT J
AU Ullah, A
   Masood, R
   Spencer, PJ
   Murakami, MT
   Arni, RK
AF Ullah, Anwar
   Masood, Rehana
   Spencer, Patrick Jack
   Murakami, Mario Tyago
   Arni, Raghuvir Krishnaswamy
TI Crystallization and preliminary X-ray diffraction studies of an
   L-amino-acid oxidase from Lachesis muta venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID SNAKE-VENOM; STRUCTURAL-CHARACTERIZATION; SKIN MUCUS; MECHANISM;
   PROTEINS; PURIFICATION; PROTEOME; INSIGHTS; LAAO
AB Snake-venom proteins form multi-component defence systems by the recruitment and rapid evolution of nonvenomous proteins and hence serve as model systems to understand the structural modifications that result in toxicity. l-Amino-acid oxidases (LAAOs) are encountered in a number of snake venoms and have been implicated in the inhibition of platelet aggregation, cytotoxicity, haemolysis, apoptosis and haemorrhage. An l-amino-acid oxidase from Lachesis muta venom has been purified and crystallized. The crystals belonged to space group P2(1), with unit-cell parameters a = 66.05, b = 79.41, c= 100.52 angstrom, beta = 96.55 degrees. The asymmetric unit contained two molecules and the structure has been determined and partially refined at 3.0 angstrom resolution.
C1 [Ullah, Anwar; Masood, Rehana; Arni, Raghuvir Krishnaswamy] UNESP IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Spencer, Patrick Jack] IPEN, Inst Pesquisas Energet & Nucl, Comissao Nacl Energia Nucl, BR-05508900 Sao Paulo, Brazil.
   [Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, BR-13083970 Campinas, Brazil.
RP Arni, RK (corresponding author), UNESP IBILCE, Dept Phys, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/F-5640-2016; Ullah, Anwar/B-1720-2013; Arni, Raghuvir
   K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; Murakami, Mario
   T/C-2087-2012
OI Murakami, Mario T/0000-0002-0405-8010; Ullah, Anwar/0000-0003-3793-7393;
   Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Spencer, Patrick/0000-0001-8949-7735
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; DAADDeutscher Akademischer Austausch Dienst (DAAD)
FX This research was supported by grants from FAPESP, CNPq, CAPES and DAAD.
   AU is supported by a FAPESP post-doctoral fellowship.
CR Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007
   Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x
   Bregge-Silva C, 2012, TOXICON, V60, P1263, DOI 10.1016/j.toxicon.2012.08.008
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Georgieva D, 2011, MOL BIOSYST, V7, P379, DOI 10.1039/c0mb00101e
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Jorge MT, 1997, TOXICON, V35, P545, DOI 10.1016/S0041-0101(96)00142-0
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x
   Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197
   LI ZY, 1994, TOXICON, V32, P1349, DOI 10.1016/0041-0101(94)90407-3
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Nagashima Y, 2009, COMP BIOCHEM PHYS B, V154, P55, DOI 10.1016/j.cbpb.2009.05.006
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rodrigues RS, 2009, BIOCHIMIE, V91, P490, DOI 10.1016/j.biochi.2008.12.004
   Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006
   Sun MZ, 2010, BIOCHIMIE, V92, P343, DOI 10.1016/j.biochi.2010.01.013
   Ullah A, 2012, BIOCHEM BIOPH RES CO, V421, P124, DOI 10.1016/j.bbrc.2012.03.129
   Ullah A, 2012, ACTA CRYSTALLOGR F, V68, P211, DOI 10.1107/S1744309111054923
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Yang HH, 2009, MYCOL RES, V113, P924, DOI 10.1016/j.mycres.2009.04.004
   Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046
   Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044
NR 29
TC 4
Z9 4
U1 0
U2 17
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD NOV
PY 2014
VL 70
BP 1556
EP 1559
DI 10.1107/S2053230X14017877
PN 11
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA AT2UE
UT WOS:000344790900021
PM 25372830
OA Green Published
DA 2020-12-01
ER

PT J
AU Viala, VL
   Hildebrand, D
   Trusch, M
   Arni, RK
   Pimenta, DC
   Schluter, H
   Betzel, C
   Spencer, PJ
AF Viala, Vincent L.
   Hildebrand, Diana
   Trusch, Maria
   Arni, Raghuvir K.
   Pimenta, Daniel C.
   Schlueter, Hartmut
   Betzel, Christian
   Spencer, Patrick J.
TI Pseudechis guttatus venom proteome: Insights into evolution and toxin
   clustering
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Pseudechis guttatus; Elapidae; Toxins; High throughput; Proteomics;
   2D-PAGE
ID AMINO-ACID OXIDASE; AUSTRALIAN KING BROWN; AGKISTRODON-HALYS-BLOMHOFFII;
   APOPTOSIS-INDUCING FACTOR; BLACK SNAKES PSEUDECHIS; RICH SECRETORY
   PROTEINS; GATED ION CHANNELS; ACCELERATED EVOLUTION;
   PLATELET-AGGREGATION; GEL-ELECTROPHORESIS
AB The Australian Elapidae spotted black snake Pseudechis guttatus venom proteome composition was analyzed by high throughput mass spectrometry. The crude venom proteins were decomplexed by 2D-PAGE and in-gel digestion peptides from 66 spot samples and analyzed by tandem mass spectrometry-LC-ESI-ion trap. Protein identification was performed combining PEAKS studio 7.0 and Mascot software. The analysis identified L-amino-acid oxidases, phospholipases A2, metalloproteases, nerve growth factors and ecto-5'-nucleotidases, and for the first time in this venom the components cysteine-rich secretory proteins similar to pseudechetoxin, phospholipase B and transferrin-like protein. The envenomation symptoms are in agreement with the identified components, but the present limitations of database information might impair the detection of toxin families, protein species and still unknown toxins. From the qualitative point of view, the similarity of this venom with the ones from other Pseudechis species could be assigned to recent speciation events.
   Biological significance
   Studies on the proteome of Australian Elapidae (Ancanthophiinae) are quite rare. In the present work we performed, using classic proteomic methods, a qualitative and partial analysis of the proteic components of Pseudechis guttatus venom. Although previous studies contributed to the knowledge of the major components of this venom, our study revealed some yet undescribed protein species, as well as new toxins, such as CRiSPs, phospholipase B, transferrin-like protein and ecto 5'-nucleotidase. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Viala, Vincent L.; Spencer, Patrick J.] IPEN, Ctr Biotechnol, BR-05508000 Sao Paulo, Brazil.
   [Hildebrand, Diana; Trusch, Maria; Schlueter, Hartmut] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, D-20246 Hamburg, Germany.
   [Arni, Raghuvir K.] UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Pimenta, Daniel C.] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil.
   [Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany.
RP Viala, VL (corresponding author), IPEN, Ctr Biotechnol, Av Lineu Prestes 2242, BR-05508000 Sao Paulo, Brazil.
EM pspencer@ipen.br
RI Schluter, Hartmut/D-1371-2015; Riedner, Maria/W-5546-2019; Viala,
   Vincent L/C-9924-2014; Betzel, Christian/G-8105-2018; Arni, Raghuvir
   K/N-9338-2018; Pimenta, Daniel C/B-4361-2008; Arni, Raghuvir
   K/B-2222-2013
OI Schluter, Hartmut/0000-0002-9358-7036; Betzel,
   Christian/0000-0002-3879-5019; Arni, Raghuvir K/0000-0003-2460-1145;
   Pimenta, Daniel C/0000-0003-2406-0860; Arni, Raghuvir
   K/0000-0003-2460-1145; Viala, Vincent/0000-0003-2267-9985; Spencer,
   Patrick/0000-0001-8949-7735
FU Programa Brasil-Alemanha (CAPES/DAAD/PROBRAL) [364/11]; FAPESP
   fellowshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/1305-8]
FX This work was supported by the Programa Brasil-Alemanha
   (CAPES/DAAD/PROBRAL - no. 364/11) and FAPESP fellowship (2009/1305-8).
   We acknowledge Venom Supplies (Tanunda, Australia) and Peter Mirtschin
   for providing the venom samples. We also thank Peter Mirtschin for
   precious suggestions and for the critical review of the manuscript.
CR Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048
   Bateman Emma, 2013, J Venom Res, V4, P21
   Bemheimer AW, 1987, TOXICON, V25, P547
   Bemheimer AW, 1986, TOXICON, V24, P841
   Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200
   Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754
   Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024
   Calvete JJ, 2013, TOXICON, V75, P44, DOI 10.1016/j.toxicon.2013.03.020
   Calvete JJ, 2012, J PROTEOMICS, V75, P4091, DOI 10.1016/j.jprot.2012.05.026
   Calvete JJ, 2011, EXPERT REV PROTEOMIC, V8, P739, DOI [10.1586/EPR.11.61, 10.1586/epr.11.61]
   Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091
   Chatrath ST, 2011, J PROTEOME RES, V10, P739, DOI 10.1021/pr1008916
   Ciuraszklewicz J, 2007, GENE, V396, P28, DOI 10.1016/j.gene.2007.02.018
   Cogger H. G., 2014, REPTILES AMPHIBIANS
   Dhananjaya BL, 2010, CELL BIOCHEM FUNCT, V28, P171, DOI 10.1002/cbf.1637
   DOERY HM, 1964, BIOCHEM J, V92, P599, DOI 10.1042/bj0920599
   Dyr J E, 1988, Folia Haematol Int Mag Klin Morphol Blutforsch, V115, P203
   Georgieva D, 2011, J PROTEOME RES, V10, P2440, DOI 10.1021/pr101248e
   Georgieva D, 2008, EXPERT REV PROTEOMIC, V5, P787, DOI 10.1586/14789450.5.6.787
   Guo CM, 2012, TOXICON, V60, P302, DOI 10.1016/j.toxicon.2012.05.001
   Hart AJ, 2013, TOXICOL LETT, V219, P262, DOI 10.1016/j.toxlet.2013.03.026
   Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219
   Inagaki H, 2012, TOXICON, V59, P74, DOI 10.1016/j.toxicon.2011.10.005
   Jansen M, 2007, MED J AUSTRALIA, V186, P41, DOI 10.5694/j.1326-5377.2007.tb00788.x
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4
   Koh CY, 2012, TOXICON, V59, P497, DOI 10.1016/j.toxicon.2011.03.017
   LEONARDI TM, 1979, TOXICON, V17, P549, DOI 10.1016/0041-0101(79)90229-0
   Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196
   Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004
   Marshall Thomas, 1994, Applied and Theoretical Electrophoresis, V4, P25
   Matsunaga Y, 2009, J BIOCHEM, V145, P365, DOI 10.1093/jb/mvn174
   Meganathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044228
   Mendgen GA, 1986, HERPETOLOGICA, V42, P215
   Mirtschin P, 1991, SNAKES AUSTR DANGERO
   NAKASHIMA K, 1993, P NATL ACAD SCI USA, V90, P5964, DOI 10.1073/pnas.90.13.5964
   Nascimento DG, 2006, TOXICON, V47, P628, DOI 10.1016/j.toxicon.2006.01.015
   Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307
   Pierre LS, 2005, MOL BIOL EVOL, V22, P1853, DOI 10.1093/molbev/msi181
   Portas TJ, 2007, J ZOO WILDLIFE MED, V38, P483, DOI 10.1638/1042-7260(2007)38[483:SBSPGE]2.0.CO;2
   Ramasamy S, 2005, CLIN EXP PHARMACOL P, V32, P7, DOI 10.1111/j.1440-1681.2005.04151.x
   Ramasamy S, 2004, TOXICON, V44, P837, DOI 10.1016/j.toxicon.2004.08.005
   Reza MA, 2006, J THROMB HAEMOST, V4, P1346, DOI 10.1111/j.1538-7836.2006.01969.x
   Rodrigues RS, 2012, J PROTEOMICS, V75, P2707, DOI 10.1016/j.jprot.2012.03.028
   Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008
   Sakurai Y, 2003, BBA-PROTEINS PROTEOM, V1649, P51, DOI 10.1016/S1570-9639(03)00157-2
   SCHMIDT JJ, 1989, TOXICON, V27, P805, DOI 10.1016/0041-0101(89)90048-2
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   St Pierre L, 2008, CELL MOL LIFE SCI, V65, P4039, DOI 10.1007/s00018-008-8573-5
   St Pierre L, 2007, CELL MOL LIFE SCI, V64, P2829, DOI 10.1007/s00018-007-7352-z
   St Pierre L, 2006, BIOCHIMIE, V88, P1923, DOI 10.1016/j.biochi.2006.06.014
   STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I
   STOCKER KF, 1990, MED USE SNAKE VENOM
   Suhr SM, 1996, BIOCHEM BIOPH RES CO, V224, P134, DOI 10.1006/bbrc.1996.0996
   Sun QY, 2010, TOXICON, V56, P1459, DOI 10.1016/j.toxicon.2010.08.013
   Sutherland SK, 2001, AUSTR ANIMAL TOXINS
   TAKASAKI C, 1990, TOXICON, V28, P319, DOI 10.1016/0041-0101(90)90067-H
   TAKASAKI C, 1985, BIOCHEM J, V232, P367, DOI 10.1042/bj2320367
   Takatsuka H, 2001, BBA-PROTEIN STRUCT M, V1544, P267, DOI 10.1016/S0167-4838(00)00229-6
   Torii S, 1997, J BIOL CHEM, V272, P9539, DOI 10.1074/jbc.272.14.9539
   Torii S, 2000, BIOCHEMISTRY-US, V39, P3197, DOI 10.1021/bi992416z
   Trummal K, 2011, TOXICON, V58, P363, DOI 10.1016/j.toxicon.2011.07.005
   VAUGHAN GT, 1981, TOXICON, V19, P95, DOI 10.1016/0041-0101(81)90121-5
   Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290
   White J., 1995, HDB CLIN TOXICOLOGY
   Wuster W, 2005, MOL PHYLOGENET EVOL, V34, P1, DOI 10.1016/j.ympev.2004.08.018
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
   Yamazaki Y, 2002, BIOCHEMISTRY-US, V41, P11331, DOI 10.1021/bi026132h
   YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752
NR 70
TC 15
Z9 15
U1 3
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD OCT 14
PY 2014
VL 110
BP 32
EP 44
DI 10.1016/j.jprot.2014.07.030
PG 13
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AT8KW
UT WOS:000345183200004
PM 25108201
DA 2020-12-01
ER

PT J
AU Ullah, A
   Magalhaes, GS
   Masood, R
   Mariutti, RB
   Coronado, MA
   Murakami, MT
   Barbaro, KC
   Arni, RK
AF Ullah, Anwar
   Magalhaes, Geraldo Santana
   Masood, Rehana
   Mariutti, Ricardo Barros
   Coronado, Monika Aparecida
   Murakami, Mario Tyago
   Barbaro, Katia Cristina
   Arni, Raghuvir Krishnaswamy
TI Crystallization and preliminary X-ray diffraction analysis of a novel
   sphingomyelinase D from Loxosceles gaucho venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID CATALYTIC MECHANISM; EXPRESSION; INSIGHTS; SPIDERS; CLONING
AB Brown spider envenomation results in dermonecrosis, intravascular coagulation, haemolysis and renal failure, mainly owing to the action of sphingomyelinases D (SMases D), which catalyze the hydrolysis of sphingomyelin to produce ceramide 1-phosphate and choline or the hydrolysis of lysophosphatidylcholine to produce lysophosphatidic acid. Here, the heterologous expression, purification, crystallization and preliminary X-ray diffraction analysis of LgRec1, a novel SMase D from Loxosceles gaucho venom, are reported. The crystals belonged to space group P2(1)2(1)2, with unit-cell parameters a = 52.98, b = 62.27, c = 84.84 angstrom and diffracted to a maximum resolution of 2.6 angstrom.
C1 [Ullah, Anwar; Masood, Rehana; Mariutti, Ricardo Barros; Coronado, Monika Aparecida; Arni, Raghuvir Krishnaswamy] UNESP IBILCE, Dept Phys, Multiuser Ctr Biomol Innovat, BR-15054000 Sao Paulo, Brazil.
   [Magalhaes, Geraldo Santana; Barbaro, Katia Cristina] Inst Butantan, Lab Imunopatol, Div Desenvolvimento Cient, BR-05503900 Sao Paulo, Brazil.
   [Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, BR-13083970 Campinas, SP, Brazil.
RP Arni, RK (corresponding author), UNESP IBILCE, Dept Phys, Multiuser Ctr Biomol Innovat, Rua Cristovao Colombo 2265, BR-15054000 Sao Paulo, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/N-9338-2018; Murakami,
   Mario T/F-5640-2016; Barbaro, Katia/M-2664-2013; Ullah,
   Anwar/B-1720-2013; Arni, Raghuvir K/B-2222-2013; Magalhaes, Geraldo
   S./M-4645-2014
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir
   K/0000-0003-2460-1145; mariutti, ricardo/0000-0001-6720-4655
FU CAPES-Toxinologia; CAPES/DAADCAPESDeutscher Akademischer Austausch
   Dienst (DAAD); CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX This work was supported by grants from CAPES-Toxinologia, CAPES/DAAD,
   CNPq and FAPESP. AU is a FAPESP postdoctoral fellow.
CR BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643
   Binford GJ, 2005, TOXICON, V45, P547, DOI 10.1016/j.toxicon.2004.11.011
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   Gomes MTR, 2011, TOXICON, V57, P574, DOI 10.1016/j.toxicon.2011.01.001
   Gremski LH, 2014, TOXICON, V83, P91, DOI 10.1016/j.toxicon.2014.02.023
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Lajoie DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072372
   Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N
   Meeteren L.A.van, 2004, J BIOL CHEM, V279, P10833
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Platnick N.I, 2009, WORLD SPIDER CATALOG
   Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001
   Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474
   Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931
NR 18
TC 7
Z9 7
U1 0
U2 10
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD OCT
PY 2014
VL 70
BP 1418
EP 1420
DI 10.1107/S2053230X14019207
PN 10
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA AQ8FR
UT WOS:000343060200024
PM 25286953
OA Green Published
DA 2020-12-01
ER

PT J
AU Gremski, LH
   Trevisan-Silva, D
   Ferrer, VP
   Matsubara, FH
   Meissner, GO
   Wille, ACM
   Vuitika, L
   Dias-Lopes, C
   Ullah, A
   de Moraes, FR
   Chavez-Olortegui, C
   Barbaro, KC
   Murakami, MT
   Arni, RK
   Senff-Ribeiro, A
   Chaim, OM
   Veiga, SS
AF Gremski, Luiza Helena
   Trevisan-Silva, Dilza
   Ferrer, Valeria Pereira
   Matsubara, Fernando Hitomi
   Meissner, Gabriel Otto
   Martins Wille, Ana Carolina
   Vuitika, Larissa
   Dias-Lopes, Camila
   Ullah, Anwar
   de Moraes, Fabio Rogerio
   Chavez-Olortegui, Carlos
   Barbaro, Katia Cristina
   Murakami, Mario Tyago
   Arni, Raghuvir Krishnaswamy
   Senff-Ribeiro, Andrea
   Chaim, Olga Meiri
   Veiga, Silvio Sanches
TI Recent advances in the understanding of brown spider venoms: From the
   biology of spiders to the molecular mechanisms of toxins
SO TOXICON
LA English
DT Review
DE Brown spider; Loxosceles; Venom; Toxins; Loxoscelism; Dermonecrosis
ID GENERALIZED EXANTHEMATOUS PUSTULOSIS; LOXOSCELES-INTERMEDIA VENOM;
   CONTROLLED TUMOR PROTEIN; RECOMBINANT PHOSPHOLIPASE-D;
   SPHINGOMYELINASE-D ACTIVITY; EXPERIMENTAL ACUTE EXPOSURE; ANTIGENIC
   CROSS-REACTIVITY; POSITIVE HEMOLYTIC-ANEMIA; D DERMONECROTIC TOXIN;
   FUNCTIONAL-CHARACTERIZATION
AB The Loxosceles genus spiders (the brown spiders) are encountered in all the continents, and the clinical manifestations following spider bites include skin necrosis with gravitational lesion spreading and occasional systemic manifestations, such as intravascular hemolysis, thrombocytopenia and acute renal failure. Brown spider venoms are complex mixtures of toxins especially enriched in three molecular families: the phospholipases D, astacin-like metalloproteases and Inhibitor Cystine Knot (ICK) peptides. Other toxins with low level of expression also present in the venom include the serine proteases, serine protease inhibitors, hyaluronidases, allergen factors and translationally controlled tumor protein (TCTP). The mechanisms by which the Loxosceles venoms act and exert their noxious effects are not fully understood. Except for the brown spider venom phospholipase D, which causes dermonecrosis, hemolysis, thrombocytopenia and renal failure, the pathological activities of the other venom toxins remain unclear. The objective of the present review is to provide insights into the brown spider venoms and loxoscelism based on recent results. These insights include the biology of brown spiders, the clinical features of loxoscelism and the diagnosis and therapy of brown spider bites. Regarding the brown spider venom, this review includes a description of the novel toxins revealed by molecular biology and proteomics techniques, the data regarding three-dimensional toxin structures, and the mechanism of action of these molecules. Finally, the biotechnological applications of the venom components, especially for those toxins reported as recombinant molecules, and the challenges for future study are discussed. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Gremski, Luiza Helena; Trevisan-Silva, Dilza; Ferrer, Valeria Pereira; Matsubara, Fernando Hitomi; Meissner, Gabriel Otto; Martins Wille, Ana Carolina; Vuitika, Larissa; Senff-Ribeiro, Andrea; Chaim, Olga Meiri; Veiga, Silvio Sanches] Univ Fed Parana, Dept Biol Celular, BR-81531990 Curitiba, Parana, Brazil.
   [Gremski, Luiza Helena] Univ Fed Parana, Hosp Clin, Dept Patol Clin, BR-81531990 Curitiba, Parana, Brazil.
   [Martins Wille, Ana Carolina] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, Parana, Brazil.
   [Dias-Lopes, Camila; Chavez-Olortegui, Carlos] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Ullah, Anwar; de Moraes, Fabio Rogerio; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusutirio Inovacao Biomol, Sao Jose Do Rio Preto, SP, Brazil.
   [Barbaro, Katia Cristina] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil.
   [Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil.
RP Veiga, SS (corresponding author), Univ Fed Parana, Dept Cell Biol, BR-81531990 Curitiba, Parana, Brazil.
EM veigass@ufpr.br
RI Senff-Ribeiro, Andrea/D-6246-2018; Barbaro, Katia/M-2664-2013;
   Senff-Ribeiro, Andrea/K-8745-2019; Chavez-Olortegui, Carlos/F-9227-2019;
   Trevisan-Silva, Dilza/L-6707-2016; Murakami, Mario T/C-2087-2012;
   Murakami, Mario T/F-5640-2016; Arni, Raghuvir K/N-9338-2018; Chaim, Olga
   Meiri/Y-7559-2019; Vuitika, Larissa/L-4664-2016; de Moraes, Fabio
   R/B-8331-2017; Gremski, Luiza H/X-3674-2018; Ferrer, Valeria
   Pereira/N-9890-2018; Ullah, Anwar/B-1720-2013; Arni, Raghuvir
   K/B-2222-2013; Veiga, Silvio Sanches/C-2194-2013
OI Senff-Ribeiro, Andrea/0000-0002-7967-6307; Senff-Ribeiro,
   Andrea/0000-0002-7967-6307; Chavez-Olortegui,
   Carlos/0000-0001-9390-7207; Trevisan-Silva, Dilza/0000-0002-6519-346X;
   Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Chaim, Olga Meiri/0000-0002-3854-3292; de Moraes,
   Fabio R/0000-0002-0425-0352; Gremski, Luiza H/0000-0003-3347-4571;
   Ferrer, Valeria Pereira/0000-0002-5210-3445; Ullah,
   Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145; Veiga,
   Silvio Sanches/0000-0002-9691-1225; Meissner,
   Gabriel/0000-0003-3203-1728
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   INCTTOX; Fundacao Araucaria-ParanaFundacao Araucaria; Secretaria de
   Tecnologia e Ensino Superior do Parana, SETI-PR, Brasil
FX This work was supported by grants from the CAPES, CNPq, FAPESP, FAPEMIG,
   INCTTOX, Fundacao Araucaria-Parana and Secretaria de Tecnologia e Ensino
   Superior do Parana, SETI-PR, Brasil.
CR Abdulkader RCRM, 2008, SEMIN NEPHROL, V28, P373, DOI 10.1016/j.semnephrol.2008.04.006
   Akdeniz Sedat, 2007, Dermatol Online J, V13, P11
   Alvarenga LM, 2003, TOXICON, V42, P725, DOI 10.1016/j.toxicon.2003.09.006
   Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002
   Amson R, 2013, CURR OPIN ONCOL, V25, P59, DOI 10.1097/CCO.0b013e32835b7d21
   Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200
   Andersen R.J., 2011, J EMERGENCY MED, V41, P31
   Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200
   Appel M. H., 2005, ISJ - Invertebrate Survival Journal, V2, P152
   Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007
   Araujo H.R.C., 2009, THESIS FUNDACAO O CR, P86
   Araujo SC, 2003, TOXICON, V41, P261, DOI 10.1016/S0041-0101(02)00282-9
   Arlian LG, 2002, ANNU REV ENTOMOL, V47, P395, DOI 10.1146/annurev.ento.47.091201.145224
   Bajin MS, 2011, CUTAN OCUL TOXICOL, V30, P302, DOI 10.3109/15569527.2011.577494
   Barbaro K.C., 2003, ANIMAIS PECONHENTOS, P160
   Barbaro KC, 2010, TOXICON, V56, P972, DOI 10.1016/j.toxicon.2010.06.022
   Barbaro KC, 2005, TOXICON, V45, P489, DOI 10.1016/j.toxicon.2004.12.009
   Barla F, 2009, BIOSCI BIOTECH BIOCH, V73, P2335, DOI 10.1271/bbb.90365
   Barretto OCDO, 2007, HUM EXP TOXICOL, V26, P817, DOI 10.1177/0960327107084070
   Bazile F, 2009, CARCINOGENESIS, V30, P555, DOI 10.1093/carcin/bgp022
   Bentele C, 2006, BIOCHEM J, V395, P449, DOI 10.1042/BJ20051947
   Bertani R, 2010, J ARACHNOL, V38, P364, DOI 10.1636/A09-92.1
   Binford GJ, 2005, TOXICON, V45, P547, DOI 10.1016/j.toxicon.2004.11.011
   Binford GJ, 2003, COMP BIOCHEM PHYS B, V135, P25, DOI 10.1016/S1096-4959(03)00045-9
   Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003
   Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274
   Bircher AJ, 2005, DERMATOLOGY, V210, P119, DOI 10.1159/000082567
   Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9
   Bommer UA, 2012, OPEN ALLERGY J, V5, P19, DOI DOI 10.2174/1874838401205010019
   Borer AS, 2012, J MOL BIOL, V415, P635, DOI 10.1016/j.jmb.2011.10.009
   Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200
   Boyer S, 2012, BIOL CONTROL, V62, P75, DOI 10.1016/j.biocontrol.2012.02.001
   Brasil, 2001, MAN DIAGN TRAT AC AN, P120
   Bucaretchi F, 2010, CLIN TOXICOL, V48, P764, DOI 10.3109/15563650.2010.502123
   Burgess A, 2008, ONCOGENE, V27, P5554, DOI 10.1038/onc.2008.167
   Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564
   Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399
   Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005
   Chaim OM, 2011, TOXINS, V3, P309, DOI 10.3390/toxins3030309
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637
   Chatzaki M, 2012, TOXICON, V60, P21, DOI 10.1016/j.toxicon.2012.03.007
   Chaves-Moreira D, 2011, J CELL BIOCHEM, V112, P2529, DOI 10.1002/jcb.23177
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188
   Chen X, 2012, GENE, V495, P170, DOI [10.1016/j.gene.2011.12.051, 10.1016/j.biocel.2011.10.013]
   Choi KW, 2007, CELL ADHES MIGR, V1, P129, DOI 10.4161/cam.1.3.4901
   Christoff ADO, 2008, TOXICON, V52, P695, DOI 10.1016/j.toxicon.2008.08.001
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811
   Correa-Netto C, 2011, J PROTEOMICS, V74, P1795, DOI 10.1016/j.jprot.2011.04.003
   Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5
   Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3
   Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4
   Cramer KL, 2008, J ARACHNOL, V36, P140, DOI 10.1636/St06-27.1
   Cunha RB, 2003, J PROTEIN CHEM, V22, P135, DOI 10.1023/A:1023470829671
   da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   da Silva PH, 2003, TOXICON, V42, P155, DOI 10.1016/S0041-0101(03)00127-2
   Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363
   da Silveira RB, 2007, TOXICON, V49, P758, DOI 10.1016/j.toxicon.2006.11.024
   da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002
   da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008
   da Silveira RB, 2002, TOXICON, V40, P815, DOI 10.1016/S0041-0101(02)00078-8
   Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008
   de Almeida DM, 2008, AM J TROP MED HYG, V79, P463, DOI 10.4269/ajtmh.2008.79.463
   de Castro CS, 2004, TOXICON, V44, P273, DOI 10.1016/j.toxicon.2004.05.028
   de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053
   de Moura J, 2011, VACCINE, V29, P7992, DOI 10.1016/j.vaccine.2011.08.065
   de Oliveira KC, 2005, TOXICON, V45, P421, DOI 10.1016/j.toxicon.2004.08.022
   de Roodt AR, 2002, J NAT TOXINS, V11, P193
   Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013
   de Souza AL, 2008, TOXICON, V51, P151, DOI 10.1016/j.toxicon.2007.08.011
   Desai A, 1999, J TOXICOL-CLIN TOXIC, V37, P447, DOI 10.1081/CLT-100102435
   Desai A, 2000, INFLAMMATION, V24, P1, DOI 10.1023/A:1006995023982
   Devaraja S, 2010, J THROMB THROMBOLYS, V29, P119, DOI 10.1007/s11239-009-0341-3
   Dias-Lopes C, 2010, TOXICON, V56, P1426, DOI 10.1016/j.toxicon.2010.08.008
   Domingos MO, 2003, TOXICON, V42, P471, DOI 10.1016/S0041-0101(03)00200-9
   Donepudi SK, 2005, INT J PEDIATR OTORHI, V69, P1559, DOI 10.1016/j.ijporl.2005.04.015
   dos Santos LD, 2009, PROTEIN PEPTIDE LETT, V16, P933, DOI 10.2174/092986609788923383
   dos Santos VLP, 2000, TOXICON, V38, P265, DOI 10.1016/S0041-0101(99)00155-5
   Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644
   Duarte MM, 1999, TOXICON, V37, P1673, DOI 10.1016/S0041-0101(99)00109-9
   Duncan RP, 2010, MOL PHYLOGENET EVOL, V55, P234, DOI 10.1016/j.ympev.2009.11.026
   Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596
   Dyachenko P, 2006, J EUR ACAD DERMATOL, V20, P1121, DOI 10.1111/j.1468-3083.2006.01749.x
   Efferth T, 2005, DRUG RESIST UPDATE, V8, P85, DOI 10.1016/j.drup.2005.04.003
   Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177
   ESKAFI FM, 1976, TOXICON, V14, P7, DOI 10.1016/0041-0101(76)90114-8
   Estrada G, 2007, BBA-GEN SUBJECTS, V1770, P1161, DOI 10.1016/j.bbagen.2007.04.006
   Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4
   Felicori L, 2006, TOXICON, V48, P509, DOI 10.1016/j.toxicon.2006.06.019
   Felicori L, 2009, VACCINE, V27, P4201, DOI 10.1016/j.vaccine.2009.04.038
   Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279
   Ferrer VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002206
   Fischer ML, 2005, J ARACHNOL, V33, P758, DOI 10.1636/S03-39.1
   Fischer ML, 2005, J MED ENTOMOL, V42, P756, DOI 10.1603/0022-2585(2005)042[0756:MOBLIA]2.0.CO;2
   Flight S, 2005, PATHOPHYSIOL HAEMO T, V34, P188, DOI 10.1159/000092421
   Franca FOD, 2002, T ROY SOC TROP MED H, V96, P287
   FUNK C, 1971, BRIT J HAEMATOL, V21, P43, DOI 10.1111/j.1365-2141.1971.tb03415.x
   Gilbert S.F., 1997, EMBRYOLOGY CONSTRUCT
   Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037
   Girish KS, 2005, BIOCHEMISTRY-MOSCOW+, V70, P708, DOI 10.1007/s10541-005-0172-6
   Girish KS, 2004, BIOCHIMIE, V86, P193, DOI 10.1016/j.biochi.2004.02.004
   Gomes MTR, 2011, TOXICON, V57, P574, DOI 10.1016/j.toxicon.2011.01.001
   Gomez HF, 2002, ANN EMERG MED, V39, P469, DOI 10.1067/mem.2002.122914
   Gomez HF, 2001, TOXICON, V39, P817, DOI 10.1016/S0041-0101(00)00212-9
   Gomez HF, 1999, INFLAMMATION, V23, P207
   Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157
   Goncaves-de-Andrade RM, 2012, ZOOKEYS, P27, DOI 10.3897/zookeys.175.2259
   Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679
   Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a
   Guo Y, 2006, CHINESE MED J-PEKING, V119, P662, DOI 10.1097/00029330-200604020-00010
   Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160
   Hinojosa-Moya J, 2008, J MOL EVOL, V66, P472, DOI 10.1007/s00239-008-9099-z
   Hoffman DR, 2008, CURR OPIN ALLERGY CL, V8, P338, DOI 10.1097/ACI.0b013e3283036a7d
   Hogan CJ, 2004, ANN EMERG MED, V44, P608, DOI 10.1016/j.annemergmed.2004.08.028
   Horta CCR, 2013, J INVEST DERMATOL, V133, P1682, DOI 10.1038/jid.2013.40
   Hostetler MA, 2003, J EMERG MED, V25, P277, DOI 10.1016/S0736-4679(03)00202-6
   Hubbard JJ, 2011, CLIN PEDIATR, V50, P252, DOI 10.1177/0009922810388510
   Huguet J.L.B., 2012, FMC, V19, P517
   Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1016/S0378-1097(99)00669-2
   Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1
   Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P291, DOI 10.1081/CLT-120021114
   Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x
   JONG YS, 1979, TOXICON, V17, P529, DOI 10.1016/0041-0101(79)90227-7
   Kalapothakis E, 2007, TOXICON, V50, P938, DOI 10.1016/j.toxicon.2007.07.001
   Kalapothakis E, 2002, TOXICON, V40, P1691, DOI 10.1016/S0041-0101(02)00201-5
   Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261
   Kimura T., 2012, INT J PEPT, V2012
   King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020
   King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940
   Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424
   Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337
   KONDO H, 1990, J BIOL CHEM, V265, P15832
   Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011
   Lane DR, 2004, CUTIS, V74, P341
   Lane L, 2011, PEDIATR DERMATOL, V28, P685, DOI 10.1111/j.1525-1470.2010.01302.x
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200
   Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753
   Lockett CJ, 2012, BIOL CONTROL, V62, P183, DOI 10.1016/j.biocontrol.2012.04.004
   Lokeshwar VB, 2008, SEMIN CANCER BIOL, V18, P281, DOI 10.1016/j.semcancer.2008.03.008
   Lucato RV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001182
   Luciano MN, 2004, J HISTOCHEM CYTOCHEM, V52, P455, DOI 10.1177/002215540405200404
   Lung JM, 2000, INT J DERMATOL, V39, P287, DOI 10.1046/j.1365-4362.2000.00928.x
   Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029
   MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803
   Machado LF, 2005, PROTEOMICS, V5, P2167, DOI 10.1002/pmic.200401096
   Maeng J, 2013, ANAL BIOCHEM, V435, P47, DOI 10.1016/j.ab.2012.11.029
   Magalhaes GS, 2013, BIOCHIMIE, V95, P1773, DOI 10.1016/j.biochi.2013.06.002
   Magalhaes MR, 2008, TOXICON, V51, P1060, DOI 10.1016/j.toxicon.2008.01.008
   Makris Michael, 2009, Allergology International, V58, P301, DOI 10.2332/allergolint.08-CR-0035
   Malaque CMS, 2011, TOXICON, V58, P664, DOI 10.1016/j.toxicon.2011.09.011
   Manriquez JJ, 2009, REV CHIL INFECTOL, V26, P420, DOI /S0716-10182009000600004
   Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091
   Gutierrez JM, 2011, BIOLOGICALS, V39, P129, DOI 10.1016/j.biologicals.2011.02.005
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Wille ACM, 2013, TOXICON, V67, P17, DOI 10.1016/j.toxicon.2013.01.027
   Matsubara FH, 2013, TOXICON, V71, P147, DOI 10.1016/j.toxicon.2013.05.014
   McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021
   MCGLASSON DL, 1993, AM J CLIN PATHOL, V100, P576, DOI 10.1093/ajcp/100.5.576
   Menaldo DL, 2012, BIOCHIMIE, V94, P2545, DOI 10.1016/j.biochi.2012.07.007
   Mendes TM, 2013, VACCINE, V31, P2749, DOI 10.1016/j.vaccine.2013.03.048
   Mohrlen F, 2003, EUR J BIOCHEM, V270, P4909, DOI 10.1046/j.1432-1033.2003.03891.x
   Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x
   Moore S.J., 2011, DRUG DISCOV TODAY TE, V9, pe3
   Morey SS, 2006, TOXICON, V47, P188, DOI 10.1016/j.toxicon.2005.10.014
   Morgenstern D, 2013, TOXICON, V63, P120, DOI 10.1016/j.toxicon.2012.11.022
   MOTA I, 1995, J TOXICOL-TOXIN REV, V14, P401, DOI 10.3109/15569549509019471
   Muanpasitporn C, 2007, TOXICON, V49, P1083, DOI 10.1016/j.toxicon.2007.01.015
   Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8
   Mullin JL, 2000, J BIOL CHEM, V275, P25239, DOI 10.1074/jbc.M004142200
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Navarro-Silva MA, 2010, J ECON ENTOMOL, V103, P166, DOI 10.1603/EC09092
   Neiva M, 2009, TOXICON, V53, P427, DOI 10.1016/j.toxicon.2009.01.006
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Neshich G, 2005, NUCLEIC ACIDS RES, V33, pW29, DOI 10.1093/nar/gki397
   Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006
   Nowatzki J, 2010, TOXICON, V56, P535, DOI 10.1016/j.toxicon.2010.03.027
   Olvera A, 2006, TOXICON, V48, P64, DOI 10.1016/j.toxicon.2006.04.010
   Ospedal KZ, 2002, INT J EXP PATHOL, V83, P287, DOI 10.1046/j.1365-2613.2002.00241.x
   Padavattan S, 2008, J MOL BIOL, V383, P178, DOI 10.1016/j.jmb.2008.08.023
   Paludo KS, 2006, TOXICON, V47, P844, DOI 10.1016/j.toxicon.2006.02.006
   Paludo KS, 2009, COMP BIOCHEM PHYS C, V149, P323, DOI 10.1016/j.cbpc.2008.08.009
   PATEL KD, 1994, J CLIN INVEST, V94, P631, DOI 10.1172/JCI117379
   Pauli I, 2009, TOXICON, V53, P660, DOI 10.1016/j.toxicon.2009.01.033
   Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Pernet C, 2010, ANN DERMATOL VENER, V137, P808, DOI 10.1016/j.annder.2010.08.008
   Pippirs U, 2009, BRIT J DERMATOL, V161, P208, DOI 10.1111/j.1365-2133.2009.09234.x
   Platnick N.I., 2013, WORLD SPIDER CATALOG
   Pretel F, 2005, TOXICON, V45, P449, DOI 10.1016/j.toxicon.2004.12.002
   Rader RK, 2012, TOXICON, V60, P1, DOI 10.1016/j.toxicon.2012.03.012
   Ramires E.N., 2004, J. Venom. Anim. Toxins incl. Trop. Dis, V10, P185, DOI 10.1590/S1678-91992004000200008
   Ramires EN, 2007, J VENOM ANIM TOXINS, V13, P607, DOI 10.1590/S1678-91992007000300005
   Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013
   Rattmann YD, 2008, TOXICON, V51, P363, DOI 10.1016/j.toxicon.2007.10.007
   Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]
   Reitinger S, 2008, PROTEIN EXPRES PURIF, V57, P226, DOI 10.1016/j.pep.2007.10.001
   Ribeiro ROS, 2007, TOXICON, V50, P1162, DOI 10.1016/j.toxicon.2007.08.001
   Ribuffo D, 2012, EUR REV MED PHARMACO, V16, P414
   Robb CW, 2007, J CUTAN PATHOL, V34, P513, DOI 10.1111/j.1600-0560.2006.00657.x
   Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008
   Rosen JL, 2012, ANN EMERG MED, V60, P439, DOI 10.1016/j.annemergmed.2011.12.011
   Ruppert E. E., 2004, INVERTEBRATE ZOOLOGY
   Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385
   Sanchez-Olivas Manuel Anastacio, 2011, Rev Alerg Mex, V58, P171
   Sandidge J, 2004, J ECON ENTOMOL, V97, P230, DOI 10.1603/0022-0493-97.2.230
   Sandidge Jamel S., 2005, Transactions of the Kansas Academy of Science, V108, P99, DOI 10.1660/0022-8443(2005)108[0099:BRSARO]2.0.CO;2
   Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731
   Schenone F.H., 2001, REV CHIL PEDIATR, V72, P100, DOI DOI 10.4067/S0370-41062001000200004
   Schmid-Grendelmeier P, 2001, INT ARCH ALLERGY IMM, V125, P96, DOI 10.1159/000053803
   Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105
   Senff-Ribeiro A, 2008, BIOTECHNOL ADV, V26, P210, DOI 10.1016/j.biotechadv.2007.12.003
   Silva LM, 2008, TOXICON, V51, P428, DOI 10.1016/j.toxicon.2007.10.018
   Silvestre FG, 2005, TOXICON, V46, P927, DOI 10.1016/j.toxicon.2005.09.002
   Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002
   Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003
   Stoecker WV, 2006, J AM ACAD DERMATOL, V55, P888, DOI 10.1016/j.jaad.2006.04.065
   Stoecker William V, 2009, Mo Med, V106, P425
   Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18
   Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006
   Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184
   Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002
   Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021
   Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x
   Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x
   Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001
   Taskesen M, 2011, TURKISH J PEDIATR, V53, P87
   Tavares FL, 2004, HUM EXP TOXICOL, V23, P477, DOI 10.1191/0960327104ht475oa
   Tavares FL, 2011, HUM EXP TOXICOL, V30, P1567, DOI 10.1177/0960327110393761
   Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589
   Trevisan-Silva D, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1081, DOI 10.1016/B978-0-12-382219-2.00247-7
   Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003
   Tutrone William D, 2005, J Drugs Dermatol, V4, P424
   Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101
   Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799
   Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931
   Valenta R, 2011, ALLERGY, V66, P775, DOI 10.1111/j.1398-9995.2011.02565.x
   Valeriano-Zapana JA, 2012, TOXICON, V59, P231, DOI 10.1016/j.toxicon.2011.11.018
   van Hage-Hamsten M, 2004, METHODS, V32, P281, DOI 10.1016/j.ymeth.2003.08.007
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   van Meeteren LA, 2007, J INVEST DERMATOL, V127, P1266, DOI 10.1038/sj.jid.5700745
   Veiga SS, 2000, TOXICON, V38, P825, DOI 10.1016/S0041-0101(99)00197-X
   Veiga SS, 2001, THROMB RES, V102, P229, DOI 10.1016/S0049-3848(01)00254-7
   Veiga SS, 2001, BRAZ J MED BIOL RES, V34, P843, DOI 10.1590/S0100-879X2001000700002
   Veiga SS, 2000, HISTOCHEM J, V32, P397, DOI 10.1023/A:1004031019827
   Vetter RS, 2008, J ARACHNOL, V36, P150, DOI 10.1636/RSt08-06.1
   Vetter RS, 2008, ANNU REV ENTOMOL, V53, P409, DOI 10.1146/annurev.ento.53.103106.093503
   Vetter RS, 2011, TOXICON, V58, P623, DOI 10.1016/j.toxicon.2011.09.009
   Vetter RS, 2011, J ECON ENTOMOL, V104, P986, DOI 10.1603/EC10428
   Vetter RS, 2009, SOUTH MED J, V102, P518, DOI 10.1097/SMJ.0b013e3181a0abb3
   Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681
   Vuitika L, 2013, J CELL BIOCHEM, V114, P2479, DOI 10.1002/jcb.24594
   Wong SL, 2009, AM SURGEON, V75, P1128
   Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375
   WRIGHT RP, 1973, ARCH BIOCHEM BIOPHYS, V159, P415, DOI 10.1016/0003-9861(73)90469-4
   Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149
   Yamanouye N, 2006, NAT PROTOC, V1, P2763, DOI 10.1038/nprot.2006.423
   Young AR, 2001, TOXICON, V39, P391, DOI 10.1016/S0041-0101(00)00145-8
   Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414
   Zambrano A, 2005, REV MED CHILE, V133, P219, DOI 10.4067/S0034-98872005000200011
   Zanetti VC, 2002, BLOOD COAGUL FIBRIN, V13, P135, DOI 10.1097/00001721-200203000-00009
   Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001
   Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548
   Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452
   Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje
   Zobel-Thropp PA, 2012, TOXICON, V60, P265, DOI 10.1016/j.toxicon.2012.04.350
   Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8
NR 269
TC 66
Z9 68
U1 0
U2 64
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JUN 1
PY 2014
VL 83
BP 91
EP 120
DI 10.1016/j.toxicon.2014.02.023
PG 30
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AH1JL
UT WOS:000335876300011
PM 24631373
DA 2020-12-01
ER

PT J
AU Munawar, A
   Trusch, M
   Georgieva, D
   Hildebrand, D
   Kwiatkowski, M
   Behnken, H
   Harder, S
   Arni, R
   Spencer, P
   Schluter, H
   Betzel, C
AF Munawar, Aisha
   Trusch, Maria
   Georgieva, Dessislava
   Hildebrand, Diana
   Kwiatkowski, Marcel
   Behnken, Henning
   Harder, Soenke
   Arni, Raghuvir
   Spencer, Patrick
   Schlueter, Hartmut
   Betzel, Christian
TI Elapid Snake Venom Analyses Show the Specificity of the Peptide
   Composition at the Level of Genera Naja and Notechis
SO TOXINS
LA English
DT Article
DE natriuretic peptides; Notechis scutatus from Kangaroo Island; Naja
   mossambica mossambica; snake venom; pharmacologically active peptides;
   bradykinin-potentiating peptides; Kunitz-type inhibitor; neurotoxin;
   cytotoxin
ID ANGIOTENSIN-CONVERTING ENZYME; ELECTRON-TRANSFER DISSOCIATION;
   PANCREATIC TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; MOSSAMBICA-MOSSAMBICA;
   AUSTRALIAN ELAPIDS; MASS-SPECTROMETRY; 3-FINGER TOXINS; CARDIOTOXIN;
   EVOLUTION
AB Elapid snake venom is a highly valuable, but till now mainly unexplored, source of pharmacologically important peptides. We analyzed the peptide fractions with molecular masses up to 10 kDa of two elapid snake venoms-that of the African cobra, N. m. mossambica (genus Naja), and the Peninsula tiger snake, N. scutatus, from Kangaroo Island (genus Notechis). A combination of chromatographic methods was used to isolate the peptides, which were characterized by combining complimentary mass spectrometric techniques. Comparative analysis of the peptide compositions of two venoms showed specificity at the genus level. Three-finger (3-F) cytotoxins, bradykinin-potentiating peptides (BPPs) and a bradykinin inhibitor were isolated from the Naja venom. 3-F neurotoxins, Kunitz/basic pancreatic trypsin inhibitor (BPTI)-type inhibitors and a natriuretic peptide were identified in the N. venom. The inhibiting activity of the peptides was confirmed in vitro with a selected array of proteases. Cytotoxin 1 (P01467) from the Naja venom might be involved in the disturbance of cellular processes by inhibiting the cell 20S-proteasome. A high degree of similarity between BPPs from elapid and viperid snake venoms was observed, suggesting that these molecules play a key role in snake venoms and also indicating that these peptides were recruited into the snake venom prior to the evolutionary divergence of the snakes.
C1 [Munawar, Aisha; Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Munawar, Aisha] Univ Engn & Technol, Dept Chem, Lahore 54890, Pakistan.
   [Trusch, Maria; Behnken, Henning] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany.
   [Hildebrand, Diana; Kwiatkowski, Marcel; Harder, Soenke; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf UKE, Inst Clin Chem, D-20246 Hamburg, Germany.
   [Arni, Raghuvir] IBILCE UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Spencer, Patrick] Inst Pesquisas Energet & Nucl, Ctr Biotecnol, BR-05508000 Sao Paulo, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Notkest 85,Bldg 22a, D-22603 Hamburg, Germany.
EM aishamunawar_2001@yahoo.com; trusch@chemie.uni-hamburg.de;
   octopus_dofleini@yahoo.com; d.hildebrand@uke.de; m.kwiatkowski@uke.de;
   behnken@chemie.uni-hamburg.de; soeharder@gmx.de; arni@sjrp.unesp.br;
   pspencer@IPEN.BR; hschluet@uke.de; Christian.Betzel@uni-hamburg.de
RI Arni, Raghuvir K/N-9338-2018; Betzel, Christian/G-8105-2018; Riedner,
   Maria/W-5546-2019; Schluter, Hartmut/D-1371-2015; Kwiatkowski,
   Marcel/M-3384-2016; Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Betzel,
   Christian/0000-0002-3879-5019; Schluter, Hartmut/0000-0002-9358-7036;
   Kwiatkowski, Marcel/0000-0002-5804-6031; Arni, Raghuvir
   K/0000-0003-2460-1145; Spencer, Patrick/0000-0001-8949-7735
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1, 26-1]; FAPESP/CNPq/CAPES, PROBRAL; Higher Education
   Commission of PakistanHigher Education Commission of Pakistan; German
   Academic Exchange Service (DAAD), GermanyDeutscher Akademischer
   Austausch Dienst (DAAD); Alexander von Humboldt FoundationAlexander von
   Humboldt Foundation [3.3-BUL/1073481 STP]
FX This research was financed by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1, 26-1) and
   FAPESP/CNPq/CAPES, PROBRAL. The work of Aisha Munawar was supported by
   the Higher Education Commission of Pakistan and German Academic Exchange
   Service (DAAD), Germany. Dessislava Georgieva thanks the Alexander von
   Humboldt Foundation for grant 3.3-BUL/1073481 STP. The authors thank the
   venom suppliers in Australia for kindly providing the venom samples.
CR Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024
   Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417
   BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Calvete JJ, 2012, J PROTEOMICS, V75, P4091, DOI 10.1016/j.jprot.2012.05.026
   Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306
   CHIEN KY, 1994, J BIOL CHEM, V269, P14473
   Cron KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073710
   Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423
   Dubovskii PV, 2003, EUR J BIOCHEM, V270, P2038, DOI 10.1046/j.1432-1033.2003.03580.x
   Earl STH, 2012, TOXICON, V59, P456, DOI 10.1016/j.toxicon.2010.12.010
   El-Saadani MAM, 2003, COMP BIOCHEM PHYS C, V136, P387, DOI 10.1016/j.cca.2003.11.001
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2
   Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1
   Georgieva D, 2010, J PROTEOME RES, V9, P2302, DOI 10.1021/pr901042p
   GREGOIRE J, 1977, EUR J BIOCHEM, V80, P283, DOI 10.1111/j.1432-1033.1977.tb11881.x
   Helland R, 1998, EUR J BIOCHEM, V256, P317, DOI 10.1046/j.1432-1327.1998.2560317.x
   Hodgson WC, 2009, CURR OPIN PHARMACOL, V9, P173, DOI 10.1016/j.coph.2008.11.007
   Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079
   King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940
   Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x
   Lin KL, 2010, TOXICON, V55, P1263, DOI 10.1016/j.toxicon.2010.01.017
   Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717
   Millers EKI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054104
   Millers EKI, 2009, FEBS J, V276, P3163, DOI 10.1111/j.1742-4658.2009.07034.x
   Munawar A, 2011, MOL BIOSYST, V7, P3298, DOI 10.1039/c1mb05309d
   Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200
   OCONNELL JF, 1993, EUR J BIOCHEM, V213, P891, DOI 10.1111/j.1432-1033.1993.tb17833.x
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   PETERS JM, 1994, J BIOL CHEM, V269, P7709
   Petras D, 2011, J PROTEOME RES, V10, P1266, DOI 10.1021/pr101040f
   Quinton L, 2011, J AM SOC MASS SPECTR, V22, P1891, DOI 10.1007/s13361-011-0210-0
   REES B, 1987, P NATL ACAD SCI USA, V84, P3132, DOI 10.1073/pnas.84.10.3132
   RITONJA A, 1983, BIOCHIM BIOPHYS ACTA, V748, P429, DOI 10.1016/0167-4838(83)90189-9
   Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902
   St Pierre L, 2008, CELL MOL LIFE SCI, V65, P4039, DOI 10.1007/s00018-008-8573-5
   St Pierre L, 2007, CELL MOL LIFE SCI, V64, P2829, DOI 10.1007/s00018-007-7352-z
   St Pierre L, 2006, BIOCHIMIE, V88, P1923, DOI 10.1016/j.biochi.2006.06.014
   Steckelings UM, 2001, ACTA DERM-VENEREOL, V81, P321
   Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101
   Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200
   Vyas Vivek Kumar, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P156, DOI 10.1016/S2221-1691(13)60042-8
   Wang JS, 2006, CELL MOL IMMUNOL, V3, P255
   Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8
NR 46
TC 15
Z9 15
U1 1
U2 9
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2072-6651
J9 TOXINS
JI Toxins
PD MAR
PY 2014
VL 6
IS 3
BP 850
EP 868
DI 10.3390/toxins6030850
PG 19
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA AG9QY
UT WOS:000335755700005
PM 24590383
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Okamoto, DN
   Kondo, MY
   Oliveira, LCG
   Honorato, RV
   Zanphorlin, LM
   Coronado, MA
   Araujo, MS
   da Motta, G
   Veronez, CL
   Andrade, SS
   Oliveira, PSL
   Arni, RK
   Cintra, ACO
   Sampaio, SV
   Juliano, MA
   Juliano, L
   Murakami, MT
   Gouvea, IE
AF Okamoto, Debora N.
   Kondo, Marcia Y.
   Oliveira, Lilian C. G.
   Honorato, Rodrigo V.
   Zanphorlin, Leticia M.
   Coronado, Monika A.
   Araujo, Mariana S.
   da Motta, Guacyara
   Veronez, Camila L.
   Andrade, Sheila S.
   Oliveira, Paulo S. L.
   Arni, Raghuvir K.
   Cintra, Adelia C. O.
   Sampaio, Suely V.
   Juliano, Maria A.
   Juliano, Luiz
   Murakami, Mario T.
   Gouvea, Iuri E.
TI P-I class metalloproteinase from Bothrops moojeni venom is a
   post-proline cleaving peptidase with kininogenase activity: Insights
   into substrate selectivity and kinetic behavior
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Snake venom metalloproteinase; Kininogenase activity; FRET peptides;
   Substrate specificity; Molecular dynamics simulations
ID SNAKE-VENOM; FORCE-FIELD; KALLIKREIN; PROTEASES; PROTEINS; CLEAVAGE;
   BINDING; ENZYME
AB Snake venom metalloproteinases (SVMPs) belonging to P-I class are able to hydrolyze extracellular matrix proteins and coagulation factors triggering local and systemic reactions by multiple molecular mechanisms that are not fully understood. BmooMP alpha-I, a P-I class SMVP from Bothrops moojeni venom, was active upon neuro- and vaso-active peptides including angiotensin I, bradykinin, neurotensin, oxytocin and substance P. Interestingly, BmooMPa-I showed a strong bias towards hydrolysis after proline residues, which is unusual for most of characterized peptidases. Moreover, the enzyme showed kininogenase activity similar to that observed in plasma and cells by kallikrein. FRET peptide assays indicated a relative promiscuity at its S-2-S '(2) subsites, with proline determining the scissile bond. This unusual post-proline cleaving activity was confirmed by the efficient hydrolysis of the synthetic combinatorial library MCA-GXXPXXQ-EDDnp, described as resistant for canonical peptidases, only after Pro residues. Structural analysis of the tripeptide LPL complexed with BmooMP alpha-I, generated by molecular dynamics simulations, assisted in defining the subsites and provided the structural basis for subsite preferences such as the restriction of basic residues at the S-2 subsite due to repulsive electrostatic effects and the steric impediment for large aliphatic or aromatic side chains at the Si subsite. These new functional and structural findings provided a further understanding of the molecular mechanisms governing the physiological effects of this important class of enzymes in envenomation process. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Okamoto, Debora N.; Kondo, Marcia Y.; Oliveira, Lilian C. G.; Juliano, Maria A.; Juliano, Luiz; Gouvea, Iuri E.] Univ Fed Sao Paulo, Dept Biofis, BR-04044020 Sao Paulo, Brazil.
   [Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Murakami, Mario T.] Ctr Nacl Pesquisas Energia & Mat, Lab Nacl Biociencias, BR-13083100 Campinas, SP, Brazil.
   [Zanphorlin, Leticia M.] Univ Estadual Campinas, Inst Quim, Dept Organ, BR-13083970 Campinas, SP, Brazil.
   [Coronado, Monika A.; Arni, Raghuvir K.] UNESP, Dept Fis, IBILCE, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   [Araujo, Mariana S.; da Motta, Guacyara; Veronez, Camila L.] Univ Fed Sao Paulo, Dept Bioquim, BR-04044020 Sao Paulo, Brazil.
   [Andrade, Sheila S.] Univ Fed Sao Paulo, Dept Ginecol, BR-04044020 Sao Paulo, Brazil.
   [Cintra, Adelia C. O.; Sampaio, Suely V.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Murakami, MT (corresponding author), CNPEM, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.
EM mario.murakami@Inbio.cnpem.br; iurig@yahoo.com
RI Juliano, Luiz/D-7204-2012; MOTTA, GUACYARA/C-4429-2015; Oliveira,
   Paulo/K-5588-2013; Veronez, Camila Lopes/O-6134-2015; Honorato,
   Rodrigo/H-9773-2013; Murakami, Mario T/C-2087-2012; Murakami, Mario
   T/F-5640-2016; de Oliveira, Lilian Caroline Goncalves/AAV-5080-2020;
   MOTTA, GUACYARA/AAW-5808-2020; Araujo, Mariana/E-5434-2014; Arni,
   Raghuvir K/B-2222-2013; Vilela, Suely/D-7429-2012
OI Juliano, Luiz/0000-0002-5589-2822; MOTTA, GUACYARA/0000-0001-5427-1795;
   Veronez, Camila Lopes/0000-0001-9565-1911; Honorato,
   Rodrigo/0000-0001-5267-3002; Murakami, Mario T/0000-0002-0405-8010; de
   Oliveira, Lilian Caroline Goncalves/0000-0001-5117-6979; MOTTA,
   GUACYARA/0000-0001-5427-1795; Araujo, Mariana/0000-0001-5312-5075; Arni,
   Raghuvir K/0000-0003-2460-1145; Vilela, Suely/0000-0003-3274-180X
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq);  [FAPESP-2012/50191-4]
FX This work was supported by grants from FAPESP-2012/50191-4, CAPES and
   CNPq.
CR Akao PK, 2010, TOXICON, V55, P361, DOI 10.1016/j.toxicon.2009.08.013
   Andrezza JG, 2002, INT IMMUNOPHARMACOL, V2, P1861, DOI 10.1016/S1567-5769(02)00145-5
   Araujo MC, 2000, BIOCHEMISTRY-US, V39, P8519, DOI 10.1021/bi9928905
   Bernardes CP, 2008, TOXICON, V51, P574, DOI 10.1016/j.toxicon.2007.11.017
   Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Hamako J, 1998, THROMB HAEMOSTASIS, V80, P499
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kamiguti AS, 1998, BRAZ J MED BIOL RES, V31, P853, DOI 10.1590/S0100-879X1998000700001
   Kay BK, 2000, FASEB J, V14, P231
   Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63
   Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104
   Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lingott T, 2009, BIOCHEMISTRY-US, V48, P6166, DOI 10.1021/bi9002315
   Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   Nagasawa S., 1974, CHEM BIOL KALLIKREIN
   Okamoto DN, 2010, BIOL CHEM, V391, P1461, DOI 10.1515/BC.2010.145
   Oliveira LCG, 2012, ANAL BIOCHEM, V421, P299, DOI 10.1016/j.ab.2011.10.025
   Leme AFP, 2011, J PROTEOMICS, V74, P401, DOI 10.1016/j.jprot.2010.12.002
   SCHIFFMAN S, 1980, J BIOL CHEM, V255, P6433
   Shimamoto S, 2001, J BACTERIOL, V183, P3742, DOI 10.1128/JB.183.12.3742-3751.2001
   Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092
NR 28
TC 7
Z9 7
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 0006-3002
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAR
PY 2014
VL 1844
IS 3
BP 545
EP 552
DI 10.1016/j.bbapap.2013.12.014
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD8BI
UT WOS:000333491100008
PM 24373874
OA Green Published
DA 2020-12-01
ER

PT J
AU de Oliveira, LMF
   Ullah, A
   Masood, R
   Zelanis, A
   Spencer, PJ
   Serrano, SMT
   Arni, RK
AF Fernandes de Oliveira, Liliane Maria
   Ullah, Anwar
   Masood, Rehana
   Zelanis, Andre
   Spencer, Patrick J.
   Serrano, Solange M. T.
   Arni, Raghuvir K.
TI Rapid purification of serine proteinases from Bothrops alternatus and
   Bothrops moojeni venoms
SO TOXICON
LA English
DT Article
DE Serine proteinases; Crude venom; Bothrops alternatus; Bothrops moojeni;
   Fibrinogenolysis; Proteolytic activity
ID THROMBIN-LIKE ENZYME; MULTIPLE SEQUENCE ALIGNMENT; FIBRINOGEN-CLOTTING
   ENZYME; AMINO-ACID-SEQUENCE; SNAKE-VENOM; ATROX VENOM;
   STRUCTURAL-CHARACTERIZATION; DEFIBRINOGENATING ENZYMES;
   SUBSTRATE-SPECIFICITY; PLATELET-AGGREGATION
AB Envenomation by Bothrops species results, among other symptoms, in hemostatic disturbances. These changes can be ascribed to the presence of enzymes, primarily serine proteinases some of which are structurally similar to thrombin and specifically cleave fibrinogen releasing fibrinopeptides. A rapid, three-step, chromatographic procedure was developed to routinely purify serine proteinases from the venoms of Bothrops alternatus and Bothrops moojeni. The serine proteinase from B. alternatus displays an apparent molecular mass of similar to 32 kDa whereas the two closely related serine proteinases from B. moojeni display apparent molecular masses of similar to 32 kDa and similar to 35 kDa in SDS-PAGE gels. The partial sequences indicated that these enzymes share high identity with serine proteinases from the venoms of other Bothrops species. These proteins coagulate plasma and possess fibrinogenolytic activity but lack fibrinolytic activity. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fernandes de Oliveira, Liliane Maria; Ullah, Anwar; Masood, Rehana; Arni, Raghuvir K.] Univ Estadual Paulista, UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Zelanis, Andre; Serrano, Solange M. T.] Inst Butantan, Lab Especial Toxinol Aplicada CeTICS, BR-05503000 Sao Paulo, Brazil.
   [Spencer, Patrick J.] Ctr Biotechnol, Inst Pesquisas Energet Nucl CNEN SP, BR-05508000 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Center of Toxins, Immune-response/J-5731-2015; Zelanis,
   Andre/AAD-4618-2019; Arni, Raghuvir K/B-2222-2013; Ullah,
   Anwar/B-1720-2013; Serrano, Solange M. T./A-7132-2008
OI Zelanis, Andre/0000-0003-3066-6527; Arni, Raghuvir
   K/0000-0003-2460-1145; Ullah, Anwar/0000-0003-3793-7393; Serrano,
   Solange M. T./0000-0001-8994-1904; Fernandes de Oliveira, Liliane
   Maria/0000-0003-3696-9414; Spencer, Patrick/0000-0001-8949-7735
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu
   (TUBITAK); FAPESP Pos-doc fellowship
FX This research was supported by the grants from FAPESP, CNPq, CAPES and
   TWAS. Anwar Ullah is the recipt of a FAPESP Pos-doc fellowship.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227
   BASHEER AR, 1995, BBA-PROTEIN STRUCT M, V1250, P97, DOI 10.1016/0167-4838(95)00050-5
   Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005
   Bell WR, 1997, DRUGS, V54, P30
   Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X
   Costa JD, 2010, TOXICON, V55, P1365, DOI 10.1016/j.toxicon.2010.02.014
   de Giuseppe PO, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3045, DOI 10.1016/B978-0-12-382219-2.00668-2
   de Morais NCG, 2012, TOXICON, V60, P1251, DOI 10.1016/j.toxicon.2012.08.017
   Edgar W., 1973, THROMB RES, V2, P85, DOI DOI 10.1016/0049-3848(73)90082-0
   EMI M, 1986, GENE, V41, P305
   Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495
   HERZIG RH, 1970, J LAB CLIN MED, V76, P451
   HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508
   HOFMANN H, 1983, BIOCHIMIE, V65, P201, DOI 10.1016/S0300-9084(83)80085-6
   Huang QQ, 1999, TOXICON, V37, P999, DOI 10.1016/S0041-0101(98)00228-1
   ITOH N, 1987, J BIOL CHEM, V262, P3132
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323
   Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424
   KIRBY EP, 1979, BIOCHEMISTRY-US, V18, P3564, DOI 10.1021/bi00583a020
   Kitano ES, 2013, BIOCHIMIE, V95, P1655, DOI 10.1016/j.biochi.2013.04.006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leitao DPS, 2000, COMP BIOCHEM PHYS A, V125, P113, DOI 10.1016/S1095-6433(99)00166-X
   Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197
   Lewis RL, 2004, SEMIN NEUROL, V24, P175, DOI 10.1055/s-2004-830904
   LOCHNIT G, 1995, EUR J BIOCHEM, V228, P805, DOI 10.1111/j.1432-1033.1995.tb20326.x
   MACGILLIVRAY RTA, 1984, BIOCHEMISTRY-US, V23, P1626, DOI 10.1021/bi00303a007
   MANDELBAUM FR, 1964, ARCH BIOCHEM BIOPHYS, V104, P369, DOI 10.1016/0003-9861(64)90477-1
   Markland FS, 1998, THROMB HAEMOSTASIS, V79, P668
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   Menaldo DL, 2012, BIOCHIMIE, V94, P2545, DOI 10.1016/j.biochi.2012.07.007
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   Nikai T, 1998, J NAT TOXINS, V7, P23
   NISHIDA S, 1994, BIOCHEMISTRY-US, V33, P1843, DOI 10.1021/bi00173a030
   Ohler M, 2010, J PROTEOME RES, V9, P2422, DOI 10.1021/pr901128x
   Oliveira F, 1999, BIOCHEM MOL BIOL INT, V47, P1069
   Perez AV, 2008, BRAZ J MED BIOL RES, V41, P12, DOI 10.1590/S0100-879X2006005000189
   Petretski JH, 2000, BRAZ J MED BIOL RES, V33, P1293, DOI 10.1590/S0100-879X2000001100005
   Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958
   Saguchi K, 2005, TOXICON, V46, P72, DOI 10.1016/j.toxicon.2005.03.011
   Ana CDS, 2008, COMP BIOCHEM PHYS A, V151, P443, DOI 10.1016/j.cbpa.2007.02.036
   SERRANO SMT, 1993, TOXICON, V31, P471, DOI 10.1016/0041-0101(93)90182-I
   Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   Serrano SMT, 1998, EUR J BIOCHEM, V251, P845, DOI 10.1046/j.1432-1327.1998.2510845.x
   Serrano SMT, 2013, TOXICON, V62, P19, DOI 10.1016/j.toxicon.2012.09.003
   Smolka MB, 1998, TOXICON, V36, P1059, DOI 10.1016/S0041-0101(98)80008-1
   Stocker K., 1976, Methods Enzymol, V45, P214
   SUGIHARA H, 1980, YAKUGAKU ZASSHI, V100, P1035, DOI 10.1248/yakushi1947.100.10_1035
   Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009
   THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Ullah A, 2013, PROTEIN SCI, V22, P128, DOI 10.1002/pro.2189
   Ullah A, 2012, ACTA CRYSTALLOGR F, V68, P1222, DOI 10.1107/S1744309112036603
   Vieira DF, 2004, ACTA BIOCH BIOPH SIN, V36, P798, DOI 10.1093/abbs/36.12.798
   Vitorino-Cardoso AF, 2006, COMP BIOCHEM PHYS B, V144, P334, DOI 10.1016/j.cbpb.2006.03.010
   Wang Hai-tao, 2009, Zhonghua Yi Xue Za Zhi, V89, P3181
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Zaganelli GL, 1996, TOXICON, V34, P807, DOI 10.1016/0041-0101(96)00006-2
NR 61
TC 11
Z9 11
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 15
PY 2013
VL 76
BP 282
EP 290
DI 10.1016/j.toxicon.2013.10.016
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 275EH
UT WOS:000328658600035
PM 24140922
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Gabdulkhakov, A
   Georgieva, D
   Sankaran, B
   Murakami, MT
   Arni, RK
   Betzel, C
AF Coronado, Monika A.
   Gabdulkhakov, Azat
   Georgieva, Dessislava
   Sankaran, Banumathi
   Murakami, Mario T.
   Arni, Raghuvir K.
   Betzel, Christian
TI Structure of the polypeptide crotamine from the Brazilian rattlesnake
   Crotalus durissus terrificus
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID ANTIMICROBIAL PEPTIDES; INSECT DEFENSIN; VENOM; ANTIBACTERIAL; MYOTOXIN;
   DISTINCT; TOXIN; MODEL
AB The crystal structure of the myotoxic, cell-penetrating, basic polypeptide crotamine isolated from the venom of Crotalus durissus terrificus has been determined by single-wavelength anomalous dispersion techniques and refined at 1.7 angstrom resolution. The structure reveals distinct cationic and hydrophobic surface regions that are located on opposite sides of the molecule. This surface-charge distribution indicates its possible mode of interaction with negatively charged phospholipids and other molecular targets to account for its diverse pharmacological activities. Although the sequence identity between crotamine and human beta-defensins is low, the three-dimensional structures of these functionally related peptides are similar. Since crotamine is a leading member of a large family of myotoxic peptides, its structure will provide a basis for the design of novel cell-penetrating molecules.
C1 [Coronado, Monika A.; Arni, Raghuvir K.] Sao Paulo State Univ, UNESP IBILCE, Dept Phys, Multi User Ctr Biomol Innovat, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Coronado, Monika A.; Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany.
   [Gabdulkhakov, Azat] RAS, Inst Prot Res, Pushchino 142290, Moscow Region, Russia.
   [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94702 USA.
   [Murakami, Mario T.] Natl Ctr Energy & Mat Res, Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.
EM christian.betzel@uni-hamburg.de
RI Murakami, Mario T/F-5640-2016; Gabdulkhakov, Azat/H-4343-2013; Betzel,
   Christian/G-8105-2018; Murakami, Mario T/C-2087-2012; Arni, Raghuvir
   K/B-2222-2013
OI Murakami, Mario T/0000-0002-0405-8010; Gabdulkhakov,
   Azat/0000-0003-1016-5936; Betzel, Christian/0000-0002-3879-5019; Arni,
   Raghuvir K/0000-0003-2460-1145
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1, 26-1]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; DAADDeutscher Akademischer Austausch
   Dienst (DAAD) [PROBAL 50754442]; CAPESCAPES [NR-8248/12-5]; Alexander
   von Humboldt Foundation (AvH), Bonn, GermanyAlexander von Humboldt
   Foundation; National Institutes of Health, National Institute of General
   Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS); Howard Hughes Medical
   InstituteHoward Hughes Medical Institute; US Department of EnergyUnited
   States Department of Energy (DOE) [DE-AC02-05CH11231]
FX This project was supported by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1, 26-1), FAPESP, CNPq, CAPES
   and DAAD (PROBAL 50754442). MAC thanks CAPES (grant NR-8248/12-5) for
   the exchange fellowship. DG thanks the Alexander von Humboldt Foundation
   (AvH), Bonn, Germany for providing a Research Fellowship. The Berkeley
   Center for Structural Biology is supported in part by the National
   Institutes of Health, National Institute of General Medical Sciences and
   the Howard Hughes Medical Institute. The Advanced Light Source is
   supported by the US Department of Energy under Contract No.
   DE-AC02-05CH11231. We would like to thank Dr Alexey Kikhney and the
   staff of the Biological Small Angle Scattering group (EMBL/Hamburg,
   Germany) for providing the opportunity to perform SAXS measurements.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Boni-Mitake M, 2001, BRAZ J MED BIOL RES, V34, P1531, DOI 10.1590/S0100-879X2001001200004
   BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003
   Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018
   COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
   CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0
   Coronado MA, 2012, ACTA CRYSTALLOGR F, V68, P1052, DOI 10.1107/S1744309112032721
   Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   ENDO T, 1989, J PROTEIN CHEM, V8, P807, DOI 10.1007/BF01024904
   Fadel V, 2005, TOXICON, V46, P759, DOI 10.1016/j.toxicon.2005.07.018
   GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120
   Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150
   Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GIORGI R, 1993, TOXICON, V31, P1257, DOI 10.1016/0041-0101(93)90399-4
   GONCALVES JM, 1947, ARCH BIOCHEM, V13, P253
   Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200
   Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200
   Huang RH, 2004, BIOCHEMISTRY-US, V43, P6005, DOI 10.1021/bi036263y
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kerkis A, 2004, FASEB J, V18, P1407, DOI 10.1096/fj.03-1459fje
   Kerkis I, 2010, EXPERT OPIN INV DRUG, V19, P1515, DOI 10.1517/13543784.2010.534457
   Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563
   Landon C, 1996, EUR J BIOCHEM, V236, P395, DOI 10.1111/j.1432-1033.1996.00395.x
   Lee JY, 2011, INT J CANCER, V128, P2470, DOI 10.1002/ijc.25578
   LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541
   Mancin AC, 1998, TOXICON, V36, P1927, DOI 10.1016/S0041-0101(98)00117-2
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Nicastro G, 2003, EUR J BIOCHEM, V270, P1969, DOI 10.1046/j.1432-1033.2003.03563.x
   Oguiura N, 2011, J ANTIBIOT, V64, P327, DOI 10.1038/ja.2011.10
   Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853
   Ponce-Soto LA, 2007, PROTEIN J, V26, P533, DOI 10.1007/s10930-007-9094-z
   Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200
   Sverdlova A. N., 1999, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P34
   Torres AM, 2000, BIOCHEM J, V348, P649, DOI 10.1042/0264-6021:3480649
   Toyama MH, 2000, BBA-GEN SUBJECTS, V1474, P56, DOI 10.1016/S0304-4165(99)00211-1
   Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106
NR 39
TC 20
Z9 22
U1 1
U2 9
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD OCT
PY 2013
VL 69
BP 1958
EP 1964
DI 10.1107/S0907444913018003
PN 10
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 231GM
UT WOS:000325403900010
PM 24100315
OA Green Published
DA 2020-12-01
ER

PT J
AU Ullah, A
   Souza, TACB
   Zanphorlin, LM
   Mariutti, RB
   Santana, VS
   Murakami, MT
   Arni, RK
AF Ullah, A.
   Souza, T. A. C. B.
   Zanphorlin, L. M.
   Mariutti, R. B.
   Santana, V. S.
   Murakami, M. T.
   Arni, R. K.
TI Crystal structure of Jararacussin-I: The highly negatively charged
   catalytic interface contributes to macromolecular selectivity in snake
   venom thrombin-like enzymes
SO PROTEIN SCIENCE
LA English
DT Article
DE Jararacussin-I; thrombin-like enzyme; Bothrops jararacussu; crystal
   structure
ID BOTHROPS-ATROX VENOM; PLASMINOGEN-ACTIVATOR; SERINE PROTEINASES;
   PURIFICATION; CRYSTALLIZATION; PROTHROMBIN; ALTERNATUS; BATROXOBIN;
   SEQUENCE; PROTEASE
AB Snake venom serine proteinases (SVSPs) are hemostatically active toxins that perturb the maintenance and regulation of both the blood coagulation cascade and fibrinolytic feedback system at specific points, and hence, are widely used as tools in pharmacological and clinical diagnosis. The crystal structure of a thrombin-like enzyme (TLE) from Bothrops jararacussu venom (Jararacussin-I) was determined at 2.48 angstrom resolution. This is the first crystal structure of a TLE and allows structural comparisons with both the Agkistrodon contortrix contortrix Protein C Activator and the Trimeresurus stejnegeri plasminogen activator. Despite the highly conserved overall fold, significant differences in the amino acid compositions and three-dimensional conformations of the loops surrounding the active site significantly alter the molecular topography and charge distribution profile of the catalytic interface. In contrast to other SVSPs, the catalytic interface of Jararacussin-I is highly negatively charged, which contributes to its unique macromolecular selectivity.
C1 [Ullah, A.; Zanphorlin, L. M.; Mariutti, R. B.; Santana, V. S.; Arni, R. K.] IBILCE UNESP, Dept Phys, Multi User Ctr Biomol Innovat, Sao Jose Do Rio Preto, SP, Brazil.
   [Souza, T. A. C. B.; Murakami, M. T.] CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Ullah, Anwar/B-1720-2013; Arni, Raghuvir K/B-2222-2013; Murakami, Mario
   T/C-2087-2012; Murakami, Mario T/F-5640-2016
OI Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145;
   Murakami, Mario T/0000-0002-0405-8010; mariutti,
   ricardo/0000-0001-6720-4655
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK);
   DAADDeutscher Akademischer Austausch Dienst (DAAD); CAPESCAPES
FX Grant sponsors: FAPESP, CNPq, TWAS, DAAD, CAPES.
CR Alberio L, 1999, EUR J CLIN INVEST, V29, P1066
   ARONSON DL, 1976, THROMB HAEMOSTASIS, V36, P9, DOI 10.1055/s-0038-1648004
   Baglia FA, 1998, BIOCHEMISTRY-US, V37, P2271, DOI 10.1021/bi972113+
   BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227
   Bell WR, 1998, HEMOSTASIS ANIMAL VE, P541
   Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X
   Costa JD, 2010, TOXICON, V55, P1365, DOI 10.1016/j.toxicon.2010.02.014
   de Oliveira DGL, 2009, ACTA BIOCH BIOPH SIN, V41, P21, DOI 10.1093/abbs/gmn003
   HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508
   ITOH N, 1987, J BIOL CHEM, V262, P3132
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kini RM, 2005, TOXICON, V45, P1133, DOI 10.1016/j.toxicon.2005.02.019
   KIRBY EP, 1979, BIOCHEMISTRY-US, V18, P3564, DOI 10.1021/bi00583a020
   MANDELBAUM FR, 1964, ARCH BIOCHEM BIOPHYS, V104, P369, DOI 10.1016/0003-9861(64)90477-1
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   Monroe DM, 2012, HAEMOPHILIA, V18, P11, DOI 10.1111/j.1365-2516.2012.02889.x
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   NISHIDA S, 1994, BIOCHEMISTRY-US, V33, P1843, DOI 10.1021/bi00173a030
   Oliveira F, 1999, BIOCHEM MOL BIOL INT, V47, P1069
   Oliver JA, 2002, BLOOD, V100, P539, DOI 10.1182/blood.V100.2.539
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Petretski JH, 2000, BRAZ J MED BIOL RES, V33, P1293, DOI 10.1590/S0100-879X2000001100005
   SERRANO SMT, 1993, TOXICON, V31, P483, DOI 10.1016/0041-0101(93)90183-J
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   Smolka MB, 1998, TOXICON, V36, P1059, DOI 10.1016/S0041-0101(98)80008-1
   Stocker K., 1976, Methods Enzymol, V45, P214
   Tu A.T, 1991, HDB NATURAL TOXINS
   Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531
NR 31
TC 13
Z9 14
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD JAN
PY 2013
VL 22
IS 1
BP 128
EP 132
DI 10.1002/pro.2189
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 057AV
UT WOS:000312535000014
PM 23139169
OA Green Published
DA 2020-12-01
ER

PT J
AU Ullah, A
   de Souza, TDCB
   Masood, R
   Murakami, MT
   Arni, RK
AF Ullah, Anwar
   Campos Brasil de Souza, Tatiana de Arruda
   Masood, Rehana
   Murakami, Mario Tyago
   Arni, Raghuvir Krishnaswamy
TI Purification, crystallization and preliminary X-ray diffraction analysis
   of a class P-III metalloproteinase (BmMP-III) from the venom of Bothrops
   moojeni
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID SNAKE; PROTEINS; INSIGHTS
AB Snake-venom metalloproteinases (SVMPs) comprise a family of haemostatically active toxins which can cause haemorrhage, coagulopathy, inhibition of platelet aggregation and inflammatory response. These effects are attributed to the proteolytic action of SVMPs on extracellular matrix components, plasma proteins and cell-surface proteins. SVMPs are classified into four classes (P-I to P-IV) based on their domain structures. In order to understand the multiple roles played by the domains of P-III SVMPs, a P-III SVMP (BmMP-III) from the venom of Bothrops moojeni was purified, characterized and crystallized. The crystals belonged to space group I4(1)22, with unit-cell parameters a = b = 108.16, c = 196.09 angstrom. Initially, flash-cooled crystals diffracted poorly to a resolution of about 10 angstrom. However, a significant improvement in the diffraction resolution was observed upon annealing and a complete data set was collected to 3.3 angstrom resolution. The asymmetric unit contained one molecule and the structure was determined and partially refined to an R factor of 34%. Structural comparisons indicated that the cysteine-rich domain can adopt different conformations in relation to the catalytic domain, which may modulate the enzyme activity.
C1 [Ullah, Anwar; Masood, Rehana; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, Sao Jose Do Rio Preto 15054000, SP, Brazil.
   [Campos Brasil de Souza, Tatiana de Arruda; Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, BR-13083970 Campinas, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, Sao Jose Do Rio Preto 15054000, SP, Brazil.
EM arni@sjrp.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Murakami, Mario T/F-5640-2016; Murakami,
   Mario T/C-2087-2012; Ullah, Anwar/B-1720-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Ullah, Anwar/0000-0003-3793-7393
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); CAPESCAPES; TWASTurkiye Bilimsel ve Teknolojik Arastirma
   Kurumu (TUBITAK)
FX This work was supported by grants from CNPq, FAPESP, CAPES and TWAS.
CR Akao PK, 2010, TOXICON, V55, P361, DOI 10.1016/j.toxicon.2009.08.013
   BJARNASON JB, 1995, METHOD ENZYMOL, V248, P345
   Calvete JJ, 2007, J MASS SPECTROM, V42, P1405, DOI 10.1002/jms.1242
   Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Jeon OH, 1999, EUR J BIOCHEM, V263, P526, DOI 10.1046/j.1432-1327.1999.00525.x
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Muniz JRC, 2008, TOXICON, V52, P807, DOI 10.1016/j.toxicon.2008.08.021
   Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
NR 17
TC 6
Z9 6
U1 0
U2 8
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD OCT
PY 2012
VL 68
BP 1222
EP 1225
DI 10.1107/S1744309112036603
PN 10
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 014EF
UT WOS:000309357200017
PM 23027752
OA Green Published
DA 2020-12-01
ER

PT J
AU Ullah, A
   Souza, TACB
   Betzel, C
   Murakami, MT
   Arni, RK
AF Ullah, A.
   Souza, T. A. C. B.
   Betzel, C.
   Murakami, M. T.
   Arni, R. K.
TI Crystallographic portrayal of different conformational states of a Lys49
   phospholipase A(2) homologue: Insights into structural determinants for
   myotoxicity and dimeric configuration
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Lys49 phospholipase A(2) homologue; Bothrops brazili; Tetraethylene
   glycol; Conformational states; Oligomerization
ID ASPER SNAKE-VENOM; CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION;
   LYS49-PHOSPHOLIPASE A(2); ZHAOERMIA-MANGSHANENSIS; SYNTHETIC PEPTIDES;
   IDENTIFICATION; MECHANISM; BINDING; REGION
AB Catalytically inactive phospholipase A(2) (PLA(2)) homologues play key roles in the pathogenesis induced by snake envenomation, causing extensive tissue damage via a mechanism still unknown. Although, the amino acid residues directly involved in catalysis are conserved, the substitution of Asp49 by Arg/Lys/Gln or Set prevents the binding of the essential calcium ion and hence these proteins are incapable of hydrolyzing phospholipids. In this work, the crystal structure of a Lys49-PLA(2) homologue from Bothrops brazili (MIX-II) was solved in two conformational states: (a) native, with Lys49 singly coordinated by the backbone oxygen atom of Val31 and (b) complexed with tetraethylene glycol (TTEG). Interestingly, the TTEG molecule was observed in two different coordination cages depending on the orientation of the nominal calcium-binding loop and of the residue Lys49. These structural observations indicate a direct role for the residue Lys49 in the functioning of a catalytically inactive PLA(2) homologue suggesting a contribution of the active site-like region in the expression of pharmacological effects such as myotoxicity and edema formation. Despite the several crystal structures of Lys49-PLA(2) homologues already determined, their biological assembly remains controversial with two possible conformations. The extended dimer with the hydrophobic channel exposed to the solvent and the compact dimer in which the active site-like region is occluded by the dimeric interface. In the MTX-II crystal packing analysis was found only the extended dimer as a possible stable quaternary arrangement. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Ullah, A.; Arni, R. K.] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Souza, T. A. C. B.; Murakami, M. T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil.
   [Betzel, C.] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013; Murakami,
   Mario T/F-5640-2016; Betzel, Christian/G-8105-2018; Ullah,
   Anwar/B-1720-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Betzel, Christian/0000-0002-3879-5019; Ullah,
   Anwar/0000-0003-3793-7393
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK);
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   DAADDeutscher Akademischer Austausch Dienst (DAAD); CAPESCAPES;
   Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [23012034] Funding Source: KAKEN
FX This research was supported by grants from CNPq, TWAS, FAPESP, DAAD and
   CAPES.
CR Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Costa TR, 2008, PEPTIDES, V29, P1645, DOI 10.1016/j.peptides.2008.05.021
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   Huancahuire-Vega S, 2009, TOXICON, V54, P818, DOI 10.1016/j.toxicon.2009.06.008
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Ketelhut DFJ, 2003, BIOCHIMIE, V85, P983, DOI 10.1016/j.biochi.2003.09.011
   Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1986, TOXICON, V24, P895
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOMONTE B, 1993, INFLAMMATION, V17, P93, DOI 10.1007/BF00916097
   Lomonte B, 1999, BBA-BIOMEMBRANES, V1461, P19, DOI 10.1016/S0005-2736(99)00143-1
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P41, DOI 10.1016/0041-0101(94)90020-5
   Magro AJ, 2004, BIOCHEM BIOPH RES CO, V323, P24, DOI 10.1016/j.bbrc.2004.08.046
   Mebs D, 2006, TOXICON, V47, P797, DOI 10.1016/j.toxicon.2006.01.031
   Murakami MT, 2006, BIOCHIMIE, V88, P543, DOI 10.1016/j.biochi.2005.10.014
   Murakami MT, 2008, PROTEIN PEPTIDE LETT, V15, P1002, DOI 10.2174/092986608785849245
   Murakami MT, 2008, TOXICON, V51, P723, DOI 10.1016/j.toxicon.2007.11.018
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Murakami MT, 2006, ACTA CRYSTALLOGR F, V62, P423, DOI 10.1107/S1744309106010700
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Nunez V, 2004, TOXICON, V44, P91, DOI 10.1016/j.toxicon.2004.04.013
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012
   Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011
   Tsunasawa S. Chwetzoff, 1989, J BIOL CHEM, V22, P13289
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Wen-Hwa L, 1999, ACTA CRYSTALLOGR D, V55, P1229, DOI 10.1107/S0907444999004576
   Yamazaki Y, 2005, J BIOL CHEM, V280, P29989, DOI 10.1074/jbc.C500236200
NR 43
TC 12
Z9 13
U1 2
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT
PY 2012
VL 51
IS 3
BP 209
EP 214
DI 10.1016/j.ijbiomac.2012.05.006
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 983QQ
UT WOS:000307134200005
PM 22584077
OA Green Published
DA 2020-12-01
ER

PT J
AU Coronado, MA
   Georgieva, D
   Buck, F
   Gabdoulkhakov, AH
   Ullah, A
   Spencer, PJ
   Arni, RK
   Betzel, C
AF Coronado, Monika A.
   Georgieva, Dessislava
   Buck, Friedrich
   Gabdoulkhakov, Azat H.
   Ullah, Anwar
   Spencer, Patrick J.
   Arni, Raghuvir K.
   Betzel, Christian
TI Purification, crystallization and preliminary X-ray diffraction analysis
   of crotamine, a myotoxic polypeptide from the Brazilian snake Crotalus
   durissus terrificus
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE crotamine; myotoxins; Crotalus durissus terrificus
AB Crotamine, a highly basic myotoxic polypeptide (molecular mass 4881 Da) isolated from the venom of the Brazilian rattlesnake Crotalus durissus terrificus, causes skeletal muscle contraction and spasms, affects the functioning of voltage-sensitive sodium channels by inducing sodium influx and possesses antitumour activity, suggesting potential pharmaceutical applications. Crotamine was purified from C. durissus terrificus venom; the crystals diffracted to 1.9 angstrom resolution and belonged to the orthorhombic space group I212121 or I222, with unit-cell parameters a = 67.75, b = 74.4, c = 81.01 angstrom. The self-rotation function indicated that the asymmetric unit contained three molecules. However, structure determination by molecular replacement using NMR-determined coordinates was unsuccessful and a search for potential derivatives has been initiated.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, DESY, Lab Struct Biol Infect & Inflammat, D-22603 Hamburg, Germany.
   [Coronado, Monika A.; Ullah, Anwar; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Buck, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany.
   [Gabdoulkhakov, Azat H.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia.
   [Spencer, Patrick J.] Inst Pesquisas Energet & Nucl CNEN SP, Ctr Biotecnol, BR-05508000 Sao Paulo, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, DESY, Lab Struct Biol Infect & Inflammat, Notkestr 85, D-22603 Hamburg, Germany.
EM christian.betzel@uni-hamburg.de
RI Arni, Raghuvir K/B-2222-2013; Ullah, Anwar/B-1720-2013; Gabdulkhakov,
   Azat/H-4343-2013; Betzel, Christian/G-8105-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Ullah, Anwar/0000-0003-3793-7393;
   Gabdulkhakov, Azat/0000-0003-1016-5936; Betzel,
   Christian/0000-0002-3879-5019; Spencer, Patrick/0000-0001-8949-7735
FU DFGGerman Research Foundation (DFG) [BE 1443-18-1]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPqNational Council
   for Scientific and Technological Development (CNPq); CAPESCAPES
   [80563/2911]; DAADDeutscher Akademischer Austausch Dienst (DAAD) [PROBAL
   50754442]; Alexander von Humboldt Foundation, Bonn, GermanyAlexander von
   Humboldt Foundation [3.3-BUL/1073481 STP]
FX This study was financed by grants from the DFG (Project BE 1443-18-1),
   FAPESP, CNPq, CAPES (80563/2911) and DAAD (PROBAL 50754442). DG thanks
   the Alexander von Humboldt Foundation, Bonn, Germany for providing a
   research fellowship (3.3-BUL/1073481 STP).
CR Boni-Mitake M, 2001, BRAZ J MED BIOL RES, V34, P1531, DOI 10.1590/S0100-879X2001001200004
   Fadel V, 2005, TOXICON, V46, P759, DOI 10.1016/j.toxicon.2005.07.018
   Garcia-Caballero A, 2011, CRYST GROWTH DES, V11, P2112, DOI 10.1021/cg1013768
   GIGLIO JR, 1975, ANAL BIOCHEM, V69, P207, DOI 10.1016/0003-2697(75)90581-3
   GONCALVES JM, 1947, ARCH BIOCHEM, V13, P253
   Katagiri C, 1998, CAN J PHYSIOL PHARM, V76, P395, DOI 10.1139/cjpp-76-4-395
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAURE CJ, 1975, H-S Z PHYSIOL CHEM, V356, P213
   Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4
   Matavel ACS, 1998, EUR J PHARMACOL, V348, P167, DOI 10.1016/S0014-2999(98)00152-6
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   McPherson A., 1999, CRYSTALLIZATION BIOL
   Nascimento FD, 2012, MOL PHARMACEUT, V9, P211, DOI 10.1021/mp2000605
   Nicastro G, 2003, EUR J BIOCHEM, V270, P1969, DOI 10.1046/j.1432-1033.2003.03563.x
   Oguiura N, 2005, TOXICON, V46, P363, DOI 10.1016/j.toxicon.2005.06.009
   Peigneur S, 2012, MOL PHARMACOL, V82, P90, DOI 10.1124/mol.112.078188
   Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
NR 19
TC 8
Z9 8
U1 0
U2 9
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD SEP
PY 2012
VL 68
BP 1052
EP 1054
DI 10.1107/S1744309112032721
PN 9
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 000SA
UT WOS:000308407200011
PM 22949192
OA Green Published
DA 2020-12-01
ER

PT J
AU Ullah, A
   Souza, TACB
   Abrego, JRB
   Betzel, C
   Murakami, MT
   Arni, RK
AF Ullah, A.
   Souza, T. A. C. B.
   Abrego, J. R. B.
   Betzel, C.
   Murakami, M. T.
   Arni, R. K.
TI Structural insights into selectivity and cofactor binding in snake venom
   L-amino acid oxidases
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE L-Amino acid oxidase; Bothrops jararacussu; Crystal structure; Amino
   acid specificity; FAD-binding mode
ID BOTHROPS-MOOJENI; PURIFICATION; PROTEINS; CRYSTALLIZATION; INACTIVATION;
   MECHANISM
AB L-Amino acid oxidases (LAAOs) are flavoenzymes that catalytically deaminate L-amino acids to corresponding alpha-keto acids with the concomitant production of ammonia (NH3) and hydrogen peroxide (H2O2). Particularly, snake venom LAAOs have been attracted much attention due to their diverse clinical and biological effects, interfering on human coagulation factors and being cytotoxic against some pathogenic bacteria and Leishmania ssp. In this work, a new LAAO from Bothrops jararacussu venom (BjsuLAAO) was purified, functionally characterized and its structure determined by X-ray crystallography at 3.1 angstrom resolution. BjsuLAAO showed high catalytic specificity for aromatic and aliphatic large side-chain amino acids. Comparative structural analysis with prokaryotic LAAOs, which exhibit low specificity, indicates the importance of the active-site volume in modulating enzyme selectivity. Surprisingly, the flavin adenine dinucleotide (FAD) cofactor was found in a different orientation canonically described for both prokaryotic and eukaryotic LAAOs. In this new conformational state, the adenosyl group is flipped towards the 62-71 loop, being stabilized by several hydrogen-bond interactions, which is equally stable to the classical binding mode. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Ullah, A.; Abrego, J. R. B.; Arni, R. K.] Univ Estadual Paulista, Ctr Multiusuario Inovacao Biomol, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Souza, T. A. C. B.; Murakami, M. T.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil.
   [Betzel, C.] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
RP Arni, RK (corresponding author), Univ Estadual Paulista, Ctr Multiusuario Inovacao Biomol, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Murakami, Mario T/F-5640-2016; Betzel, Christian/G-8105-2018; Arni,
   Raghuvir K/B-2222-2013; Ullah, Anwar/B-1720-2013; Murakami, Mario
   T/C-2087-2012
OI Murakami, Mario T/0000-0002-0405-8010; Betzel,
   Christian/0000-0002-3879-5019; Arni, Raghuvir K/0000-0003-2460-1145;
   Ullah, Anwar/0000-0003-3793-7393; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu
   (TUBITAK)
FX This work was supported by grants from FAPESP, CNPq, CAPES and TWAS.
CR Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007
   CURTI B, 1968, J BIOL CHEM, V243, P2306
   Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2
   Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071
   Georgieva D, 2011, MOL BIOSYST, V7, P379, DOI 10.1039/c0mb00101e
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197
   Lewis RL, 2004, SEMIN NEUROL, V24, P175, DOI 10.1055/s-2004-830904
   LI ZY, 1994, TOXICON, V32, P1349, DOI 10.1016/0041-0101(94)90407-3
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rodrigues RS, 2009, BIOCHIMIE, V91, P490, DOI 10.1016/j.biochi.2008.12.004
   Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006
   Sun MZ, 2010, BIOCHIMIE, V92, P343, DOI 10.1016/j.biochi.2010.01.013
   Tempone AG, 2001, BIOCHEM BIOPH RES CO, V280, P620, DOI 10.1006/bbrc.2000.4175
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Wei JF, 2009, TOXICON, V54, P262, DOI 10.1016/j.toxicon.2009.04.017
   WELLNER D, 1966, BIOCHEMISTRY-US, V5, P1585, DOI 10.1021/bi00869a019
   Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046
   Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044
NR 22
TC 20
Z9 21
U1 1
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 27
PY 2012
VL 421
IS 1
BP 124
EP 128
DI 10.1016/j.bbrc.2012.03.129
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 948KF
UT WOS:000304501400022
PM 22490662
OA Green Published
DA 2020-12-01
ER

PT J
AU Ullah, A
   Coronado, M
   Murakami, MT
   Betzel, C
   Arni, RK
AF Ullah, Anwar
   Coronado, Monika
   Murakami, Mario T.
   Betzel, Christian
   Arni, Raghuvir K.
TI Crystallization and preliminary X-ray diffraction analysis of an
   l-amino-acid oxidase from Bothrops jararacussu venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE l-amino-acid oxidases; snake venoms
ID SNAKE-VENOM; STRUCTURAL-CHARACTERIZATION; CALLOSELASMA-RHODOSTOMA; SKIN
   MUCUS; PROTEINS; PURIFICATION; MECHANISM; MOOJENI; LAAO
AB Snake-venom l-amino-acid oxidases (SV-LAAOs) trigger a wide range of local and systematic effects, including inhibition of platelet aggregation, cytotoxicity, haemolysis, apoptosis and haemorrhage. These effects mainly arise from the uncontrolled release of the hydrogen peroxide that is produced by the redox reaction involving l-amino acids catalyzed by these flavoenzymes. Taking their clinical relevance into account, few SV-LAAOs have been structurally characterized and the structural determinants responsible for their broad direct and indirect pharmacological activities remain unclear. In this work, an LAAO from Bothrops jararacussu venom (BJu-LAAO) was purified and crystallized. The BJu-LAAO crystals belonged to space group P21, with unit-cell parameters a similar to=similar to 66.38, b = 72.19, c = 101.53 angstrom, beta = 90.9 degrees. The asymmetric unit contained two similar to molecules and the structure was determined and partially refined at 3.0 angstrom resolution.
C1 [Ullah, Anwar; Coronado, Monika; Arni, Raghuvir K.] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, LNBio, BR-13083970 Campinas, SP, Brazil.
   [Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect, D-22603 Hamburg, Germany.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Betzel, Christian/G-8105-2018; Murakami, Mario T/F-5640-2016; Murakami,
   Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013; Ullah,
   Anwar/B-1720-2013; Arni, Raghuvir K/N-9338-2018
OI Betzel, Christian/0000-0002-3879-5019; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Ullah,
   Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; DAADDeutscher Akademischer Austausch Dienst (DAAD);
   TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)
FX This research was supported by grants from FAPESP, CNPq, CAPES, DAAD and
   TWAS.
CR Alves RM, 2008, COMP BIOCHEM PHYS A, V151, P542, DOI 10.1016/j.cbpa.2008.07.007
   Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071
   Georgieva D, 2011, MOL BIOSYST, V7, P379, DOI 10.1039/c0mb00101e
   Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x
   Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LI ZY, 1994, TOXICON, V32, P1349, DOI 10.1016/0041-0101(94)90407-3
   Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Nagashima Y, 2009, COMP BIOCHEM PHYS B, V154, P55, DOI 10.1016/j.cbpb.2009.05.006
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rodrigues RS, 2009, BIOCHIMIE, V91, P490, DOI 10.1016/j.biochi.2008.12.004
   Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006
   STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I
   Sun MZ, 2010, BIOCHIMIE, V92, P343, DOI 10.1016/j.biochi.2010.01.013
   Tempone AG, 2001, BIOCHEM BIOPH RES CO, V280, P620, DOI 10.1006/bbrc.2000.4175
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Yang HH, 2009, MYCOL RES, V113, P924, DOI 10.1016/j.mycres.2009.04.004
   Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046
   Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044
NR 28
TC 7
Z9 7
U1 0
U2 10
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD FEB
PY 2012
VL 68
BP 211
EP 213
DI 10.1107/S1744309111054923
PN 2
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 887RW
UT WOS:000299948000023
PM 22298002
OA Green Published
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Coronado, M
   Oberthur, D
   Buck, F
   Duhalov, D
   Arni, RK
   Betzel, C
AF Georgieva, Dessislava
   Coronado, Monika
   Oberthuer, Dominik
   Buck, Friedrich
   Duhalov, Deyan
   Arni, Raghuvir K.
   Betzel, Christian
TI Crystal structure of a dimeric Ser49 PLA(2)-like myotoxic component of
   the Vipera ammodytes meridionalis venomics reveals determinants of
   myotoxicity and membrane damaging activity
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID PHOSPHOLIPASE A(2) HOMOLOG; SNAKE-VENOM; ENZYMATIC-ACTIVITY;
   CATALYTIC-ACTIVITY; ECARPHOLIN-S; LYS49; MECHANISM; BINDING;
   IDENTIFICATION; RESOLUTION
AB Myotoxicity and membrane damage play a central role in the life-threatening effects of the viper envenomation. Myotoxins are an important part of the viper venomics. A Ser49 PLA(2)-like myotoxin from the venom of Vipera ammodytes meridionalis, the most venomous snake in Europe, was crystallized and its three-dimensional structure determined. The toxin is devoid of phospholipolytic activity. The structure demonstrates a formation of dimers. In the dimers functionally important peptide segments, located on the protein surface, point in the same direction which can strengthen the pharmacological effect. This supports the hypothesis about the physiological importance of the toxin oligomerization for the myotoxicity and membrane damage. The crystallographic model revealed that the structural determinants of myotoxicity (a positively charged C-terminal region and a hydrophobic knuckle) are fully exposed on the protein surface and accessible for interactions with target membranes. Distortion of the catalytic site region explains the absence of enzymatic activity. The structure reveals anion-binding sites which can be considered as possible sites of interactions of the toxin with a negatively charged membrane surface. The high structural similarity of the Ser49 myotoxin and Asp49 PLA(2) from the same venom suggests an evolutionary relationship: probably, the Ser49 myotoxin is a product of evolution of the catalytically active phospholipase A(2). The first toxin lost the enzymatic activity which is not necessary for the myotoxicity but preserved the cytotoxicity and membrane damaging activity as important components of the venom toxicity.
C1 [Georgieva, Dessislava; Coronado, Monika; Oberthuer, Dominik; Betzel, Christian] Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Inst Biochem & Mol Biol, D-22603 Hamburg, Germany.
   [Georgieva, Dessislava] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
   [Buck, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany.
   [Duhalov, Deyan] BUL BIO NCIPD Ltd, Sofia, Bulgaria.
   [Arni, Raghuvir K.; Betzel, Christian] Univ Estadual Paulista UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Inst Biochem & Mol Biol, Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Arni, Raghuvir K/N-9338-2018; Betzel, Christian/G-8105-2018; Arni,
   Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Betzel,
   Christian/0000-0002-3879-5019; Arni, Raghuvir K/0000-0003-2460-1145
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; CAPESCAPES [80563/2911]; DAAD (PROBAL) [50754442]; Bulgarian
   National Foundation for Scientific ResearchNational Science Fund of
   Bulgaria [TK-B-1610/06]
FX This study was financed by a grant of the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1) CAPES (80563/2911) and
   DAAD (PROBAL 50754442). The work was also supported in part by the
   Bulgarian National Foundation for Scientific Research, Grant
   TK-B-1610/06.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   ALEKSIEV B, 1976, TOXICON, V14, P477, DOI 10.1016/0041-0101(76)90065-9
   Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Banumathi S, 2001, ACTA CRYSTALLOGR D, V57, P1552, DOI 10.1107/S0907444901013543
   Cantor C. R., 1980, SIZE SHAPE MACROMO 2, P539
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   INCERPI S, 1995, BBA-MOL CELL RES, V1268, P137, DOI 10.1016/0167-4889(95)00053-U
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Murakami MT, 2006, BIOCHIMIE, V88, P543, DOI 10.1016/j.biochi.2005.10.014
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Murakami MT, 2006, ACTA CRYSTALLOGR F, V62, P423, DOI 10.1107/S1744309106010700
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Ohno M, 2003, TOXICON, V42, P841, DOI 10.1016/j.toxicon.2003.11.003
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   Petan T, 2007, BIOCHEMISTRY-US, V46, P12795, DOI 10.1021/bi701304e
   Polgar J, 1996, BIOCHEM J, V319, P961, DOI 10.1042/bj3190961
   PUNGERCAR J, 1990, NUCLEIC ACIDS RES, V18, P4601, DOI 10.1093/nar/18.15.4601
   Pungercar J, 1998, BIOCHEM BIOPH RES CO, V244, P514, DOI 10.1006/bbrc.1998.8297
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Soares AM, 2003, TOXICON, V42, P855, DOI 10.1016/j.toxicon.2003.11.004
   THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0
   THUNNISSEN MMGM, 1990, J MOL BIOL, V216, P425, DOI 10.1016/S0022-2836(05)80332-8
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747
NR 42
TC 4
Z9 4
U1 2
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2012
VL 8
IS 5
BP 1405
EP 1411
DI 10.1039/c2mb05490f
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 919YR
UT WOS:000302368600003
PM 22362132
DA 2020-12-01
ER

PT J
AU Kang, TS
   Georgieva, D
   Genov, N
   Murakami, MT
   Sinha, M
   Kumar, RP
   Kaur, P
   Kumar, S
   Dey, S
   Sharma, S
   Vrielink, A
   Betzel, C
   Takeda, S
   Arni, RK
   Singh, TP
   Kini, RM
AF Kang, Tse Siang
   Georgieva, Dessislava
   Genov, Nikolay
   Murakami, Mario T.
   Sinha, Mau
   Kumar, Ramasamy P.
   Kaur, Punit
   Kumar, Sanjit
   Dey, Sharmistha
   Sharma, Sujata
   Vrielink, Alice
   Betzel, Christian
   Takeda, Soichi
   Arni, Raghuvir K.
   Singh, Tej P.
   Kini, R. Manjunatha
TI Enzymatic toxins from snake venom: structural characterization and
   mechanism of catalysis
SO FEBS JOURNAL
LA English
DT Review
DE acetylcholinesterase; l-amino acid oxidase; metalloproteinase;
   phospholipase A2; serine proteinase
ID AMINO-ACID OXIDASE; CYSTEINE-RICH DOMAIN; SECRETORY PHOSPHOLIPASE A(2);
   DABOIA-RUSSELLI-PULCHELLA; ANTIINFLAMMATORY DRUGS NSAIDS;
   PSEUDONAJA-TEXTILIS VENOM; AGKISTRODON HALYS PALLAS;
   NAJA-NAJA-SAGITTIFERA; VON-WILLEBRAND-FACTOR; CRYSTAL-STRUCTURE
AB Snake venoms are cocktails of enzymes and non-enzymatic proteins used for both the immobilization and digestion of prey. The most common snake venom enzymes include acetylcholinesterases, l-amino acid oxidases, serine proteinases, metalloproteinases and phospholipases A2. Higher catalytic efficiency, thermal stability and resistance to proteolysis make these enzymes attractive models for biochemists, enzymologists and structural biologists. Here, we review the structures of these enzymes and describe their structure-based mechanisms of catalysis and inhibition. Some of the enzymes exist as protein complexes in the venom. Thus we also discuss the functional role of non-enzymatic subunits and the pharmacological effects of such protein complexes. The structures of inhibitorenzyme complexes provide ideal platforms for the design of potent inhibitors which are useful in the development of prototypes and lead compounds with potential therapeutic applications.
C1 [Kini, R. Manjunatha] Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, Singapore 117543, Singapore.
   [Kang, Tse Siang] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore.
   [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, Hamburg, Germany.
   [Genov, Nikolay] Bulgarian Acad Sci, Inst Organ Chem, Sofia, Bulgaria.
   [Murakami, Mario T.] Natl Ctr Res Energy & Mat, Natl Lab Biosci, Campinas, SP, Brazil.
   [Sinha, Mau; Kumar, Ramasamy P.; Kaur, Punit; Kumar, Sanjit; Dey, Sharmistha; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.
   [Vrielink, Alice] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia.
   [Takeda, Soichi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Suita, Osaka, Japan.
   [Arni, Raghuvir K.] Sao Paulo State Univ, Ctr Multiusuario Inovacao Biomol, Dept Phys, Sao Jose Do Rio Preto, Brazil.
RP Kini, RM (corresponding author), Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, 14 Sci Dr 4,Block S3,03-17, Singapore 117543, Singapore.
EM dbskinim@nus.edu.sg
RI Ramasamy, Prem Kumar/I-6801-2019; Murakami, Mario T/F-5640-2016; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Kini,
   Manjunatha/H-8029-2012; Murakami, Mario T/C-2087-2012; Vrielink,
   Alice/D-3652-2013; Betzel, Christian/G-8105-2018
OI Ramasamy, Prem Kumar/0000-0002-6555-8289; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Vrielink, Alice/0000-0001-8197-3725;
   Betzel, Christian/0000-0002-3879-5019; Kini,
   Manjunatha/0000-0002-6100-3251
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443/18-1, BE 1443/23-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B 1610/06]; Department of
   Science and Technology (Ministry of Science and Technology, New Delhi,
   India)Department of Science & Technology (India); Department of
   Biotechnology, Ministry of Science and Technology, New DelhiDepartment
   of Science & Technology (India); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; Grants-in-Aid for
   Scientific ResearchMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23121536]
   Funding Source: KAKEN
FX This work was supported by the Deutsche Forschungsgemeinschaft via the
   project BE 1443/18-1, the Bulgarian National Foundation for Scientific
   Research, grant TK-B 1610/06, and the Department of Science and
   Technology (Ministry of Science and Technology, New Delhi, India). CB
   thanks the Deutsche Forschungsgemeinschaft for financial support through
   the project BE 1443/23-1. TPS thanks the Department of Biotechnology,
   Ministry of Science and Technology, New Delhi, for the award of a
   Distinguished Biotechnology Research Professorship. MTM and RKA thank
   FAPESP, CNPq and CAPES for financial support. RMK thanks the National
   University of Singapore for financial support through the Academic
   Research Grant.
CR ABREGO JRB, 1993, BIOPHYS J, V64, P560, DOI 10.1016/S0006-3495(93)81395-X
   Abu Reza M, 2005, THROMB HAEMOSTASIS, V93, P40, DOI 10.1160/TH04-07-0435
   Ahmed MA, 2009, HDB VENOMS TOXINS RE, P207
   AIRD SD, 1985, BIOCHEMISTRY-US, V24, P7054, DOI 10.1021/bi00346a005
   Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106
   Aldunate R, 2004, BRAIN RES REV, V47, P96, DOI 10.1016/j.brainresrev.2004.07.019
   ALEKSIEV B, 1976, TOXICON, V14, P477, DOI 10.1016/0041-0101(76)90065-9
   ALEKSIEV B, 1971, H-S Z PHYSIOL CHEM, V352, P1183, DOI 10.1515/bchm2.1971.352.2.1183
   Ande SR, 2006, APOPTOSIS, V11, P1439, DOI 10.1007/s10495-006-7959-9
   Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340
   ARAKI S, 1993, BIOCHEM BIOPH RES CO, V190, P148, DOI 10.1006/bbrc.1993.1023
   Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x
   Balasubramanya R, 2005, BBA-PROTEINS PROTEOM, V1752, P177, DOI 10.1016/j.bbapap.2005.07.020
   Banumathi S, 2001, ACTA CRYSTALLOGR D, V57, P1552, DOI 10.1107/S0907444901013543
   BARAK D, 1994, J BIOL CHEM, V269, P6296
   BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019
   Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w
   Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790
   Bernard P, 2001, EUR J MED CHEM, V36, P1, DOI 10.1016/S0223-5234(00)01183-1
   Betzel C, 1999, CELL MOL LIFE SCI, V56, P384, DOI 10.1007/s000180050440
   BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0
   Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0
   Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548
   BLOW D, 1990, NATURE, V343, P694, DOI 10.1038/343694a0
   BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   Bon C, 1979, Adv Cytopharmacol, V3, P231
   Bon C, 1997, VENOM PHOSPHOLIPASE, P269
   BON S, 1979, P NATL ACAD SCI USA, V76, P2546, DOI 10.1073/pnas.76.6.2546
   Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X
   BOUCHIER C, 1991, BIOCHIM BIOPHYS ACTA, V1088, P401, DOI 10.1016/0167-4781(91)90132-6
   BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0
   BRAUN M, 1992, APPL MICROBIOL BIOT, V37, P594
   BREARLEY GM, 1994, APPL MICROBIOL BIOT, V41, P670
   Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200
   Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9
   BURKHART W, 1992, FEBS LETT, V297, P297, DOI 10.1016/0014-5793(92)80559-Y
   Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024
   CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711
   Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014
   Cha SS, 1996, J MED CHEM, V39, P3878, DOI 10.1021/jm960502g
   Chandra V, 2002, J BIOL CHEM, V277, P41079, DOI 10.1074/jbc.M206130200
   Chandra V, 2002, J MOL BIOL, V320, P215, DOI 10.1016/S0022-2836(02)00473-4
   Chandra V, 2002, ACTA CRYSTALLOGR D, V58, P1813, DOI 10.1107/S0907444902013720
   Chandra V, 2001, ACTA CRYSTALLOGR D, V57, P1793, DOI 10.1107/S0907444901014524
   Chandra V, 2002, BIOCHEMISTRY-US, V41, P10914, DOI 10.1021/bi0258593
   Chandra V, 2000, J MOL BIOL, V296, P1117, DOI 10.1006/jmbi.2000.3537
   CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241
   Chen YH, 2004, BIOCHEM J, V381, P25, DOI 10.1042/BJ20040125
   CHOUMET V, 1993, EUR J BIOCHEM, V211, P57, DOI 10.1111/j.1432-1033.1993.tb19869.x
   CHU CC, 1995, J CHROMATOGR A, V694, P492, DOI 10.1016/0021-9673(94)01173-C
   Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175
   Cousin X, 1998, J BIOL CHEM, V273, P9812, DOI 10.1074/jbc.273.16.9812
   Cousin X, 1996, FEBS LETT, V387, P196, DOI 10.1016/0014-5793(96)00447-4
   CURTI B, 1968, J BIOL CHEM, V243, P2306
   DEKOK A, 1968, BIOCHIM BIOPHYS ACTA, V167, P35, DOI 10.1016/0005-2744(68)90275-1
   DEKOK A, 1969, BIOCHEMISTRY-US, V8, P1405, DOI 10.1021/bi00832a015
   Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8
   Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001
   EICHLER J, 1994, MOL PHARMACOL, V45, P335
   EPSTEIN DM, 1992, BIOCHEMISTRY-US, V31, P11216, DOI 10.1021/bi00160a036
   EVENTOFF W, 1975, Critical Reviews in Biochemistry, V3, P111, DOI 10.3109/10409237509102554
   Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071
   Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342
   Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5
   Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4
   GELB MH, 1995, ANNU REV BIOCHEM, V64, P653
   Gempeler-Messina PM, 2001, HAEMOSTASIS, V31, P266
   Georgieva DN, 2004, BIOCHEM BIOPH RES CO, V319, P1314, DOI 10.1016/j.bbrc.2004.05.106
   Georgieva DN, 2004, BIOCHEM BIOPH RES CO, V316, P33, DOI 10.1016/j.bbrc.2004.01.174
   Georgieva DN, 2004, BIOPHYS J, V86, P461, DOI 10.1016/S0006-3495(04)74123-5
   Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047
   Geyer A, 2001, EUR J BIOCHEM, V268, P4044, DOI 10.1046/j.1432-1327.2001.02321.x
   GOMISRUTH FX, 1994, J MOL BIOL, V239, P513, DOI 10.1006/jmbi.1994.1392
   GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x
   GOPALAKRISHNAKONE P, 1980, BRIT J PHARMACOL, V69, P421, DOI 10.1111/j.1476-5381.1980.tb07031.x
   GOWDA DC, 1994, J BIOL CHEM, V269, P10644
   Gu LC, 2002, ACTA CRYSTALLOGR D, V58, P104, DOI [10.1107/S0907444901018170, 10.1107/SO907444901018170]
   Guan HH, 2010, J STRUCT BIOL, V169, P294, DOI 10.1016/j.jsb.2009.11.009
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Hansford KA, 2003, CHEMBIOCHEM, V4, P181, DOI 10.1002/cbic.200390029
   Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k
   HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913
   HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0
   HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006
   Ida K, 2008, J BIOL CHEM, V283, P16584, DOI 10.1074/jbc.M800366200
   Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057
   ITOH N, 1987, J BIOL CHEM, V262, P3132
   Iyengar N. K., 1938, Current Science Bangalore, V7, P51
   Jabeen T, 2005, TOXICON, V46, P865, DOI 10.1016/j.toxicon.2005.08.008
   Jabeen T, 2006, PROTEINS, V62, P329, DOI 10.1002/prot.20708
   Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014
   Jasti J, 2004, ACTA CRYSTALLOGR D, V60, P66, DOI 10.1107/S090744490302208X
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   Jin Y, 2007, TOXICON, V50, P479, DOI 10.1016/j.toxicon.2007.04.013
   Johnson JL, 2005, CHEM-BIOL INTERACT, V157, P384, DOI 10.1016/j.cbi.2005.10.066
   Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631
   Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3
   KEARNEY EB, 1951, ARCH BIOCHEM BIOPHYS, V33, P414, DOI 10.1016/0003-9861(51)90127-0
   KEARNEY EB, 1951, ARCH BIOCHEM BIOPHYS, V33, P397, DOI 10.1016/0003-9861(51)90126-9
   KEARNEY EB, 1951, ARCH BIOCHEM BIOPHYS, V33, P377, DOI 10.1016/0003-9861(51)90125-7
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450
   Kini RM, 1997, VENOM PHOSPHOLIPASE, P1
   KISIEL W, 1987, J BIOL CHEM, V262, P12607
   Kitadokoro K, 1998, J BIOCHEM, V123, P619
   Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X
   KRAMER RM, 1991, METHOD ENZYMOL, V197, P373
   Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5
   Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280
   KUMAR V, 1973, EUR J BIOCHEM, V34, P586, DOI 10.1111/j.1432-1033.1973.tb02799.x
   KUSAKABE H, 1980, J BIOL CHEM, V255, P976
   KWONG PD, 1995, STRUCTURE, V3, P1109, DOI 10.1016/S0969-2126(01)00246-5
   LE KHD, 1978, BIOCHIM BIOPHYS ACTA, V524, P288, DOI 10.1016/0005-2744(78)90165-1
   Le TNM, 2005, THROMB HAEMOSTASIS, V93, P420, DOI 10.1160/TH040-11-0707
   LI ZY, 1994, TOXICON, V32, P1349, DOI 10.1016/0041-0101(94)90407-3
   Limam I, 2010, MATRIX BIOL, V29, P117, DOI 10.1016/j.matbio.2009.09.009
   Lingott T, 2009, BIOCHEMISTRY-US, V48, P6166, DOI 10.1021/bi9002315
   Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258
   Liu SQ, 2006, BIOCHEM BIOPH RES CO, V348, P1279, DOI 10.1016/j.bbrc.2006.07.183
   Lok SM, 2005, FEBS J, V272, P1211, DOI 10.1111/j.1742-4658.2005.04547.x
   Lu QM, 2002, J NAT TOXINS, V11, P345
   Braga MDM, 2008, TOXICON, V51, P199, DOI 10.1016/j.toxicon.2007.09.003
   Mallow D., 2003, TRUE VIPERS NATURAL
   MANCHEVA I, 1987, BIOL CHEM H-S, V368, P343, DOI 10.1515/bchm3.1987.368.1.343
   Marchi-Salvador DP, 2008, PROTEINS, V72, P883, DOI 10.1002/prot.21980
   Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   MASCI PP, 1988, BIOCHEM INT, V17, P825
   MASSEY V, 1967, J BIOL CHEM, V242, P1259
   Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7
   MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y
   Masuda S, 2000, BIOCHEM BIOPH RES CO, V278, P197, DOI 10.1006/bbrc.2000.3770
   Masuda S, 1998, EUR J BIOCHEM, V253, P36, DOI 10.1046/j.1432-1327.1998.2530036.x
   MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005
   Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2
   Menezes MC, 2008, FEBS LETT, V582, P3915, DOI 10.1016/j.febslet.2008.10.034
   Mizuno H, 2001, P NATL ACAD SCI USA, V98, P7230, DOI 10.1073/pnas.131179698
   Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x
   Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021
   Morita Takashi, 1998, P179
   Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0
   Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008
   Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459
   NAKAGAKI T, 1992, THROMB RES, V65, P105, DOI 10.1016/0049-3848(92)90230-8
   NATHAN I, 1982, THROMB HAEMOSTASIS, V48, P277
   NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538
   OHLSSON I, 1974, J MOL BIOL, V89, P339, DOI 10.1016/0022-2836(74)90523-3
   ORDENTLICH A, 1995, J BIOL CHEM, V270, P2082, DOI 10.1074/jbc.270.5.2082
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Patrick G.L., 2001, INTRO MED CHEM CHOLI
   Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204
   Perbandt M, 1997, FEBS LETT, V412, P573, DOI 10.1016/S0014-5793(97)00853-3
   Perbandt M, 2003, ACTA CRYSTALLOGR D, V59, P1679, DOI 10.1107/S0907444903014987
   PERONA JJ, 1995, PROTEIN SCI, V4, P337
   PIEDRAS P, 1992, PLANTA, V188, P13, DOI 10.1007/BF00198934
   PONNUDURAI G, 1994, ARCH BIOCHEM BIOPHYS, V313, P373, DOI 10.1006/abbi.1994.1401
   Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424
   RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018
   Rao VS, 2004, THROMB HAEMOSTASIS, V92, P509, DOI 10.1160/TH04-03-0144
   Rao VS, 2003, BLOOD, V102, P1347, DOI 10.1182/blood-2002-12-3839
   Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611
   Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkh071
   Ray S, 2007, BIOCHEMISTRY-US, V46, P13089, DOI 10.1021/bi7015102
   RENETSEDER R, 1988, J MOL BIOL, V200, P181, DOI 10.1016/0022-2836(88)90342-7
   Reza MA, 2007, J THROMB HAEMOST, V5, P117, DOI 10.1111/j.1538-7836.2006.02266.x
   Reza MA, 2006, J THROMB HAEMOST, V4, P1346, DOI 10.1111/j.1538-7836.2006.01969.x
   Rodrigues RS, 2009, BIOCHIMIE, V91, P490, DOI 10.1016/j.biochi.2008.12.004
   ROSING J, 1991, THROMB HAEMOSTASIS, V65, P627
   ROTHENBERG MA, 1947, J BIOL CHEM, V168, P223
   Sakurai Y, 2001, TOXICON, V39, P1827, DOI 10.1016/S0041-0101(01)00133-7
   Sanchez EF, 2006, BBA-GEN SUBJECTS, V1760, P1762, DOI 10.1016/j.bbagen.2006.08.023
   Santos KF, 2007, ACTA CRYSTALLOGR F, V63, P287, DOI 10.1107/S1744309107006719
   Santos NA, 2008, TOXICON, V52, P908, DOI 10.1016/j.toxicon.2008.08.020
   Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070
   SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815
   SEILHAMER JJ, 1986, DNA-J MOLEC CELL BIO, V5, P519, DOI 10.1089/dna.1.1986.5.519
   Selistre-de-Araujo HS, 2005, BRAZ J MED BIOL RES, V38, P1505, DOI 10.1590/S0100-879X2005001000007
   Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483
   Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x
   Serrano SMT, 2006, J BIOL CHEM, V281, P39746, DOI 10.1074/jbc.M604855200
   Shimokawa K, 1997, ARCH BIOCHEM BIOPHYS, V343, P35, DOI 10.1006/abbi.1997.0133
   SHIPOLIN.RA, 1974, EUR J BIOCHEM, V48, P465, DOI 10.1111/j.1432-1033.1974.tb03787.x
   Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035
   Singh G, 2005, PROTEIN SCI, V14, P395, DOI 10.1110/ps.041115505
   Singh G, 2001, J MOL BIOL, V307, P1049, DOI 10.1006/jmbi.2001.4550
   Singh N, 2006, ACTA CRYSTALLOGR D, V62, P410, DOI 10.1107/S0907444906003660
   Singh N, 2004, BIOCHEMISTRY-US, V43, P14577, DOI 10.1021/bi0483561
   Singh N, 2006, PROTEINS, V64, P89, DOI 10.1002/prot.20970
   Singh N, 2009, J MOL RECOGNIT, V22, P437, DOI 10.1002/jmr.960
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175
   Stabeli RG, 2004, BIOORGAN MED CHEM, V12, P2881, DOI 10.1016/j.bmc.2004.03.049
   STOCKER K, 1977, HDB EXPT PHARM, P451
   Suhr SM, 1996, BIOCHEM BIOPH RES CO, V224, P134, DOI 10.1006/bbrc.1996.0996
   Suhr SM, 1999, J BIOCHEM-TOKYO, V125, P305, DOI 10.1093/oxfordjournals.jbchem.a022287
   SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899
   Takatsuka H, 2001, BBA-PROTEIN STRUCT M, V1544, P267, DOI 10.1016/S0167-4838(00)00229-6
   Takeda S., 2010, TOXINS HEMOSTASIS BE, P465
   Takeda S, 2010, HDB METALLOPROTEINS, V5, P699
   Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062
   Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009
   Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131
   TAKEYA H, 1992, J BIOL CHEM, V267, P14109
   Tang L, 1998, J MOL BIOL, V282, P1, DOI 10.1006/jmbi.1998.1987
   Tans G, 2001, HAEMOSTASIS, V31, P225
   TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433
   TCHORBANOV B, 1977, TOXICON, V16, P37
   Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08
   Torii S, 1997, J BIOL CHEM, V272, P9539, DOI 10.1074/jbc.272.14.9539
   UMHAU S, 1999, FLAVINS FLAVOPROTEIN, P567
   USAMI Y, 1994, BIOCHEM BIOPH RES CO, V201, P331, DOI 10.1006/bbrc.1994.1706
   Valdez-Cruz NA, 2004, EUR J BIOCHEM, V271, P1453, DOI 10.1111/j.1432-1033.2004.04047.x
   VIGNY M, 1978, EUR J BIOCHEM, V85, P317, DOI 10.1111/j.1432-1033.1978.tb12241.x
   Waite M, 1987, HDB LIPID RES
   WANG YM, 1992, EUR J BIOCHEM, V209, P635, DOI 10.1111/j.1432-1033.1992.tb17330.x
   Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5
   WELCHES W, 1985, TOXICON, V23, P747, DOI 10.1016/0041-0101(85)90004-2
   WELLNER D, 1966, BIOCHEMISTRY-US, V5, P1585, DOI 10.1021/bi00869a019
   WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0
   WILSON IB, 1961, J BIOL CHEM, V236, P2292
   Xu S, 2003, ACTA CRYSTALLOGR D, V59, P1574, DOI 10.1107/S0907444903014598
   Xu SJ, 2003, BIOCHEM BIOPH RES CO, V300, P271, DOI 10.1016/S0006-291X(02)02833-4
   ZELLER EA, 1948, ADV ENZYMOL REL S BI, V8, P459
   Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046
   ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246
   Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531
   Zhong SR, 2009, TOXICON, V54, P763, DOI 10.1016/j.toxicon.2009.06.004
   Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200
NR 243
TC 144
Z9 148
U1 1
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD DEC
PY 2011
VL 278
IS 23
SI SI
BP 4544
EP 4576
DI 10.1111/j.1742-4658.2011.08115.x
PG 33
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 849WL
UT WOS:000297155900009
PM 21470368
OA Bronze
DA 2020-12-01
ER

PT J
AU de Giuseppe, PO
   Ullah, A
   Silva, DT
   Gremski, LH
   Wille, ACM
   Moreira, DC
   Ribeiro, AS
   Chaim, OM
   Murakami, MT
   Veiga, SS
   Arni, RK
AF de Giuseppe, Priscila Oliveira
   Ullah, Anwar
   Silva, Dilza Trevisan
   Gremski, Luiza Helena
   Martins Wille, Ana Carolina
   Moreira, Daniele Chaves
   Ribeiro, Andrea Senff
   Chaim, Olga Meiri
   Murakami, Mario Tyago
   Veiga, Silvio Sanches
   Arni, Raghuvir Krishnaswamy
TI Structure of a novel class II phospholipase D: Catalytic cleft is
   modified by a disulphide bridge
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Loxosceles spider venom; Phospholipase D; Crystal structure
ID BROWN RECLUSE SPIDER; DERMONECROTIC TOXIN; SPHINGOMYELINASES-D;
   GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; VENOM;
   CLONING; IDENTIFICATION; MECHANISM; FAMILY
AB Phospholipases D (PLDs) are principally responsible for the local and systemic effects of Loxosceles envenomation including dermonecrosis and hemolysis. Despite their clinical relevance in loxoscelism, to date, only the SMase I from Loxosceles beta, a class I member, has been structurally characterized. The crystal structure of a class II member from Loxosceles intermedia venom has been determined at 1.7 angstrom resolution. Structural comparison to the class I member showed that the presence of an additional disulphide bridge which links the catalytic loop to the flexible loop significantly changes the volume and shape of the catalytic cleft. An examination of the crystal structures of PLD homologues in the presence of low molecular weight compounds at their active sites suggests the existence of a ligand-dependent rotamer conformation of the highly conserved residue Trp230 (equivalent to Trp192 in the glycerophosphodiester phosphodiesterase from Thermus therrnophofilus, PDB code: 1VD6) indicating its role in substrate binding in both enzymes. Sequence and structural analyses suggest that the reduced sphingomyelinase activity observed in some class IIb PLDs is probably due to point mutations which lead to a different substrate preference. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ullah, Anwar; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista UNESP, Ctr Multiusuario Inovacao Biomol, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [de Giuseppe, Priscila Oliveira; Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, BR-13083970 Campinas, SP, Brazil.
   [Silva, Dilza Trevisan; Gremski, Luiza Helena; Martins Wille, Ana Carolina; Moreira, Daniele Chaves; Ribeiro, Andrea Senff; Chaim, Olga Meiri; Veiga, Silvio Sanches] Univ Fed Parana, Dept Biol Celular, BR-80060000 Curitiba, Parana, Brazil.
   [Martins Wille, Ana Carolina] Univ Estadual Ponta Grossa, Dept Struct Mol Biol & Genet, Ponta Grossa, Parana, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista UNESP, Ctr Multiusuario Inovacao Biomol, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Chaim, Olga Meiri/Y-7559-2019; Gremski, Luiza H/X-3674-2018;
   Chaves-Moreira, daniele/L-5133-2015; Arni, Raghuvir K/B-2222-2013;
   Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Veiga,
   Silvio Sanches/C-2194-2013; Ullah, Anwar/B-1720-2013; Trevisan-Silva,
   Dilza/L-6707-2016; Oliveira de Giuseppe, Priscila/D-4922-2012
OI Chaim, Olga Meiri/0000-0002-3854-3292; Gremski, Luiza
   H/0000-0003-3347-4571; Arni, Raghuvir K/0000-0003-2460-1145; Murakami,
   Mario T/0000-0002-0405-8010; Veiga, Silvio Sanches/0000-0002-9691-1225;
   Ullah, Anwar/0000-0003-3793-7393; Trevisan-Silva,
   Dilza/0000-0002-6519-346X; Oliveira de Giuseppe,
   Priscila/0000-0003-2094-7325; Moreira, Daniele/0000-0001-6562-8817
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Secretaria de Estado
   de Ciencia, Tecnologia e Ensino Superior (SETI) do Parana; Fundacao
   Araucaria-PRFundacao Araucaria; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPES, BrazilCAPES
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP), Secretaria de Estado de Ciencia,
   Tecnologia e Ensino Superior (SETI) do Parana, Fundacao Araucaria-PR,
   CNPq and CAPES, Brazil.
CR Appel MH, 2008, BBA-GEN SUBJECTS, V1780, P167, DOI 10.1016/j.bbagen.2007.11.007
   Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274
   Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   da Silveira RB, 2007, BIOCHIMIE, V89, P289, DOI 10.1016/j.biochi.2006.12.002
   da Silveira RB, 2006, BIOCHIMIE, V88, P1241, DOI 10.1016/j.biochi.2006.02.008
   de Andrade SA, 2006, TOXICON, V47, P380, DOI 10.1016/j.toxicon.2005.12.005
   Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013
   Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   Gassler CS, 1997, BIOCHEMISTRY-US, V36, P12802, DOI 10.1021/bi971102d
   Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788
   Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314
   Kalapothakis E, 2007, TOXICON, V50, P938, DOI 10.1016/j.toxicon.2007.07.001
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8
   LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Rao KN, 2006, PROTEINS, V65, P514, DOI 10.1002/prot.21079
   Ribeiro ROS, 2007, TOXICON, V50, P1162, DOI 10.1016/j.toxicon.2007.08.001
   Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921
   Ullah A, 2011, ACTA CRYSTALLOGR F, V67, P234, DOI 10.1107/S1744309110050931
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
NR 38
TC 29
Z9 29
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 17
PY 2011
VL 409
IS 4
BP 622
EP 627
DI 10.1016/j.bbrc.2011.05.053
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 787ED
UT WOS:000292358500006
PM 21616057
OA Green Published
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Greunke, K
   Arni, RK
   Betzel, C
AF Georgieva, Dessislava
   Greunke, Kerstin
   Arni, Raghuvir K.
   Betzel, Christian
TI Three-Dimensional Modelling of Honeybee Venom Allergenic Proteases:
   Relation to Allergenicity
SO ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES
LA English
DT Article
DE Honeybee Venom; Allergenic Proteases; Protein Modelling
ID SERINE-PROTEASE; MOLECULAR-CLONING; INSECT CELLS; DOMAIN; EXPRESSION;
   ACID; PREDICTION; GENES
AB Api SI and Api SIT are serine proteases of the honeybee venom containing allergenic determinants. Each protease consists of two structural modules: an N-terminal CUB (Api SI) or a clip domain (Api SII) and a C-terminal serine protease-like (SPL) domain. Both domains are connected with a linker peptide. The knowledge about the structure and function of Api SI and Api SII is limited mainly to their amino acid sequences. We constructed 3-D models of the two proteases using their amino acid sequences and crystallographic coordinates of related proteins. The models of the SPL domains were built using the structure of the prophenoloxidase-activating factor (PPAF)-II as a template. For modelling of the Api SI CUB domain the coordinates of porcine spermadhesin PSP-I were used. The models revealed the catalytic and substrate-binding sites and the negatively charged residue responsible for the trypsin-like activity. IgE-binding and antigenic sites in the two allergens were predicted using the models and programs based on the structure of known epitopes. Api SI and Api SII show structural and functional similarity to the members of the PPAF-II family. Most probably, they are part of the defence system of Apis mellifera.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Greunke, Kerstin] Prot Ligand Struct PLS Design GmbH, Hamburg, Germany.
   [Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Notkestr 85,Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Arni, Raghuvir K/B-2222-2013; Betzel, Christian/G-8105-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Betzel,
   Christian/0000-0002-3879-5019
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; RIS Project; FAPESP/CNPq/CAPESNational Council for
   Scientific and Technological Development (CNPq)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)CAPES
FX This work was supported by the Deutsche Forschungsgemeinschaft via the
   Project BE 1443-18-1. Ch. B. acknowledges the RIS Project for providing
   financial support. R. K. A. acknowledges the support of
   FAPESP/CNPq/CAPES.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200
   BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305
   DUDLER T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P201, DOI 10.1016/0005-2760(92)90188-2
   Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008
   Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706
   Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331
   Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109
   Jeep S, 1996, ALLERGY, V51, P540, DOI 10.1111/j.1398-9995.1996.tb00110.x
   Johns ME, 2004, J NEUROBIOL, V61, P377, DOI 10.1002/neu.20056
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Misra S, 1998, DEVELOPMENT, V125, P1261
   Muller UR, 2002, ALLERGY, V57, P570, DOI 10.1034/j.1398-9995.2002.02157.x
   Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891
   Rajashankar K, 2002, ACTA CRYSTALLOGR D, V58, P1175, DOI 10.1107/S0907444902007254
   Romero A, 1997, NAT STRUCT BIOL, V4, P783, DOI 10.1038/nsb1097-783
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Soldatova LN, 2000, J ALLERGY CLIN IMMUN, V105, pS378, DOI 10.1016/S0091-6749(00)91531-8
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   Winningham KM, 2004, J ALLERGY CLIN IMMUN, V114, P928, DOI 10.1016/j.jaci.2004.07.043
   Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x
NR 26
TC 5
Z9 5
U1 0
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0939-5075
EI 1865-7125
J9 Z NATURFORSCH C
JI Z.Naturforsch.(C)
PD MAY-JUN
PY 2011
VL 66
IS 5-6
BP 305
EP 312
DI 10.5560/ZNC.2011.66c0305
PG 8
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 806JX
UT WOS:000293804800015
PM 21812349
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Seifert, J
   Ohler, M
   von Bergen, M
   Spencer, P
   Arni, RK
   Genov, N
   Betzel, C
AF Georgieva, Dessislava
   Seifert, Jana
   Oehler, Michaela
   von Bergen, Martin
   Spencer, Patrick
   Arni, Raghuvir K.
   Genov, Nicolay
   Betzel, Christian
TI Pseudechis australis Venomics: Adaptation for a Defense against
   Microbial Pathogens and Recruitment of Body Transferrin
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE snake venomics; Pseudechis australis; 2-D electrophoresis; electrospray
   mass spectrometry; venom transferrin; enzyme activity
ID KING-BROWN SNAKE; AMINO-ACID-SEQUENCES; PLATELET-AGGREGATION;
   TOXINOLOGICAL IMPLICATIONS; TRANSCRIPTOMIC ANALYSIS; PHYLOGENETIC
   ANALYSIS; MOLECULAR EVOLUTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY;
   TOXIN COMPOSITION
AB The venom composition of Pseudechis australis, a widely distributed in Australia reptile, was analyzed by 2-DE and mass spectrometric analysis. In total, 102 protein spots were identified as venom toxins. The gel is dominated by horizontal trains of spots with identical or very similar molecular masses but differing in the pI values. This suggests possible post-translational modifications of toxins, changing their electrostatic charge. The results demonstrate a highly specialized biosynthesis of toxins destroying the hemostasis (P-III metalloproteases, SVMPs), antimicrobial proteins (L-amino acid oxidases, LAAOs, and transferrin-like proteins, TFLPs), and myotoxins (phospholipase A(2)s, PLA(2)s). The three transferrin isoforms of the Australian P. avstralis (Elapidae snake) venom are highly homologous to the body transferrin of the African Lamprophis fuliginosus (Colubridae), an indication for the recruitment of body transferrin. The venomic composition suggests an adaptation for a defense against microbial pathogens from the prey. Transferrins have not previously been reported as components of elapid or other snake venoms. Ecto-5'-nucleotidases (5'-NTDs), nerve growth factors (VNGFs), and a serine proteinase inhibitor (SPI) were also identified. The venom composition and enzymatic activities explain the clinical manifestation of the king brown snakebite. The results can be used for medical, scientific, and biotechnological purposes.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Seifert, Jana; Oehler, Michaela; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany.
   [Spencer, Patrick] IPEN CNEN SP, Ctr Biotecnol, BR-05508000 Sao Paulo, Brazil.
   [Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Genov, Nicolay] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Notkestr 85,Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Spencer, Patrick/C-6353-2012; Betzel, Christian/G-8105-2018; Arni,
   Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; von Bergen,
   Martin/D-7960-2011
OI Betzel, Christian/0000-0002-3879-5019; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; von Bergen,
   Martin/0000-0003-2732-2977; Spencer, Patrick/0000-0001-8949-7735;
   Seifert, Jana/0000-0002-7690-8539
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1, BE1443]; FAPESP/CNPq/CAPESNational Council for Scientific and
   Technological Development (CNPq)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP)CAPES
FX This work was supported by a grant from the Deutsche
   Forschungsgemeinschaft (project BE 1443-18-1 and BE1443) and from
   FAPESP/CNPq/CAPES. We are grateful to Dr. P. Mirtschin (Venom Supplies,
   Pyt. Ltd., Australia) for providing us with the venom sample.
CR Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p
   Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Betzel C, 1999, CELL MOL LIFE SCI, V56, P384, DOI 10.1007/s000180050440
   Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200
   Birrell GW, 2006, MOL CELL PROTEOMICS, V5, P379, DOI 10.1074/mcp.M500270-MCP200
   Boldrini-Franca J, 2010, J PROTEOMICS, V73, P1758, DOI 10.1016/j.jprot.2010.06.001
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Calvete JJ, 2009, J PROTEOMICS, V72, P227, DOI 10.1016/j.jprot.2009.01.005
   Calvete JJ, 2009, J PROTEOMICS, V72, P121, DOI 10.1016/j.jprot.2009.01.018
   Ciuraszklewicz J, 2007, GENE, V396, P28, DOI 10.1016/j.gene.2007.02.018
   Currie BJ, 2004, MED J AUSTRALIA, V181, P693, DOI 10.5694/j.1326-5377.2004.tb06526.x
   DAMBISYA YM, 1995, TOXICON, V33, P1378, DOI 10.1016/0041-0101(95)00067-V
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   FATEHI M, 1994, TOXICON, V32, P1559, DOI 10.1016/0041-0101(94)90315-8
   Fernandez Jorge Hernandez, 2004, Genet Mol Res, V3, P554
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022
   Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148
   Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2
   Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613
   Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328
   Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1
   GEH SL, 1992, TOXICON, V30, P1051, DOI 10.1016/0041-0101(92)90050-F
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008
   Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219
   HIRD DW, 1983, APPL ENVIRON MICROB, V46, P1423, DOI 10.1128/AEM.46.6.1423-1425.1983
   Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   JOHNSON AJ, 1969, THROMB DIATH HAEMOST, V21, P259
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   Kuch U, 2005, NATURWISSENSCHAFTEN, V92, P121, DOI 10.1007/s00114-004-0602-0
   Kulkeaw K, 2007, TOXICON, V49, P1026, DOI 10.1016/j.toxicon.2007.01.019
   Leao LI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-112
   Li ST, 2004, BIOCHEM J, V384, P119, DOI 10.1042/BJ20040354
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   MACGILLIVRAY RTA, 1982, P NATL ACAD SCI-BIOL, V79, P2504, DOI 10.1073/pnas.79.8.2504
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   NISHIDA S, 1985, TOXICON, V23, P87, DOI 10.1016/0041-0101(85)90112-6
   NISHIDA S, 1985, TOXICON, V23, P73, DOI 10.1016/0041-0101(85)90111-4
   Ohler M, 2010, J PROTEOME RES, V9, P2422, DOI 10.1021/pr901128x
   Olamendi-Portugal T, 2008, PROTEOMICS, V8, P1919, DOI 10.1002/pmic.200700668
   Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204
   Ponraj D, 1996, LAB ANIM SCI, V46, P393
   Ramasamy S, 2005, CLIN EXP PHARMACOL P, V32, P7, DOI 10.1111/j.1440-1681.2005.04151.x
   Ramasamy S, 2004, TOXICON, V44, P837, DOI 10.1016/j.toxicon.2004.08.005
   Rocha SLG, 2009, J PROTEOME RES, V8, P2351, DOI 10.1021/pr800977s
   ROWAN EG, 1989, TOXICON, V27, P551, DOI 10.1016/0041-0101(89)90116-5
   Sanz L, 2008, J PROTEOMICS, V71, P198, DOI [10.1016/j.jprot.2008.05.003, 10.1016/j.jprot.2008.03.001]
   Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   Siang AS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-24
   SILKOWSKI E, 1963, J BIOL CHEM, V238, P2477
   SKARNES RC, 1970, NATURE, V225, P1072, DOI 10.1038/2251072a0
   Soares AM, 2003, TOXICON, V42, P855, DOI 10.1016/j.toxicon.2003.11.004
   St Pierre L, 2005, CELL MOL LIFE SCI, V62, P2679, DOI 10.1007/s00018-005-5384-9
   STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I
   TAKASAKI C, 1990, TOXICON, V28, P319, DOI 10.1016/0041-0101(90)90067-H
   TAKASAKI C, 1990, TOXICON, V28, P329, DOI 10.1016/0041-0101(90)90068-I
   Tashima AK, 2008, J PROTEOMICS, V71, P473, DOI 10.1016/j.jprot.2008.07.007
   TU AT, 1966, COMP BIOCHEM PHYSIOL, V17, P297, DOI 10.1016/0010-406X(66)90029-6
   Valente RH, 2009, J PROTEOMICS, V72, P241, DOI 10.1016/j.jprot.2009.01.001
   Wagstaff' SC, 2009, J PROTEOMICS, V71, P609, DOI 10.1016/j.jprot.2008.10.003
   WELLNER D, 1971, METHODS ENZYMOLOGY B, V17, P592
   White J, 2000, THER DRUG MONIT, V22, P65, DOI 10.1097/00007691-200002000-00014
   Wuster W, 2005, MOL PHYLOGENET EVOL, V34, P1, DOI 10.1016/j.ympev.2004.08.018
   YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 78
TC 26
Z9 26
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD MAY
PY 2011
VL 10
IS 5
BP 2440
EP 2464
DI 10.1021/pr101248e
PG 25
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 759IU
UT WOS:000290234800027
PM 21417486
DA 2020-12-01
ER

PT J
AU Santos, CR
   Tonoli, CCC
   Trindade, DM
   Betzel, C
   Takata, H
   Kuriki, T
   Kanai, T
   Imanaka, T
   Arni, RK
   Murakami, MT
AF Santos, Camila R.
   Tonoli, Celisa C. C.
   Trindade, Daniel M.
   Betzel, Christian
   Takata, Hiroki
   Kuriki, Takashi
   Kanai, Tamotsu
   Imanaka, Tadayuki
   Arni, Raghuvir K.
   Murakami, Mario T.
TI Structural basis for branching-enzyme activity of glycoside hydrolase
   family 57: Structure and stability studies of a novel branching enzyme
   from the hyperthermophilic archaeon Thermococcus Kodakaraensis KOD1
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE glycoside hydrolase family 57; branching enzyme; crystal structure;
   catalytic mechanism
ID BIOLOGICAL MACROMOLECULES; THERMOTOGA-MARITIMA; SOLUTION SCATTERING;
   ALPHA-AMYLASE; RESOLUTION
AB Branching enzymes (BEs) catalyze the formation of branch points in glycogen and amylopectin by cleavage of alpha-1,4 glycosidic bonds and subsequent transfer to a new alpha-1,6 position. BEs generally belong to glycoside hydrolase family 13 (GH13); however TK1436, isolated from the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1, is the first GH57 member, which possesses BE activity. To date, the only BE structure that had been determined is a GH13-type from Escherichia coli. Herein, we have determined the crystal structure of TK1436 in the native state and in complex with glucose and substrate mimetics that permitted mapping of the substrate-binding channel and identification of key residues for glucanotransferase activity. Its structure encompasses a distorted (beta/alpha)(7)-barrel juxtaposed to a C-terminal alpha-helical domain, which also participates in the formation of the active-site cleft. The active site comprises two acidic catalytic residues (Glu183 and Asp354), the polarizer His 10, aromatic gate-keepers (Trp28, Trp270, Trp407, and Trp416) and the residue Tyr233, which is fully conserved among GH13- and GH57-type BEs. Despite TK1436 displaying a completely different fold and domain organization when compared to E. coli BE, they share the same structural determinants for BE activity. Structural comparison with AmyC, a GH57 alpha-amylase devoid of BE activity, revealed that the catalytic loop involved in substrate recognition and binding, is shortened in AmyC structure and it has been addressed as a key feature for its inability for glucanotransferase activity. The oligomerization has also been pointed out as a possible determinant for functional differentiation among GH57 members. Proteins 2011; 79:547-557. (C) 2010 Wiley-Liss, Inc.
C1 [Santos, Camila R.; Tonoli, Celisa C. C.; Trindade, Daniel M.; Murakami, Mario T.] Natl Ctr Res Energy & Mat, Natl Lab Biosci, Campinas, SP, Brazil.
   [Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany.
   [Takata, Hiroki; Kuriki, Takashi] Ezaki Glico Co Ltd, Inst Hlth Sci, Osaka, Japan.
   [Kanai, Tamotsu] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan.
   [Imanaka, Tadayuki] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kusatsu, Japan.
   [Arni, Raghuvir K.] State Univ Sao Paulo, Dept Phys, Sao Jose Do Rio Preto, Brazil.
RP Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Natl Lab Biosci, Giuseppe Maximo Scolfaro 10000, Campinas, SP, Brazil.
EM arni@sjrp.unesp.br; mario.murakami@lnbio.org.br
RI Betzel, Christian/G-8105-2018; Trindade, Daniel Maragno/J-6085-2012;
   Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Murakami,
   Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Kanai,
   Tamotsu/I-5842-2012; Santos, Camila/F-7095-2013
OI Betzel, Christian/0000-0002-3879-5019; Trindade, Daniel
   Maragno/0000-0002-8005-8784; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Murakami, Mario T/0000-0002-0405-8010;
   Kanai, Tamotsu/0000-0003-3537-2114; Santos, Camila/0000-0003-0652-4211
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Grants-in-Aid for Scientific
   ResearchMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [22550151] Funding Source: KAKEN
FX Grant sponsor: The Fundacao de Amparo a Pesquisa do Estado de Sao Paulo;
   Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico
CR Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200
   Afonine PV, 2005, CCP4 NEWSL, V42, P8
   Ballschmiter M, 2006, APPL ENVIRON MICROB, V72, P2206, DOI 10.1128/AEM.72.3.2206-2211.2006
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   DeLano W.L., 2002, PYMOL
   Dickmanns A, 2006, ACTA CRYSTALLOGR D, V62, P262, DOI [10.1107/S0907444905041363, 10.1107/S0904777905041363]
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309
   Hizukuri H, 1981, CARBOHYD RES, V94, P205
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658
NR 19
TC 38
Z9 40
U1 1
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2011
VL 79
IS 2
BP 547
EP 557
DI 10.1002/prot.22902
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 715SE
UT WOS:000286905600017
PM 21104698
DA 2020-12-01
ER

PT J
AU Ullah, A
   de Giuseppe, PO
   Murakami, MT
   Trevisan-Silva, D
   Wille, ACM
   Chaves-Moreira, D
   Gremski, LH
   da Silveira, RB
   Sennf-Ribeiro, A
   Chaim, OM
   Veiga, SS
   Arni, RK
AF Ullah, Anwar
   de Giuseppe, Priscila Oliveira
   Murakami, Mario Tyago
   Trevisan-Silva, Dilza
   Martins Wille, Ana Carolina
   Chaves-Moreira, Daniele
   Gremski, Luiza Helena
   da Silveira, Rafael Bertoni
   Sennf-Ribeiro, Andrea
   Chaim, Olga Meiri
   Veiga, Silvio Sanches
   Arni, Raghuvir Krishnaswamy
TI Crystallization and preliminary X-ray diffraction analysis of a class II
   phospholipase D from Loxosceles intermedia venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID D DERMONECROTIC TOXIN; BROWN SPIDER VENOM; CATALYTIC MECHANISM;
   SPHINGOMYELINASES-D; NEPHROTOXICITY
AB Phospholipases D are the major dermonecrotic component of Loxosceles venom and catalyze the hydrolysis of phospholipids, resulting in the formation of lipid mediators such as ceramide-1-phosphate and lysophosphatidic acid which can induce pathological and biological responses. Phospholipases D can be classified into two classes depending on their catalytic efficiency and the presence of an additional disulfide bridge. In this work, both wild-type and H12A-mutant forms of the class II phospholipase D from L. intermedia venom were crystallized. Wild-type and H12A-mutant crystals were grown under very similar conditions using PEG 200 as a precipitant and belonged to space group P12(1)1, with unit-cell parameters a = 50.1, b = 49.5, c = 56.5 angstrom, beta = 105.9 degrees. Wild-type and H12A-mutant crystals diffracted to maximum resolutions of 1.95 and 1.60 angstrom, respectively.
C1 [Ullah, Anwar; Arni, Raghuvir Krishnaswamy] Univ Estadual Paulista, UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [de Giuseppe, Priscila Oliveira; Murakami, Mario Tyago] Ctr Nacl Pesquisa Energia & Mat, LNBio, BR-13083970 Campinas, SP, Brazil.
   [Trevisan-Silva, Dilza; Martins Wille, Ana Carolina; Chaves-Moreira, Daniele; Gremski, Luiza Helena; da Silveira, Rafael Bertoni; Sennf-Ribeiro, Andrea; Chaim, Olga Meiri; Veiga, Silvio Sanches] Univ Fed Parana, Dept Biol Celular, BR-81531960 Curitiba, Parana, Brazil.
   [Martins Wille, Ana Carolina; da Silveira, Rafael Bertoni] Univ Estadual Ponta Grossa, Dept Biol Estrutural Biol Mol & Genet, BR-84030900 Ponta Grossa, PR, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, UNESP, Dept Fis, Ctr Multiusuario Inovacao Biomol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@sjrp.unesp.br
RI Chaim, Olga Meiri/Y-7559-2019; Arni, Raghuvir K/B-2222-2013;
   Trevisan-Silva, Dilza/L-6707-2016; Murakami, Mario T/C-2087-2012;
   Murakami, Mario T/F-5640-2016; Veiga, Silvio Sanches/C-2194-2013; da
   Silveira, Rafael Bertoni/D-8117-2016; Ullah, Anwar/B-1720-2013;
   Chaves-Moreira, daniele/L-5133-2015; Gremski, Luiza H/X-3674-2018;
   Oliveira de Giuseppe, Priscila/D-4922-2012
OI Chaim, Olga Meiri/0000-0002-3854-3292; Arni, Raghuvir
   K/0000-0003-2460-1145; Trevisan-Silva, Dilza/0000-0002-6519-346X;
   Murakami, Mario T/0000-0002-0405-8010; Veiga, Silvio
   Sanches/0000-0002-9691-1225; Ullah, Anwar/0000-0003-3793-7393; Gremski,
   Luiza H/0000-0003-3347-4571; Moreira, Daniele/0000-0001-6562-8817;
   Oliveira de Giuseppe, Priscila/0000-0003-2094-7325
FU Secretaria de Estado de Ciencia, Tecnologia e Ensino Superior (SETI) do
   Parana; Fundacao Araucaria-PRFundacao Araucaria; TWASTurkiye Bilimsel ve
   Teknolojik Arastirma Kurumu (TUBITAK); FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); CNPqNational Council for
   Scientific and Technological Development (CNPq); CAPES-BrazilCAPES
FX This work was supported by grants from Secretaria de Estado de Ciencia,
   Tecnologia e Ensino Superior (SETI) do Parana, Fundacao Araucaria-PR,
   TWAS, FAPESP, CNPq and CAPES-Brazil.
CR Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves-Moreira D, 2009, J CELL BIOCHEM, V107, P655, DOI 10.1002/jcb.22148
   da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   Gremski LH, 2010, MOL BIOSYST, V6, P2403, DOI 10.1039/c004118a
   Kalapothakis E, 2007, TOXICON, V50, P938, DOI 10.1016/j.toxicon.2007.07.001
   Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Meeteren L.A.van, 2004, J BIOL CHEM, V279, P10833
   Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Senff-Ribeiro A, 2008, BIOTECHNOL ADV, V26, P210, DOI 10.1016/j.biotechadv.2007.12.003
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
NR 18
TC 13
Z9 14
U1 0
U2 8
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD FEB
PY 2011
VL 67
BP 234
EP 236
DI 10.1107/S1744309110050931
PN 2
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 717GC
UT WOS:000287030600013
PM 21301094
OA Green Published
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Murakami, M
   Perband, M
   Arni, R
   Betzel, C
AF Georgieva, Dessislava
   Murakami, Mario
   Perband, Markus
   Arni, Raghuvir
   Betzel, Christian
TI The structure of a native L-amino acid oxidase, the major component of
   the Vipera ammodytes ammodytes venomic, reveals dynamic active site and
   quaternary structure stabilization by divalent ions
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID CALLOSELASMA-RHODOSTOMA; SNAKE-VENOM; CRYSTAL-STRUCTURE; POLYAMINE
   OXIDASE; SUBSTRATE; INDUCTION; MECHANISM
AB The crystal structure of the major component of the Vipera ammodytes ammodytes venomic, a flavotoxin, member of the L-amino acid oxidase (LAAO) family, has been determined and refined at 2.6 angstrom resolution. The asymmetric unit consists of four molecules, each bound to oxidized FAD, representing a dimer of dimers. The binding of four Zn2+ ions stabilizes the enzymatically active quaternary structure and is considered important for the biological activity of LAAO and other flavoproteins. Each monomer consists of three domains with a cofactor bound between the FAD and substrate binding domains, and a solvent exposed glycosylation site which is considered crucial for the toxicity. Comparison of LAAO structures in the absence and presence of a substrate indicates conformational changes in the dynamic active site. The active site H-bond network involving the triad Lys326-Water-N5 of FAD is formed only upon substrate binding, and results in the increased mobility of the isoalloxazine system. Details of the catalytic transformation of amino acid substrates are discussed.
C1 [Georgieva, Dessislava; Perband, Markus; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Georgieva, Dessislava] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
   [Murakami, Mario] Natl Ctr Res Energy & Mat, Natl Lab Biosci, BR-13083970 Campinas, SP, Brazil.
   [Perband, Markus] Univ Med Ctr, Inst Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany.
   [Arni, Raghuvir] IBILCE UNESP, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Arni,
   Raghuvir K/N-9338-2018; Betzel, Christian/G-8105-2018; Arni, Raghuvir
   K/B-2222-2013
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Betzel, Christian/0000-0002-3879-5019; Arni,
   Raghuvir K/0000-0003-2460-1145
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B-1610/06]; FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/54865-1];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [303593/2009-1, 474989/2009-7]; Excellence Initiative of the Federal
   State Hamburg, Germany
FX This research was financed by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1), the Bulgarian National
   Foundation for Scientific Research (Grant TK-B-1610/06), FAPESP
   (2007/54865-1), and CNPq (303593/2009-1 and 474989/2009-7). The work of
   MP was supported by the Graduate School for Structure and Dynamics (SDI)
   funded by the Excellence Initiative of the Federal State Hamburg,
   Germany.
CR Ande SR, 2008, YEAST, V25, P349, DOI 10.1002/yea.1592
   Ande SR, 2006, APOPTOSIS, V11, P1439, DOI 10.1007/s10495-006-7959-9
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   Binda C, 2001, BIOCHEMISTRY-US, V40, P2766, DOI 10.1021/bi002751j
   Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9
   BLUNGER AT, 1998, ACTA CRYSTALLOGR D, V54, P905
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Georgieva D, 2008, ACTA CRYSTALLOGR F, V64, P918, DOI 10.1107/S1744309108027036
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   Geyer A, 2001, EUR J BIOCHEM, V268, P4044, DOI 10.1046/j.1432-1327.2001.02321.x
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   Kini RM, 2005, TOXICON, V45, P1133, DOI 10.1016/j.toxicon.2005.02.019
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P183
   Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496
   Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032
   Murphy GS, 2007, J CARDIOTHOR VASC AN, V21, P113, DOI 10.1053/j.jvca.2006.08.011
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204
   Sakurai Y, 2001, TOXICON, V39, P1827, DOI 10.1016/S0041-0101(01)00133-7
   Santos MMD, 2008, BASIC CLIN PHARMACOL, V102, P533, DOI 10.1111/j.1742-7843.2008.00229.x
   WELLNER D, 1961, J BIOL CHEM, V236, P2357
   Zhang H, 2004, ACTA CRYSTALLOGR E, V60, pO299, DOI 10.1107/S1600536804001564
NR 26
TC 18
Z9 19
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2011
VL 7
IS 2
BP 379
EP 384
DI 10.1039/c0mb00101e
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 708UU
UT WOS:000286390600011
PM 20938508
DA 2020-12-01
ER

PT J
AU Souza, TACB
   Trindade, DM
   Tonoli, CCC
   Santos, CR
   Ward, RJ
   Arni, RK
   Oliveira, AHC
   Murakami, MT
AF Souza, Tatiana A. C. B.
   Trindade, Daniel M.
   Tonoli, Celisa C. C.
   Santos, Camila R.
   Ward, Richard J.
   Arni, Raghuvir K.
   Oliveira, Arthur H. C.
   Murakami, Mario T.
TI Molecular adaptability of nucleoside diphosphate kinase b from
   trypanosomatid parasites: stability, oligomerization and structural
   determinants of nucleotide binding
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; MACROMOLECULAR CRYSTALLOGRAPHY;
   BIOLOGICAL MACROMOLECULES; 3-DIMENSIONAL STRUCTURE; SOLUTION SCATTERING;
   RESOLUTION; LEISHMANIASIS; ACTIVATION; MECHANISM
AB Nucleoside diphosphate kinases play a crucial role in the purine-salvage pathway of trypanosomatid protozoa and have been found in the secretome of Leishmania sp., suggesting a function related to host-cell integrity for the benefit of the parasite. Due to their importance for housekeeping functions in the parasite and by prolonging the life of host cells in infection, they become an attractive target for drug discovery and design. In this work, we describe the first structural characterization of nucleoside diphosphate kinases b from trypanosomatid parasites (tNDKbs) providing insights into their oligomerization, stability and structural determinants for nucleotide binding. Crystallographic studies of LmNDKb when complexed with phosphate, AMP and ADP showed that the crucial hydrogen-bonding residues involved in the nucleotide interaction are fully conserved in tNDKbs. Depending on the nature of the ligand, the nucleotide-binding pocket undergoes conformational changes, which leads to different cavity volumes. SAXS experiments showed that tNDKbs, like other eukaryotic NDKs, form a hexamer in solution and their oligomeric state does not rely on the presence of nucleotides or mimetics. Fluorescence-based thermal-shift assays demonstrated slightly higher stability of tNDKbs compared to human NDKb (HsNDKb), which is in agreement with the fact that tNDKbs are secreted and subjected to variations of temperature in the host cells during infection and disease development. Moreover, tNDKbs were stabilized upon nucleotide binding, whereas HsNDKb was not influenced. Contrasts on the surface electrostatic potential around the nucleotide-binding pocket might be a determinant for nucleotide affinity and protein stability differentiation. All these together demonstrated the molecular adaptation of parasite NDKbs in order to exert their biological functions intra-parasite and when secreted by regulating ATP levels of host cells.
C1 [Souza, Tatiana A. C. B.; Trindade, Daniel M.; Tonoli, Celisa C. C.; Santos, Camila R.; Murakami, Mario T.] CNPEM, LNLS, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil.
   [Ward, Richard J.; Oliveira, Arthur H. C.] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
   [Arni, Raghuvir K.] Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil.
RP Murakami, MT (corresponding author), Rua Giuseppe Maximo Scolfaro 10000,Polo 2 Alta Te, BR-13083970 Campinas, SP, Brazil.
EM tatiana.brasil@lnbio.org.br; daniel.trindade@lnbio.org.br;
   celisa.tonoli@lnbio.org.br; camila.santos@lnbio.org.br;
   rjward@ffclrp.usp.br; arni@sjrp.unesp.br;
   arthurdeoliveira@ffclrp.usp.br; mario.murakami@lnbio.org.br
RI de Oliveira, Arthur Henrique Cavalcante/A-1797-2013; Arni, Raghuvir
   K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Trindade, Daniel
   Maragno/J-6085-2012; Murakami, Mario T/F-5640-2016; Ward,
   Richard/C-2460-2012; Santos, Camila/F-7095-2013; Murakami, Mario
   T/C-2087-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Trindade, Daniel Maragno/0000-0002-8005-8784;
   Murakami, Mario T/0000-0002-0405-8010; Ward,
   Richard/0000-0003-1136-5737; Santos, Camila/0000-0003-0652-4211; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX We thank the Brazilian Biosciences National Laboratory and Brazilian
   Synchrotron Light Laboratory (CNPEM, Campinas, Brazil) for the provision
   of crystallization (RoboLab) and X-ray diffraction (W01B-MX2 and
   D02A-SAXS2 beamlines) facilities. This research was supported by grants
   from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Admiraal SJ, 1999, BIOCHEMISTRY-US, V38, P4701, DOI 10.1021/bi9827565
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   Biondi RM, 1998, ARCH BIOCHEM BIOPHYS, V353, P85, DOI 10.1006/abbi.1997.0617
   Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858
   Chagas Carlos, 1909, Memorias do Instituto Oswaldo Cruz, V1
   Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Tonoli CCC, 2009, ACTA CRYSTALLOGR F, V65, P1116, DOI 10.1107/S1744309109037567
   Croft SL, 1997, PARASITOLOGY, V114, pS3, DOI 10.1017/S0031182097001182
   Cunha-Neto E, 1999, MEDICINA-BUENOS AIRE, V59, P496
   de Oliveira AHC, 2006, COMP BIOCHEM PHYS D, V1, P300, DOI 10.1016/j.cbd.2006.05.003
   den Boer ML, 2009, EXPERT OPIN EMERG DR, V14, P395, DOI 10.1517/14728210903153862
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Engers HD, 1996, DEV BIOL STAND, V87, P73
   Giraud MF, 2006, J BIOENERG BIOMEMBR, V38, P261, DOI 10.1007/s10863-006-9043-0
   GOUAUX JE, 1990, BIOCHEMISTRY-US, V29, P7702, DOI 10.1021/bi00485a020
   Grisard EC, 2000, ACTA TROP, V74, P89, DOI 10.1016/S0001-706X(99)00054-6
   Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303
   Jannin J, 2007, MEM I OSWALDO CRUZ, V102, P95, DOI 10.1590/S0074-02762007005000106
   Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004
   Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212
   Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172
   MARR JJ, 1991, J LAB CLIN MED, V118, P111
   Meyer P, 2000, EMBO J, V19, P3520, DOI 10.1093/emboj/19.14.3520
   MORERA S, 1994, BIOCHEMISTRY-US, V33, P459, DOI 10.1021/bi00168a010
   MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011
   MOURAD N, 1966, J BIOL CHEM, V241, P271
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PARKS RE, 1973, COMP BIOCHEM PHYSIOL, V45, P355, DOI 10.1016/0305-0491(73)90070-9
   Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621
   SAKTHIANANDESWA.A, 2000, TRENDS PARASITOL, V25, P383
   SHIMADA N, 1993, J BIOL CHEM, V268, P2583
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang H, 2008, ACTA CRYSTALLOGR F, V64, P572, DOI 10.1107/S1744309108015212
   WEBB PA, 1995, J MOL BIOL, V251, P574, DOI 10.1006/jmbi.1995.0457
   *WHO, 2008, WHO CONTR TROP DIS C
   Xu YW, 1997, P NATL ACAD SCI USA, V94, P3579, DOI 10.1073/pnas.94.8.3579
   YAMAGUCHI H, 1993, J MOL BIOL, V229, P1083, DOI 10.1006/jmbi.1993.1106
NR 46
TC 26
Z9 27
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2011
VL 7
IS 7
BP 2189
EP 2195
DI 10.1039/c0mb00307g
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 776TC
UT WOS:000291559900011
PM 21528129
DA 2020-12-01
ER

PT J
AU Munawar, A
   Trusch, M
   Georgieva, D
   Spencer, P
   Frochaux, V
   Harder, S
   Arni, RK
   Duhalov, D
   Genov, N
   Schluter, H
   Betzel, C
AF Munawar, Aisha
   Trusch, Maria
   Georgieva, Dessislava
   Spencer, Patrick
   Frochaux, Violette
   Harder, Soenke
   Arni, Raghuvir K.
   Duhalov, Deyan
   Genov, Nicolay
   Schlueter, Hartmut
   Betzel, Christian
TI Venom peptide analysis of Vipera ammodytes meridionalis (Viperinae) and
   Bothrops jararacussu (Crotalinae) demonstrates subfamily-specificity of
   the peptidome in the family Viperidae
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID ANGIOTENSIN-CONVERTING ENZYME; DENDROASPIS NATRIURETIC PEPTIDE; SNAKE
   VENOMICS; TRYPSIN-INHIBITOR; MASS-SPECTROMETRY; GENE-EXPRESSION; GLAND;
   IDENTIFICATION; ANTIVENOMICS; VARIABILITY
AB Snake venom peptidomes are valuable sources of pharmacologically active compounds. We analyzed the peptidic fractions (peptides with molecular masses < 10 000 Da) of venoms of Vipera ammodytes meridionalis (Viperinae), the most toxic snake in Europe, and Bothrops jararacussu (Crotalinae), an extremely poisonous snake of South America. Liquid chromatography/mass spectrometry (LC/MS), direct infusion electrospray mass spectrometry (ESI-MS) and matrix-assisted desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) were applied to characterize the peptides of both snake venoms. 32 bradykinin-potentiating peptides (BPPs) were identified in the Crotalinae venom and their sequences determined. 3 metalloproteinase inhibitors, 10 BPPs and a Kunitz-type inhibitor were observed in the Viperinae venom peptidome. Variability in the C-terminus of homologous BPPs was observed, which can influence the pharmacological effects. The data obtained so far show a subfamily specificity of the venom peptidome in the Viperidae family: BPPs are the major peptide component of the Crotalinae venom peptidome lacking Kunitz-type inhibitors (with one exception) while the Viperinae venom, in addition to BPPs, can contain peptides of the bovine pancreatic trypsin inhibitor family. We found indications for a post-translational phosphorylation of serine residues in Bothrops jararacussu venom BPP (<(S)under bar>QGLPPGPPIP), which could be a regulatory mechanism in their interactions with ACE, and might influence the hypotensive effect. Homology between venom BPPs from Viperidae snakes and venom natriuretic peptide precursors from Elapidae snakes suggests a structural similarity between the respective peptides from the peptidomes of both snake families. The results demonstrate that the venoms of both snakes are rich sources of peptides influencing important physiological systems such as blood pressure regulation and hemostasis. The data can be used for pharmacological and medical applications.
C1 [Munawar, Aisha; Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Munawar, Aisha] Univ Engn & Technol, Dept Chem, Lahore, Pakistan.
   [Trusch, Maria; Harder, Soenke; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf UKE, Inst Clin Chem, Hamburg, Germany.
   [Spencer, Patrick] IPEN CNEN SP, Ctr Biotecnol, BR-05508000 Sao Paulo, Brazil.
   [Frochaux, Violette] Humboldt Univ, Dept Chem, Berlin, Germany.
   [Arni, Raghuvir K.] UNESP, Dept Phys, IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Duhalov, Deyan] BUL BIO NCIPD Ltd, Sofia, Bulgaria.
   [Genov, Nicolay] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Notkestr 85,Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Riedner, Maria/W-5546-2019; Spencer, Patrick/C-6353-2012; Betzel,
   Christian/G-8105-2018; Schluter, Hartmut/D-1371-2015; Arni, Raghuvir
   K/N-9338-2018; Arni, Raghuvir K/B-2222-2013
OI Betzel, Christian/0000-0002-3879-5019; Schluter,
   Hartmut/0000-0002-9358-7036; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Spencer, Patrick/0000-0001-8949-7735
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1, 26-1]; FAPESP/CNPq/CAPESNational Council for Scientific and
   Technological Development (CNPq)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP)CAPES; Higher Education Commission, PakistanHigher
   Education Commission of Pakistan; DAAD, GermanyDeutscher Akademischer
   Austausch Dienst (DAAD)
FX This research was financed by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1, 26-1) and
   FAPESP/CNPq/CAPES. The work of AM was supported by the Higher Education
   Commission, Pakistan and DAAD, Germany.
CR Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024
   Best PJM, 2002, CARDIOVASC RES, V55, P375, DOI 10.1016/S0008-6363(02)00402-9
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Calvete JJ, 2005, CURR PHARM DESIGN, V11, P829, DOI 10.2174/1381612053381783
   Calvete JJ, 2010, J PROTEOME RES, V9, P528, DOI 10.1021/pr9008749
   Calvete JJ, 2009, J PROTEOMICS, V72, P227, DOI 10.1016/j.jprot.2009.01.005
   Calvete JJ, 2009, J PROTEOMICS, V72, P121, DOI 10.1016/j.jprot.2009.01.018
   Cardoso KC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-605
   Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306
   Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723
   Chou WM, 2010, TOXICON, V55, P353, DOI 10.1016/j.toxicon.2009.08.012
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   Correa LC, 2008, BBA-PROTEINS PROTEOM, V1784, P591, DOI 10.1016/j.bbapap.2008.01.007
   Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423
   Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x
   Fernandez J, 2010, J PROTEOME RES, V9, P4234, DOI 10.1021/pr100545d
   Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024
   Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1
   Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   Georgieva D, 2008, EXPERT REV PROTEOMIC, V5, P787, DOI 10.1586/14789450.5.6.787
   Hayashi MAF, 2005, TOXICON, V45, P1163, DOI 10.1016/j.toxicon.2005.02.017
   Hodgson WC, 2009, CURR OPIN PHARMACOL, V9, P173, DOI 10.1016/j.coph.2008.11.007
   Huang KF, 1998, BIOCHEM BIOPH RES CO, V248, P562, DOI 10.1006/bbrc.1998.9017
   Ianzer D, 2004, PEPTIDES, V25, P1085, DOI 10.1016/j.peptides.2004.04.006
   Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079
   KOMORI Y, 1990, INT J BIOCHEM, V22, P767, DOI 10.1016/0020-711X(90)90013-S
   Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197
   Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   NG KKF, 1970, NATURE, V225, P1142, DOI 10.1038/2251142b0
   ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004
   Patocka Jiri, 2004, Acta Medica (Hradec Kralove), V47, P157
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pimenta DC, 2007, RAPID COMMUN MASS SP, V21, P1034, DOI 10.1002/rcm.2931
   Rioli V, 2008, FEBS J, V275, P2442, DOI 10.1111/j.1742-4658.2008.06389.x
   RITONJA A, 1983, BIOCHIM BIOPHYS ACTA, V748, P429, DOI 10.1016/0167-4838(83)90189-9
   Sanchez EE, 2009, ARCH TOXICOL, V83, P271, DOI 10.1007/s00204-008-0358-y
   Sanz L, 2008, J PROTEOMICS, V71, P198, DOI [10.1016/j.jprot.2008.05.003, 10.1016/j.jprot.2008.03.001]
   Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004
   Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500
   Scaloni A, 1996, BIOCHEM J, V319, P775, DOI 10.1042/bj3190775
   SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928
   SIDDIQI AR, 1991, FEBS LETT, V294, P141, DOI 10.1016/0014-5793(91)81361-B
   Souza GHMF, 2008, J MASS SPECTROM, V43, P594, DOI 10.1002/jms.1351
   Steckelings UM, 2001, ACTA DERM-VENEREOL, V81, P321
   Tsai IH, 2011, TOXICON, V57, P332, DOI 10.1016/j.toxicon.2010.12.012
   Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217
   Wermelinger LS, 2005, RAPID COMMUN MASS SP, V19, P1703, DOI 10.1002/rcm.1973
   Zhang Y, 2011, TOXICON, V57, P134, DOI 10.1016/j.toxicon.2010.10.014
   Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8
NR 51
TC 20
Z9 21
U1 2
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2011
VL 7
IS 12
BP 3298
EP 3307
DI 10.1039/c1mb05309d
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 843CB
UT WOS:000296648800013
PM 21959992
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Ohler, M
   Seifert, J
   von Bergen, M
   Arni, RK
   Genov, N
   Betzel, C
AF Georgieva, Dessislava
   Oehler, Michaela
   Seifert, Jana
   von Bergen, Martin
   Arni, Raghuvir K.
   Genov, Nicolay
   Betzel, Christian
TI Snake Venomic of Crotalus durissus terrificus-Correlation with
   Pharmacological Activities
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE snake venomic; Crotalus durissus terrificus; 2-D electrophoresis;
   electrospray mass spectrometry
ID AGKISTRODON-CONTORTRIX-CONTORTRIX; AMINO-ACID-SEQUENCE; PHOSPHOLIPASE-A2
   NEUROTOXIN; PHYLOGENETIC ANALYSIS; ALPHA-FIBRINOGENASE;
   MASS-SPECTROMETRY; TOXIN COMPOSITION; SERINE-PROTEASE; CROTOXIN;
   BOTHROPS
AB The snake venomic of Crotalus durissus terrificus was analyzed by 2-D and 1-D electrophoresis and subsequent MS/MS and enzymatic assays. The venomic of the South American rattlesnake comprises toxins from seven protein families: phospholipases A(2), serine proteinases, ecto-5'-nucleotidases, metalloproteinases, nerve growth factors, phosphodiesterases, and glutaminyl cyclase. The venom toxin composition correlates with the clinical manifestation of the crotalinae snake bites and explains pathological effects of the venom such as neurotoxicity, systemic myonecrosis, hemostatic disorders, myoglobinuria, and acute renal failure. The vast majority of toxins are potentially involved in neurotoxicity, myotoxicity, and coagulopathy. The predominant venom components are neurotoxic phospholipases A2 and serine proteinases. The venom is a rich source of 5'-nucleotidases (7.8% of the identified toxins) inducing hemostatic disorders. Analysis of the venom protein composition provided a catalogue for secreted toxins. The venomic composition of Crotalus d. terrificus and venom gland transcriptome of the synonymous subspecies Crotalus d. collilineatus show differences in the occurrence of protein families and in the abundance of toxins. Some of the venom components identified by the proteomic analysis were not reported in the transcriptome of the Crotalus d. collilineatus venom gland. Enzymatic activities of the Crotalus d. terrificus venom were determined and correlated with the proteomic composition.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Lab Struct Biol Infect & Inflammat, Inst Biochem & Mol Biol, DESY, D-22603 Hamburg, Germany.
   [Oehler, Michaela; Seifert, Jana; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany.
   [Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Genov, Nicolay] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
RP Betzel, C (corresponding author), Univ Hamburg, Lab Struct Biol Infect & Inflammat, Inst Biochem & Mol Biol, DESY, Notkestr 85,Bldg 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI von Bergen, Martin/D-7960-2011; Arni, Raghuvir K/N-9338-2018; Arni,
   Raghuvir K/B-2222-2013; Betzel, Christian/G-8105-2018
OI von Bergen, Martin/0000-0003-2732-2977; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; Betzel,
   Christian/0000-0002-3879-5019; Seifert, Jana/0000-0002-7690-8539
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -
   FAPESP/BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2007/54865-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B-1610/06]
FX This research was funded by grants from the Deutsche
   Forschungsgemeinschaft (project BE 1443-18-1 to C.B.), Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo - FAPESP/Brazil (2007/54865-1
   to R.K.A.), and the Bulgarian National Foundation for Scientific
   Research (Grant TK-B-1610/06 to N.G.).
CR AIRD SD, 1990, BIOCHIM BIOPHYS ACTA, V1040, P217, DOI 10.1016/0167-4838(90)90079-U
   Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p
   ALEXANDER G, 1988, TOXICON, V26, P953, DOI 10.1016/0041-0101(88)90260-7
   Amiconi G, 2000, BIOCHEMISTRY-US, V39, P10294, DOI 10.1021/bi000145i
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   AZEVEDOMARQUES MM, 1985, TOXICON, V23, P631, DOI 10.1016/0041-0101(85)90367-8
   Baranauskas V, 2002, J VAC SCI TECHNOL B, V20, P1317, DOI 10.1116/1.1486007
   Bazaa A, 2005, PROTEOMICS, V5, P4223, DOI 10.1002/pmic.200402024
   Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Boldrini-Franca J, 2009, BIOCHIMIE, V91, P586, DOI 10.1016/j.biochi.2009.02.001
   BON C, 1989, ACTA PHYSIOL PHARM L, V39, P439
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Calvete JJ, 2007, J PROTEOME RES, V6, P326, DOI 10.1021/pr060494k
   Calvete JJ, 2009, J PROTEOME RES, V8, P3055, DOI 10.1021/pr900249q
   Calvete JJ, 2009, J PROTEOMICS, V72, P227, DOI 10.1016/j.jprot.2009.01.005
   Calvete JJ, 2009, J PROTEOMICS, V72, P121, DOI 10.1016/j.jprot.2009.01.018
   De Perez OCA, 1998, TOXICON, V36, P1165, DOI 10.1016/S0041-0101(98)00007-5
   de Sousa-e-Silva MCC, 2003, HUM EXP TOXICOL, V22, P491, DOI 10.1191/0960327103ht392oa
   FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x
   FAURE G, 1991, BIOCHEMISTRY-US, V30, P8074, DOI 10.1021/bi00246a028
   FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022
   Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328
   Georgieva D, 2008, EXPERT REV PROTEOMIC, V5, P787, DOI 10.1586/14789450.5.6.787
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008
   Hahn BS, 1996, J BIOCHEM-TOKYO, V119, P835, DOI 10.1093/oxfordjournals.jbchem.a021319
   Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219
   HITE LA, 1992, BIOCHEMISTRY-US, V31, P6203, DOI 10.1021/bi00142a005
   HUNG CC, 1994, BIOCHEM BIOPH RES CO, V201, P1414, DOI 10.1006/bbrc.1994.1861
   Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64
   JOHNSON AJ, 1969, THROMB DIATH HAEMOST, V21, P259
   Juarez P, 2004, PROTEOMICS, V4, P327, DOI 10.1002/pmic.200300628
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   Lee Jung Eun, 1992, Korean Biochemical Journal, V25, P684
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   McDiarmid R.W., 1999, SNAKE SPECIES WORLD, VI
   Moura-da-Silva AM, 2008, BIOCHIMIE, V90, P484, DOI 10.1016/j.biochi.2007.11.009
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   Murakami MT, 2003, BIOCHEM BIOPH RES CO, V310, P478, DOI 10.1016/j.bbrc.2003.09.032
   PAN H, 1999, SHENG WU HUA XUE YU, V31, P79
   Pawlak J, 2006, TOXICON, V48, P278, DOI 10.1016/j.toxicon.2006.05.013
   POLLACK SE, 1983, J PROTEIN CHEM, V2, P1, DOI 10.1007/BF01025165
   Risch M, 2009, J PROTEOMICS, V72, P256, DOI 10.1016/j.jprot.2009.01.006
   Sanz L, 2008, J PROTEOMICS, V71, P198, DOI [10.1016/j.jprot.2008.05.003, 10.1016/j.jprot.2008.03.001]
   Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004
   Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   SHERMAN DG, 2002, ANCROD CURR MED R S2, V18, pS48
   Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527
   Soares AM, 2001, INT J BIOCHEM CELL B, V33, P877, DOI 10.1016/S1357-2725(01)00065-6
   SULKOWSKI E, 1963, J BIOL CHEM, V238, P2477
   Tashima AK, 2008, J PROTEOMICS, V71, P473, DOI 10.1016/j.jprot.2008.07.007
   Tokunaga Y, 2005, ARCH BIOCHEM BIOPHYS, V439, P241, DOI 10.1016/j.abb.2005.05.020
   TU AT, 1966, COMP BIOCHEM PHYSIOL, V17, P297, DOI 10.1016/0010-406X(66)90029-6
   Wagstaff' SC, 2009, J PROTEOMICS, V71, P609, DOI 10.1016/j.jprot.2008.10.003
   Wei Q, 2002, J NAT TOXINS, V11, P337
   WELLNER D, 1971, METHODS ENZYMOLOGY B, V17, P592
   Yonamine CM, 2009, TOXICON, V54, P110, DOI 10.1016/j.toxicon.2009.03.022
   Zambelli VO, 2008, TOXICON, V51, P1357, DOI 10.1016/j.toxicon.2008.03.004
   Zhang HL, 2006, TOXICON, V48, P175, DOI 10.1016/j.toxicon.2006.04.008
NR 71
TC 43
Z9 44
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD MAY
PY 2010
VL 9
IS 5
BP 2302
EP 2316
DI 10.1021/pr901042p
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 592CR
UT WOS:000277353200022
PM 20205475
DA 2020-12-01
ER

PT J
AU Ohler, M
   Georgieva, D
   Seifert, J
   von Bergen, M
   Arni, RK
   Genov, N
   Betzel, C
AF Oehler, Michaela
   Georgieva, Dessislava
   Seifert, Jana
   von Bergen, Martin
   Arni, Raghuvir K.
   Genov, Nicolay
   Betzel, Christian
TI The Venomics of Bothrops alternatus is a Pool of Acidic Proteins with
   Predominant Hemorrhagic and Coagulopathic Activities
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE snake venomics; Bothrops alternatus; 2-D electrophoresis
ID SNAKE-VENOM; MASS-SPECTROMETRY; PHYLOGENETIC ANALYSIS;
   PLATELET-AGGREGATION; GLAND TRANSCRIPTOME; TOXIN COMPOSITION;
   SERINE-PROTEASE; DISINTEGRIN; EVOLUTION; PROTEOMES
AB The venom proteome of Bothrops alternatus, a venomous snake widespread in South America, was analyzed by 2-D electrophoresis followed by mass spectrometric analysis and determination of enzymatic activities. The venomic composition revealed that metallo- and serine proteinases play primary roles in the pathogenesis of the envenomation by this pitviper. The identified 100 venom components with molecular masses from 10 to 100 kDa belong to six protein families: metalloproteinases, serine/thrombin-like proteinases, phospholipases A(2), L-amino acid oxidases, disintegrins and thrombin inhibitors. Metalloproteinases predominate and belong exclusively to the P-III class including the most potent hemorrhagic toxins. They represent 50% of all identified proteins. Two isoforms were identified: homologous to jararhagin, a hemorrhagic toxin, and to beritractivase, a nonhemorrhagic and pro-coagulant metalloproteinase. The B. alternatus venom is a rich source of proteins influencing the blood coagulation system with a potential for medical application. The isoelectric points of the components are distributed in the acidic pH range (the p/values are between 4 and 7) and no basic proteins were detected.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Oehler, Michaela; Seifert, Jana; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany.
   [Arni, Raghuvir K.] UNESP, Dept Phys, IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Genov, Nicolay] Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Notkestr 85,Build 22A, D-22603 Hamburg, Germany.
EM Christian.Betzel@uni-hamburg.de
RI Arni, Raghuvir K/N-9338-2018; von Bergen, Martin/D-7960-2011; Arni,
   Raghuvir K/B-2222-2013; Betzel, Christian/G-8105-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; von Bergen,
   Martin/0000-0003-2732-2977; Arni, Raghuvir K/0000-0003-2460-1145;
   Betzel, Christian/0000-0002-3879-5019; Seifert, Jana/0000-0002-7690-8539
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B-1610/06]; FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/54865-1];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [303593/2009-1, 474989/2009-7]
FX This research was financed by grants from the Deutsche
   Forschungsgemeinschaft (Project BE 1443-18-1), the Bulgarian National
   Foundation for Scientific Research (Grant TK-B-1610/06), FAPESP
   (2007/54865-1), and CNPq (303593/2009-1 & 474989/2009-7).
CR Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p
   Amiconi G, 2000, BIOCHEMISTRY-US, V39, P10294, DOI 10.1021/bi000145i
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   AROCAS V, 1996, TOXICON, V34, P1077
   Bazaa A, 2005, PROTEOMICS, V5, P4223, DOI 10.1002/pmic.200402024
   Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Calvete JJ, 2007, J PROTEOME RES, V6, P326, DOI 10.1021/pr060494k
   Calvete JJ, 2009, J PROTEOMICS, V72, P227, DOI 10.1016/j.jprot.2009.01.005
   Calvete JJ, 2009, J PROTEOMICS, V72, P121, DOI 10.1016/j.jprot.2009.01.018
   Campbell J.A., 2004, VENOMOUS REPTILES W
   Castro HC, 1998, TOXICON, V36, P1903, DOI 10.1016/S0041-0101(98)00111-1
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   Cogo JC, 1998, TOXICON, V36, P1323, DOI 10.1016/S0041-0101(97)00174-8
   Cogo JC, 2006, BIOCHIMIE, V88, P1947, DOI 10.1016/j.biochi.2006.10.006
   Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4
   De Perez OCA, 1998, TOXICON, V36, P1165, DOI 10.1016/S0041-0101(98)00007-5
   de Roodt AR, 2003, TOXICON, V41, P949, DOI 10.1016/S0041-0101(02)00392-6
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022
   Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148
   Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2
   Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613
   Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328
   Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1
   Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200
   Gay CC, 2009, TOXICON, V53, P53, DOI 10.1016/j.toxicon.2008.10.010
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   GEORGIEVA DJ, 2009, J PROTEOME RES UNPUB
   Guo Y, 2006, CHINESE MED J-PEKING, V119, P662, DOI 10.1097/00029330-200604020-00010
   Gutierrez JM, 2009, J PROTEOMICS, V72, P165, DOI 10.1016/j.jprot.2009.01.008
   Hennerici MG, 2006, LANCET, V368, P1871, DOI 10.1016/S0140-6736(06)69776-6
   Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64
   JOHNSON AJ, 1969, THROMB DIATH HAEMOST, V21, P259
   Juarez P, 2004, PROTEOMICS, V4, P327, DOI 10.1002/pmic.200300628
   Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635
   Kashima S, 2004, BIOCHIMIE, V86, P211, DOI 10.1016/j.biochi.2004.02.002
   Kauskot A, 2008, FRONT BIOSCI-LANDMRK, V13, P6604, DOI 10.2741/3176
   Kawasaki T, 1996, BIOCHIMIE, V78, P245, DOI 10.1016/0300-9084(96)82187-0
   Laing GD, 2005, TOXICON, V45, P987, DOI 10.1016/j.toxicon.2005.02.013
   LOCHNIT G, 1995, EUR J BIOCHEM, V228, P805, DOI 10.1111/j.1432-1033.1995.tb20326.x
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Mariano-Oliveira A, 2003, EUR J BIOCHEM, V270, P4799, DOI 10.1046/j.1432-1033.2003.03867.x
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   Moura-da-Silva AM, 2008, BIOCHIMIE, V90, P484, DOI 10.1016/j.biochi.2007.11.009
   Nascimento JM, 2007, BIOCHEM CELL BIOL, V85, P591, DOI 10.1139/O07-067
   Neiva M, 2009, TOXICON, V53, P427, DOI 10.1016/j.toxicon.2009.01.006
   Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484
   PAN H, 1999, SHENG WU HUA XUE YU, V31, P79
   Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204
   Perez O. A. de, 1997, Journal of Venomous Animals and Toxins, V3, P43
   Queiroz GP, 2008, TOXICON, V52, P842, DOI 10.1016/j.toxicon.2008.10.002
   Ramos OHP, 2008, CLIN EXP METASTAS, V25, P53, DOI 10.1007/s10585-007-9101-y
   Ramos OHP, 2007, ARCH BIOCHEM BIOPHYS, V461, P1, DOI 10.1016/j.abb.2007.02.021
   Risch M, 2009, J PROTEOMICS, V72, P256, DOI 10.1016/j.jprot.2009.01.006
   Rocha SLG, 2009, J PROTEOME RES, V8, P2351, DOI 10.1021/pr800977s
   RUCINSKI B, 1990, BIOCHIM BIOPHYS ACTA, V1054, P257, DOI 10.1016/0167-4889(90)90096-V
   Saguchi K, 2005, TOXICON, V46, P72, DOI 10.1016/j.toxicon.2005.03.011
   Sant'Ana Estela Maria Correia, 2008, Arch Biochem Biophys, V479, P20, DOI 10.1016/j.abb.2008.07.030
   Sanz L, 2008, J PROTEOMICS, V71, P198, DOI [10.1016/j.jprot.2008.05.003, 10.1016/j.jprot.2008.03.001]
   Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004
   Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   Souza DHF, 2000, ARCH BIOCHEM BIOPHYS, V384, P341, DOI 10.1006/abbi.2000.2120
   Stabeli RG, 2007, INT J BIOL MACROMOL, V41, P132, DOI 10.1016/j.ijbiomac.2007.01.006
   SULKOWSKI E, 1963, J BIOL CHEM, V238, P2477
   Tashima AK, 2008, J PROTEOMICS, V71, P473, DOI 10.1016/j.jprot.2008.07.007
   TU AT, 1966, COMP BIOCHEM PHYSIOL, V17, P297, DOI 10.1016/0010-406X(66)90029-6
   Valente RH, 2009, J PROTEOMICS, V72, P241, DOI 10.1016/j.jprot.2009.01.001
   Vitorino-Cardoso AF, 2006, COMP BIOCHEM PHYS B, V144, P334, DOI 10.1016/j.cbpb.2006.03.010
   Wagstaff' SC, 2009, J PROTEOMICS, V71, P609, DOI 10.1016/j.jprot.2008.10.003
   WELLNER D, 1971, METHODS ENZYMOLOGY B, V17, P592
   Yu XL, 2007, PROTEIN EXPRES PURIF, V55, P257, DOI 10.1016/j.pep.2007.07.002
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 82
TC 49
Z9 51
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD MAY
PY 2010
VL 9
IS 5
BP 2422
EP 2437
DI 10.1021/pr901128x
PG 16
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 592CR
UT WOS:000277353200032
PM 20329766
DA 2020-12-01
ER

PT J
AU Akao, PK
   Tonoli, CCC
   Navarro, MS
   Cintra, ACO
   Neto, JR
   Arni, RK
   Murakami, MT
AF Akao, P. K.
   Tonoli, C. C. C.
   Navarro, M. S.
   Cintra, A. C. O.
   Neto, J. R.
   Arni, R. K.
   Murakami, M. T.
TI Structural studies of BmooMP alpha-I, a non-hemorrhagic
   metalloproteinase from Bothrops moojeni venom
SO TOXICON
LA English
DT Article
DE Snake venom metalloproteinase; Bothrops moojeni; Crystal structure
ID SNAKE-VENOM; CRYSTAL-STRUCTURE; REFINEMENT; ASTACINS; FAMILY
AB Hemostatically active snake venom metalloproteinases (SVMPs) perturb the blood coagulation cascade at specific points and due to their potential application as thrombolytic agents, the fibrin(ogen)olytic non-hemorrhagic SVMPs have been employed as biochemical tools in coagulation research and diagnosis. Structural studies complemented by the design of metalloproteinase inhibitors have been instrumental in understanding their stereo specificity and action mechanism. We present here, details of the crystal structure of BmooMP alpha-I, a 22.6 kDa non-hemorrhagic P-I class SVMP isolated from Bothrops moojeni venom, determined at 1.76 angstrom resolution. In this structure, the catalytic zinc ion displays an unusual octahedral coordination formed by the three canonical histiclines (His(142), HiS(146) and His(152)) and additionally, by three solvent molecules. Comparative sequence and structural studies indicate that the motif comprising amino acid segments 153-164 and 167-176 adjacent to the methionine-turn is a salient feature that differentiates both non and hemorrhagic P-I class SVMPs and could directly be involved in the development of the hemorrhagic activity. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Akao, P. K.; Tonoli, C. C. C.; Navarro, M. S.; Murakami, M. T.] Brazilian Synchrotron Light Lab, Ctr Struct Mol Biol, BR-13083970 Campinas, SP, Brazil.
   [Cintra, A. C. O.] Univ Sao Paulo, FCFRP, Dept Clin Toxicol & Bromatol Anal, Ribeirao Preto, Brazil.
   [Akao, P. K.; Neto, J. R.; Arni, R. K.] UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   [Arni, R. K.] Butantan Inst, CAT CEPID, Ctr Appl Toxicol, Sao Paulo, Brazil.
RP Murakami, MT (corresponding author), Brazilian Synchrotron Light Lab, Ctr Struct Mol Biol, BR-13083970 Campinas, SP, Brazil.
EM mtmurakami@lnls.br
RI Arni, Raghuvir K/B-2222-2013; Murakami, Mario T/C-2087-2012; Cintra,
   Adelia/K-6034-2013; Biotec molecular, Cepid/I-4314-2013; Murakami, Mario
   T/F-5640-2016; Neto, Joao Ruggiero/C-7716-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [471192/2007-4]; Fundacao de Amparo A Pesquisa do Estado de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [98/14138-2]; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP); CAPESCAPES; DAADDeutscher Akademischer Austausch
   Dienst (DAAD)
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, 471192/2007-4) and Fundacao de Amparo A
   Pesquisa do Estado de Sao Paulo (FAPESP, 98/14138-2). MTM and RKA
   acknowledge support from FAPESP, CNPq, CAPES and DAAD.
CR ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bernardes CP, 2008, TOXICON, V51, P574, DOI 10.1016/j.toxicon.2007.11.017
   BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0
   BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GOMISRUTH FX, 1994, J MOL BIOL, V239, P513, DOI 10.1006/jmbi.1994.1392
   Gong WM, 1998, J MOL BIOL, V283, P657, DOI 10.1006/jmbi.1998.2110
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kumasaka T, 1996, J BIOCHEM, V119, P49, DOI 10.1093/oxfordjournals.jbchem.a021215
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4
   Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403
   White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030
NR 25
TC 26
Z9 27
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD FEB-MAR
PY 2010
VL 55
IS 2-3
BP 361
EP 368
DI 10.1016/j.toxicon.2009.08.013
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 556GU
UT WOS:000274579100024
PM 19706302
DA 2020-12-01
ER

PT J
AU Tonoli, CCC
   Vieira, PS
   Ward, RJ
   Arni, RK
   de Oliveira, AHC
   Murakami, MT
AF Costa Tonoli, Celisa Caldana
   Vieira, Plinio Salmazo
   Ward, Richard John
   Arni, Raghuvir Krishnaswamy
   Cavalcante de Oliveira, Arthur Henrique
   Murakami, Mario Tyago
TI Production, purification, crystallization and preliminary X-ray
   diffraction studies of the nucleoside diphosphate kinase b from
   Leishmania major
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID CRYSTAL-STRUCTURE; SPECIFICITY
AB Nucleoside diphosphate kinases (NDKs; EC 2.7.4.6) play an essential role in the synthesis of nucleotides from intermediates in the salvage pathway in all parasitic trypanosomatids and their structural studies will be instrumental in shedding light on the biochemical machinery involved in the parasite life cycle and host-parasite interactions. In this work, NDKb from Leishmania major was overexpressed in Escherichia coli, purified to homogeneity and crystallized using the sitting-drop vapour-diffusion method. The NDK crystal diffracted to 2.2 angstrom resolution and belonged to the trigonal crystal system, with unit-cell parameters a = 114.2, c = 93.9 angstrom. Translation-function calculations yielded an unambiguous solution in the enantiomorphic space group P3(2)21.
C1 [Costa Tonoli, Celisa Caldana; Murakami, Mario Tyago] Brazilian Assoc Synchrotron Light Technol, Ctr Struct Mol Biol, Campinas, SP, Brazil.
   [Vieira, Plinio Salmazo; Ward, Richard John; Cavalcante de Oliveira, Arthur Henrique] FFCLRP USP, Dept Chem, Ribeirao Preto, SP, Brazil.
   [Arni, Raghuvir Krishnaswamy] IBILCE UNESP, Dept Phys, Sao Jose do Rio Preto, SP, Brazil.
RP Murakami, MT (corresponding author), Brazilian Assoc Synchrotron Light Technol, Ctr Struct Mol Biol, Campinas, SP, Brazil.
EM mtmurakami@lnls.br
RI Vieira, Plinio/K-7007-2012; Ward, Richard/C-2460-2012; Murakami, Mario
   T/C-2087-2012; Murakami, Mario T/F-5640-2016; Arni, Raghuvir
   K/B-2222-2013; de Oliveira, Arthur Henrique Cavalcante/A-1797-2013
OI Vieira, Plinio/0000-0001-9960-7176; Ward, Richard/0000-0003-1136-5737;
   Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; 
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [07/06755-2, 07/54865]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [307853/2006-3, 473997/2007-0,
   471192/2007-4]
FX We gratefully thank the Center for Structural Molecular Biology (ABTLuS,
   Campinas, Brazil) and the Brazilian Synchrotron Light Laboratory
   (ABTLuS, Campinas, Brazil) for provision of the automated
   crystallization laboratory (RoboLab) and synchrotron-radiation
   facilities (beamline W01B-MX2), respectively. This research was
   supported by grants from FAPESP (07/06755-2) to AHCO, FAPESP (07/54865)
   and CNPq (307853/2006-3, 473997/2007-0) to RKA and CNPq (471192/2007-4)
   to MTM.
CR Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x
   de Oliveira AHC, 2006, COMP BIOCHEM PHYS D, V1, P300, DOI 10.1016/j.cbd.2006.05.003
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gounaris K, 2001, INFECT IMMUN, V69, P3658, DOI 10.1128/IAI.69.6.3658-3662.2001
   Jeudy S, 2009, J VIROL, V83, P7142, DOI 10.1128/JVI.00511-09
   Kolli BK, 2008, MOL BIOCHEM PARASIT, V158, P163, DOI 10.1016/j.molbiopara.2007.12.010
   LACOMBE ML, 1991, EUR J CANCER, V27, P1302, DOI 10.1016/0277-5379(91)90101-I
   Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004
   Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141
   MARR JJ, 1991, BIOCH PROTOZOOLOGY, P525
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Misra G, 2009, PROTEINS, V76, P496, DOI 10.1002/prot.22364
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parks RJ, 1973, ENZYMES, V8, P307
   Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621
   Punj V, 2000, INFECT IMMUN, V68, P4930, DOI 10.1128/IAI.68.9.4930-4937.2000
   Shankar S, 1996, J BACTERIOL, V178, P1777, DOI 10.1128/jb.178.7.1777-1781.1996
   WEBB PA, 1995, J MOL BIOL, V251, P574, DOI 10.1006/jmbi.1995.0457
   Zaborina O, 1999, INFECT IMMUN, V67, P5231, DOI 10.1128/IAI.67.10.5231-5242.1999
NR 21
TC 4
Z9 5
U1 0
U2 7
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD NOV
PY 2009
VL 65
BP 1116
EP 1119
DI 10.1107/S1744309109037567
PN 11
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 514US
UT WOS:000271421800010
PM 19923730
OA Green Published
DA 2020-12-01
ER

PT J
AU Ferrara, GID
   Fernandes-Pedrosa, MD
   Junqueira-de-Azevedo, IDM
   Goncalves-de-Andrade, RM
   Portaro, FCV
   Manzoni-de-Almeida, D
   Murakami, MT
   Arni, RK
   van den Berg, CW
   Ho, PL
   Tambourgi, DV
AF de Santi Ferrara, Guilherme I.
   Fernandes-Pedrosa, Matheus de F.
   Junqueira-de-Azevedo, Inacio de L. M.
   Goncalves-de-Andrade, Rute M.
   Portaro, Fernanda C. V.
   Manzoni-de-Almeida, Daniel
   Murakami, Mario T.
   Arni, Raghuvir K.
   van den Berg, Carmen W.
   Ho, Paulo L.
   Tambourgi, Denise V.
TI SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland:
   Molecular cloning, expression, function and structural analysis
SO TOXICON
LA English
DT Article
DE Loxosceles laeta; Venom; Sphingomyelinase gene; Activity; Protein
   structure
ID BROWN RECLUSE SPIDER; BACTERIAL SPHINGOMYELINASES; CATALYTIC MECHANISM;
   MEDIATED LYSIS; MODELS; METALLOPROTEINASE; DERMONECROSIS; INTERMEDIA;
   HEMOLYSIS; PROTEINS
AB Sphingomyelinase D (SMase D) present in the venoms of Loxosceles spiders is the principal component responsible for local and systemic effects observed in the loxoscelism. By using "expressed sequencing tag", it was possible to identify, in a L. laeta venom gland library, clones containing inserts coding for proteins with similarity to SMase D. One of these clones was expressed and the recombinant protein compared with the previously characterized SMase I from L laeta, in terms of their biological, biochemical and structural properties. The new recombinant protein, SMase II, possesses all the biological properties ascribed to the whole venom and SMase I. SMase II shares 40% and 77% sequence similarity with SMase I and Lb3, respectively; the latter, a SMase D isoform from L boned, catalytically inactive. Molecular modeling and molecular dynamics simulations were employed to understand the structural basis, especially the presence of an additional disulfide bridge, in an attempt to account for the observed differences in SMases D activity. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [de Santi Ferrara, Guilherme I.; Fernandes-Pedrosa, Matheus de F.; Goncalves-de-Andrade, Rute M.; Portaro, Fernanda C. V.; Manzoni-de-Almeida, Daniel; van den Berg, Carmen W.; Tambourgi, Denise V.] Inst Butantan, Lab Imunoquim, BR-05503900 Sao Paulo, Brazil.
   [Junqueira-de-Azevedo, Inacio de L. M.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil.
   [Murakami, Mario T.] Ctr Biol Mol Estrutural, Lab Brasileiro Luz Synchrotron, Sao Paulo, Brazil.
   [Arni, Raghuvir K.] UNESP, IBILCE, Dept Fis, Sao Jose Do Rio Preto, Brazil.
   [van den Berg, Carmen W.] Cardiff Univ, Dept Pharmacol Therapeut & Toxicol, Cardiff, S Glam, Wales.
RP Tambourgi, DV (corresponding author), Inst Butantan, Lab Imunoquim, Av Vital Brazil 1500, BR-05503900 Sao Paulo, Brazil.
EM dvtambourgi@butantan.gov.br
RI Arni, Raghuvir K/N-9338-2018; de Freitas Fernandes-Pedrosa,
   Matheus/C-6398-2014; Tambourgi, Denise/H-7114-2016; Murakami, Mario
   T/C-2087-2012; Murakami, Mario T/F-5640-2016; Junqueira-de-Azevedo,
   Inacio L. M./H-5239-2011; Portaro, F/B-8397-2012; Ho, Paulo/P-8267-2015;
   Portaro, Fernanda/I-6644-2015; Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; de Freitas Fernandes-Pedrosa,
   Matheus/0000-0003-4221-9580; Tambourgi, Denise/0000-0003-1896-9074;
   Murakami, Mario T/0000-0002-0405-8010; Junqueira-de-Azevedo, Inacio L.
   M./0000-0003-4491-0180; Ho, Paulo/0000-0003-3652-241X; Arni, Raghuvir
   K/0000-0003-2460-1145
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao Butantan
FX This work was supported by FAPESP, CNPq and Fundacao Butantan.
CR ANDRADE SA, 2006, TOXICON, V47, P380
   ANDRADE SA, 2005, BIOCHEM BIOPH RES CO, V327, P117
   BUCHERL W, 1969, AM ZOOL, V9, P157
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FERNANDESPEDROS.MF, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   NILSEN H, 1997, INT J NEURAL SYST, V8, P581
   Paixao-Cavalcante D, 2006, J INVEST DERMATOL, V126, P61, DOI 10.1038/sj.jid.5700049
   Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001
   Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013
   Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002
   Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474
   Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x
   Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027
   Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x
   Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683
   Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   van den Berg CW, 2007, J THROMB HAEMOST, V5, P989, DOI 10.1111/j.1538-7836.2007.02382.x
   van den Berg CW, 2002, IMMUNOLOGY, V107, P102, DOI 10.1046/j.1365-2567.2002.01468.x
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   VANGUNSTEREN WF, 1996, MOL SIMULATION GROMO
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565
NR 37
TC 21
Z9 22
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JUN
PY 2009
VL 53
IS 7-8
BP 743
EP 753
DI 10.1016/j.toxicon.2009.02.013
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 455IS
UT WOS:000266752900007
PM 19249326
DA 2020-12-01
ER

PT J
AU Risch, M
   Georgieva, D
   von Bergen, M
   Jehmlich, N
   Genov, N
   Arni, RK
   Betzel, C
AF Risch, Michaela
   Georgieva, Dessislava
   von Bergen, Martin
   Jehmlich, Nico
   Genov, Nicolay
   Arni, Raghuvir K.
   Betzel, Christian
TI Snake venomics of the Siamese Russell's viper (Daboia russelli
   siamensis) - Relation to pharmacological activities
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Proteome; Snake venom; Protein family; Daboia russelli siamensis; 2-D
   electrophoresis
ID AMINO-ACID-SEQUENCE; PHOSPHOLIPASE A(2); FACTOR-X; TOXINOLOGICAL
   IMPLICATIONS; PHYLOGENETIC ANALYSIS; MACROVIPERA-LEBETINA; MOLECULAR
   EVOLUTION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; TOXIN COMPOSITION
AB The venom proteome of Daboia russelli siamensis, a snake of medical importance in several Asian countries, was analysed by 2-D electrophoresis, subsequent MS/MS and enzymatic assays. The proteome comprises toxins from six protein families: serine proteinases, metalloproteinases, phospholipases A(2), L-amino acid oxidases, vascular endothelial growth factors and C-type lectin-like proteins. The venom toxin composition correlates with the clinical manifestation of the Russell's viper bite and explains pathological effects of the venom such as coagulopathy, oedema, hypotensive, necrotic and tissue damaging effects. The vast majority of toxins are potentially involved in coagulopathy and neurotoxic effects. The predominant venom components are proteinases capable of activating blood coagulation factors and promoting a rapid clotting of the blood, and neurotoxic phospholipase A(2)s. The analysis of the venom protein composition provides a catalogue of secreted toxins. The proteome of D. r. siamensis exhibits a lower level of toxin diversity than the proteomes of other viperid snakes. In comparison to the venoms of Vipera ammodytes ammodytes and Vipera ammodytes meridionalis, the venom from D. r. siamensis showed quantitative differences in the proteolytic, phospholipase A2, L-amino acid oxidase and alkaline phosphatase activities. (c) 2009 Published by Elsevier B.V.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, D-22603 Hamburg, Germany.
   [Risch, Michaela; von Bergen, Martin; Jehmlich, Nico] UFZ Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany.
   [Arni, Raghuvir K.] UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   [Georgieva, Dessislava; Genov, Nicolay] Bulgarian Acad Sci, Inst Organ Chem, Sofia 1000, Bulgaria.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, DESY, Build 22A,Notkestr 85, D-22603 Hamburg, Germany.
EM Betzel@unisgi1.desy.de
RI Jehmlich, Nico/B-5403-2009; von Bergen, Martin/D-7960-2011; Arni,
   Raghuvir K/N-9338-2018; Betzel, Christian/G-8105-2018; Arni, Raghuvir
   K/B-2222-2013
OI Jehmlich, Nico/0000-0002-5638-6868; von Bergen,
   Martin/0000-0003-2732-2977; Arni, Raghuvir K/0000-0003-2460-1145;
   Betzel, Christian/0000-0002-3879-5019; Arni, Raghuvir
   K/0000-0003-2460-1145
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [1443-18-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B 1610/06]
FX This work was supported by a grant from the Deutsche
   Forschungsgemeinschaft (project BE 1443-18-1) and by the Bulgarian
   National Foundation for Scientific Research (project TK-B 1610/06).
   R.K.A. thanks the Brazilian funding agencies CNPq and FAPESP. We would
   also like to thank Christine Schumann for the excellent technical
   assistance.
CR Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   Banumathi S, 2001, ACTA CRYSTALLOGR D, V57, P1552, DOI 10.1107/S0907444901013543
   Bazaa A, 2005, PROTEOMICS, V5, P4223, DOI 10.1002/pmic.200402024
   Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x
   Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39
   Betzel C, 1999, CELL MOL LIFE SCI, V56, P384, DOI 10.1007/s000180050440
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Calvete JJ, 2007, J PROTEOME RES, V6, P326, DOI 10.1021/pr060494k
   CLEMENS R, 1995, TOXICON, V33, P77, DOI 10.1016/0041-0101(94)00131-Q
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148
   Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2
   Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613
   FRY BG, 2005, NATURE
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   Huang MZ, 1997, ARCH BIOCHEM BIOPHYS, V338, P150, DOI 10.1006/abbi.1996.9814
   Hung DZ, 2002, TOXICON, V40, P1291, DOI 10.1016/S0041-0101(02)00137-X
   Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64
   JOHNSON AJ, 1969, THROMB DIATH HAEMOST, V21, P259
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   Komori Y, 1996, ARCH BIOCHEM BIOPHYS, V327, P303, DOI 10.1006/abbi.1996.0126
   Kumar JR, 2008, BIOCHIMIE, V90, P1545, DOI 10.1016/j.biochi.2008.05.018
   LEWIS GM, 1990, TOXICON, V28, P351, DOI 10.1016/0041-0101(90)90072-F
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   Mandal S, 2008, FEBS J, V275, P2078, DOI 10.1111/j.1742-4658.2008.06362.x
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   Mizuno H, 2001, P NATL ACAD SCI USA, V98, P7230, DOI 10.1073/pnas.131179698
   Morita T, 2005, PATHOPHYSIOL HAEMO T, V34, P156, DOI 10.1159/000092415
   Mukherjee AK, 2000, TOXICON, V38, P163, DOI 10.1016/S0041-0101(99)00125-7
   Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7
   PE T, 1995, TOXICON, V33, P373, DOI 10.1016/0041-0101(94)00172-5
   Perbandt M, 2003, ACTA CRYSTALLOGR D, V59, P1679, DOI 10.1107/S0907444903014987
   Sanz L, 2008, J PROTEOMICS, V71, P198, DOI [10.1016/j.jprot.2008.05.003, 10.1016/j.jprot.2008.03.001]
   Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004
   Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   Siigur E, 2004, BBA-PROTEINS PROTEOM, V1702, P41, DOI 10.1016/j.bbapap.2004.07.007
   Siigur E, 2003, THROMB HAEMOSTASIS, V89, P826
   SULKOWSKI E, 1963, J BIOL CHEM, V238, P2477
   Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062
   TAKEYA H, 1992, J BIOL CHEM, V267, P14109
   Tashima AK, 2008, J PROTEOMICS, V71, P473, DOI 10.1016/j.jprot.2008.07.007
   THWIN MM, 1995, TOXICON, V33, P63, DOI 10.1016/0041-0101(94)00133-S
   Tokunaga Y, 2005, ARCH BIOCHEM BIOPHYS, V439, P241, DOI 10.1016/j.abb.2005.05.020
   Tsai IH, 1996, TOXICON, V34, P99, DOI 10.1016/0041-0101(95)00114-X
   Tsai IH, 2007, BBA-PROTEINS PROTEOM, V1774, P1020, DOI 10.1016/j.bbapap.2007.04.012
   TU AT, 1966, COMP BIOCHEM PHYSIOL, V17, P297, DOI 10.1016/0010-406X(66)90029-6
   WANG YM, 1992, EUR J BIOCHEM, V209, P635, DOI 10.1111/j.1432-1033.1992.tb17330.x
   WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8
   WELLNER D, 1971, METHODS ENZYMOLOGY B, V17, P592
   WOODHAMS BJ, 1990, TOXICON, V28, P427, DOI 10.1016/0041-0101(90)90081-H
   Zhong SR, 2006, TOXICON, V47, P104, DOI 10.1016/j.toxicon.2005.10.002
NR 61
TC 42
Z9 45
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD MAR 6
PY 2009
VL 72
IS 2
SI SI
BP 256
EP 269
DI 10.1016/j.jprot.2009.01.006
PG 14
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 424NX
UT WOS:000264574500013
PM 19457351
DA 2020-12-01
ER

PT J
AU de Oliveira, DGL
   Murakami, MT
   Cintra, ACO
   Franco, JJ
   Sampaio, SV
   Arni, RK
AF de Oliveira, Daniela G. L.
   Murakami, Mario T.
   Cintra, Adelia C. O.
   Franco, Joao J.
   Sampaio, Suely V.
   Arni, Raghuvir K.
TI Functional and structural analysis of two fibrinogen-activating enzymes
   isolated from the venoms of Crotalus durissus terrificus and Crotalus
   durissus collilineatus
SO ACTA BIOCHIMICA ET BIOPHYSICA SINICA
LA English
DT Article
DE Crotalus durissus sp; thrombin-like enzyme; functional characterization;
   crystallization; molecular modeling
ID EXOGENOUS HEMOSTATIC FACTORS; THROMBIN-LIKE ENZYME; STANDARDIZATION
   COMMITTEE; INTERNATIONAL SOCIETY; BLOOD-COAGULATION; UPDATED INVENTORY;
   SNAKE-VENOMS; PROTEIN-C; PURIFICATION; CRYSTALLIZATION
AB Fibrinogen-activating enzymes, widely distributed in Crotalidae and Viperidae venoms, are single-chain glycosylated serine proteases that display high macromolecular selectivity and are often referred to as thrombin-like enzymes (TLEs). TLEs serve as structural models to extend our understanding of the structure-function relationships of blood coagulation factors, have been clinically used for the treatment of thrombotic diseases, and are used as tools in clinical assays. The combination of gel filtration and ion-exchange chromatography proved to be successful in obtaining milligram quantities of pure samples of TLEs from the venoms of Crotalus durissus terrificus ( white venom) and Crotalus durissus collilineatus ( yellow venom). Functional characterization indicates that both enzymes preferentially degrade the B beta chain of bovine fibrinogen and possess edema-inducing and coagulant activities. However, the TLE from C. d. collilineatus venom shows twofold higher coagulant activity with a minimum coagulant dose (MCD) of 0.6 mg/ml, whereas the enzyme isolated from C. d. terrificus indicated an MCD of 1.5 mg/ml. Molecular modeling of gyroxin and structural comparisons with other highly conserved snake venom serine proteases, underlines the key role played by the surface charge distribution and the double insertion in the 174-surface loop in macromolecular substrate recognition by TLEs.
C1 [de Oliveira, Daniela G. L.; Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, Ctr Struct & Mol Biol, Sao Jose Dos Campos, SP, Brazil.
   [Murakami, Mario T.] Ctr Struct Mol Biol, Brazilian Synchrotron Light Lab, Campinas, SP, Brazil.
   [Cintra, Adelia C. O.; Franco, Joao J.; Sampaio, Suely V.] Univ Sao Paulo, FCFRP, Dept Clin Toxicol & Bromatol Anal, Ribeirao Preto, SP, Brazil.
   [Arni, Raghuvir K.] CAT CEPID, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), IBILCE UNESP, Dept Phys, Ctr Struct & Mol Biol, Sao Jose Dos Campos, SP, Brazil.
EM arni@ibilce.unesp.br
RI Cintra, Adelia/K-6034-2013; Arni, Raghuvir K/B-2222-2013; Vilela,
   Suely/D-7429-2012; Murakami, Mario T/F-5640-2016; Murakami, Mario
   T/C-2087-2012; VILELA SAMPAIO, SUELY/C-3433-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Vilela, Suely/0000-0003-3274-180X;
   Murakami, Mario T/0000-0002-0405-8010; 
FU FAPESP/DFGFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)German Research Foundation (DFG); FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by the grants from FAPESP/DFG, FAPESP, and CNPq.
CR Aguiar AS, 1996, TOXICON, V34, P555, DOI 10.1016/0041-0101(95)00159-X
   AndriaoEscarso SH, 1997, TOXICON, V35, P1043, DOI 10.1016/S0041-0101(96)00222-X
   ARAGONORTIZ F, 1993, TOXICON, V31, P1435, DOI 10.1016/0041-0101(93)90209-2
   Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0
   EHRENPREIS S, 1957, J BIOL CHEM, V227, P1043
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   ERNST E, 1994, ANGIOLOGY, V45, P87, DOI 10.1177/000331979404500201
   FARID TM, 1989, BIOCHEMISTRY-US, V28, P371, DOI 10.1021/bi00427a051
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   GAFFNEY P J, 1973, Biochemical Society Transactions, V1, P1208
   HARLEY BS, 1971, ENZYMES, P323
   Heinrich J, 1995, J Cardiovasc Risk, V2, P197, DOI 10.1097/00043798-199506000-00004
   Huang QQ, 1999, TOXICON, V37, P999, DOI 10.1016/S0041-0101(98)00228-1
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MARKLAND FS, 1991, THROMB HAEMOSTASIS, V65, P438
   Markland FS, 1998, THROMB HAEMOSTASIS, V79, P668
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   Murakami MT, 2005, BBA-PROTEINS PROTEOM, V1752, P202, DOI 10.1016/j.bbapap.2005.08.003
   OUYANG C, 1992, TOXICON, V30, P945, DOI 10.1016/0041-0101(92)90040-C
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Pirkle H, 1998, THROMB HAEMOSTASIS, V79, P675
   Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958
   SCHAFER AI, 1985, ANN INTERN MED, V102, P814, DOI 10.7326/0003-4819-102-6-814
   SHIEH TC, 1985, J BIOCHEM, V98, P713, DOI 10.1093/oxfordjournals.jbchem.a135329
   Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V378, P201, DOI 10.1006/abbi.2000.1790
   Sweetnam PM, 1996, EUR HEART J, V17, P1814
   VILJOEN CC, 1979, TOXICON, V17, P145, DOI 10.1016/0041-0101(79)90293-9
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565
   Zaganelli GL, 1996, TOXICON, V34, P807, DOI 10.1016/0041-0101(96)00006-2
NR 38
TC 15
Z9 16
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1672-9145
EI 1745-7270
J9 ACTA BIOCH BIOPH SIN
JI Acta Biochim. Biophys. Sin.
PD JAN
PY 2009
VL 41
IS 1
BP 21
EP 29
DI 10.1093/abbs/gmn003
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 422VE
UT WOS:000264455000003
PM 19129947
OA Bronze
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Kini, RM
   Arni, RK
AF Murakami, M. T.
   Kini, R. M.
   Arni, R. K.
TI Crystal Structure of Bucain, a Three-Fingered Toxin from the Venom of
   the Malayan Krait (Bungarus candidus)
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Bucain; crystal structure; Bungarus candidus; three-finger
   alpha-neurotoxin
ID NEUROTOXINS; RESOLUTION; BLOCKER; MODEL
AB Bucain, a potent neurotoxin isolated from the venom of the Malayan krait (Bungarus candidus), induces paralysis and death. Its crystal structure has been determined at 2.10 angstrom resolution and based on the molecular topology and hydrophobicity profile is structurally classified as a three-fingered neurotoxin possessing a positively charged AChR-binding site.
C1 [Murakami, M. T.; Arni, R. K.] UNESP, IBILCE, Dept Phys, Ctr Struct & Mol Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Kini, R. M.] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.
   [Kini, R. M.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.
   [Arni, R. K.] Butantan Inst, CAT CEPID, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Ctr Struct & Mol Biol, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Kini, Manjunatha/H-8029-2012; Murakami, Mario T/F-5640-2016; Murakami,
   Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Kini, Manjunatha/0000-0002-6100-3251
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2007/5865-1]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [501958/2008-8, 553753/2008-8, 307853/2006-3,
   471192/2007-4]
FX This research was supported by grants from FAPESP (2007/5865-1) and CNPq
   (501958/2008-8; 553753/2008-8 and 307853/2006-3) to RKA and CNPq
   (471192/2007-4) to MTM.
CR ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357
   CERVENANSKY C, 1991, INT ENCY PHARM THERA, V1, P303
   Connolly PJ, 1996, BIOCHEMISTRY-US, V35, P418, DOI 10.1021/bi9520287
   DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437
   Doley R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-196
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   ENDO T, 1987, PHARMACOL THERAPEUT, V34, P403, DOI 10.1016/0163-7258(87)90002-7
   JERUSALINSKY D, 1994, TRENDS PHARMACOL SCI, V15, P424, DOI 10.1016/0165-6147(94)90092-2
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhn P, 2000, ACTA CRYSTALLOGR D, V56, P1401, DOI 10.1107/S0907444900011501
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x
   Watanabe L, 2002, ACTA CRYSTALLOGR D, V58, P1879, DOI 10.1107/S0907444902011022
NR 22
TC 7
Z9 7
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PY 2009
VL 16
IS 12
BP 1473
EP 1477
DI 10.2174/092986609789839304
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 517NC
UT WOS:000271620200010
PM 20001910
DA 2020-12-01
ER

PT J
AU Georgieva, D
   Arni, RK
   Betzel, C
AF Georgieva, Dessislava
   Arni, Raghuvir K.
   Betzel, Christian
TI Proteome analysis of snake venom toxins: pharmacological insights
SO EXPERT REVIEW OF PROTEOMICS
LA English
DT Review
DE pharmacological activity; proteomics; snake venom; toxin; venom protein
   family
ID AGKISTRODON ACUTUS VENOM; MASS-SPECTROMETRY; GLAND TRANSCRIPTOME;
   TOXINOLOGICAL IMPLICATIONS; BIOLOGICAL-PROPERTIES; PHYLOGENETIC
   ANALYSIS; ONTOGENIC VARIATIONS; C ACTIVATOR; EVOLUTION; VIPER
AB Snake venoms are an extremely rich source of pharmacologically active proteins with a considerable clinical and medical potential. To date, this potential has not been fully explored, mainly because of our incomplete knowledge of the venom proteome and the pharmacological properties of its components, in particular those devoid of enzymatic activity. This review summarizes the latest achievements in the determination of snake venom proteome, based primarily on the development of new strategies and techniques. Detailed knowledge of the venom toxin composition and biological properties of the protein constituents should provide the scaffold for the design of new more effective drugs for the treatment of the hemostatic system and heart disorders, inflammation, cancer and consequences of snake bites, as well as new tools for clinical diagnostic and assays of hemostatic parameters.
C1 [Georgieva, Dessislava; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany.
   [Arni, Raghuvir K.] Univ Estadual Paulista, Dept Phys, IBILCE, Ctr Struct & Mol Biol, BR-15054000 Sao Paulo, Brazil.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.
EM georgie@chemie.uni-hamburg.de; arni@ibilce.unesp.br;
   betzel@unisgi1.desy.de
RI Betzel, Christian/G-8105-2018; Arni, Raghuvir K/N-9338-2018; Arni,
   Raghuvir K/B-2222-2013
OI Betzel, Christian/0000-0002-3879-5019; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BE
   1443-18-1]; Bulgarian National Foundation for Scientific
   ResearchNational Science Fund of Bulgaria [TK-B 1610/06]
FX This work was supported by grants from the Deutsche
   Forschungsgemeinschaft (project BE 1443-18-1) and the Bulgarian National
   Foundation for Scientific Research (project TK-B 1610/06). The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p
   Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   Bazaa A, 2005, PROTEOMICS, V5, P4223, DOI 10.1002/pmic.200402024
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Calvete JJ, 2007, J PROTEOME RES, V6, P326, DOI 10.1021/pr060494k
   Chen JS, 2001, ACTA PHARMACOL SIN, V22, P420
   Ching ATC, 2006, FEBS LETT, V580, P4417, DOI 10.1016/j.febslet.2006.07.010
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022
   Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024
   Frank AM, 2007, J PROTEOME RES, V6, P114, DOI 10.1021/pr060271u
   Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405
   Fry BG, 2004, MOL BIOL EVOL, V21, P870, DOI 10.1093/molbev/msh091
   Fry BG, 2003, J MOL EVOL, V57, P446, DOI 10.1007/s00239-003-2497-3
   Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148
   Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2
   Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613
   Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328
   Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200
   Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   Guercio RAP, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-11
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   Harrison RA, 2004, VACCINE, V22, P1648, DOI 10.1016/j.vaccine.2003.09.046
   Hennerici MG, 2006, LANCET, V368, P1871, DOI 10.1016/S0140-6736(06)69776-6
   Huang MZ, 1997, ARCH BIOCHEM BIOPHYS, V338, P150, DOI 10.1006/abbi.1996.9814
   Huang P, 2004, TOXICON, V44, P27, DOI 10.1016/j.toxicon.2004.03.027
   Juarez P, 2004, PROTEOMICS, V4, P327, DOI 10.1002/pmic.200300628
   Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515
   Kashima S, 2004, BIOCHIMIE, V86, P211, DOI 10.1016/j.biochi.2004.02.002
   Kim DS, 2007, J BIOCHEM MOL BIOL, V40, P290
   Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302
   Kini R. Manjunatha, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P301, DOI 10.2174/1568006043335835
   Kini RM, 2005, TOXICON, V45, P1133, DOI 10.1016/j.toxicon.2005.02.019
   KISIEL W, 1987, J BIOL CHEM, V262, P12607
   Li M, 2005, MOL BIOL EVOL, V22, P934, DOI 10.1093/molbev/msi077
   Li ST, 2004, BIOCHEM J, V384, P119, DOI 10.1042/BJ20040354
   Liu QH, 2006, BIOCHEM BIOPH RES CO, V341, P522, DOI 10.1016/j.bbrc.2006.01.006
   Lomonte B, 2008, J PROTEOME RES, V7, P2445, DOI 10.1021/pr8000139
   Marcinkiewicz C, 2005, CURR PHARM DESIGN, V11, P815, DOI 10.2174/1381612053381765
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x
   Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032
   Murakami MT, 2005, J BIOL CHEM, V280, P39309, DOI 10.1074/jbc.M508502200
   Murphy GS, 2007, J CARDIOTHOR VASC AN, V21, P113, DOI 10.1053/j.jvca.2006.08.011
   Pal Sanjoy Kumar, 2002, Indian Journal of Experimental Biology, V40, P1353
   Pimenta DC, 2007, RAPID COMMUN MASS SP, V21, P1034, DOI 10.1002/rcm.2931
   Rioux V, 1998, ELECTROPHORESIS, V19, P788, DOI 10.1002/elps.1150190531
   Rosing J, 2001, HAEMOSTASIS, V31, P241
   Samel M, 2003, COMP BIOCHEM PHYS B, V135, P575, DOI 10.1016/S1096-4959(03)00171-4
   Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027
   TAN NH, 1992, COMP BIOCHEM PHYS C, V103, P299, DOI 10.1016/0742-8413(92)90011-U
   TAN NH, 1992, INT J BIOCHEM, V24, P331
   TAN NH, 1990, COMP BIOCHEM PHYS B, V95, P577, DOI 10.1016/0305-0491(90)90024-N
   TAN NH, 1989, COMP BIOCHEM PHYS B, V93, P757, DOI 10.1016/0305-0491(89)90042-4
   TAN NH, 1991, COMP BIOCHEM PHYS B, V100, P361, DOI 10.1016/0305-0491(91)90387-S
   Tokunaga Y, 2005, ARCH BIOCHEM BIOPHYS, V439, P241, DOI 10.1016/j.abb.2005.05.020
   TOMARU T, 1988, CLIN CARDIOL, V11, P223, DOI 10.1002/clc.4960110406
   Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740
   Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001
   Wagstaff SC, 2006, GENE, V377, P21, DOI 10.1016/j.gene.2006.03.008
   Wang QQ, 2004, ACTA PHARMACOL SIN, V25, P514
   White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030
   *WIK, ANG CONV ENZ INH
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
   Yeh CH, 2001, MOL PHARMACOL, V59, P1333
NR 75
TC 59
Z9 59
U1 0
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-9450
EI 1744-8387
J9 EXPERT REV PROTEOMIC
JI Expert Rev. Proteomics
PD DEC
PY 2008
VL 5
IS 6
BP 787
EP 797
DI 10.1586/14789450.5.6.787
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 399BI
UT WOS:000262775000009
PM 19086859
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Lourenzoni, MR
   Arruda, EZ
   Tomaz, MA
   Vicoti, MM
   Abrego, JRB
   Melo, PA
   Arni, RK
AF Murakami, Mario T.
   Lourenzoni, Marco R.
   Arruda, Emerson Z.
   Tomaz, Marcelo A.
   Vicoti, Magno M.
   Abrego, Jose R. B.
   Melo, Paulo A.
   Arni, Raghuvir K.
TI Biochemical and structural investigations of Bothropstoxin-II, a
   myotoxic Asp49 phospholipase A(2) from Bothrops jararacussu venom
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE phospholipases A(2); suramin; pharmacological activities; structural
   studies
ID PLATELET-AGGREGATION INHIBITOR; AMINO-ACID-SEQUENCE; SNAKE-VENOM;
   HIGH-RESOLUTION; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; PROTEIN
   STRUCTURES; SKELETAL-MUSCLE; FACTOR XA; BINDING
AB Bothropstoxin-II a calcium-dependent enzyme from Bothrops jararacussu venom causes tissue damage and several haemostatic disorders including platelet aggregation. In order to elucidate the structural determinants of its multiple pharmacological activities, we have studied the effects of suramin on Bothropstoxin-II and present details concerning the mode of binding.
C1 [Murakami, Mario T.; Vicoti, Magno M.; Abrego, Jose R. B.; Arni, Raghuvir K.] IBILCE UNESP, Dept Phys, Ctr Struct & Mol Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Murakami, Mario T.] LNLS, Brazilian Synchrotron Light Lab, Ctr Struct Mol Biol, Campinas, SP, Brazil.
   [Arruda, Emerson Z.; Tomaz, Marcelo A.; Melo, Paulo A.] UFRJ, CCS, ICB, Dept Basic & Clin Pharmacol, Rio De Janeiro, Brazil.
   [Arni, Raghuvir K.] Butantan Inst, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), IBILCE UNESP, Dept Phys, Ctr Struct & Mol Biol, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145
FU FAPESP/DFGFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)German Research Foundation (DFG); CNPqNational Council for
   Scientific and Technological Development (CNPq);
   CAPES/DAADCAPESDeutscher Akademischer Austausch Dienst (DAAD); CAT/CEPID
FX We are grateful for financial support provided by FAPESP/DFG, CNPq,
   CAPES/DAAD and CAT/CEPID.
CR Andriao-Escarso SH, 2002, BIOCHEM PHARMACOL, V64, P723, DOI 10.1016/S0006-2952(02)01210-8
   Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   de Oliveira M, 2003, TOXICON, V42, P373, DOI 10.1016/S0041-0101(03)00166-1
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   EVANS HJ, 1997, VENOM PHOSPHOLIPASE, P97
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   Fuly AL, 2004, BIOCHIMIE, V86, P731, DOI 10.1016/j.biochi.2004.07.001
   Guinier A, 1955, SMALL ANGLE SCATTERI, P17
   GUTIERREZ JM, 1991, EXP MOL PATHOL, V55, P217, DOI 10.1016/0014-4800(91)90002-F
   Harris J.B., 1991, P91
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   INADA M, 1994, J BIOL CHEM, V269, P26338
   Ketelhut DFJ, 2003, BIOCHIMIE, V85, P983, DOI 10.1016/j.biochi.2003.09.011
   Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1997, VENOM PHOSPHOLIPASE, P369
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Magro AJ, 2004, BIOCHEM BIOPH RES CO, V323, P24, DOI 10.1016/j.bbrc.2004.08.046
   MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7
   Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4
   MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P548
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mounier CM, 1998, J BIOL CHEM, V273, P23764, DOI 10.1074/jbc.273.37.23764
   Mounier CM, 2000, EUR J BIOCHEM, V267, P4960, DOI 10.1046/j.1432-1327.2000.01523.x
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   Murakami MT, 2006, BIOCHIMIE, V88, P543, DOI 10.1016/j.biochi.2005.10.014
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2004, BBA-PROTEINS PROTEOM, V1703, P83, DOI 10.1016/j.bbapap.2004.08.009
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413
   Rigden DJ, 2003, ACTA CRYSTALLOGR D, V59, P255, DOI 10.1107/S0907444902021467
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   SOARES AM, 2004, REV TOXICON, V42, P855
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   THUNNISSEN MMGM, 1990, J MOL BIOL, V216, P425, DOI 10.1016/S0022-2836(05)80332-8
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024
NR 48
TC 11
Z9 11
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD SEP
PY 2008
VL 15
IS 9
BP 1002
EP 1008
DI 10.2174/092986608785849245
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 352PQ
UT WOS:000259509800020
PM 18991778
DA 2020-12-01
ER

PT J
AU Moro, LP
   Murakami, MT
   Cabral, H
   Vidotto, A
   Tajara, EH
   Arni, RK
   Juliano, L
   Bonilla-Rodriguez, GO
AF Moro, L. P.
   Murakami, M. T.
   Cabral, H.
   Vidotto, A.
   Tajara, E. H.
   Arni, R. K.
   Juliano, L.
   Bonilla-Rodriguez, G. O.
TI Purification, biochemical and functional characterization of miliin, a
   new thiol-dependent serine protease isolated from the latex of Euphorbia
   milii
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE medicinal plant; latex; Euphorbia milii; serine protease; purification;
   characterization
ID IMMOBILIZED PH GRADIENTS; STABLE CYSTEINE PROTEASE; CUCUMISIN-LIKE
   PROTEASE; ERVATAMIA-CORONARIA; CURRENT STATE; ELECTROPHORESIS;
   PROTEINASE; SARCOCARP; CLEAVAGE; FRUITS
AB Miliin, a new thiol-dependent serine protease purified from the latex of Euphorbia milii possesses a molecular weight of 79 kDa, an isoelectric point of 4.3 and is optimally active at 60 degrees C in the pH range of and 7.5-11.0. Activity tests indicate that milliin is a thiol-dependent serine protease.
C1 [Bonilla-Rodriguez, G. O.] UNESP, IBILCE, DQCA, Dept Chem & Environm Sci, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Moro, L. P.] UNESP, IBILCE, Mol Biophys Grad Program, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Murakami, M. T.] Ctr Struct Mol Biol, Campinas, SP, Brazil.
   [Cabral, H.] Univ Sao Paulo, Fac Pharm, BR-14049 Ribeirao Preto, SP, Brazil.
   [Vidotto, A.; Tajara, E. H.] FAMERP, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil.
   [Arni, R. K.] UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Juliano, L.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil.
RP Bonilla-Rodriguez, GO (corresponding author), UNESP, IBILCE, DQCA, Dept Chem & Environm Sci, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM bonilla@ibilce.unesp.br
RI Complexos, INCT Fluidos/H-9172-2013; Murakami, Mario T/C-2087-2012;
   Cabral, Hamilton/D-8280-2012; Arni, Raghuvir K/B-2222-2013; Vidotto,
   Alessandra/F-2907-2012; Bonilla-Rodriguez, Gustavo Orlando/B-9948-2011;
   Juliano, Luiz/D-7204-2012; Tajara, Eloiza H/G-7586-2012; Murakami, Mario
   T/F-5640-2016; Bonilla-Rodriguez, Gustavo Orlando/C-5968-2012
OI Cabral, Hamilton/0000-0002-7365-1694; Arni, Raghuvir
   K/0000-0003-2460-1145; Bonilla-Rodriguez, Gustavo
   Orlando/0000-0001-9902-2557; Juliano, Luiz/0000-0002-5589-2822; Tajara,
   Eloiza H/0000-0002-2603-2057; Murakami, Mario T/0000-0002-0405-8010;
   Bonilla-Rodriguez, Gustavo Orlando/0000-0001-9902-2557
CR Antao CM, 2005, PLANT PHYSIOL BIOCH, V43, P637, DOI 10.1016/j.plaphy.2005.05.001
   Arima K, 2000, PHYTOCHEMISTRY, V53, P639, DOI 10.1016/S0031-9422(99)00605-6
   Asif-Ullah M, 2006, PHYTOCHEMISTRY, V67, P870, DOI 10.1016/j.phytochem.2006.02.020
   BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6
   BOLLER T, 1986, PLANT PROTEOLYTIC EN, V1, P67
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103
   Cabral H, 2006, PROTEIN PEPTIDE LETT, V13, P83, DOI 10.2174/092986606774502072
   CUROTTO E, 1989, FEBS LETT, V243, P363, DOI 10.1016/0014-5793(89)80162-0
   Delgado IF, 2003, TOXICOL LETT, V145, P175, DOI 10.1016/S0378-4274(03)00303-5
   DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720
   Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3
   Dunn B. M., 1996, PROTEOLYTIC ENZYMES, P57
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   GARCIACARRENO FL, 1993, ANAL BIOCHEM, V214, P65, DOI 10.1006/abio.1993.1457
   Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V
   GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913
   James F, 1996, BIOCHEM J, V320, P283, DOI 10.1042/bj3200283
   Kaneda M, 1997, BIOSCI BIOTECH BIOCH, V61, P2100, DOI 10.1271/bbb.61.2100
   KEMBHAVI AA, 1993, ARCH BIOCHEM BIOPHYS, V303, P208, DOI 10.1006/abbi.1993.1274
   Kundu S, 2000, J AGR FOOD CHEM, V48, P171, DOI 10.1021/jf990661j
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEE KH, 1982, PHYTOCHEMISTRY, V21, P1119, DOI 10.1016/S0031-9422(00)82428-0
   LYNN KR, 1988, PHYTOCHEMISTRY, V27, P45, DOI 10.1016/0031-9422(88)80591-0
   LYNN KR, 1984, PHYTOCHEMISTRY, V23, P682, DOI 10.1016/S0031-9422(00)80408-2
   Nallamsetty S, 2003, J PROTEIN CHEM, V22, P1, DOI 10.1023/A:1023047309023
   Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a
   PATEL AK, 2007, J AGR FOOD CHEM, V10, P1021
   Patel BK, 2003, J AGR FOOD CHEM, V51, P6326, DOI 10.1021/jf026184d
   Pile E., 2001, Brazilian Journal of Veterinary Research and Animal Science, V38, P288
   Rudenskaya GN, 1998, FEBS LETT, V437, P237, DOI 10.1016/S0014-5793(98)01243-5
   Savelli G, 2000, CURR OPIN COLLOID IN, V5, P111, DOI 10.1016/S1359-0294(00)00043-1
   Sequeiros C, 2003, FITOTERAPIA, V74, P570, DOI 10.1016/S0367-326X(03)00146-1
   SHANNON JD, 1979, EUR J BIOCHEM, V102, P399, DOI 10.1111/j.1432-1033.1979.tb04255.x
   SMIT HF, 1995, J ETHNOPHARMACOL, V47, P75, DOI 10.1016/0378-8741(95)01255-C
   Sokolova EA, 1998, EUR J BIOCHEM, V255, P501, DOI 10.1046/j.1432-1327.1998.2550501.x
   Sundd M, 1998, BIOSCI BIOTECH BIOCH, V62, P1947, DOI 10.1271/bbb.62.1947
   TAYLOR RM, 1993, FEBS LETT, V331, P76, DOI 10.1016/0014-5793(93)80300-J
   TROVOMARQUI AB, 2006, J BIOCHEM MOL BIOL, V39, P216
   Uchikoba T, 1998, PHYTOCHEMISTRY, V49, P2215, DOI 10.1016/S0031-9422(98)00135-6
   UCHIKOBA T, 1995, J BIOCHEM-TOKYO, V117, P1126, DOI 10.1093/oxfordjournals.jbchem.a124817
   UCHIKOBA T, 1990, PHYTOCHEMISTRY, V29, P1879, DOI 10.1016/0031-9422(90)85032-B
   Valles D, 2007, ENZYME MICROB TECH, V40, P409, DOI 10.1016/j.enzmictec.2006.07.011
   VASCONCELLOS M C D, 1986, Memorias do Instituto Oswaldo Cruz, V81, P475, DOI 10.1590/S0074-02761986000400017
   Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386
   Vogg G, 1999, ENVIRON HEALTH PERSP, V107, P753, DOI 10.2307/3434661
   Yadav SC, 2006, PHYTOCHEMISTRY, V67, P1414, DOI 10.1016/j.phytochem.2006.06.002
   YAMAGATA H, 1989, AGR BIOL CHEM TOKYO, V53, P1009, DOI 10.1080/00021369.1989.10869404
NR 48
TC 12
Z9 12
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD JUL
PY 2008
VL 15
IS 7
BP 724
EP 730
DI 10.2174/092986608785133744
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 352PO
UT WOS:000259509600012
PM 18782069
DA 2020-12-01
ER

PT J
AU Moro, LP
   Murakami, MT
   Cabral, H
   Vidotto, A
   Tajara, EH
   Arni, RK
   Juliano, L
   Bonilla-Rodriguez, GO
AF Moro, L. P.
   Murakami, M. T.
   Cabral, H.
   Vidotto, A.
   Tajara, E. H.
   Arni, R. K.
   Juliano, L.
   Bonilla-Rodriguez, G. O.
TI A new thiol-dependent serine protease isolated from the latex of
   Euphorbia milii
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT Joint Conference of the 33rd FEBS Congress/11th IUBMB Conference
CY JUN 28-JUL 03, 2008
CL Athens, GREECE
C1 [Moro, L. P.; Murakami, M. T.; Bonilla-Rodriguez, G. O.] UNESP, IBILCE, Sao Jose Do Rio Preto, Brazil.
   [Cabral, H.] USP, Ribeirao Preto, Brazil.
   [Vidotto, A.; Tajara, E. H.] FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Juliano, L.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RI Bonilla-Rodriguez, Gustavo Orlando/B-9948-2011; Cabral,
   Hamilton/D-8280-2012; Tajara, Eloiza H/G-7586-2012; Vidotto,
   Alessandra/F-2907-2012; Kumar, Anil/K-2136-2019; Juliano,
   Luiz/D-7204-2012; Arni, Raghuvir K/B-2222-2013; Bonilla-Rodriguez,
   Gustavo Orlando/C-5968-2012
OI Bonilla-Rodriguez, Gustavo Orlando/0000-0001-9902-2557; Cabral,
   Hamilton/0000-0002-7365-1694; Tajara, Eloiza H/0000-0002-2603-2057;
   Juliano, Luiz/0000-0002-5589-2822; Arni, Raghuvir K/0000-0003-2460-1145;
   Bonilla-Rodriguez, Gustavo Orlando/0000-0001-9902-2557
NR 0
TC 0
Z9 0
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2008
VL 275
SU 1
BP 393
EP 393
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 311XI
UT WOS:000256633301375
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Kuch, U
   Betzel, C
   Mebs, D
   Arni, RK
AF Murakami, Mario T.
   Kuch, Ulrich
   Betzel, Christian
   Mebs, Dietrich
   Arni, Raghuvir K.
TI Crystal structure of a novel myotoxic Arg49 phospholipase A(2) homolog
   (zhaoermiatoxin) from Zhaoermia mangshanensis snake venom: Insights into
   Arg49 coordination and the role of Lys122 in the polarization of the
   C-terminus
SO TOXICON
LA English
DT Article
DE Zhaoermia mangshanensis; snake venom; Arg49-phospholipase A(2);
   Lys49-phospholipase A(2); myotoxin; crystal structure
ID LYS(49)-PHOSPHOLIPASE A(2); DIMERIC PHOSPHOLIPASE-A2;
   CATALYTIC-ACTIVITY; PROTEIN; LYS49; IDENTIFICATION; MECHANISM; SEQUENCE;
   BINDING; ASP-49
AB The venom of Zhaoermia mangshanensis, encountered solely in Mt Mang in China's Hunan Province, exhibits coagulant, phosphodiesterase, L-amino acid oxidase, kallikrein, phospholipase A(2) and myotoxic activities. The catalytically inactive PLA(2) homolog referred to as zhaoermiatoxin is highly myotoxic and displays high myonecrotic and edema activities. Zhaoermiatoxin possesses a molecular weight of 13,972 Da, consists of 121 amino-acid residues crosslinked by seven disulfide bridges and shares high sequence homology with Lys49-PLA(2)s from the distantly related Asian pitvipers. However, zhaoermiatoxin possesses an arginine residue at position 49 instead of a lysine, thereby suggesting a secondary Lys49 -> Arg substitution which results in a catalytically inactive protein. We have determined the first crystal structure of zhaoermiatoxin, an Arg49-PLA(2), from Zhaoermia mangshanensis venom at 2.05 A resolution, which represents a novel member of phospholipase A(2) family. In this structure, unlike the Lys49 PLA(2)s, the C-terminus is well ordered and an unexpected non-polarized state of the putative calcium-binding loop due to the flip of Lys122 towards the bulk solvent is observed. The orientation of the Arg-49 side chain results in a similar binding mode to that observed in the Lys49 PLA(2)s; however, the guadinidium group is tri-coordinated by carbonyl oxygen atoms of the putative calcium-binding loop, whereas the N zeta atom of lysine is tetra-coordinated as a result of the different conformation adopted by the putative calcium-binding loop. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Murakami, Mario T.; Arni, Raghuvir K.] Univ Estadual Paulista, IBILCE, Ctr Struct & Mol Biol, Dept Phys, BR-15054000 Sao Paulo, Brazil.
   [Kuch, Ulrich; Mebs, Dietrich] Goethe Univ Frankfurt, Klinikum Frankfurt, Zentrum Rechtsmed, D-60596 Frankfurt, Germany.
   [Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, D-22603 Hamburg, Germany.
   [Arni, Raghuvir K.] CEPID, CAT, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, IBILCE, Ctr Struct & Mol Biol, Dept Phys, R Cristovao Colombo 2265,Sao Jose Rio Preto, BR-15054000 Sao Paulo, Brazil.
EM arni@ibilce.unesp.br
RI Murakami, Mario T/F-5640-2016; Arni, Raghuvir K/N-9338-2018; Murakami,
   Mario T/C-2087-2012; Betzel, Christian/G-8105-2018; Arni, Raghuvir
   K/B-2222-2013; Kuch, Ulrich/C-6656-2013
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Betzel, Christian/0000-0002-3879-5019; Arni,
   Raghuvir K/0000-0003-2460-1145; Kuch, Ulrich/0000-0002-5091-7752
CR Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   Chijiwa T, 2006, TOXICON, V48, P672, DOI 10.1016/j.toxicon.2006.06.021
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   KEITH C, 1981, J BIOL CHEM, V256, P8602
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1986, TOXICON, V24, P895
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   LOMONTE B, 1993, INFLAMMATION, V17, P93, DOI 10.1007/BF00916097
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P41, DOI 10.1016/0041-0101(94)90020-5
   Mebs D, 2006, TOXICON, V47, P797, DOI 10.1016/j.toxicon.2006.01.031
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Pan H, 1998, TOXICON, V36, P1155, DOI 10.1016/S0041-0101(98)00013-0
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   Polgar J, 1996, BIOCHEM J, V319, P961, DOI 10.1042/bj3190961
   Sanders Kate L., 2004, Russian Journal of Herpetology, V11, P163
   Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Teixeira CFP, 2003, TOXICON, V42, P947, DOI 10.1016/j.toxicon.2003.11.006
   Tsai IH, 2004, BIOCHEM J, V377, P215, DOI 10.1042/BJ20030818
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VANGUNSTEREN WF, 1996, GRONINGEN MOL SIMULA
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   WARD RJ, 1995, GENE, V156, P305, DOI 10.1016/0378-1119(95)00099-R
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Wen-Hwa L, 1999, ACTA CRYSTALLOGR D, V55, P1229, DOI 10.1107/S0907444999004576
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565
   Yamazaki Y, 2005, J BIOL CHEM, V280, P29989, DOI 10.1074/jbc.C500236200
   Zhao E., 1990, Sichuan Journal of Zoology, V9, P11
   Zuliani JP, 2005, TOXICON, V45, P335, DOI 10.1016/j.toxicon.2004.11.004
NR 60
TC 13
Z9 15
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD APR
PY 2008
VL 51
IS 5
BP 723
EP 735
DI 10.1016/j.toxicon.2007.11.018
PG 13
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 290VI
UT WOS:000255150400001
PM 18295812
DA 2020-12-01
ER

PT J
AU Rios-Steiner, JL
   Murakami, MT
   Tulinsky, A
   Arni, RK
AF Rios-Steiner, Jorge L.
   Murakami, Mario T.
   Tulinsky, Alexander
   Arni, Raghuvir K.
TI Active and exo-site inhibition of human factor Xa: Structure of des-Gla
   factor Xa inhibited by NAP5, a potent nematode anticoagulant protein
   from Ancylostoma caninum
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE nematode anticoagulant proteins; factor X/Xa; ixolaris; tissue factor
   pathway inhibitor; active and exo-site binding
ID COAGULATION-FACTOR-XA; PANCREATIC TRYPSIN-INHIBITOR;
   BETA-HYDROXYASPARTIC ACID; HIGH-RESOLUTION STRUCTURE; FACTOR PATHWAY
   INHIBITOR; HUMAN ALPHA-THROMBIN; BLOOD-COAGULATION; CRYSTAL-STRUCTURE;
   BINDING-SITE; FACTOR-VIIA
AB Hookworms are hematophagous nematodes capable of growth, development and subsistence in living host systems such as humans and other mammals. Approximately one billion, or one in six, people worldwide are infected by hookworms causing gastrointestinal blood loss and iron deficiency anemia. The hematophagous hookworm Ancylostoma caninum produces a family of small, disulfide-linked protein anticoagulants (75-84 amino acid residues). One of these nematode anticoagulant proteins, NAP5, inhibits the amidolytic activity of factor Xa (fXa) with K-i = 43 pM, and is the most potent natural fXa inhibitor identified thus far. The crystal structure of NAP5 bound at the active site of gamma-carboxyglutamic acid domainless factor Xa (des-fXa) has been determined at 3.1 angstrom resolution, which indicates that Asp189 (fXa, S1 subsite) binds to Arg40 (NAP5, P1 site) in a mode similar to that of the BPTI/trypsin interaction. However, the hydroxyl group of Ser39 of NAP5 additionally forms a hydrogen bond (2.5 angstrom) with His57 NE2 of the catalytic triad, replacing the hydrogen bond of Ser195 OG to the latter in the native structure, resulting in an interaction that has not been observed before. Furthermore, the C-terminal extension of NAP5 surprisingly interacts with the fXa exosite of a symmetry-equivalent molecule forming a short intermolecular beta-strand as observed in the structure of the NAPc2/fXa complex. This indicates that NAP5 can bind to fXa at the active site, or the exosite, and to fX at the exosite. However, unlike NAPc2, NAP5 does not inhibit fVIIa of the fVIIa/TF complex. (c) 2007 Elsevier Ltd. All rights reserved.
C1 UNESP, Dept Phys, BR-15054000 Sao Jose do Rio Preto, Brazil.
   Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   Ctr Appl Toxinol CAT CEPID, BR-05503900 Sao Paulo, Brazil.
   UNESP, Ctr Struct Genom, BR-15054000 Sao Jose do Rio Preto, Brazil.
RP Arni, RK (corresponding author), UNESP, Dept Phys, BR-15054000 Sao Jose do Rio Preto, Brazil.
EM arni@ibilce.unesp.br
RI Arni, Raghuvir K/N-9338-2018; Murakami, Mario T/F-5640-2016; Arni,
   Raghuvir K/B-2222-2013; Murakami, Mario T/C-2087-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; 
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL43229, HL-43229, HL-25942] Funding Source: Medline;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL025942, R01HL025942,
   R01HL043229, R01HL043229, R01HL043229, R01HL025942, R01HL043229,
   R01HL025942, R01HL025942, R01HL043229, R01HL043229, R01HL043229,
   R01HL025942, R01HL043229, R01HL025942, R01HL025942, R01HL043229,
   R01HL043229, R01HL025942, R01HL043229, R01HL025942, R01HL025942,
   R01HL025942, R01HL043229, R01HL025942, R01HL043229, R01HL025942,
   R01HL043229, R01HL043229] Funding Source: NIH RePORTER
CR BABIN DR, 1984, ARCH BIOCHEM BIOPHYS, V232, P143, DOI 10.1016/0003-9861(84)90530-7
   BAJAJ SP, 1992, P NATL ACAD SCI USA, V89, P152, DOI 10.1073/pnas.89.1.152
   BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2
   BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x
   Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029
   CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152
   Charles Robert St., 1999, Journal of Medicinal Chemistry, V42, P1376
   CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414
   Czapinska H, 2000, J MOL BIOL, V295, P1237, DOI 10.1006/jmbi.1999.3445
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574
   DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015
   DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786
   Duggan BM, 1999, EUR J BIOCHEM, V265, P539, DOI 10.1046/j.1432-1327.1999.00781.x
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   FERNLUND P, 1983, J BIOL CHEM, V258, P2509
   Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237
   Ganesh V, 1996, PROTEIN SCI, V5, P825
   GRASBERGER BL, 1994, STRUCTURE, V2, P669, DOI 10.1016/S0969-2126(00)00067-8
   Hirsh J, 1999, LANCET, V353, P1431, DOI 10.1016/S0140-6736(98)09233-2
   HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X
   HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6
   Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   Kamata K, 1998, P NATL ACAD SCI USA, V95, P6630, DOI 10.1073/pnas.95.12.6630
   Krishnan R, 1998, BIOCHEMISTRY-US, V37, P12094, DOI 10.1021/bi980840e
   LAROCHE Y, 1994, BIO-TECHNOL, V12, P1119, DOI 10.1038/nbt1194-1119
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MANN KG, 1990, BLOOD, V76, P1
   Matthews JH, 1996, BIOPHYS J, V71, P2830, DOI 10.1016/S0006-3495(96)79479-1
   MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016
   Mizuno H, 2001, P NATL ACAD SCI USA, V98, P7230, DOI 10.1073/pnas.131179698
   Mochalkin I, 1999, ACTA CRYSTALLOGR D, V55, P785, DOI 10.1107/S0907444999000359
   MORITA T, 1986, J BIOL CHEM, V261, P4015
   Murakami MT, 2007, J MOL BIOL, V366, P602, DOI 10.1016/j.jmb.2006.11.040
   NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141
   ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0
   ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   PERSSON E, 1993, J BIOL CHEM, V268, P22531
   Rebello SS, 1997, J PHARMACOL EXP THER, V283, P91
   ROCHE M, 1966, AM J TROP MED HYG, V15, P1032, DOI 10.4269/ajtmh.1966.15.1032
   RYDEL TJ, 1994, J BIOL CHEM, V269, P22000
   SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48
   SCHWABACHER AW, 1993, J AM CHEM SOC, V115, P6995, DOI 10.1021/ja00068a076
   SINGH J, 1987, FEBS LETT, V224, P161, DOI 10.1016/0014-5793(87)80441-6
   Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149
   STAUFFER DA, 1990, J ORG CHEM, V55, P2762, DOI 10.1021/jo00296a038
   STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9
   STRICKLAND DK, 1980, ARCH BIOCHEM BIOPHYS, V199, P61, DOI 10.1016/0003-9861(80)90256-8
   SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331
   WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510
   Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069
   Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007
   Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452
   Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2
NR 64
TC 20
Z9 23
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 17
PY 2007
VL 371
IS 3
BP 774
EP 786
DI 10.1016/j.jmb.2007.05.042
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 199TY
UT WOS:000248719300017
PM 17588602
DA 2020-12-01
ER

PT J
AU Murakami, RT
   Kuch, U
   Mebs, D
   Arni, RK
AF Murakami, Rio T.
   Kuch, Ulrich
   Mebs, Dietrich
   Arni, Raghuvir K.
TI Crystallization and preliminary X-ray diffraction analysis of a novel
   Arg49 phospholipase A(2) homologue from Zhaoermia mangshanensis venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID SNAKE-VENOM; MYOTOXIN-II; PHARMACOLOGICAL-PROPERTIES;
   CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; FATTY-ACID; LYS49;
   IDENTIFICATION; PROTEIN; SITE
AB Zhaoermiatoxin, an Arg49 phospholipase A(2) homologue from Zhaoermia mangshanensis (formerly Trimeresurus mangshanensis, Ermia mangshanensis) venom is a novel member of the PLA(2)-homologue family that possesses an arginine residue at position 49, probably arising from a secondary Lys49 -> Arg substitution that does not alter the catalytic inactivity towards phospholipids. Like other Lys49 PLA(2) homologues, zhaoermiatoxin induces oedema and strong myonecrosis without detectable PLA(2) catalytic activity. A single crystal with maximum dimensions of 0.2 x 0.2 x 0.5 mm was used for X-ray diffraction data collection to a resolution of 2.05 angstrom using synchrotron radiation and the diffraction pattern was indexed in the hexagonal space group P6(4), with unit-cell parameters a = 72.9, b = 72.9, c = 93.9 angstrom.
C1 State Univ Sao Paulo, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   Ctr Appl Toxicol, CEPID, Sao Paulo, Brazil.
   State Univ Sao Paulo, Adv Ctr Genom & Proteom, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   Klinikum Univ Frankfurt, Zent Rechtsmed, D-60596 Frankfurt, Germany.
RP Arni, RK (corresponding author), State Univ Sao Paulo, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
EM arni@ibilce.unesp.br
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013; Kuch,
   Ulrich/C-6656-2013; Murakami, Mario T/F-5640-2016; Arni, Raghuvir
   K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Kuch, Ulrich/0000-0002-5091-7752;
   Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145
CR Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1986, TOXICON, V24, P895
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mebs D, 2006, TOXICON, V47, P797, DOI 10.1016/j.toxicon.2006.01.031
   Murakami MT, 2007, TOXICON, V49, P378, DOI 10.1016/j.toxicon.2006.10.011
   Murakami MT, 2006, ACTA CRYSTALLOGR F, V62, P423, DOI 10.1107/S1744309106010700
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Yamazaki Y, 2005, J BIOL CHEM, V280, P29989, DOI 10.1074/jbc.C500236200
NR 28
TC 2
Z9 2
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD JUL
PY 2007
VL 63
BP 605
EP 607
DI 10.1107/S1744309107026073
PN 7
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 190FZ
UT WOS:000248045300018
PM 17620723
OA Green Published
DA 2020-12-01
ER

PT J
AU Santos, KF
   Murakami, MT
   Cintra, ACO
   Toyama, MH
   Marangoni, S
   Forrer, VP
   Neto, JRB
   Polikarpov, I
   Arni, RK
AF Santos, K. F.
   Murakami, M. T.
   Cintra, A. C. O.
   Toyama, M. H.
   Marangoni, S.
   Forrer, V. P.
   Brandao Neto, J. R.
   Polikarpov, I.
   Arni, R. K.
TI Crystallization and preliminary X-ray crystallographic analysis of the
   heterodimeric crotoxin complex and the isolated subunits crotapotin and
   phospholipase A(2)
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID CROTALUS-DURISSUS-TERRIFICUS; SNAKE-VENOMS; BIOLOGICAL-ACTIVITIES;
   DIFFRACTION DATA; IN-VITRO; RATTLESNAKE; EXPRESSION; CRYSTALS; PROTEIN;
   PHARMACOLOGY
AB Crotoxin, a potent neurotoxin from the venom of the South American rattlesnake Crotalus durissus terrificus, exists as a heterodimer formed between a phospholipase A(2) and a catalytically inactive acidic phospholipase A(2) analogue (crotapotin). Large single crystals of the crotoxin complex and of the isolated subunits have been obtained. The crotoxin complex crystal belongs to the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 38.2, b = 68.7, c = 84.2 angstrom, and diffracted to 1.75 angstrom resolution. The crystal of the phospholipase A(2) domain belongs to the hexagonal space group P6(1)22 (or its enantiomorph P6(5)22), with unit-cell parameters a = b = 38.7, c = 286.7 angstrom, and diffracted to 2.6 angstrom resolution. The crotapotin crystal diffracted to 2.3 angstrom resolution; however, the highly diffuse diffraction pattern did not permit unambiguous assignment of the unit-cell parameters.
C1 UNESP, Dept Phys, IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Dept Anal Clin Toxicol & Bromatol, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Estadual Campinas, Dept Bioquim, Campinas, SP, Brazil.
   Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
   Univ Sao Paulo, Inst Fis Sao Carlos, BR-05508 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, Dept Phys, IBILCE, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Cintra, Adelia/K-6034-2013; Murakami, Mario T/F-5640-2016; Polikarpov,
   Igor/D-2575-2012; Neto, Joao Ruggiero/C-7716-2012; Arni, Raghuvir
   K/B-2222-2013; Toyama, Marcos H/P-4673-2017; Murakami, Mario
   T/C-2087-2012
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Toyama, Marcos H/0000-0001-6836-3084;
   Brandao-Neto, Jose/0000-0001-6015-320X; Polikarpov,
   Igor/0000-0001-9496-4174
CR ACHARI A, 1985, J BIOL CHEM, V260, P9385
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Baek SH, 2000, J IMMUNOL, V164, P6359, DOI 10.4049/jimmunol.164.12.6359
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   BON C, 1989, ACTA PHYSIOL PHARM L, V39, P439
   BON C, 1982, TOXICON, V20, P105, DOI 10.1016/0041-0101(82)90173-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BREITHAUPT H, 1971, N-S ARCH PHARMAKOL, V269, P403
   Cecchini AL, 2004, COMP BIOCHEM PHYS C, V138, P429, DOI 10.1016/j.cca.2004.07.010
   CORIN RE, 1993, INVEST NEW DRUG, V11, P11, DOI 10.1007/BF00873905
   CROWL RM, 1991, J BIOL CHEM, V266, P2647
   Cura JE, 2002, CLIN CANCER RES, V8, P1033
   Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352
   Dorandeu F, 2002, BIOCHEM PHARMACOL, V63, P755, DOI 10.1016/S0006-2952(01)00896-6
   ELLIS RJ, 1990, SCIENCE, V250, P954, DOI 10.1126/science.250.4983.954
   Faure G, 2000, EUR J BIOCHEM, V267, P4799, DOI 10.1046/j.1432-1327.2000.01532.x
   GELB MH, 1995, ANNU REV BIOCHEM, V64, P653
   GOPALAKRISHNAKONE P, 1984, TOXICON, V22, P85, DOI 10.1016/0041-0101(84)90141-7
   HABERMANN E, 1972, N-S ARCH PHARMACOL, V273, P313, DOI 10.1007/BF00499666
   HABERMANN E, 1978, Toxicon, V16, P19, DOI 10.1016/0041-0101(78)90056-9
   Harris J.B., 1991, P91
   HAWGOOD BJ, 1977, BRIT J PHARMACOL, V61, P597, DOI 10.1111/j.1476-5381.1977.tb07553.x
   HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560
   JENG TW, 1978, P NATL ACAD SCI USA, V75, P600, DOI 10.1073/pnas.75.2.600
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   KOUYOUMDJIAN JA, 1986, TOXICON, V24, P575, DOI 10.1016/0041-0101(86)90178-9
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Landucci ECT, 2000, TOXICON, V38, P199, DOI 10.1016/S0041-0101(99)00143-9
   LESLIE AGW, 1992, JNP CCP4 ESF EACBM N, V26
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   NEWMAN RA, 1993, INVEST NEW DRUG, V11, P151, DOI 10.1007/BF00874149
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1997, TOXICON, V35, P111, DOI 10.1016/S0041-0101(96)00054-2
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   PONCESOTO LA, 2007, IN PRESS
   Rangel-Santos A, 2004, TOXICON, V44, P609, DOI 10.1016/j.toxicon.2004.07.004
   Rangel-Santos A, 2004, TOXICON, V43, P801, DOI 10.1016/j.toxicon.2004.03.011
   RUBSAMEN K, 1971, N-S ARCH PHARMAKOL, V270, P274
   RUDD CJ, 1994, INVEST NEW DRUG, V12, P183, DOI 10.1007/BF00873958
   Sampaio SC, 2006, TOXICON, V47, P909, DOI 10.1016/j.toxicon.2006.03.004
   Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874
   Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527
   VADAS P, 1993, J LIPID MEDIATOR, V8, P1
   VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x
   Zhang HL, 2006, TOXICON, V48, P175, DOI 10.1016/j.toxicon.2006.04.008
NR 49
TC 10
Z9 10
U1 0
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD APR
PY 2007
VL 63
BP 287
EP 290
DI 10.1107/S1744309107006719
PN 4
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 154KL
UT WOS:000245505800008
PM 17401196
OA Green Published
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Vicoti, MM
   Abrego, JRB
   Lourenzoni, MR
   Cintra, ACO
   Arruda, EZ
   Tomaz, MA
   Melo, PA
   Arni, RK
AF Murakami, Mario T.
   Vicoti, Magno M.
   Abrego, Jose R. B.
   Lourenzoni, Marco R.
   Cintra, Adelia C. O.
   Arruda, Emerson Z.
   Tomaz, Marcelo A.
   Melo, Paulo A.
   Arni, Raghuvir K.
TI Interfacial surface charge and free accessibility to the PLA(2)-active
   site-like region are essential requirements for the activity of Lys49
   PLA(2) homologues
SO TOXICON
LA English
DT Article
DE Lys49 phospholipases A2 homologues; myonecrosis; suramin; polyethylene
   glycol; small angle scattering; crystal structure and molecular dynamics
ID PHOSPHOLIPASE A(2); MYOTOXIN-II; BIOLOGICAL MACROMOLECULES; SOLUTION
   SCATTERING; CRYSTAL-STRUCTURE; BOTHROPSTOXIN-I; HIGH-RESOLUTION; VENOM;
   PACKAGE; PROTEIN
AB Lys49 phospholipase A(2) homologues are highly myotoxic and cause extensive tissue damage but do not display hydrolytic activity towards natural phospholipids. The binding of heparin, heparin derivatives and polyanionic compounds such as suramin result in partial inhibition (up to 60%) of the myotoxic effects due to a change in the overall charge of the interfacial surface. In vivo experiments demonstrate that polyethylene glycol inhibits more than 90% of the myotoxic effects without exhibiting secondary toxic effects. The crystal structure of bothropstoxin-I complexed with polyethylene glycol reveals that this inhibition is due to steric hindrance of the access to the PLA(2)-active site-like region. These two inhibitory pathways indicate the roles of the overall surface charge and free accessibility to the PLA2-active site-like region in the functioning of Lys49 phospholipases A(2) homologues. Molecular dynamics simulations, small angle X-ray scattering and structural analysis indicate that the oligomeric states both in solution and in the crystalline states of Lys49 phospholipases A2 are principally mediated by hydrophobic contacts formed between the interfacial surfaces. These results provide the framework for the potential application of both clinically approved drugs for the treatment of Viperidae snakebites. (c) 2006 Elsevier Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   Associated Res, Sao Carlos, SP, Brazil.
   Univ Sao Paulo, Dept Toxicol, Ribeirao Preto, Brazil.
   Univ Fed Rio de Janeiro, CCS, ICB, Dept Basic & Clin Pharmacol, Rio de Janeiro, Brazil.
   Butantan Inst, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, Brazil.
EM arni@ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Cintra, Adelia/K-6034-2013; Arni, Raghuvir
   K/N-9338-2018; Murakami, Mario T/F-5640-2016; Murakami, Mario
   T/C-2087-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Murakami, Mario T/0000-0002-0405-8010; 
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Arruda EZ, 2002, BRAZ J MED BIOL RES, V35, P723, DOI 10.1590/S0100-879X2002000600013
   Berendsen H. J., 1981, INTERMOLECULAR FORCE, P331, DOI DOI 10.1007/978-94-015-7658-1_21
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURCH TA, 1951, AM J TROP MED, V31, P617
   Calil-Elias S, 2002, HISTOL HISTOPATHOL, V17, P463, DOI 10.14670/HH-17.463
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Oliveira M, 2003, TOXICON, V42, P373, DOI 10.1016/S0041-0101(03)00166-1
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Guinier A, 1955, SMALL ANGLE SCATTERI, P17
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   JOHNSON EK, 1993, TOXICON, V31, P243, DOI 10.1016/0041-0101(93)90143-7
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAROCCA RV, 1993, J MOL BIOL, V231, P1049
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545
   Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4
   MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0
   MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   Spencer PJ, 1998, BRAZ J MED BIOL RES, V31, P1125, DOI 10.1590/S0100-879X1998000900004
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   VANOOSTEROM AT, 1991, EUR J CANCER, V27, P747, DOI 10.1016/0277-5379(91)90180-L
   Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   WILLIAMSON J, 1956, NATURE, V177, P1074, DOI 10.1038/1771074a0
NR 44
TC 50
Z9 52
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR 1
PY 2007
VL 49
IS 3
BP 378
EP 387
DI 10.1016/j.toxicon.2006.10.011
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 142GT
UT WOS:000244638100009
PM 17157889
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Rios-Steiner, J
   Weaver, SE
   Tulinsky, A
   Geiger, JH
   Arni, RK
AF Murakami, M. T.
   Rios-Steiner, J.
   Weaver, S. E.
   Tulinsky, A.
   Geiger, J. H.
   Arni, R. K.
TI Intermolecular interactions and characterization of the novel factor Xa
   exosite involved in macromolecular recognition and inhibition: Crystal
   structure of human Gla-domainless factor Xa complexed with the
   anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma
   caninum
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE factor Xa exosite; nematode anticoagulant protein; selectide inhibitor;
   factor VIIa/tissue factor complex; inhibition
ID BETA-HYDROXYASPARTIC ACID; COAGULATION-FACTOR XA; BLOOD-COAGULATION;
   CALCIUM-BINDING; ACTIVE-SITE; THROMBIN; PEPTIDE; REFINEMENT; RESOLUTION;
   ENZYME
AB NAPc2, an anticoagulant protein from the hematophagous nematode Ancylostoma caninum evaluated in phase-II/IIa clinical trials, inhibits the extrinsic blood coagulation pathway by a two step mechanism, initially interacting with the hitherto uncharacterized factor Xa exosite involved in macromolecular recognition and subsequently inhibiting factor VIIa (K-i = 8.4 pM) of the factor VIIa/tissue factor complex. NAPc2 is highly flexible, becoming partially ordered and undergoing significant structural changes in the C terminus upon binding to the factor Xa exosite. In the crystal structure of the ternary factor Xa/NAPc2/selectide complex, the binding interface consists of an intermolecular antiparallel beta-sheet formed by the segment of the polypeptide chain consisting of residues 74-80 of NAPc2 with the residues 86-93 of factor Xa that is additional maintained by contacts between the short helical segment (residues 67-73) and a turn (residues 26-29) of NAPc2 with the short C-terminal helix of factor Xa (residues 233-243). This exosite is physiologically highly relevant for the recognition and inhibition of factor X/Xa by macromolecular substrates and provides a structural motif for the development of a new class of inhibitors for the treatment of deep vein thrombosis and angioplasty. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   CEPID, Ctr Appl Toxinol, BR-05503900 Sao Paulo, Brazil.
RP Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
EM geiger@cem.msu.edu; arni@ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Murakami, Mario T/F-5640-2016; Murakami,
   Mario T/C-2087-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Geiger, James/0000-0002-9443-4488
FU NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229] Funding Source: NIH RePORTER;
   NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL43229] Funding Source: Medline
CR BAJAJ SP, 1992, P NATL ACAD SCI USA, V89, P152, DOI 10.1073/pnas.89.1.152
   BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2
   Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988
   Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200
   CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786
   Duggan BM, 1999, EUR J BIOCHEM, V265, P539, DOI 10.1046/j.1432-1327.1999.00781.x
   FERNLUND P, 1983, J BIOL CHEM, V258, P2509
   HARLEY BS, 1971, ENZYMES, P323
   Kamata K, 1998, P NATL ACAD SCI USA, V95, P6630, DOI 10.1073/pnas.95.12.6630
   LAROCHE Y, 1994, BIO-TECHNOL, V12, P1119, DOI 10.1038/nbt1194-1119
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LIM Z, 1995, FEBS LETT, V370, P1
   MANN KG, 1990, BLOOD, V76, P1
   MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016
   Mochalkin I, 1999, ACTA CRYSTALLOGR D, V55, P785, DOI 10.1107/S0907444999000359
   MORITA T, 1986, J BIOL CHEM, V261, P4015
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141
   Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445
   ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0
   ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441
   ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77
   SCHWABACHER AW, 1993, J AM CHEM SOC, V115, P6995, DOI 10.1021/ja00068a076
   St Charles R, 2000, PROTEIN SCI, V9, P265
   Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149
   STAUFFER DA, 1990, J ORG CHEM, V55, P2762, DOI 10.1021/jo00296a038
   STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9
   STRICKLAND DK, 1980, ARCH BIOCHEM BIOPHYS, V199, P61, DOI 10.1016/0003-9861(80)90256-8
   SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331
   WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510
   Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069
   Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2
NR 36
TC 30
Z9 31
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 16
PY 2007
VL 366
IS 2
BP 602
EP 610
DI 10.1016/j.jmb.2006.11.040
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 135WH
UT WOS:000244184100022
PM 17173931
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Melo, CC
   Angulo, Y
   Lomonte, B
   Arni, RK
AF Murakami, MT
   Melo, CC
   Angulo, Y
   Lomonte, B
   Arni, RK
TI Structure of myotoxin II, a catalytically inactive Lys49 phospholipase
   A(2) homologue from Atropoides nummifer venom
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID SNAKE-VENOM; CRYSTAL-STRUCTURES; BOTHROPS; CALCIUM; CRYSTALLIZATION;
   PROTEIN
AB Lys49 snake-venom phospholipase A(2) (PLA(2)) homologues are highly myotoxic proteins which, although lacking catalytic activity, possess the ability to disrupt biological membranes, inducing significant muscle-tissue loss and permanent disability in severely envenomed patients. Since the structural basis for their toxic activity is still only partially understood, the structure of myotoxin II, a monomeric Lys49 PLA(2) homologue from Atropoides nummifer, has been determined at 2.08 angstrom resolution and the anion-binding site has been characterized.
C1 Inst Clodomiro Picado, Fac Microbiol, San Jose, Costa Rica.
   UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica.
   Butantan Inst, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Murakami, MT (corresponding author), Inst Clodomiro Picado, Fac Microbiol, San Jose, Costa Rica.
EM blomonte@cariari.ucr.ac.cr; arni@ibilce.unesp.br
RI Arni, Raghuvir K/N-9338-2018; Lomonte, Bruno/B-8862-2019; Murakami,
   Mario T/C-2087-2012; Murakami, Mario T/F-5640-2016; Arni, Raghuvir
   K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Lomonte,
   Bruno/0000-0003-2419-6469; Murakami, Mario T/0000-0002-0405-8010; Arni,
   Raghuvir K/0000-0003-2460-1145
CR Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Angulo Y, 2005, TOXICON, V46, P291, DOI 10.1016/j.toxicon.2005.03.025
   Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Angulo Y, 2000, INT J BIOCHEM CELL B, V32, P63, DOI 10.1016/S1357-2725(99)00099-0
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   de Azevedo WF, 1999, TOXICON, V37, P371, DOI 10.1016/S0041-0101(98)00189-5
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LESLIE AGW, 1992, JNT CCP4 ESFEACBM NE, V26
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NISHIOKA SD, 1992, AM J TROP MED HYG, V47, P805
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Roussel A, 1991, SILICON GRAPHICS GEO, P86
   Ruller R, 2005, BIOCHIMIE, V87, P993, DOI 10.1016/j.biochi.2005.04.008
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   SOLORZANO A, 1989, REV BIOL TROP, V37, P133
   Taylor RT, 1974, REV BIOL TROP, V21, P383
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X
   Watanabe L, 2004, BBA-PROTEINS PROTEOM, V1703, P87, DOI 10.1016/j.bbapap.2004.09.006
   Yamazaki Y, 2005, J BIOL CHEM, V280, P29989, DOI 10.1074/jbc.C500236200
NR 34
TC 11
Z9 12
U1 0
U2 3
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD MAY
PY 2006
VL 62
BP 423
EP 426
DI 10.1107/S1744309106010700
PN 5
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 037PK
UT WOS:000237159000001
PM 16682766
OA Green Published
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Gabdoulkhakov, A
   Genov, N
   Cintra, ACO
   Betzel, C
   Arni, RK
AF Murakami, M. T.
   Gabdoulkhakov, A.
   Genov, N.
   Cintra, A. C. O.
   Betzel, C.
   Arni, R. K.
TI Insights into metal ion binding in phospholipases A(2): ultra
   high-resolution crystal structures of an acidic phospholipase A(2) in
   the Ca2+ free and bound states
SO BIOCHIMIE
LA English
DT Article
DE snake venom; phospholipases A(2); Ca2+ coordination; anticoagulant
   activity; X-ray analysis
ID PLATELET-AGGREGATION INHIBITOR; X-RAY-STRUCTURE; SUBSTRATE-SPECIFICITY;
   VENOM; MODEL
AB The electrophile Ca2+ is an essential multifunctional co-factor in the phospholipase A(2) mediated hydrolysis of phospholipids. Crystal structures of an acidic phospholipase A(2) from the venom of Bothrops jararacussu have been determined both in the Ca2+ free and bound states at 0.97 and 1.60 angstrom resolutions, respectively. In the Ca2+ bound state, the Ca2+ ion is penta-coordinated by a distorted pyramidal cage of oxygen and nitrogen atoms that is significantly different to that observed in structures of other Group I/II phospholipases A(2). In the absence of Ca2+, a water molecule occupies the position of the Ca2+ ion and the side chain of Asp49 and the calcium-binding loop adopts a different conformation. (c) 2005 Elsevier SAS. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia.
   Bulgarian Acad Sci, Inst Organ Chem, BU-1113 Sofia, Bulgaria.
   Univ Sao Paulo, Dept Biochem, BR-14040902 Ribeirao Preto, Brazil.
   Inst Med Biochem & Mol Biol, D-22603 Hamburg, Germany.
   Butantan Inst, Ctr Appl Toxinol, BR-05503900 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Murakami, Mario T/F-5640-2016; Betzel,
   Christian/G-8105-2018; Murakami, Mario T/C-2087-2012; Gabdulkhakov,
   Azat/H-4343-2013; Cintra, Adelia/K-6034-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Betzel, Christian/0000-0002-3879-5019;
   Gabdulkhakov, Azat/0000-0003-1016-5936; 
CR Andriao-Escarso SH, 2002, BIOCHEM PHARMACOL, V64, P723, DOI 10.1016/S0006-2952(02)01210-8
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Carredano E, 1998, TOXICON, V36, P75, DOI 10.1016/S0041-0101(97)00051-2
   Chandra V, 2000, J MOL BIOL, V296, P1117, DOI 10.1006/jmbi.2000.3537
   Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z
   EVANS HJ, 1997, VENOM PHOSPHOLIPASE, P97
   GOWDA VT, 1994, TOXICON, V32, P665, DOI 10.1016/0041-0101(94)90336-0
   Gu LC, 2002, TOXICON, V40, P917, DOI 10.1016/S0041-0101(02)00085-5
   Jasti J, 2004, ACTA CRYSTALLOGR D, V60, P66, DOI 10.1107/S090744490302208X
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   Ketelhut DFJ, 2003, BIOCHIMIE, V85, P983, DOI 10.1016/j.biochi.2003.09.011
   KINI RM, 1997, VENOM PHOSPHOLIPASE, P369
   Lamzin V.S., 2001, INT TABLES CRYSTALLO, VF, P720
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Magro AJ, 2004, BIOCHEM BIOPH RES CO, V323, P24, DOI 10.1016/j.bbrc.2004.08.046
   Murakami MT, 2004, BBA-PROTEINS PROTEOM, V1703, P79, DOI 10.1016/j.bbapap.2004.08.008
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523
   Rogers J, 1996, BIOCHEMISTRY-US, V35, P9375, DOI 10.1021/bi960526p
   SCOTT DL, 1994, BIOPHYS J, V67, P493, DOI 10.1016/S0006-3495(94)80546-6
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070
   SCOTT DL, 1997, VENOM PHOSPHOLIPASE, P97
   Segelke BW, 1998, J MOL BIOL, V279, P223, DOI 10.1006/jmbi.1998.1759
   Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   Steiner RA, 2001, ACTA CRYSTALLOGR D, V57, P516, DOI 10.1107/S0907444901002530
   Sumandea M, 1999, BIOCHEMISTRY-US, V38, P16290, DOI 10.1021/bi9921384
   TESHIMA K, 1989, J BIOCHEM, V106, P518, DOI 10.1093/oxfordjournals.jbchem.a122885
   THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0
   Valentin E, 2000, BIOCHIMIE, V82, P815, DOI 10.1016/S0300-9084(00)01168-8
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   WAITE M, 1990, ADV EXP MED BIOL, V279, P1
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   Yedgar S, 2000, BBA-MOL CELL BIOL L, V1488, P182, DOI 10.1016/S1388-1981(00)00120-7
NR 38
TC 20
Z9 21
U1 0
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD MAY
PY 2006
VL 88
IS 5
BP 543
EP 549
DI 10.1016/j.biochi.2005.10.014
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 066ZU
UT WOS:000239270500015
PM 16376474
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Fernandes-Pedrosa, MF
   de Andrade, SA
   Gabdoulkhakov, A
   Betzel, C
   Tambourgi, DV
   Arni, RK
AF Murakami, MT
   Fernandes-Pedrosa, MF
   de Andrade, SA
   Gabdoulkhakov, A
   Betzel, C
   Tambourgi, DV
   Arni, RK
TI Structural insights into the catalytic mechanism of sphingomyelinases D
   and evolutionary relationship to glycerophosphodiester
   phosphodiesterases
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE sphingomyelinase D; catalytic mechanism; Mg2+-binding site; hydrodynamic
   behavior; crystal structure; glycerophosphodiester phosphodiesterases
AB Spider venom sphingomyelinases D catalyze the hydrolysis of sphingomyelin via an Mg2+ ion-dependent acid-base catalytic mechanism which involves two histidines. In the crystal structure of the sulfate free enzyme determined at 1.85 angstrom resolution, the metal ion is tetrahedrally coordinated instead of the trigonal-bipyramidal coordination observed in the sulfate bound form. The observed hyperpolarized state of His47 requires a revision of the previously suggested catalytic mechanism. Molecular modeling indicates that the fundamental structural features important for catalysis are fully conserved in both classes of SMases D and that the Class II SMases D contain an additional intra-chain disulphide bridge (Cys53-Cys201). Structural analysis suggests that the highly homologous enzyme from Loxosceles bonetti is unable to hydrolyze sphingomyelin due to the 95G1y -> Asn and 134Pro -> Glu mutations that modify the local charge and hydrophobicity of the interfacial face. Structural and sequence comparisons confirm the evolutionary relationship between sphingomyelinases D and the glicerophosphodiester phosphoesterases which utilize a similar catalytic mechanism. (c) 2006 Elsevier Inc. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.
   RAS, Inst Prot Res, Moscow 117901, Russia.
   Univ Hamburg, Div Biochem & Mol Biol, Hamburg, Germany.
   Butantan Inst, Ctr Appl Toxicol, Sao Paulo, Brazil.
RP Tambourgi, DV (corresponding author), UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
EM dvtambourgi@yahoo.com; arni@ibilce.unesp.br
RI Gabdulkhakov, Azat/H-4343-2013; Murakami, Mario T/C-2087-2012; Betzel,
   Christian/G-8105-2018; Tambourgi, Denise/H-7114-2016; de Freitas
   Fernandes-Pedrosa, Matheus/C-6398-2014; Murakami, Mario T/F-5640-2016;
   Andrade, Sonia A/F-4253-2015; Arni, Raghuvir K/N-9338-2018; Arni,
   Raghuvir K/B-2222-2013
OI Gabdulkhakov, Azat/0000-0003-1016-5936; Betzel,
   Christian/0000-0002-3879-5019; Tambourgi, Denise/0000-0003-1896-9074; de
   Freitas Fernandes-Pedrosa, Matheus/0000-0003-4221-9580; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145
FU Wellcome TrustWellcome Trust Funding Source: Medline
CR Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200
   Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FERNANDESPEDROS.MF, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NEWLANDS G, 1982, T ROY SOC TROP MED H, V76, P610, DOI 10.1016/0035-9203(82)90222-X
   Openshaw AEA, 2005, J BIOL CHEM, V280, P35011, DOI 10.1074/jbc.M506800200
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027
   Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3
NR 24
TC 45
Z9 47
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAR 31
PY 2006
VL 342
IS 1
BP 323
EP 329
DI 10.1016/j.bbrc.2006.01.123
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 018VV
UT WOS:000235793800044
PM 16480957
DA 2020-12-01
ER

PT J
AU de Andrade, SA
   Murakami, MT
   Cavalcante, DP
   Arni, RK
   Tambourgi, DV
AF de Andrade, SA
   Murakami, MT
   Cavalcante, DP
   Arni, RK
   Tambourgi, DV
TI Kinetic and mechanistic characterization of the Sphingomyelinases D from
   Loxosceles intermedia spider venom
SO TOXICON
LA English
DT Article
DE Loxosceles venoms; Sphingomyelinase D; sphingomyelin; kinetic
   parameters; structure
ID BROWN RECLUSE SPIDER; MOLECULAR-CLONING; ENVENOMATION; EXPRESSION; LYSIS
AB Envenomation by arachnids of the genus Loxosceles leads to local dermonecrosis and serious systemic toxicity mainly induced by sphingomyelinases D (SMase D). These enzymes catalyze the hydrolysis of sphingomyelin resulting in the formation of ceramide-phosphate and choline as well as the cleavage of lysophosphatidyl choline generating the lipid mediator lysophosphatidic acid. We have, previously, cloned and expressed two functional SMase D isoforms, named P1 and P2, from Loxosceles intertnedia venom and comparative protein sequence analysis revealed that they are highly homologous to SMase I from Loxosceles laeta which folds to form an (alpha/beta)(8) barrel. In order to further characterize these proteins, pH dependence kinetic experiments and chemical modification of the two active SMases D isoforms were performed. We show here that the amino acids involved in catalysis and in the metal ion binding sites are strictly conserved in the SMase D isoforms from L. intermedia. However, the kinetic studies indicate that SMase P1 hydrolyzes sphingomyelin less efficiently than P2, which can be attributed to a substitution at position 203 (Pro-Leu) and local amino acid substitutions in the hydrophobic channel that could probably play a role in the substrate recognition and binding. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Inst Butantan, Lab Imunoquim, BR-05503900 Sao Paulo, Brazil.
   UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, Brazil.
RP Tambourgi, DV (corresponding author), Inst Butantan, Lab Imunoquim, Av Prof Vital Brazil 1500, BR-05503900 Sao Paulo, Brazil.
EM dvtambourgi@butantan.gov.br
RI Arni, Raghuvir K/N-9338-2018; Murakami, Mario T/F-5640-2016; Arni,
   Raghuvir K/B-2222-2013; Murakami, Mario T/C-2087-2012; Andrade, Sonia
   A/F-4253-2015; Tambourgi, Denise/H-7114-2016
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Tambourgi,
   Denise/0000-0003-1896-9074
CR ANDRADE SA, 2005, BIOCHEM BIOPH RES CO, V327, P117
   BARRETO CO, 1985, REV INST MED TROP SP, V27, P264
   Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1
   FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   GENDRON BP, 1990, AM J EMERG MED, V8, P51, DOI 10.1016/0735-6757(90)90297-D
   GINSBURG CM, 1988, J PEDIATR-US, V112, P496, DOI 10.1016/S0022-3476(88)80348-2
   KUPRIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467
   Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200
   Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638
   Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013
   SCHENONE H, 1989, REV I MED TROP, V31, P403, DOI 10.1590/S0036-46651989000600007
   Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9
   Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474
   Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027
   TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459
   Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   White Julian, 1995, P259
NR 23
TC 14
Z9 14
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR 15
PY 2006
VL 47
IS 4
BP 380
EP 386
DI 10.1016/j.toxicon.2005.12.005
PG 7
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 029CD
UT WOS:000236534700002
PM 16458340
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Arni, RK
AF Murakami, MT
   Arni, RK
TI Thrombomodulin-independent activation of protein C and specificity of
   hemostatically active snake venom serine proteinases - Crystal
   structures of native and inhibited Agkistrodon contortrix contortrix
   protein C activator
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR; BLOOD-COAGULATION; FACTOR-V; INACTIVATION;
   PURIFICATION; MUTAGENESIS; REFINEMENT; PLASMA; SITE
AB Protein C activation initiated by the thrombin-thrombomodulin complex forms the major physiological anticoagulant pathway. Agkistrodon contortrix contortrix protein C activator, a glycosylated single-chain serine proteinase, activates protein C without relying on thrombomodulin. The crystal structures of native and inhibited Agkistrodon contortrix contortrix protein C activator determined at 1.65 and 1.54 angstrom resolutions, respectively, indicate the pivotal roles played by the positively charged belt and the strategic positioning of the three carbohydrate moieties surrounding the catalytic site in protein C recognition, binding, and activation. Structural changes in the benzamidine-inhibited enzyme suggest a probable function in allosteric regulation for the anion-binding site located in the C-terminal extension, which is fully conserved in snake venom serine proteinases, that preferentially binds Cl1- instead of SO42-.
C1 UNESP, IBILCE, Dept Phys, Biochem & Struct Biol Grp, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Biochem & Struct Biol Grp, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@ibilce.unesp.br
RI Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Arni,
   Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145
CR ADLER M, 1995, J BIOL CHEM, V270, P23366, DOI 10.1074/jbc.270.40.23366
   BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2
   COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   ESMON CT, 1995, SEMIN CELL BIOL, V6, P259, DOI 10.1006/scel.1995.0035
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683
   FULCHER CA, 1984, BLOOD, V63, P486
   Gempeler-Messina PM, 2001, HAEMOSTASIS, V31, P266
   Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093
   HARLEY BS, 1971, ENZYMES, P323
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   KISIEL W, 1987, J BIOL CHEM, V262, P12607
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016
   Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x
   MCMULLEN BA, 1989, BIOCHEMISTRY-US, V28, P674, DOI 10.1021/bi00428a039
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAGASHIMA M, 1993, J BIOL CHEM, V268, P2888
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797
   SCHWARZ HP, 1984, BLOOD, V64, P1297
   STENFLO J, 1976, J BIOL CHEM, V251, P355
   Stocker K., 1978, HDB EXPT PHARM, P451
   STURZEBECHER J, 1991, TOXICON, V29, P151, DOI 10.1016/0041-0101(91)90099-D
   Tu AT, 1991, HDB NATURAL TOXINS R, P827
   WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7
   ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246
   Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531
   Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200
NR 32
TC 32
Z9 35
U1 1
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 25
PY 2005
VL 280
IS 47
BP 39309
EP 39315
DI 10.1074/jbc.M508502200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 985FL
UT WOS:000233362200050
PM 16162508
OA Bronze
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Arni, RK
   Vieira, DS
   Degreve, L
   Ruller, R
   Ward, RJ
AF Murakami, MT
   Arni, RK
   Vieira, DS
   Degreve, L
   Ruller, R
   Ward, RJ
TI Correlation of temperature induced conformation change with optimum
   catalytic activity in the recombinant G/11 xylanase A from Bacillus
   subtilis strain 168 (1A1)
SO FEBS LETTERS
LA English
DT Article
DE thermostable enzyme; crystal structure; molecular dynamics
ID CIRCULANS XYLANASE; GLYCOSIDE HYDROLASES; MOLECULAR-DYNAMICS;
   TRICHODERMA-REESEI; SITE; STABILITY; PROTEINS; THERMOSTABILIZATION;
   CRYSTALLIZATION; PACKAGE
AB The 1.7 angstrom resolution crystal structure of recombinant family G/11 beta-1,4-xylanase (rXynA) from Bacillus subtilis 1A1 shows a jellyroll fold in which two curved P-sheets form the active-site and substrate-binding cleft. The onset of thermal denaturation of rXynA occurs at 328 K, in excellent agreement with the optimum catalytic temperature. Molecular dynamics simulations at temperatures of 298-328 K demonstrate that below the optimum temperature the thumb loop and palm domain adopt a closed conformation. However, at 328 K these two domains separate facilitating substrate access to the active-site pocket, thereby accounting for the optimum catalytic temperature of the rXynA. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, Sao Paulo, Brazil.
   Univ Sao Paulo, FMRP, Dept Cellular & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, FFCLRP, Dept Chem, BR-14049 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Cristovao Colombo 2265,Sao Jose do Rio Preto, Sao Paulo, Brazil.
EM rjward@fmrp.usp.br
RI Murakami, Mario T/C-2087-2012; Ward, Richard/C-2460-2012; Murakami,
   Mario T/F-5640-2016; Arni, Raghuvir K/N-9338-2018; Vieira, Davi
   S/E-7424-2015; Arni, Raghuvir K/B-2222-2013; Ruller, ROBERTO/D-1260-2014
OI Ward, Richard/0000-0003-1136-5737; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Ruller, ROBERTO/0000-0002-5087-9493;
   Ruller, Roberto/0000-0001-7501-5176; Vieira, Davi/0000-0001-8353-6262
CR Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200
   Berendsen H. J. C., 1981, INTERMOLECULAR FORCE
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Connelly GP, 2000, PROTEIN SCI, V9, P512
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543
   ESWARAMOORTHY S, 1994, J MOL BIOL, V243, P806, DOI 10.1016/0022-2836(94)90052-3
   FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151
   Georis J, 2000, PROTEIN SCI, V9, P466
   Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163
   Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l
   GUPTA MN, 1991, BIOTECHNOL APPL BIOC, V14, P1
   Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x
   Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3
   Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   JONES TA, 1985, METHODS ENZYMOL, V115
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26
   LEE YE, 1993, J BACTERIOL, V175, P5890, DOI 10.1128/JB.175.18.5890-5898.1993
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Muilu J, 1998, PROTEINS, V31, P434
   Murakami MT, 2005, ACTA CRYSTALLOGR F, V61, P219, DOI 10.1107/S1744309105000904
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Plesniak LA, 1996, PROTEIN SCI, V5, P2319, DOI 10.1002/pro.5560051118
   Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382
   RULLER R, 2005, IN PRESS BIOTECHNOL
   Sa JM, 2004, BIOCHEM J, V382, P191, DOI 10.1042/BJ20031946
   SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006
   TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x
   Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3
   Turunen O, 2002, PROTEIN ENG, V15, P141, DOI 10.1093/protein/15.2.141
   VANGUNSTEREN WF, 1996, BIOMOLECULA SIMULATI
   WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467
   WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379
   Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641
NR 39
TC 33
Z9 35
U1 4
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD NOV 21
PY 2005
VL 579
IS 28
BP 6505
EP 6510
DI 10.1016/j.febslet.2005.10.039
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 987LZ
UT WOS:000233520700034
PM 16289057
OA Green Published
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Arni, RK
AF Murakami, MT
   Arni, RK
TI Crystallization and preliminary X-ray crystallographic studies of Protac
   (R), a commercial protein C activator isolated from Agkistrodon
   contortrix contortrix venom
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE protein C activator; serine proteinase; Agkistrodon contortrix
   contortrix venom; X-ray diffraction analysis
ID INACTIVATION; ASSAY
AB The protein C pathway plays an important role in the control and regulation of the blood coagulation cascade and prevents the propagation of the clotting process on the endothelium surface. In physiological systems, protein C activation is catalyzed by thrombin, which requires thrombomodulin as a cofactor. The protein C activator from Agkistrodon contortrix contortrix acts directly on the zymogen of protein C converting it into the active form, independently of thrombomodulin. Suitable crystals of the protein C activator from Agkistrodon contortrix contortrix were obtained from a solution containing 2 M ammonium sulfate as the precipitant and these crystals diffracted to 1.95 angstrom resolution at a synchrotron beamline. The crystalline array belongs to the monoclinic space group C2 with unit cell dimensions a=80.4, b = 63.3 and c = 48.2 angstrom, alpha = gamma = 90.0 degrees and beta = 90.8 degrees. (C) 2005 Elsevier B.V. All rights reserved.
C1 Univ Estadual Paulista, IBILCE, Dept Phys, BR-15054000 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, IBILCE, Dept Phys, Cristovao Colombo 2265, BR-15054000 Sao Paulo, Brazil.
EM arni@ibilce.unesp.br
RI Murakami, Mario T/F-5640-2016; Murakami, Mario T/C-2087-2012; Arni,
   Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145
CR BAKKER HM, 1993, BLOOD COAGUL FIBRIN, V4, P605, DOI 10.1097/00001721-199308000-00012
   BERTINA RM, 1985, THROMB HAEMOSTASIS, V53, P268
   EDSON JR, 1990, AM J CLIN PATHOL, V94, P176, DOI 10.1093/ajcp/94.2.176
   ESMON CT, 1995, SEMIN CELL BIOL, V6, P259, DOI 10.1006/scel.1995.0035
   FULCHER CA, 1984, BLOOD, V63, P486
   Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   KOBAYASHI I, 1989, CLIN CHEM, V35, P1644
   KOGAN AE, 1993, THROMB RES, V70, P385, DOI 10.1016/0049-3848(93)90080-8
   KOGAN AE, 1991, THROMB RES, V62, P775, DOI 10.1016/0049-3848(91)90381-6
   MARTINOLI JL, 1986, THROMB RES, V43, P253, DOI 10.1016/0049-3848(86)90145-3
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Meier Jurg, 1998, P253
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   SCHWARZ HP, 1984, BLOOD, V64, P1297
   Stocker K, 1988, Folia Haematol Int Mag Klin Morphol Blutforsch, V115, P260
   STOCKER K, 1987, TOXICON, V25, P239, DOI 10.1016/0041-0101(87)90253-4
   STOCKER K, 1986, BEHRING I MITT, V79, P7
   Sun L., 2001, ZHONGGUO BINGLI SHEN, V17, P241
   SUZUKI K, 1988, THROMB RES, V49, P241, DOI 10.1016/0049-3848(88)90217-4
   Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685
   WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7
   WOLF M, 1989, THROMB HAEMOSTASIS, V62, P1144
   WOODHAMS BJ, 1988, THROMB RES, V50, P213, DOI 10.1016/0049-3848(88)90189-2
NR 27
TC 1
Z9 2
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD SEP 25
PY 2005
VL 1752
IS 2
BP 202
EP 204
DI 10.1016/j.bbapap.2005.08.003
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 970QD
UT WOS:000232323800010
PM 16129664
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Arruda, EZ
   Melo, PA
   Martinez, AB
   Calil-Elias, S
   Tomaz, MA
   Lomonte, B
   Gutierrez, JM
   Arni, RK
AF Murakami, MT
   Arruda, EZ
   Melo, PA
   Martinez, AB
   Calil-Elias, S
   Tomaz, MA
   Lomonte, B
   Gutierrez, JM
   Arni, RK
TI Inhibition of myotoxic activity of Bothrops asper myotoxin II by the
   anti-trypanosomal drug surarnin
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE suramin; heparin; myotoxicity; inhibition; crystal structure
ID LYSINE-49 PHOSPHOLIPASE A(2); SNAKE-VENOM; CRYSTAL-STRUCTURE;
   LYS(49)-PHOSPHOLIPASE A(2); PHARMACOLOGICAL-PROPERTIES; SYNTHETIC
   PEPTIDES; CATALYTIC-ACTIVITY; JARARACUSSU VENOM; REGION 115-129; SURAMIN
AB Suramin, a synthetic polysulfonated compound, developed initially for the treatment of African trypanosomiasis and onchocerciasis, is currently used for the treatment of several medically relevant disorders. Suramin, heparin, and other polyanions inhibit the myotoxic activity of Lys49 phospholipase A(2) analogues both in vitro and in vivo, and are thus of potential importance as therapeutic agents in the treatment of viperid snake bites. Due to its conformational flexibility around the single bonds that link the central phenyl rings to the secondary amide backbone, the symmetrical suramin molecule binds by an induced-fit mechanism complementing the hydrophobic surfaces of the dimer and adopts a novel conformation that lacks C2 symmetry in the dimeric crystal structure of the suramin-Bothrops asper myotoxin II complex. The simultaneous binding of suramin at the surfaces of the two monomers partially restricts access to the nominal active sites and significantly changes the overall charge of the interfacial recognition face of the protein, resulting in the inhibition of myotoxicity. (c) 2005 Elsevier Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   Univ Fed Rio de Janeiro, IBC, Dept Farmacol Basica & Clin, Rio de Janeiro, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Inst Butantan, Ctr Appl Toxinol, Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/B-2222-2013; Arni,
   Raghuvir K/N-9338-2018; Murakami, Mario T/F-5640-2016; Lomonte,
   Bruno/B-8862-2019
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Murakami, Mario T/0000-0002-0405-8010; Lomonte,
   Bruno/0000-0003-2419-6469; Gutierrez, Jose Maria/0000-0001-8385-3081
CR Ambrosio ALB, 2005, J BIOL CHEM, V280, P7326, DOI 10.1074/jbc.M410588200
   Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Arruda EZ, 2002, BRAZ J MED BIOL RES, V35, P723, DOI 10.1590/S0100-879X2002000600013
   BURCH TA, 1951, AM J TROP MED, V31, P617
   Cadene M, 1997, J BIOL CHEM, V272, P9950, DOI 10.1074/jbc.272.15.9950
   Calderon L, 1998, ARCH BIOCHEM BIOPHYS, V358, P343, DOI 10.1006/abbi.1998.0853
   CHERRY J K, 1960, East Afr Med J, V37, P550
   Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   de Oliveira M, 2003, TOXICON, V42, P373, DOI 10.1016/S0041-0101(03)00166-1
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   Falconi M, 2000, J MOL RECOGNIT, V13, P14, DOI 10.1002/(SICI)1099-1352(200001/02)13:1<14::AID-JMR484>3.0.CO;2-F
   Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200
   Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   Hermans JM, 2003, FEBS LETT, V544, P119, DOI 10.1016/S0014-5793(03)00488-5
   Jennings FW, 2002, PARASITOL INT, V51, P381, DOI 10.1016/S1383-5769(02)00044-2
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   KINI RM, 1986, TOXICON, V24, P895
   KRIZAJ I, 1989, BIOCHIM BIOPHYS ACTA, V999, P198, DOI 10.1016/0167-4838(89)90218-5
   LAROCCA RV, 1991, UROL CLIN N AM, V18, P123
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MASS J, 1997, DRUG DISCOVERY EVALU, P732
   McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545
   Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4
   MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0
   MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A
   Murakami MT, 2004, BBA-PROTEINS PROTEOM, V1703, P83, DOI 10.1016/j.bbapap.2004.08.009
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   Raj P A, 1998, Angiogenesis, V2, P183, DOI 10.1023/A:1009244623717
   ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77
   SCHNEIDER J, 1963, B WORLD HEALTH ORGAN, V28, P763
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244
   VANOOSTEROM AT, 1991, EUR J CANCER, V27, P747, DOI 10.1016/0277-5379(91)90180-L
   Waltenberger J, 1996, J MOL CELL CARDIOL, V28, P1523, DOI 10.1006/jmcc.1996.0142
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005
   Wen-Hwa L, 1999, ACTA CRYSTALLOGR D, V55, P1229, DOI 10.1107/S0907444999004576
   WILLIAMSON J, 1956, NATURE, V177, P1074, DOI 10.1038/1771074a0
NR 58
TC 78
Z9 81
U1 2
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 15
PY 2005
VL 350
IS 3
BP 416
EP 426
DI 10.1016/j.jmb.2005.04.072
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 942QK
UT WOS:000230296700003
PM 15961104
DA 2020-12-01
ER

PT J
AU Rucavado, A
   Soto, M
   Escalante, T
   Loria, GD
   Arni, R
   Gutierrez, JM
AF Rucavado, A
   Soto, M
   Escalante, T
   Loria, GD
   Arni, R
   Gutierrez, JM
TI Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper
   snake venom
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE snake venom; coagulopathy; defibrin(ogen)ation; thrombocytopenia;
   hypoaggregation
ID AMINO-ACID-SEQUENCE; JARARACA VENOM; HEMORRHAGIC METALLOPROTEINASES;
   DEGRADATION PRODUCTS; SYSTEMIC HEMORRHAGE; FIBRINOGEN BINDING;
   CRYSTAL-STRUCTURE; AGGREGATION; RABBITS; ENVENOMATION
AB Thrombocytopenia and platelet dysfunction occur in patients bitten by Bothrops sp snakes in Latin America. An experimental model was developed in mice to study the effects of B. asper venom in platelet numbers and function. Intravenous administration of this venom induces rapid and prominent thrombocytopenia and ex vivo platelet hypoaggregation. The drop in platelet numbers was primarily due to aspercetin, a protein of the C-type lectin family which induces von Willebrand factor-mediated platelet aggregation/agglutination. In addition,the effect of class P-III hemorrhagic metalloproteinases on the microvessel wall also contributes to thrombocytopenia since jararhagin, a P-III metalloproteinase, reduced platelet counts. Hypoaggregation was associated with the action of procoagulant and defibrin(ogen)ating proteinases jararacussin-1 (a thrombin-like serine proteinase) and basparin A (a prothrombin activating metalloproteinase). At the doses which induced hypoaggregation, these enzymes caused defibrin(ogen)ation, increments in fibrin(ogen) degradation products and D-dimer and prolongation of the bleeding time. Incubation of B. asper venom with batimastat and alpha(2)-macroglobulin abrogated the hypoaggregating activity, confirming the role of venom proteinases in this effect. Neither aspercetin nor the defibrin(ogen)ating and hypoaggregating components induced hemorrhage upon intravenous injection. However, aspercetin, but not the thrombin-like or the prothrombin-activating proteinases, potentiated the hemorrhagic activity of two hemorrhagic metalloproteinases in the lungs.
C1 Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Univ Costa Rica, Fac Microbiol, Dept Microbiol & Inmunol, San Jose, Costa Rica.
   UNESP, IBILCE, Dept Phys, Sao Jose de Rio Preto, Brazil.
RP Rucavado, A (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
EM arucavad@cariari.ucr.ac.cr
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Gutierrez, Jose Maria/0000-0001-8385-3081
CR ARAGON F, 1978, TOXINS ANIMAL PLANT, P107
   BARAMOVA EN, 1990, BIOCHEMISTRY-US, V29, P1069, DOI 10.1021/bi00456a032
   BARRANTES A, 1985, TOXICON, V23, P399, DOI 10.1016/0041-0101(85)90024-8
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X
   BRINKHOUS KM, 1981, P NATL ACAD SCI-BIOL, V78, P3230, DOI 10.1073/pnas.78.5.3230
   CARDOSO JLC, 1993, Q J MED, V86, P315
   CHANG MC, 1995, J LAB CLIN MED, V125, P508
   CHEN CS, 1988, BIOCHEMISTRY-US, V27, P6121, DOI 10.1021/bi00416a044
   DASILVA AMM, 1999, ARCH BIOCHEM BIOPHYS, V369, P295
   Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524
   Escalante T, 2004, TOXICON, V43, P213, DOI 10.1016/j.toxicon.2003.11.012
   Escalante T, 2003, TOXICOL APPL PHARM, V193, P17, DOI 10.1016/S0041-008X(03)00337-5
   Estevao-Costa MI, 2000, THROMB RES, V99, P363, DOI 10.1016/S0049-3848(00)00259-0
   FAN HW, 1995, HDB CLIN TOXICOLOGY, P667
   Franceschi A, 2000, TOXICON, V38, P63, DOI 10.1016/S0041-0101(99)00127-0
   Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892
   GENE JA, 1989, TOXICON, V27, P841, DOI 10.1016/0041-0101(89)90096-2
   GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X
   Gutierrez Jose Maria, 1995, P645
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   KAMIGUTI AS, 1994, BBA-GEN SUBJECTS, V1200, P307, DOI 10.1016/0304-4165(94)90172-4
   KAMIGUTI AS, 1991, TOXICON, V29, P1097, DOI 10.1016/0041-0101(91)90207-8
   Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635
   KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   KONSTAM MA, 1989, EXP LUNG RES, V15, P867, DOI 10.3109/01902148909069632
   Loria GD, 2003, ARCH BIOCHEM BIOPHYS, V418, P13, DOI 10.1016/S0003-9861(03)00385-0
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   MOREIRA L, 1994, TOXICON, V32, P977, DOI 10.1016/0041-0101(94)90376-X
   Otero R., 1992, ACTA MED COLOMB, V17, P229
   OWNBY CL, 1987, TOXICON, V25, P517, DOI 10.1016/0041-0101(87)90287-X
   OWNBY CL, 1978, AM J PATHOL, V93, P201
   PAINE MJI, 1992, J BIOL CHEM, V267, P22869
   PASQUA JJ, 1983, BIOCHIM BIOPHYS ACTA, V757, P282, DOI 10.1016/0304-4165(83)90052-1
   PENACHAVARRIA A, 1970, AM J TROP MED HYG, V19, P342
   Pinto A, 2003, REV BIOL TROP, V51, P253
   Rodrigues VM, 2001, BIOCHIMIE, V83, P471, DOI 10.1016/S0300-9084(01)01282-2
   Rucavado A, 2004, TOXICON, V43, P417, DOI 10.1016/j.toxicon.2004.01.016
   Rucavado A, 2001, THROMB HAEMOSTASIS, V85, P710
   SANDERS WE, 1988, LAB INVEST, V59, P443
   SanoMartins IS, 1997, THROMB RES, V87, P183, DOI 10.1016/S0049-3848(97)00118-7
   Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120
   SANTORO ML, 1994, PLATELETS, V5, P162, DOI 10.3109/09537109409005530
   Sen U, 2001, BIOCHEMISTRY-US, V40, P345, DOI 10.1021/bi0021737
   SLADE CL, 1976, THROMB HAEMOSTASIS, V36, P424
   THORSEN LI, 1986, THROMB RES, V44, P611, DOI 10.1016/0049-3848(86)90163-5
   Tijssen P, 1985, PRACTICE THEORY ENZY
   Warrell D.A., 2004, VENOMOUS REPTILES W, V2, P709
   Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403
NR 50
TC 48
Z9 48
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0340-6245
EI 2567-689X
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUL
PY 2005
VL 94
IS 1
BP 123
EP 131
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 945QG
UT WOS:000230516600019
PM 16113795
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Fernandes-Pedrosa, MF
   Tambourgi, DV
   Arni, RK
AF Murakami, MT
   Fernandes-Pedrosa, MF
   Tambourgi, DV
   Arni, RK
TI Structural basis for metal ion coordination and the catalytic mechanism
   of sphingomyelinases D
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PHOSPHOLIPASE-D; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS;
   LOXOSCELES-INTERMEDIA; DNASE-I; BACTERIAL SPHINGOMYELINASES;
   CRYSTAL-STRUCTURE; SPIDER VENOM; PROTEIN; RECLUSA; ENVENOMATION
AB Sphingomyelinases D (SMases D) from Loxosceles spider venom are the principal toxins responsible for the manifestation of dermonecrosis, intravascular hemolysis, and acute renal failure, which can result in death. These enzymes catalyze the hydrolysis of sphingomyelin, resulting in the formation of ceramide 1-phosphate and choline or the hydrolysis of lysophosphatidyl choline, generating the lipid mediator lysophosphatidic acid. This report represents the first crystal structure of a member of the sphingomyelinase D family from Loxosceles laeta (SMase I), which has been determined at 1.75-angstrom resolution using the "quick cryo-soaking" technique and phases obtained from a single iodine derivative and data collected from a conventional rotating anode x-ray source. SMase I folds as an (alpha/beta)(8) barrel, the interfacial and catalytic sites encompass hydrophobic loops and a negatively charged surface. Substrate binding and/or the transition state are stabilized by a Mg2+ ion, which is coordinated by Glu(32), Asp(34), Asp(91), and solvent molecules. In the proposed acid base catalytic mechanism, His(12) and His(47) play key roles and are supported by a network of hydrogen bonds between Asp(34), Asp(52), Trp(230), Asp(233), and Asn(252).
C1 Univ Estadual Paulista, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Butantan Inst, Immunochem Lab, BR-05503900 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, IBILCE, Dept Phys, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Murakami, Mario T/F-5640-2016; Tambourgi, Denise/H-7114-2016; Arni,
   Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; Murakami, Mario
   T/C-2087-2012; de Freitas Fernandes-Pedrosa, Matheus/C-6398-2014
OI Murakami, Mario T/0000-0002-0405-8010; Tambourgi,
   Denise/0000-0003-1896-9074; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; de Freitas Fernandes-Pedrosa,
   Matheus/0000-0003-4221-9580
CR Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754
   ALLEN PBR, 1988, CAN MED ASSOC J, V138, P792
   ATKINS JA, 1958, AM J TROP MED HYG, V7, P165, DOI 10.4269/ajtmh.1958.7.165
   BARRETTO OCO, 1985, REV I MED TROP, V27, P264, DOI 10.1590/S0036-46651985000500006
   BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643
   Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1
   CARNE HR, 1978, NATURE, V271, P246, DOI 10.1038/271246a0
   Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265
   Claus R., 2000, Current Drug Targets, V1, P185, DOI 10.2174/1389450003349272
   Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352
   Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1
   FERNANDESPEDROS.MF, 2002, BIOCHEM BIOPH RES CO, V298, P638
   FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2
   FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008
   GENDRON BP, 1990, AM J EMERG MED, V8, P51, DOI 10.1016/0735-6757(90)90297-D
   GINSBURG CM, 1988, J PEDIATR-US, V112, P496, DOI 10.1016/S0022-3476(88)80348-2
   Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703
   KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leiros I, 2004, J MOL BIOL, V339, P805, DOI 10.1016/j.jmb.2004.04.003
   Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208
   MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N
   MCNAMARA PJ, 1994, MOL MICROBIOL, V12, P921, DOI 10.1111/j.1365-2958.1994.tb01080.x
   Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nagem RAP, 2001, ACTA CRYSTALLOGR D, V57, P996, DOI 10.1107/S0907444901007260
   NELSON J, 1988, CAN MED ASSOC J, V138, P888
   O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058
   Obama T, 2003, BIOL PHARM BULL, V26, P920
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013
   SCHENONE H, 1989, REV I MED TROP, V31, P403, DOI 10.1590/S0036-46651989000600007
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9
   Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6
   SOUCEK A, 1967, BIOCHIM BIOPHYS ACTA, V144, P180
   Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278
   SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0
   SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0
   Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474
   Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027
   Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x
   TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459
   Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683
   Tambourgi DV, 1998, TOXICON, V36, P391, DOI 10.1016/S0041-0101(97)00063-9
   TRUETT AP, 1993, ADV LIPID RES, V26, P275
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
   WASSERMAN GS, 1984, J TOXICOL-CLIN TOXIC, V21, P451, DOI 10.3109/15563658308990434
   Zela SP, 2004, ACTA CRYSTALLOGR D, V60, P1112, DOI 10.1107/S090744490400678X
NR 50
TC 74
Z9 76
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 8
PY 2005
VL 280
IS 14
BP 13658
EP 13664
DI 10.1074/jbc.M412437200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 912QW
UT WOS:000228095500060
PM 15654080
OA Bronze
DA 2020-12-01
ER

PT J
AU Ambrosio, ALB
   Nonato, MC
   de Araujo, HSS
   Arni, R
   Ward, RJ
   Ownby, CL
   de Souza, DHF
   Garratt, RC
AF Ambrosio, ALB
   Nonato, MC
   de Araujo, HSS
   Arni, R
   Ward, RJ
   Ownby, CL
   de Souza, DHF
   Garratt, RC
TI A molecular mechanism for Lys(49)-phospholipase A(2) activity based on
   ligand-induced conformational change
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LYSINE-49 PHOSPHOLIPASE A(2); ASPER SNAKE-VENOM; MEMBRANE-DAMAGING
   ACTIVITIES; BROAD-BANDED COPPERHEAD; TRANSITION-STATE ANALOG;
   CRYSTAL-STRUCTURE; MYOTOXIN-II; PISCIVORUS PISCIVORUS; LYSOPHOSPHATIDIC
   ACID; PLATELET-AGGREGATION
AB Agkistrodon contortrix laticinctus myotoxin is a Lys(49)- phospholipase A(2) (EC 3.1.1.4) isolated from the venom of the serpent A contortrix laticinctus (broad-banded copperhead). We present here three monomeric crystal structures of the myotoxin, obtained under different crystallization conditions. The three forms present notable structural differences and reveal that the presence of a ligand in the active site (naturally presumed to be a fatty acid) induces the exposure of a hydrophobic surface (the hydrophobic knuckle) toward the C terminus. The knuckle in A contortrix laticinctus myotoxin involves the side chains of Phe(121) and Phe(124) and is a consequence of the formation of a canonical structure for the main chain within the region of residues 118-125. Comparison with other Lys(49)-phospholipase A(2) myotoxins shows that although the knuckle is a generic structural motif common to all members of the family, it is not readily recognizable by simple sequence analyses. An activation mechanism is proposed that relates fatty acid retention at the active site to conformational changes within the C-terminal region, a part of the molecule that has long been associated with Ca2+-independent membrane damaging activity and myotoxicity. This provides, for the first time, a direct structural connection between the phospholipase "active site" and the C-terminal "myotoxic site," justifying the otherwise enigmatic conservation of the residues of the former in supposedly catalytically inactive molecules.
C1 Univ Sao Paulo, Ints Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, BR-13560970 Sao Carlos, SP, Brazil.
   Univ Sao Paulo, FCFRP, Dept Quim & Fis, BR-14040901 Ribeirao Preto, SP, Brazil.
   Univ Fed Sao Carlos, Dept Ciencias Fisiol, Ctr Biotecnol Mol Estrutural, BR-13565905 Sao Carlos, SP, Brazil.
   UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose De Rio Preto, SP, Brazil.
   Univ Sao Paulo, FFCLRP, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
   Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.
RP Garratt, RC (corresponding author), Caixa Postal 369, BR-13560970 Sao Carlos, SP, Brazil.
EM richard@if.sc.usp.br
RI Nonato, Maria Cristina C/C-5659-2012; Ambrosio, Andre/AAB-1178-2020;
   Selistre-de-Araujo, Heloisa/A-3792-2016; Souza, Dulce H.F./B-2742-2013;
   Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; garratt,
   richard c/F-6921-2011; Ambrosio, Andre/C-9089-2012; Ward,
   Richard/C-2460-2012
OI Nonato, Maria Cristina C/0000-0002-4916-1505; Selistre-de-Araujo,
   Heloisa/0000-0002-2372-7814; Arni, Raghuvir K/0000-0003-2460-1145; Arni,
   Raghuvir K/0000-0003-2460-1145; Ambrosio, Andre/0000-0002-9515-930X;
   Ward, Richard/0000-0003-1136-5737
CR Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Austin SC, 1999, PROSTAG OTH LIPID M, V58, P231, DOI 10.1016/S0090-6980(99)00041-6
   Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175
   Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317
   Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bingham CO, 1999, P ASSOC AM PHYSICIAN, V111, P516, DOI 10.1046/j.1525-1381.1999.99321.x
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   Bortoleto-Bugs RK, 2004, BIOCHEM BIOPH RES CO, V322, P364, DOI 10.1016/j.bbrc.2004.06.181
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Calderon L, 1999, TOXICON, V37, P683, DOI 10.1016/S0041-0101(98)00211-6
   Calderon L, 1998, ARCH BIOCHEM BIOPHYS, V358, P343, DOI 10.1006/abbi.1998.0853
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500
   de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DELAFORTELLE E, 1997, METHODS ENZYMOL, V276
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3
   DIAZ C, 1994, ARCH BIOCHEM BIOPHYS, V312, P336, DOI 10.1006/abbi.1994.1317
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1997, VENOM PHOSPHOLIPASE, P455
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330
   Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005
   GUTIERREZ JM, 1984, REV BIOL TROP, V32, P213
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   JOHNSON EK, 1993, TOXICON, V31, P243, DOI 10.1016/0041-0101(93)90143-7
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   JUNIORPERIOD WFD, 1998, TOXICON, V36, P1395
   JUNIORPERIOD WFD, 1999, TOXICON, V37, P371
   JUNIORPERIOD WFD, 1997, PROTEIN PEPTIDE LETT, V4, P329
   Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   LESLIE AGW, 1992, JOINT CCP4 ESF EAMCB
   Liu Q, 2003, J BIOL CHEM, V278, P41400, DOI 10.1074/jbc.M305210200
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1990, TOXICON, V28, P379, DOI 10.1016/0041-0101(90)90075-I
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250
   OWNBY CL, 1990, HDB TOXINOLOGY, P601
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   Sa JM, 2004, BIOCHEM J, V382, P191, DOI 10.1042/BJ20031946
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   Sheldrick G. M., 2001, INT TABLES CRYSTALLO, VF, P333
   SHIMOHIGASHI Y, 1995, J BIOCHEM-TOKYO, V118, P1037, DOI 10.1093/jb/118.5.1037
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0
   Treharne AC, 1997, TOXICON, V35, P613, DOI 10.1016/S0041-0101(96)00162-6
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191
   VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021
   Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   Yamaguchi Y, 1997, BIOCHEM MOL BIOL INT, V43, P19
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 89
TC 63
Z9 65
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 25
PY 2005
VL 280
IS 8
BP 7326
EP 7335
DI 10.1074/jbc.M410588200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 902DT
UT WOS:000227332700125
PM 15596433
OA Bronze
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Ruller, R
   Ward, RJ
   Arni, RK
AF Murakami, MT
   Ruller, R
   Ward, RJ
   Arni, RK
TI Crystallization and preliminary X-ray crystallographic studies of the
   mesophilic xylanase A from Bacillus subtilis 1A1
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID ACID-SEQUENCE SIMILARITIES; 3-DIMENSIONAL STRUCTURE; CIRCULANS XYLANASE;
   FAMILY-11 XYLANASE; TRICHODERMA-REESEI; ACTIVE-SITE; LOW PH; RESOLUTION;
   CLASSIFICATION; CATALYSIS
AB Xylanases have been the focus of research owing to their industrial potential in animal feed production, food processing and pulp and paper processes. In order to obtain insight into the structural stability of family 11 xylanases, the mesophilic family 11 xylanase (beta-1,4-xylan xylanohydrolase; EC 3.2.1.8) from Bacillus subtilis 1A1 has been crystallized and diffraction data have been collected to 1.7 angstrom. The crystals belong to the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 50.93, b = 70.50, c = 40.05 angstrom. The structure has been determined by molecular replacement, resulting in a crystallographic residual of 36.4% after rigid- body refinement.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   USP, Dept Chem, Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013; Murakami, Mario
   T/C-2087-2012; Murakami, Mario T/F-5640-2016; Ruller,
   ROBERTO/D-1260-2014
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Murakami, Mario T/0000-0002-0405-8010; Ruller,
   Roberto/0000-0001-7501-5176; Ruller, ROBERTO/0000-0002-5087-9493
CR BERGFORS TM, 1999, PROTEIN CRYSTALLIZAT, P245
   Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121
   GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991
   Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l
   HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309
   HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781
   Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   McCarthy AA, 2000, ACTA CRYSTALLOGR D, V56, P1367, DOI 10.1107/S0907444900009896
   Moiseeva N, 2004, ACTA CRYSTALLOGR D, V60, P1275, DOI 10.1107/S0907444904009400
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P627, DOI 10.1107/S0907444903001227
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   RULLER R, 2005, UNPUB
   Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0
   TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x
   TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019
   Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3
   WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467
   WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379
   Wouters J, 2001, ACTA CRYSTALLOGR D, V57, P1813, DOI 10.1107/S0907444901015153
   Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3
NR 22
TC 7
Z9 8
U1 1
U2 10
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD FEB
PY 2005
VL 61
BP 219
EP 220
DI 10.1107/S1744309105000904
PN 2
PG 2
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 969YM
UT WOS:000232271900017
PM 16510999
OA Green Published
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Soares, AM
   Ward, RJ
   Fontes, MRM
   Arni, RK
AF Watanabe, L
   Soares, AM
   Ward, RJ
   Fontes, MRM
   Arni, RK
TI Structural insights for fatty acid binding in a Lys49-phospholipase
   A(2): crystal structure of myotoxin II from Bothrops molojeni complexed
   with stearic acid
SO BIOCHIMIE
LA English
DT Article
DE phospholipase A(2); stearic acid; crystal structure; dimer interface
   fatty acid binding
ID PHOSPHOLIPASE A(2); LYSINE-49 PHOSPHOLIPASE-A2; CATALYTIC MECHANISM;
   PISCIVORUS-PISCIVORUS; SUBSTRATE-SPECIFICITY; SNAKE-VENOMS; CALCIUM-ION;
   HOMOLOG; INHIBITION; HYDROLYSIS
AB The crystal structure of dimeric Lys49-phospholipase A2 myotoxin-II from Bothrops moojeni (MjTX-II) co-crystallized with stearic acid (C18H36O2) has been determined at a resolution of 1.8 angstrom. The electron density maps permitted the unambiguous inclusion of six stearic acid molecules in the refinement. Two stearic acid molecules could be located in the substrate-binding cleft of each monomer in positions, which favor the interaction of their carboxyl groups with active site residues. The way of binding of stearic acids to this Lys49-PLA(2)s is analogous to phospholipids and transition state analogues to catalytically active PLA(2)s. Two additional stearic acid molecules were located at the dimer interface region, defining a hitherto unidentified acyl-binding site on the protein surface. The strictly conserved Lys122 for Lys49-PLA(2)s may play a fundamental role for stabilization of legend-protein complex. The comparison of MjTX-II/satiric acid complex with other Lys-PLA(2)s structures whose putative fatty acids were located at their active site is also analysed. Molecular details of the stearic acid/protein interactions provide insights to binding in croup I/II PLA(2)s and to the possible interactions of Lys49-PLA(2)s with target membranes. (c) 2004 Elsevier SAS. All rights reserved.
C1 UNESP, IBILCE, Dept Fis, Sao Jose Do Rio Preto, SP, Brazil.
   UNAERP, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.
   USP, FFCLRP, Dept Quim, Ribeirao Preto, SP, Brazil.
   Univ Estadual Paulista Julio Mesquita Filho, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.
RP Fontes, MRM (corresponding author), UNESP, IBILCE, Dept Fis, Sao Jose Do Rio Preto, SP, Brazil.
EM fontes@ibb.unesp.br; arni@df.ibilce.unesp.br
RI Ward, Richard/C-2460-2012; Soares, Andreimar M/K-5556-2014; Arni,
   Raghuvir K/B-2222-2013; Fontes, Marcos R/B-1941-2009; Arni, Raghuvir
   K/N-9338-2018
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Fontes, Marcos R/0000-0002-4634-6221; Arni, Raghuvir
   K/0000-0003-2460-1145; Soares, Andreimar/0000-0003-1032-2188
CR Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   de Azevedo WF, 1999, TOXICON, V37, P371, DOI 10.1016/S0041-0101(98)00189-5
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Georgieva DN, 2004, BIOCHEM BIOPH RES CO, V319, P1314, DOI 10.1016/j.bbrc.2004.05.106
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V117, P217
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee CE, 2001, MOL CELLS, V11, P28
   Magro AJ, 2003, BIOCHEM BIOPH RES CO, V311, P713, DOI 10.1016/j.bbrc.2003.10.047
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455, DOI 10.1021/bi00704a021
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   Rogers J, 1996, BIOCHEMISTRY-US, V35, P9375, DOI 10.1021/bi960526p
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   Ruller R, 2003, ARCH BIOCHEM BIOPHYS, V411, P112, DOI 10.1016/S0003-9861(02)00712-9
   SALVADOR DPM, UNPUB ARCH BIOCH BIO
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5
   Soares AM, 2004, CURR ORG CHEM, V8, P1677, DOI 10.2174/1385272043369610
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021
   Watanabe L, 2003, PROTEIN PEPTIDE LETT, V10, P525, DOI 10.2174/0929866033478726
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
NR 40
TC 46
Z9 47
U1 0
U2 1
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD FEB
PY 2005
VL 87
IS 2
BP 161
EP 167
DI 10.1016/j.biochi.2004.11.005
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 909FF
UT WOS:000227845100004
PM 15760708
DA 2020-12-01
ER

PT J
AU Mikeska, R
   Wacker, R
   Arni, R
   Singh, TP
   Mikhailov, A
   Gabdoulkhakov, A
   Voelter, W
   Betzel, C
AF Mikeska, R
   Wacker, R
   Arni, R
   Singh, TP
   Mikhailov, A
   Gabdoulkhakov, A
   Voelter, W
   Betzel, C
TI Mistletoe lectin I in complex with galactose and lactose reveals
   distinct sugar-binding properties
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID RICIN-B-CHAIN; RIBOSOME-INACTIVATING PROTEIN; VISCUM-ALBUM L;
   CRYSTAL-STRUCTURE; ANIMAL LECTINS; TOXIC LECTIN; A-CHAIN; PLANT;
   MICROGRAVITY; CRYSTALLIZATION
AB The structures of mistletoe lectin I (ML-I) from Viscum album complexed with lactose and galactose have been determined at 2.3 A resolution and refined to R factors of 20.9% (R-free = 23.6%) and 20.9 (R-free = 24.6%), respectively. ML-I is a heterodimer and belongs to the class of ribosome- inactivating proteins of type II, which consist of two chains. The A-chain has rRNA N-glycosidase activity and irreversibly inhibits eukaryotic ribosomes. The B-chain is a lectin and preferentially binds to galactose-terminated glycolipids and glycoproteins on cell membranes. Saccharide binding is performed by two binding sites in subdomains alpha 1 and gamma 2 of the ML-I B-chain separated by similar to 62 A from each other. The favoured binding of galactose in subdomain alpha 1 is achieved via hydrogen bonds connecting the 4-hydroxyl and 3-hydroxyl groups of the sugar moiety with the side chains of Asp23B, Gln36B and Lys41B and the main chain of 26B. The aromatic ring of Trp38B on top of the preferred binding pocket supports van derWaals packing of the apolar face of galactose and stabilizes the sugar-lectin complex. In the galactose-binding site II of subdomain gamma 2, Tyr249B provides the hydrophobic stacking and the side chains of Asp235B, Gln238B and Asn256B are hydrogen-bonding partners for galactose. In the case of the galactose-binding site I, the 2-hydroxyl group also stabilizes the sugar-protein complex, an interaction thus far rarely detected in galactose-specific lectins. Finally, a potential third low-affinity galactose-binding site in subunit beta 1 was identified in the present ML-I structures, in which a glycerol molecule from the cryoprotectant buffer has bound, mimicking the sugar compound.
C1 Univ Hamburg, Inst Biochem & Food Chem, DESY, D-22603 Hamburg, Germany.
   Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany.
   UNESP, IBILCE, Dept Phys, Sao Paulo, Brazil.
   All India Inst Med Sci, Dept Biophys, New Delhi, India.
   Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia.
RP Betzel, C (corresponding author), Univ Hamburg, Inst Biochem & Food Chem, DESY, Notkestr 85,Bldg 22A, D-22603 Hamburg, Germany.
EM betzel@unisgi1.desy.de
RI Betzel, Christian/G-8105-2018; Arni, Raghuvir K/B-2222-2013;
   Gabdulkhakov, Azat/H-4343-2013
OI Betzel, Christian/0000-0002-3879-5019; Arni, Raghuvir
   K/0000-0003-2460-1145; Gabdulkhakov, Azat/0000-0003-1016-5936
CR Agapov II, 1999, FEBS LETT, V452, P211, DOI 10.1016/S0014-5793(99)00639-0
   Banerjee R, 1996, J MOL BIOL, V259, P281, DOI 10.1006/jmbi.1996.0319
   BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6
   Borgstahl GEO, 2001, ACTA CRYSTALLOGR D, V57, P1204, DOI 10.1107/S0907444901007892
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   DEBAERE LTJ, 1993, J MOL BIOL, V230, P950
   Drickamer K, 1997, STRUCTURE, V5, P465, DOI 10.1016/S0969-2126(97)00202-5
   Eck J, 1999, EUR J BIOCHEM, V265, P788, DOI 10.1046/j.1432-1327.1999.00784.x
   Elgavish S, 1998, J MOL BIOL, V277, P917, DOI 10.1006/jmbi.1998.1664
   ENDO Y, 1988, FEBS LETT, V231, P378, DOI 10.1016/0014-5793(88)80853-6
   FRANZ H, 1986, ONCOLOGY, V43, P23
   FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481
   GABIUS S, 1991, DTSCH Z ONKOL, V23, P113
   Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679
   Krauspenhaar R, 1999, BIOCHEM BIOPH RES CO, V257, P418, DOI 10.1006/bbrc.1999.0470
   Krauspenhaar R, 2002, ACTA CRYSTALLOGR D, V58, P1704, DOI 10.1107/S0907444902014270
   LEE RT, 1994, CARBOHYD RES, V254, P269, DOI 10.1016/0008-6215(94)84259-0
   MOHANRAJ D, 1995, BBA-GEN SUBJECTS, V1243, P399, DOI 10.1016/0304-4165(94)00166-U
   MONTFORT W, 1987, J BIOL CHEM, V262, P5398
   Niwa H, 2003, EUR J BIOCHEM, V270, P2739, DOI 10.1046/j.1432-1033.2003.03646.x
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pascal JM, 2001, PROTEINS, V43, P319, DOI 10.1002/prot.1043
   PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347
   Reuter G, 1999, CELL MOL LIFE SCI, V55, P368, DOI 10.1007/s000180050298
   RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551
   ROBERTUS JD, 1984, J BIOL CHEM, V259, P3953
   Roussel A, 1991, SILICON GRAPHICS GEO, P86
   RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310
   SHAANAN B, 1991, SCIENCE, V254, P862, DOI 10.1126/science.1948067
   SNELL EH, 1995, ACTA CRYSTALLOGR D, V51, P1099, DOI 10.1107/S0907444995012170
   STIRPE F, 1980, BIOCHEM J, V190, P843, DOI 10.1042/bj1900843
   VITETTA ES, 1990, BIOCHIM BIOPHYS ACTA, V1049, P151, DOI 10.1016/0167-4781(90)90035-Z
   Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P
   WALES R, 1991, J BIOL CHEM, V266, P19172
   Walzel H, 2001, IMMUNOL LETT, V78, P57, DOI 10.1016/S0165-2478(01)00238-3
   Wright CS, 1997, CURR OPIN STRUC BIOL, V7, P631, DOI 10.1016/S0959-440X(97)80071-1
   ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8
NR 38
TC 24
Z9 25
U1 0
U2 1
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD JAN
PY 2005
VL 61
BP 17
EP 25
DI 10.1107/S1744309104031501
PN 1
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 968IX
UT WOS:000232157000005
PM 16508080
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Vieira, DF
   Watanabe, L
   Sant'ana, CD
   Marcussi, S
   Sampaio, SV
   Soares, AM
   Arni, RK
AF Vieira, DF
   Watanabe, L
   Sant'ana, CD
   Marcussi, S
   Sampaio, SV
   Soares, AM
   Arni, RK
TI Purification and characterization of jararassin-I, a thrombin-like
   enzyme from Bothrops jararaca snake venom
SO ACTA BIOCHIMICA ET BIOPHYSICA SINICA
LA English
DT Article
DE snake venom; Bothrops jararaca; serine protease thrombin-like;
   fibrinogenolytic activity; crystallization
ID FIBRINOGEN-CLOTTING ENZYME; AMINO-ACID-SEQUENCE; SERINE-PROTEASE;
   CRYSTALLIZATION; BJ; PA
AB A thrombin-like serine protease, jararassin-I, was isolated from the venom of Bothrops jararaca. The protein was obtained in high yield and purity by a single chromatographic step using the affinity resin Benzamidine-Sepharose CL-6B. SDS-PAGE and dynamic light scattering analyses indicated that the molecular mass of the enzyme was about 30 kD. The enzyme possessed fibrinogenolytic and coagulant activities. The jararassin-I degraded the Bbeta chain of fibrinogen while the Aalpha chain and gammachain were unchanged. Proteases inhibitors, PMSF and benzamidine inhibited the coagulant activity. These results showed jararassin-I is a serine protease similar to coagulating thrombin-like snake venom proteases, but it specifically cleaves Bbeta chain of bovine fibrinogen. Single crystals of enzyme were obtained (0.2 mmx0.2 mmx0.2 mm) and used for X-ray diffraction experiments.
C1 Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.
   Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exactas, Dept Fis, UNESP, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, FCFRP, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, FMRP, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; VILELA SAMPAIO, SUELY/C-3433-2013; Vilela,
   Suely/D-7429-2012; Soares, Andreimar M/K-5556-2014
OI Arni, Raghuvir K/0000-0003-2460-1145; Vilela, Suely/0000-0003-3274-180X;
   Soares, Andreimar/0000-0003-1032-2188
CR ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5
   Bortoleto RK, 2002, TOXICON, V40, P1307, DOI 10.1016/S0041-0101(02)00140-X
   Castro HC, 2001, BBA-PROTEIN STRUCT M, V1547, P183, DOI 10.1016/S0167-4838(01)00177-7
   GUAN LF, 1984, THROMB RES, V35, P301, DOI 10.1016/0049-3848(84)90361-X
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lopez LMI, 2000, PROTEIN EXPRES PURIF, V18, P133, DOI 10.1006/prep.1999.1165
   MANDELBAUM FR, 1982, TOXICON, V20, P955, DOI 10.1016/0041-0101(82)90098-8
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Marsh NA, 1998, BLOOD COAGUL FIBRIN, V9, P395, DOI 10.1097/00001721-199807000-00001
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   NISHIDA S, 1994, BIOCHEMISTRY-US, V33, P1843, DOI 10.1021/bi00173a030
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Pirkle H, 1998, THROMB HAEMOSTASIS, V79, P675
   ROSENFELD G, 1971, VENORNOUS ANIMALS TH
   SELISTRE HS, 1987, TOXICON, V25, P1135, DOI 10.1016/0041-0101(87)90131-0
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   Serrano SMT, 2000, THROMB HAEMOSTASIS, V83, P438
   SERRANO SMT, 1999, J VENOM ANIM TOXINS, V5, P226
NR 20
TC 19
Z9 21
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1672-9145
EI 1745-7270
J9 ACTA BIOCH BIOPH SIN
JI Acta Biochim. Biophys. Sin.
PD DEC
PY 2004
VL 36
IS 12
BP 798
EP 802
DI 10.1093/abbs/36.12.798
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 883BV
UT WOS:000225986000003
PM 15592646
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Michelan-Duarte, S
   Cintra, ACO
   Arni, RK
AF Murakami, MT
   Michelan-Duarte, S
   Cintra, ACO
   Arni, RK
TI Crytallization and high-resolution X-ray diffraction data collection of
   an Asp49 PLA(2) from Bothrops jararacussu venom both in the presence and
   absence of Ca2+ ions
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE calcium-binding loop; Asp49 PLA(2); crystallization; X-ray diffraction
ID NEUROTOXIN VIPOXIN; PHOSPHOLIPASE A(2)
AB Snake venom PLA(2)s have been extensively studied due to their role in mediating and disrupting physiological processes such as coagulation, platelet aggregation and myotoxicity. The Ca2+ ion bound to the putative calcium-binding loop is essential for hydrolytic activity. We report the crystallization in the presence and absence of Ca2+ and X-ray diffraction data collection at 1.60 Angstrom (with Ca2+) and 1.36 Angstrom (without Ca2+) of an Asp49 PLA(2) from Bothrops jararacussu venom. The crystals belong to orthorhombic space group C222(1). Initial refinement and electron density analysis indicate significant conformational. changes upon Ca2+ binding. (C) 2004 Elsevier B.V. All fights reserved.
C1 Univ Sao Paulo, Dept Anal Clin Toxicol & Bromatol, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Estadual Paulista, Dept Fis, IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), Univ Estadual Paulista, Dept Fis, IBILCE, R Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Murakami, Mario T/C-2087-2012; Cintra, Adelia/K-6034-2013; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Murakami, Mario
   T/F-5640-2016
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Murakami, Mario T/0000-0002-0405-8010
CR Chang LS, 1996, J PROTEIN CHEM, V15, P701, DOI 10.1007/BF01887143
   DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4
   Georgieva DN, 2000, SPECTROCHIM ACTA A, V56, P2811, DOI 10.1016/S1386-1425(00)00376-0
   Georgieva DN, 2004, BIOPHYS J, V86, P461, DOI 10.1016/S0006-3495(04)74123-5
   Harris J.B., 1991, P91
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
NR 12
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 0006-3002
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD DEC 1
PY 2004
VL 1703
IS 1
BP 79
EP 81
DI 10.1016/j.bbapap.2004.08.008
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 878BP
UT WOS:000225621800009
PM 15588705
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Gava, LM
   Zela, SP
   Arruda, EZ
   Melo, PA
   Gutierrez, JM
   Arni, RK
AF Murakami, MT
   Gava, LM
   Zela, SP
   Arruda, EZ
   Melo, PA
   Gutierrez, JM
   Arni, RK
TI Crystallization and preliminary X-ray diffraction analysis of suramin, a
   highly charged polysulfonated napthylurea, complexed with a myotoxic
   PLA(2) from Bothrops asper venom
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE suramin; myotoxicity; snake venom; Lys49 PLA(2)s; X-ray diffraction
ID LYS49 PHOSPHOLIPASE A(2); LYSINE RESIDUES; GROWTH-FACTOR; SNAKE-VENOMS;
   IDENTIFICATION; MECHANISM; CANCER; TRIAL; DRUG; SITE
AB Suramin is a highly charged polysulfonated napthylurea that interferes in a number of physiologically relevant processes such as myotoxicity, blood coagulation and several kinds of cancers. This synthetic compound was complexed with a myotoxic Lys49 PLA(2) from Bothrops asper venom and crystallized by the hanging-drop vapor diffusion method at 18 degreesC. The crystals belong to the orthorhombic space group P2(1)2(1)2(1), with unit cell parameters a=49.05, b=63.84 and c=85.67 Angstrom, Diffraction data was collected to 1.78 Angstrom. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Estadual Paulista, Dept Fis, IBILCE, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Fed Rio de Janeiro, Dept Farmacol Basica & Clin, IBC, Rio De Janeiro, RJ, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, Escuela Med, San Jose, Costa Rica.
RP Arni, RK (corresponding author), Univ Estadual Paulista, Dept Fis, IBILCE, Crisovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Gava, Lisandra/I-7704-2012; Murakami, Mario T/C-2087-2012; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Murakami, Mario
   T/F-5640-2016
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Murakami, Mario T/0000-0002-0405-8010; Gutierrez,
   Jose Maria/0000-0001-8385-3081
CR Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Arbuck SG, 1997, ANN ONCOL, V8, P119, DOI 10.1023/A:1008290925515
   Arruda EZ, 2002, BRAZ J MED BIOL RES, V35, P723, DOI 10.1590/S0100-879X2002000600013
   CHESON BD, 1987, JAMA-J AM MED ASSOC, V258, P1347, DOI 10.1001/jama.258.10.1347
   Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027
   de Oliveira M, 2003, TOXICON, V42, P373, DOI 10.1016/S0041-0101(03)00166-1
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   Dreicer R, 1999, INVEST NEW DRUG, V17, P183, DOI 10.1023/A:1006331518952
   EISENBERGER MA, 1993, J NATL CANCER I, V85, P611, DOI 10.1093/jnci/85.8.611
   Gradishar WJ, 2000, ONCOLOGY-BASEL, V58, P324, DOI 10.1159/000012120
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   Harris J.B., 1991, P91
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HENSEY CE, 1989, FEBS LETT, V258, P156, DOI 10.1016/0014-5793(89)81639-4
   HOSANG M, 1985, J CELL BIOCHEM, V29, P265, DOI 10.1002/jcb.240290310
   HUANG SS, 1988, J BIOL CHEM, V263, P12608
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1986, TOXICON, V24, P895
   Lomonte B, 1999, BBA-BIOMEMBRANES, V1461, P19, DOI 10.1016/S0005-2736(99)00143-1
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   Murakami MT, 2003, TOXICON, V42, P903, DOI 10.1016/j.toxicon.2003.11.014
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
   Scott D L, 1994, Adv Inorg Biochem, V10, P139
   Ward RJ, 1998, TOXICON, V36, P1623, DOI 10.1016/S0041-0101(98)00155-X
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
NR 30
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD DEC 1
PY 2004
VL 1703
IS 1
BP 83
EP 85
DI 10.1016/j.bbapap.2004.08.009
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 878BP
UT WOS:000225621800010
PM 15588706
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Gava, LM
   Angulo, Y
   Lomonte, B
   Arni, RK
AF Watanabe, L
   Gava, LM
   Angulo, Y
   Lomonte, B
   Arni, RK
TI Crystallization of the Lys49 PLA(2) homologue, myotoxin II, from the
   venom of Atropoides nummifer
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE myotoxin; snake venom; phospholipase A(2); Lysine-49; X-ray diffraction
ID PHOSPHOLIPASE A(2) HOMOLOG; SNAKE BOTHROPS-NUMMIFER; JUMPING VIPER;
   SYNTHETIC PEPTIDES; DIFFRACTION DATA; COSTA-RICA; REGION;
   IDENTIFICATION; PROTEINS; CROTALUS
AB Myotoxin H, a Lys49 catalytically inactive phospholipase A(2) homologue from Atropoides nummifer venom, was purified, characterized and crystallized. The crystals belongs to the tetragonal system, space group P4(3)2(1)2, with unit cell parameters (a=b=68.66 and c=63.87 Angstrom). Diffraction data were collected to a resolution of 2.32 Angstrom. The crystal structure is currently being determined using molecular replacement techniques. (C) 2004 Elsevier B.V. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Univ Costa Rica, Dept Bioquim, Escuela Med, San Jose, Costa Rica.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, R Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Gava, Lisandra/I-7704-2012; Lomonte, Bruno/B-8862-2019; Arni, Raghuvir
   K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Lomonte, Bruno/0000-0003-2419-6469; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145
CR Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Angulo Y, 2000, INT J BIOCHEM CELL B, V32, P63, DOI 10.1016/S1357-2725(99)00099-0
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092
   de Azevedo WF, 1999, TOXICON, V37, P371, DOI 10.1016/S0041-0101(98)00189-5
   GUTIERREZ JM, 1989, TOXICON, V27, P735, DOI 10.1016/0041-0101(89)90040-8
   GUTIERREZ JM, 1980, TOXICON, V18, P315, DOI 10.1016/0041-0101(80)90011-2
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008
   Lomonte B, 2003, TOXICON, V42, P307, DOI 10.1016/S0041-0101(03)00149-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   SOLORZANO A, 1989, REV BIOL TROP, V37, P133
   Taylor RT, 1974, REV BIOL TROP, V21, P383
   Traub P, 1971, METHOD ENZYMOL, V20, P391
NR 23
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 0006-3002
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD DEC 1
PY 2004
VL 1703
IS 1
BP 87
EP 89
DI 10.1016/j.bbapap.2004.09.006
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 878BP
UT WOS:000225621800011
PM 15588707
DA 2020-12-01
ER

PT J
AU Magro, AJ
   Murakami, MT
   Marcussi, S
   Soares, AM
   Arni, RK
   Fontes, MRM
AF Magro, AJ
   Murakami, MT
   Marcussi, S
   Soares, AM
   Arni, RK
   Fontes, MRM
TI Crystal structure of an acidic platelet aggregation inhibitor and
   hypotensive phospholipase A(2) in the monomeric and dimeric states:
   insights into its oligomeric state
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE X-ray crystallography; acidic phospholipase A(2); Bothrops jararacussu
   venom; platelet aggregation and hypotensive effects; crystal structure;
   oligomeric state; dimeric phospholipase A(2)
ID SNAKE-VENOM; MYOTOXIN-II; PISCIVORUS; HOMOLOG
AB Phospholipases A(2) belong to the superfamily of proteins which hydrolyzes the sn-2 acyl groups of membrane phospholipids to release arachidonic acid and lysophospholipids. An acidic phospholipase A(2) isolated from Bothrops juraracussu snake venom presents a high catalytic, platelet aggregation inhibition and hypotensive activities. This protein was crystallized in two oligomeric states: monomeric and dimeric. The crystal structures were solved at 1.79 and 1.90 Angstrom resolution, respectively, for the two states. It was identified a Na+ ion at the center of Ca2+-binding site of the monomeric form. A novel dimeric conformation with the active sites exposed to the solvent was observed. Conformational states of the molecule may be due to the physicochemical conditions used in the crystallization experiments. We suggest dimeric state is one found in vivo. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Estadual Paulista, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.
   UNESP, IBILCE, Dept Fis, Sao Jose do Preto, SP, Brazil.
   Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.
RP Fontes, MRM (corresponding author), Univ Estadual Paulista, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil.
EM fontes@ibb.unesp.br
RI Soares, Andreimar M/K-5556-2014; Murakami, Mario T/F-5640-2016; Magro,
   Angelo/J-9710-2012; Arni, Raghuvir K/B-2222-2013; Murakami, Mario
   T/C-2087-2012; Arni, Raghuvir K/N-9338-2018; Fontes, Marcos
   R/B-1941-2009
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; Arni, Raghuvir K/0000-0003-2460-1145; Fontes,
   Marcos R/0000-0002-4634-6221; Magro, Angelo Jose/0000-0002-4253-6992;
   Soares, Andreimar/0000-0003-1032-2188
CR Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Andriao-Escarso SH, 2002, BIOCHEM PHARMACOL, V64, P723, DOI 10.1016/S0006-2952(02)01210-8
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brunger A. T., 1992, X PLOR VERSION 3 1 S
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7
   Chandra V, 2001, ACTA CRYSTALLOGR D, V57, P1793, DOI 10.1107/S0907444901014524
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   DANIELE JJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P65, DOI 10.1006/abbi.1995.1205
   de Oliveira AHC, 2001, BIOCHEMISTRY-US, V40, P6912, DOI 10.1021/bi0026728
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Gu LC, 2002, ACTA CRYSTALLOGR D, V58, P104, DOI [10.1107/S0907444901018170, 10.1107/SO907444901018170]
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   JABEEN T, IN PRESS CRYSTAL STR
   JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   Magro AJ, 2003, BIOCHEM BIOPH RES CO, V311, P713, DOI 10.1016/j.bbrc.2003.10.047
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69
   OBERTO PG, 2004, PROTEIN J, V23, P273
   OSENBERG P, 1990, HDB TOXINOLOGY, P67
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g
   PEARSON WR, 1990, METHOD ENZYMOL, V183, P63
   Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RIDGEN DJ, 2003, ACTA CRYSTALLOGR D, V59, P255
   Roberto PG, 2004, PROTEIN EXPRES PURIF, V37, P102, DOI 10.1016/j.pep.2004.05.020
   Sanchez SA, 2001, BIOCHEMISTRY-US, V40, P6903, DOI 10.1021/bi001599i
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Serrano SMT, 1999, ARCH BIOCHEM BIOPHYS, V367, P26, DOI 10.1006/abbi.1999.1230
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890
   SOARES AM, 2004, REV TOXICON, V42, P855
   SOARES AM, 2004, IN PRESS CURR ORG CH, V8
   Valentin E, 2000, BIOCHIMIE, V82, P815, DOI 10.1016/S0300-9084(00)01168-8
   Xu SJ, 2003, BIOCHEM BIOPH RES CO, V300, P271, DOI 10.1016/S0006-291X(02)02833-4
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
   Zhao KH, 1998, ACTA CRYSTALLOGR D, V54, P510, DOI 10.1107/S0907444997013644
NR 49
TC 30
Z9 32
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 8
PY 2004
VL 323
IS 1
BP 24
EP 31
DI 10.1016/j.bbrc.2004.08.046
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 855HY
UT WOS:000223965300004
PM 15351695
DA 2020-12-01
ER

PT J
AU Zela, SP
   Pedrosa, MFF
   Murakami, MT
   de Andrade, SA
   Arni, RK
   Tambourgi, DV
AF Zela, SP
   Pedrosa, MFF
   Murakami, MT
   de Andrade, SA
   Arni, RK
   Tambourgi, DV
TI Crystallization and preliminary crystallographic analysis of SMase I, a
   sphingomyelinase from Loxosceles laeta spider venom
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; BACTERIAL SPHINGOMYELINASES;
   MEDIATED LYSIS; INTERMEDIA; CLEAVAGE; METALLOPROTEINASE; ERYTHROCYTES;
   PROTEINS
AB SMase I, a 32 kDa sphingomyelinase found in Loxosceles laeta venom, is responsible for the major pathological effects of spider envenomation. This toxin has been cloned and functionally expressed as a fusion protein containing a 6 x His tag at its N-terminus to yield a 33 kDa protein [Fernandes-Pedrosa et al. (2002), Biochem. Biophys. Res. Commun. 298, 638 - 645]. The recombinant protein possesses all the biological properties ascribed to the whole L. laeta venom, including dermonecrotic and complement-dependent haemolytic activities. Dynamic light-scattering experiments conducted at 291 K demonstrate that the sample possesses a monomodal distribution, with a hydrodynamic radius of 3.57 nm. L. laeta SMase I was crystallized by the hanging-drop vapour-diffusion technique using the sparse-matrix method. Single crystals were obtained using a buffer solution consisting of 0.08 M HEPES and 0.9 M trisodium citrate, which was titrated to pH 7.5 using 0.25 M sodium hydroxide. Complete three-dimensional diffraction data were collected to 1.8 Angstrom at the Laboratorio Nacional de Luz Sincrotron (LNLS, Campinas, Brazil). The crystals belong to the hexagonal system ( space group P6(1) or P6(5)), with unit-cell parameters a = b = 140.6, c = 113.6 Angstrom. A search for heavy-atom derivatives has been initiated and elucidation of the crystal structure is currently in progress.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Butantan Inst, Immunochem Lab, BR-05503900 Sao Paulo, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br; dvtambourgi@butantan.gov.br
RI Murakami, Mario T/F-5640-2016; Andrade, Sonia A/F-4253-2015; Arni,
   Raghuvir K/B-2222-2013; de Freitas Fernandes-Pedrosa,
   Matheus/C-6398-2014; Murakami, Mario T/C-2087-2012; Tambourgi,
   Denise/H-7114-2016
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; de Freitas Fernandes-Pedrosa,
   Matheus/0000-0003-4221-9580; Tambourgi, Denise/0000-0003-1896-9074
CR BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643
   BOSCH HVD, 1980, BIOCHIM BIOPHYS ACTA, V604, P191
   CUEVAS WA, 1993, INFECT IMMUN, V61, P4310, DOI 10.1128/IAI.61.10.4310-4316.1993
   FERNANDESPEDROS.MF, 2002, BIOCHEM BIOPH RES CO, V298, P638
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474
   Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x
   TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459
   Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683
   Tambourgi DV, 1998, TOXICON, V36, P391, DOI 10.1016/S0041-0101(97)00063-9
   van den Berg CW, 2002, IMMUNOLOGY, V107, P102, DOI 10.1046/j.1365-2567.2002.01468.x
   van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200
NR 15
TC 5
Z9 5
U1 0
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD JUN
PY 2004
VL 60
BP 1112
EP 1114
DI 10.1107/S090744490400678X
PN 6
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 822WZ
UT WOS:000221572600016
PM 15159572
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Arni, RK
AF Murakami, MT
   Arni, RK
TI A structure based model for liposome disruption and the role of
   catalytic activity in myotoxic phospholipase A(2)S
SO TOXICON
LA English
DT Article
DE phospholipase A(2); Lys49 PLA(2); Asp49 PLA(2); liposomes; surface
   electrostatic potential; catalytic activity
ID AGKISTRODON-PISCIVORUS-PISCIVORUS; CERROPHIDION BOTHROPS GODMANI;
   MEMBRANE-DAMAGING ACTIVITIES; AMINO-ACID-SEQUENCE; ASPER SNAKE-VENOM;
   CRYSTAL-STRUCTURE; PHARMACOLOGICAL-PROPERTIES; LYSINE-49
   PHOSPHOLIPASE-A(2); PANCREATIC PHOSPHOLIPASE-A2; LYS(49)-PHOSPHOLIPASE
   A(2)
AB Venom phospholipase A(2)s (PLA(2)s) display a wide spectrum of pharmacological activities and, based on the wealth of biochemical and structural data currently available for PLA(2)S, mechanistic models can now be inferred to account for some of these activities. A structural model is presented for the role played by the distribution of surface electrostatic potential in the ability of myotoxic D49/K49 PLA(2)s to disrupt multilamellar vesicles containing negatively charged natural and non-hydrolyzable phospholipids. Structural evidence is provided for the ability of K49 PLA(2)s to bind phospholipid analogues and for the existence of catalytic activity in K49 PLA(2)s. The importance of the existence of catalytic activity of D49 and K49 PLA(2)s in myotoxicity is presented. (C) 2003 Elsevier Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Biophys, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Biophys, R Cristovao Colombo 2265, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Murakami, Mario T/F-5640-2016; Murakami,
   Mario T/C-2087-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; 
CR Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Angulo Y, 2002, INT J BIOCHEM CELL B, V34, P1268, DOI 10.1016/S1357-2725(02)00060-2
   Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BULTRON E, 1993, TOXICON, V31, P217, DOI 10.1016/0041-0101(93)90289-U
   Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092
   de Azevedo WF, 1999, TOXICON, V37, P371, DOI 10.1016/S0041-0101(98)00189-5
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   de Sousa MV, 1998, BBA-PROTEIN STRUCT M, V1384, P204, DOI 10.1016/S0167-4838(98)00023-5
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1994, ARCH BIOCHEM BIOPHYS, V312, P336, DOI 10.1006/abbi.1994.1317
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   DIJKSTRA BW, 1984, BIOCHEMISTRY-US, V23, P2759, DOI 10.1021/bi00307a035
   DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x
   Falconi M, 2000, J MOL RECOGNIT, V13, P14, DOI 10.1002/(SICI)1099-1352(200001/02)13:1<14::AID-JMR484>3.0.CO;2-F
   Fletcher JE, 1996, TOXICON, V34, P1301, DOI 10.1016/S0041-0101(96)00105-5
   FLETCHER JE, 1997, VENOM PHOSPHOLIPASE, P455
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GIOTTO MTD, 1998, PROTEINS, V30, P411
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152
   Harris J.B., 1991, P91
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037
   KINI RM, 1986, TOXICON, V24, P895
   Kini RM, 1997, VENOM PHOSPHOLIPASE, P1
   KRIZAJ I, 1989, BIOCHIM BIOPHYS ACTA, V999, P198, DOI 10.1016/0167-4838(89)90218-5
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   Liu Q, 2003, J BIOL CHEM, V278, P41400, DOI 10.1074/jbc.M305210200
   Lomonte B, 1999, BBA-BIOMEMBRANES, V1461, P19, DOI 10.1016/S0005-2736(99)00143-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Mebs Dietrich, 1998, P451
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NICHOLLS A, 1993, GRASP GRAPHICAL REPR
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   Polgar J, 1996, BIOCHEM J, V319, P961, DOI 10.1042/bj3190961
   RENE L, 1988, B ORDRE MED, V2, P1
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RODRIGUESSIMIONI L, 1995, TOXICON, V33, P1479, DOI 10.1016/0041-0101(95)00089-5
   ROSENBERG P, 1997, VENOM PHOSPHOLIPASE, P155
   Rosenberg P, 1979, SNAKE VENOMS, P403
   Rosenberg P., 1986, NATURAL TOXINS ANIMA, P129
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   Scott D L, 1994, Adv Inorg Biochem, V10, P139
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070
   SCOTT DL, 1997, VENOM PHOSPHOLIPASE, P97
   Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V378, P201, DOI 10.1006/abbi.2000.1790
   Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021
   VOLWERK JJ, 1974, BIOCHEMISTRY-US, V13, P1446, DOI 10.1021/bi00704a020
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   Yamaguchi Y, 1997, BIOCHEM MOL BIOL INT, V43, P19
   Yang CC, 1997, VENOM PHOSPHOLIPASE, P185
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
NR 69
TC 34
Z9 34
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 15
PY 2003
VL 42
IS 8
BP 903
EP 913
DI 10.1016/j.toxicon.2003.11.014
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 778HF
UT WOS:000189233000007
PM 15019490
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Zela, SP
   Gava, LM
   Michelan-Duarte, S
   Cintra, ACO
   Arni, RK
AF Murakami, MT
   Zela, SP
   Gava, LM
   Michelan-Duarte, S
   Cintra, ACO
   Arni, RK
TI Crystal structure of the platelet activator convulxin, a
   disulfide-linked alpha(4)beta(4) cyclic tetramer from the venom of
   Crotalus durissus terrificus
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE C-type lectin; platelet activation factor; snake venom; Crotalus
   durissus terrificus; crystal structure; cyclic
   alpha(4)beta(4)heterotetramer
ID C-TYPE LECTIN; RATTLESNAKE VENOM; BINDING PROTEIN; SNAKE-VENOM;
   COLLAGEN; PHOSPHORYLATION; PEPTIDE; TOXIN
AB Convulxin (CVX), a C-type lectin, isolated from the venom of the South American rattlesnake Crotalus durissus terrificus, causes cardiovascular and respiratory disturbances and is a potent platelet activator which hinds to platelet glycoprotein GPVI. The structure of CVX has been solved at 2.4 Angstrom resolution to a crystallographic residual of 18.6% (R-free =26.4%). CVX is a disulfide linked heterodimer consisting of homologous alpha and beta chains. The heterodimers are additionally linked by disulfide bridges to form cyclic alpha(4)beta(4)heterotetramers. These domains exhibit significant homology to the carbohydrate-binding domains of C-type lectins, to the factor IX-binding protein (IX-bp), and to flavocetin-A (Fl-A) but sequence and Structural differences are observed in both the domains in the putative Ca2+ and carbohydrate binding regions. (C) 2003 Elsevier Inc. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, R Cristovao Colombo 2265, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, R Cristovao Colombo 2265, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Gava, Lisandra/I-7704-2012; Arni, Raghuvir K/B-2222-2013; Cintra,
   Adelia/K-6034-2013; Murakami, Mario T/F-5640-2016
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7
   Cicmil M, 2000, J BIOL CHEM, V275, P27339
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DRICKAMER K, 1993, PROG NUCLEIC ACID RE, V45, P207, DOI 10.1016/S0079-6603(08)60870-3
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V354, P255, DOI 10.1006/abbi.1998.0637
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   LEDUC M, 1998, BIOCHEM J, V15, P389
   MARLAS G, 1982, TOXICON, V20, P289, DOI 10.1016/0041-0101(82)90228-8
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mizuno H, 1999, J MOL BIOL, V289, P103, DOI 10.1006/jmbi.1999.2756
   MURAKAMI MT, IN PRESS ACTA CRYS D
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422
   Niedergang F, 2000, BIOCHEM BIOPH RES CO, V273, P246, DOI 10.1006/bbrc.2000.2940
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P661, DOI 10.1016/0041-0101(81)90103-3
   RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1982, TOXICON, V20, P279, DOI 10.1016/0041-0101(82)90227-6
NR 27
TC 39
Z9 43
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 17
PY 2003
VL 310
IS 2
BP 478
EP 482
DI 10.1016/j.bbrc.2003.09.032
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 731UF
UT WOS:000185904300034
PM 14521935
DA 2020-12-01
ER

PT J
AU Murakami, MT
   Watanabe, L
   Gava, LM
   Zela, SP
   Cintra, ACO
   Arni, RK
AF Murakami, MT
   Watanabe, L
   Gava, LM
   Zela, SP
   Cintra, ACO
   Arni, RK
TI Initial structural analysis of an alpha(4)beta(4) C-type lectin from the
   venom of Crotalus durissus terrificus
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID PLATELET GLYCOPROTEIN-IB; AGGREGATING PROTEIN; CONVULXIN; ACTIVATION;
   COLLAGEN; BINDING; ALBOAGGREGIN; SUBUNITS; RECEPTOR; TOXIN
AB Convulxin, an alphabeta C-type lectin, is a potent platelet activator isolated from the venom of the South American rattlesnake Crotalus durissus terrificus. It is a 26.5 kDa alphabeta heterodimer consisting of two homologous disulfide-linked chains. The crystals belong to space group I4, with unit-cell parameters a = b = 131.61, c = 121.85 Angstrom, and diffraction data were collected to 2.7 Angstrom. The structure was solved by molecular replacement and the asymmetric unit contains two alphabeta heterodimers, each of which forms a disulfide-linked cyclic alpha(4)beta(4) tetramer in the unit cell. These alpha(4)beta(4) tetramers are stacked to form a large solvent channel.
C1 UNESP, IBILCE, Dept Phys, BR-15005400 Sao Jose do Rio Preto, SP, Brazil.
   USP, Fac Ciencias Farmaceut Ribeirao Preto, BR-14040903 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, R Cristovao Colombo 2265, BR-15005400 Sao Jose do Rio Preto, SP, Brazil.
RI Cintra, Adelia/K-6034-2013; Murakami, Mario T/F-5640-2016; Arni,
   Raghuvir K/B-2222-2013; Gava, Lisandra/I-7704-2012
OI Murakami, Mario T/0000-0002-0405-8010; Arni, Raghuvir
   K/0000-0003-2460-1145; 
CR Andrews RK, 1996, BIOCHEMISTRY-US, V35, P12629, DOI 10.1021/bi960704e
   Asazuma N, 2001, BLOOD, V97, P3989, DOI 10.1182/blood.V97.12.3989
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   DRICKAMER K, 1993, PROG NUCLEIC ACID RE, V45, P207, DOI 10.1016/S0079-6603(08)60870-3
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Fujimura Y, 1996, THROMB HAEMOSTASIS, V76, P633
   Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   Leduc M, 1998, BIOCHEM J, V333, P389, DOI 10.1042/bj3330389
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Niedergang F, 2000, BIOCHEM BIOPH RES CO, V273, P246, DOI 10.1006/bbrc.2000.2940
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PENG ML, 1993, BLOOD, V81, P2321
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   Wang RH, 1999, BIOCHEMISTRY-US, V38, P7584, DOI 10.1021/bi982132z
   Wang WJ, 2001, THROMB HAEMOSTASIS, V86, P1077
NR 21
TC 2
Z9 2
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD OCT
PY 2003
VL 59
BP 1813
EP 1815
DI 10.1107/S0907444903016202
PN 10
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 723VA
UT WOS:000185451200018
PM 14501123
DA 2020-12-01
ER

PT J
AU Ketelhut, DFJ
   de Mello, MH
   Veronese, ELG
   Esmeraldino, LE
   Murakami, MT
   Arni, RK
   Giglio, JR
   Cintra, ACO
   Sampaio, SV
AF Ketelhut, DFJ
   de Mello, MH
   Veronese, ELG
   Esmeraldino, LE
   Murakami, MT
   Arni, RK
   Giglio, JR
   Cintra, ACO
   Sampaio, SV
TI Isolation, characterization and biological activity of acidic
   phospholipase A(2) isoforms from Bothrops jararacussu snake venom
SO BIOCHIMIE
LA English
DT Article
DE acidic PLA(2)s; Bothrops jararacussu; N-terminal sequence; platelet
   aggregation inhibition; X-ray crystallography
ID MYOTOXIC PHOSPHOLIPASES; PURIFICATION; MECHANISM; PROTEINS; SEQUENCE;
   ASPER
AB Acidic phospholipase A(2) (PLA(2)) isoforms in snake venoms, particularly those from Bothrops jararacussu, have not been characterized. This article reports the isolation and partial biochemical, functional and structural characterization of four acidic PLA(2)s (designated SIIISPIIA, SIIISPIIB, SIIISPIIIA and SIIISPIIIB) from this venom. The single chain purified proteins contained 122 amino acid residues and seven disulfide bonds with approximate molecular masses of 15 kDa and isoelectric points of 5.3. The respective N-terminal sequences were: SIIISPIIA-SLWQFGKMIDYVMGEEGAKS; SIIISPIIB-SLWQFGKMIFYTGKNEPVLS; SIIISPIIIA-SLWQFGKMILYVMGGEGVKQ and SIIISPIIIB-SLWQFGKMIFYEMTGEGVL. Crystals of the acidic protein SIIISPIIIB diffracted beyond 1.8 Angstrom resolution. These crystals are monoclinic with unit cell dimensions of a = 40.1 Angstrom, b = 54.2 Angstrom and c = 90.7 Angstrom. The crystal structure has been refined to a crystallographic residual of 16.1% (R-free = 22.9%). Specific catalytic activity (U/mg) of the isolated acidic PLA(2)s were SIIISPIIA = 290.3 U/mg; SIIISPIIB = 279.0 U/mg; SIIISPIIIA = 270.7 U/mg and SIIISPIIIB = 96.5 U/mg. Although their myotoxic activity was low, SIIISPIIA, SIIISPIIIB and SIIISPIIIA showed significant anticoagulant activity. However, there was no indirect hemolytic activity. SIIISPIIIB revealed no anticoagulant, but presented indirect hemolytic activity. With the exception of SIIISPIIIB, which inhibited platelet aggregation, all the others were capable of inducing time-independent edema. Chemical modification with 4-bromophenacyl bromide did not inhibit the induction of edema, but did suppress other activities. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicol & Bromatol, BR-14040903 Ribeirao Preto, SP, Brazil.
   Univ Estadual Paulista, Dept Fis, IBILCE, Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil.
RP Sampaio, SV (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicol & Bromatol, Avenida Cafe,S-N,Bairro Monte Alegre, BR-14040903 Ribeirao Preto, SP, Brazil.
EM suvilela@fcfrp.usp.br
RI Murakami, Mario T/F-5640-2016; Homem-de-Mello, Mauricio/G-9858-2012;
   Murakami, Mario T/C-2087-2012; VILELA SAMPAIO, SUELY/C-3433-2013;
   Ketelhuth, Daniel/F-6580-2012; Cintra, Adelia/K-6034-2013; Vilela,
   Suely/D-7429-2012; Arni, Raghuvir K/B-2222-2013
OI Murakami, Mario T/0000-0002-0405-8010; Homem-de-Mello,
   Mauricio/0000-0002-4541-9177; Ketelhuth, Daniel/0000-0002-0087-116X;
   Vilela, Suely/0000-0003-3274-180X; Arni, Raghuvir K/0000-0003-2460-1145
CR Andriao-Escarso SH, 2002, BIOCHEM PHARMACOL, V64, P723, DOI 10.1016/S0006-2952(02)01210-8
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   DANIELE JJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P65, DOI 10.1006/abbi.1995.1205
   Daniele JJ, 1997, TOXICON, V35, P1205, DOI 10.1016/S0041-0101(97)00023-8
   DAVIDSON FF, 1991, HDB NATURAL TOXINS, V5, P107
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P103, DOI 10.1016/0005-2744(68)90248-9
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   FUKAGAWA T, 1993, TOXICON, V31, P957, DOI 10.1016/0041-0101(93)90255-H
   Fully AL, 2002, BIOCHEM PHARMACOL, V63, P1589, DOI 10.1016/S0006-2952(02)00873-0
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JENG TW, 1978, P NATL ACAD SCI USA, V75, P600, DOI 10.1073/pnas.75.2.600
   KEMPARAJU K, 1994, TOXICON, V32, P1187, DOI 10.1016/0041-0101(94)90348-4
   KETTELHUT IC, 1988, DIABETES METAB REV, V4, P751, DOI 10.1002/dmr.5610040805
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413
   ROSEMBERG D, 1986, NATURAL TOXINS ANIMA, P129
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SELISTRE HS, 1990, TOXICON, V28, P261, DOI 10.1016/0041-0101(90)90062-C
   VESTERBERG O, 1972, BIOCHIM BIOPHYS ACTA, V257, P11, DOI 10.1016/0005-2795(72)90248-6
NR 35
TC 42
Z9 42
U1 0
U2 2
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD OCT
PY 2003
VL 85
IS 10
BP 983
EP 991
DI 10.1016/j.biochi.2003.09.011
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 754ZB
UT WOS:000187362400006
PM 14644553
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Fontes, MRM
   Soares, AM
   Giglio, JR
   Arni, RK
AF Watanabe, L
   Fontes, MRM
   Soares, AM
   Giglio, JR
   Arni, RK
TI Initiating structural studies of Lys49-PLA2 homologues complexed with an
   anionic detergent, a fatty acid and a natural lipid
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE phospholipase A(2); like-phospholipase; myotoxicity; crystallization;
   anionic detergent; fatty acid; natural lipid; Bothrops moojeni; Bothrops
   jararacussu
ID CRYSTAL-STRUCTURE; SNAKE-VENOM; MYOTOXIN-II; PHOSPHOLIPASE A(2);
   BOTHROPS-MOOJENI; CALCIUM; PROTEIN; PURIFICATION; SEQUENCE; REGION
AB Lys49-Phospholipase A(2) (Lys49-PLA(2) - EC 3.1.1.4) homologues damage membranes by a Ca2+-independent mechanism which does not involve catalytic activity. Both MjTX-II from Bothrops moojeni and BthTX-I from Bothrops jararacussu are dimeric in solution and in the crystalline states, and a model for the Ca2+-independent membrane damaging mechanism has been suggested in which flexibility at the dimer interface region pert-nits quaternary structural transitions between "open" and "closed" membrane bound dimer conformations which results in the perturbation of membrane phospholipids and disruption of the bilayer structure [1]. With the aim of gaining insights into the structural determinants involved in protein/lipid association, we report here the crystallization and preliminary X-ray analysis of the (i) MjTX-II/SDS complex at a resolution of 2.78Angstrom, (ii) MjTX-II/STE complex at a resolution of 1.8 Angstrom and (W) BthTX-I/DMPC complex at 2.72Angstrom. These complexes were crystallized by the hanging drop vapour-diffusion technique in (i) HEPES buffer (pH 7.5) 1.8M ammonium sulfate with 2% (w/v) polyethyleneglycol 400, in (ii) 0.6-0.8 M sodium citrate as the precipitant (pH 6.0-6.5) and in (iii) sodium citrate buffer (pH 5.8) and PEG 4000 and 20% isopropanol, respectively. Single crystals of these complexes have been obtained and X-ray diffraction data have been collected at room temperature using a R-AXIS IV imaging plate system and graphite monochromated Cu Kalpha X-ray radiation generated by a Rigaku RU300 rotating anode generator for (i) and (W) and using using a Synchrotron Radiation Source (Laboratorio Nacional de Luz Sincrotron, LNLS, Campinas, Brazil) for (ii).
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Fontes, Marcos R/B-1941-2009; Arni, Raghuvir K/B-2222-2013; Soares,
   Andreimar M/K-5556-2014
OI Fontes, Marcos R/0000-0002-4634-6221; Arni, Raghuvir
   K/0000-0003-2460-1145; Soares, Andreimar/0000-0003-1032-2188
CR Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   BOLANOS R, 1982, REV BIOL TROP, V30, P53
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   FERREIRA ML, 1992, TOXICON, V30, P1603, DOI 10.1016/0041-0101(92)90032-Z
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG HC, 1984, TOXICON, V22, P359, DOI 10.1016/0041-0101(84)90080-1
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KERRIGAN KR, 1991, AM J TROP MED HYG, V44, P93, DOI 10.4269/ajtmh.1991.44.93
   KINI RM, 1989, INT J PEPT PROT RES, V34, P277
   Lee WH, 2001, BIOCHEMISTRY-US, V40, P28, DOI 10.1021/bi0010470
   LIU SY, 1990, J BIOCHEM, V107, P400, DOI 10.1093/oxfordjournals.jbchem.a123057
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760
   NISHIOKA SD, 1992, AM J TROP MED HYG, V47, P805
   Otero R, 1992, IATREIA, V5, P96
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ribeiro L A, 1993, Rev Assoc Med Bras (1992), V39, P4
   ROSENBERG P, 1987, HDB TOXINOLOGY, P62
   Rosenfeld  G., 1971, VENOMOUS ANIMALS THE, P345
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   WAITE M, 1987, PHOSPHOLIPASES HDB L
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 44
TC 7
Z9 7
U1 0
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD OCT
PY 2003
VL 10
IS 5
BP 525
EP 530
DI 10.2174/0929866033478726
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 725XY
UT WOS:000185568700015
PM 14561144
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Shannon, JD
   Valente, RH
   Rucavado, A
   Alape-Giron, A
   Kamiguti, AS
   Theakston, RDG
   Fox, JW
   Gutierrez, JM
   Arni, RK
AF Watanabe, L
   Shannon, JD
   Valente, RH
   Rucavado, A
   Alape-Giron, A
   Kamiguti, AS
   Theakston, RDG
   Fox, JW
   Gutierrez, JM
   Arni, RK
TI Amino acid sequence and crystal structure of BaP1, a metalloproteinase
   from Bothrops asper snake venom that exerts multiple tissue-damaging
   activities
SO PROTEIN SCIENCE
LA English
DT Article
DE snake venom; zinc-dependent metalloproteinases; metzincins; hemorrhagic
   toxins; amino acid sequence; crystal structure
ID PROTEIN CRYSTALLOGRAPHY BEAMLINE; HEMORRHAGIC METALLOPROTEINASE; MATRIX
   METALLOPROTEINASES; PLATELET-AGGREGATION; MOLECULAR-CLONING; DIFFRACTION
   DATA; INHIBITION; DOMAIN; IDENTIFICATION; SERRALYSINS
AB BaP1 is a 22.7-kD P-I-type zinc-dependent metalloproteinase isolated from the venom of the snake Bothrops asper, a medically relevant species in Central America. This enzyme exerts multiple tissue-damaging activities, including hemorrhage, myonecrosis, dermonecrosis, blistering, and edema. BaP1 is a single chain of 202 amino acids that shows highest sequence identity with metalloproteinases isolated front the venoms of snakes of the subfamily Crotalinae. It has six Cys residues involved in three disulfide bridges (Cys 117-Cys 197, Cys 159-Cys 181, Cys 157-Cys 164). It has the consensus sequence H(142)E(143)XXH(146)XXGXXH(152), as well as the sequence C164I165M166, which characterize the "metzincin" superfamily of metalloproteinases. The active-site cleft separates a major subdomain (residues 1-152), comprising four a-helices and a five-stranded beta-sheet, from the minor subdomain, which is formed by a single a-helix and several loops. The catalytic zinc ion is coordinated by the N-epsilon2 nitrogen atoms of His 142, His 146, and His 152, in addition to a solvent water molecule, which in turn is bound to Glu 143. Several conserved residues contribute to the formation of the hydrophobic pocket, and Met 166 serves as a hydrophobic base for the active-site groups. Sequence and structural comparisons of hemorrhagic and nonhemorrhagic P-I metalloproteinases from snake venoms revealed differences in several regions. In particular, the loop comprising residues 153 to 176 has marked structural differences between metalloproteinases with very different hemorrhagic activities. Because this region lies in close proximity to the active-site microenvironment, it may influence the interaction of these enzymes with physiologically relevant substrates in the extracellular matrix.
C1 Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica.
   Univ Liverpool, Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England.
   Univ Liverpool, Liverpool Sch Trop Med, Venom Res Unit, Liverpool L3 5QA, Merseyside, England.
   Fiocruz MS, Dept Fisiol & Farmacodinam, BR-21045900 Rio De Janeiro, Brazil.
   Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA.
   UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose do Rio Preto, Brazil.
RP Gutierrez, JM (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
EM jgutierr@icp.ucr.ac.cr; arni@df.ibilce.unesp.br
RI Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Valente,
   Richard Hemmi/I-5300-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Valente, Richard Hemmi/0000-0002-6562-7571;
   Alape-Giron, Alberto/0000-0003-3934-8496; Gutierrez, Jose
   Maria/0000-0001-8385-3081
FU Wellcome TrustWellcome Trust Funding Source: Medline
CR BARAMOVA EN, 1991, BIOMED BIOCHIM ACTA, V50, P763
   BARAMOVA EN, 1990, MATRIX, V10, P91, DOI 10.1016/S0934-8832(11)80175-7
   BJARNASON JB, 1995, METHOD ENZYMOL, V248, P345
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I
   Bolger MB, 2001, AAPS PHARMSCI, V3
   Botos I, 1996, P NATL ACAD SCI USA, V93, P2749, DOI 10.1073/pnas.93.7.2749
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   FAN HW, 1995, CLIN TOXICOLOGY ANIM, P667
   Farsky SHP, 2000, MEDIAT INFLAMM, V9, P213, DOI 10.1080/09629350020025728
   Gasmi A, 2000, BBA-PROTEIN STRUCT M, V1481, P209, DOI 10.1016/S0167-4838(00)00128-X
   GOMISRUTH FX, 1994, J MOL BIOL, V239, P513, DOI 10.1006/jmbi.1994.1392
   GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x
   Gong WM, 1998, J MOL BIOL, V283, P657, DOI 10.1006/jmbi.1998.2110
   GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   GUTIERREZ JM, 1998, HDB PROTEOLYTIC ENZY, P1295
   GUTIERREZ JM, 1995, CLIN TOXICOLOGY ANIM, P645
   Hati R, 1999, CRIT REV TOXICOL, V29, P1, DOI 10.1080/10408449991349168
   Higgins DG, 1996, METHOD ENZYMOL, V266, P383
   HITE LA, 1994, ARCH BIOCHEM BIOPHYS, V308, P182, DOI 10.1006/abbi.1994.1026
   Huang KF, 2002, ACTA CRYSTALLOGR D, V58, P1118, DOI 10.1107/S090744490200656X
   Jeon OH, 1999, EUR J BIOCHEM, V263, P526, DOI 10.1046/j.1432-1327.1999.00525.x
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635
   Kumasaka T, 1996, J BIOCHEM, V119, P49, DOI 10.1093/oxfordjournals.jbchem.a021215
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LOVEJOY B, 1994, BIOCHEMISTRY-US, V33, P8207, DOI 10.1021/bi00193a006
   MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003
   Moura-Da-Silva AM, 1999, ARCH BIOCHEM BIOPHYS, V369, P295, DOI 10.1006/abbi.1999.1372
   Navaza J, 1994, ACTA CRYSTALLOGR D, V50, P760
   OHSAKA A, 1979, HDB EXPT PHARM, V52, P480
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051
   OWNBY CL, 1990, HDB TOXINOLOGY, P601
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Polikarpov I, 1998, NUCL INSTRUM METH A, V405, P159, DOI 10.1016/S0168-9002(97)01202-3
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   Rucavado A, 2002, MEDIAT INFLAMM, V11, P121, DOI 10.1080/09629350220131980
   Rucavado A, 1998, INT J EXP PATHOL, V79, P245
   Rucavado A, 1995, EXP MOL PATHOL, V63, P186, DOI 10.1006/exmp.1995.1042
   STOCKER W, 1995, PROTEIN SCI, V4, P823
   TAKEYA H, 1990, J BIOCHEM-TOKYO, V108, P711, DOI 10.1093/oxfordjournals.jbchem.a123270
   TAKEYA H, 1989, J BIOCHEM-TOKYO, V106, P151, DOI 10.1093/oxfordjournals.jbchem.a122805
   Tsai IH, 2000, EUR J BIOCHEM, V267, P1359, DOI 10.1046/j.1432-1327.2000.01129.x
   Watanabe L, 2002, ACTA CRYSTALLOGR D, V58, P1034, DOI 10.1107/S0907444902003633
   ZHANG DC, 1994, P NATL ACAD SCI USA, V91, P8447, DOI 10.1073/pnas.91.18.8447
   ZHOU Q, 1995, BIOCHEM J, V307, P411, DOI 10.1042/bj3070411
   Zhu XY, 1999, ACTA CRYSTALLOGR D, V55, P1834, DOI 10.1107/S0907444999010306
NR 54
TC 100
Z9 104
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD OCT
PY 2003
VL 12
IS 10
BP 2273
EP 2281
DI 10.1110/ps.03102403
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 723GW
UT WOS:000185425500016
PM 14500885
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Bell, BJ
   Watanabe, L
   Rios-Steiner, JL
   Tulinsky, A
   Lebioda, L
   Arni, RK
AF Bell, BJ
   Watanabe, L
   Rios-Steiner, JL
   Tulinsky, A
   Lebioda, L
   Arni, RK
TI Structure of 2-keto-3-deoxy-6-phosphogluconate (KDPG) aldolase from
   Pseudomonas putida
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID DIRECTED EVOLUTION; RESOLUTION
AB 2-Keto-3-deoxy-6-phosphogluconate (KDPG) aldolase from Pseudomonas putida is a key enzyme in the Entner-Doudoroff pathway which catalyses the cleavage of KDPG via a class I Schiff-base mechanism. The crystal structure of this enzyme has been refined to a crystallographic residual R = 17.1% (R-free = 21.4%). The N-terminal helix caps one side of the torus of the (betaalpha)(8)-barrel and the active site is located on the opposite, carboxylic side of the barrel. The Schiff-base-forming Lys145 is coordinated by a sulfate (or phosphate) ion and two solvent water molecules. The interactions that stabilize the trimer are predominantly hydrophobic, with the exception of the cyclically permuted bonds formed between Glu132 OE1 of one molecule and Thr129 OG1 of a symmetry-equivalent molecule. Except for the N-terminal helix, the structure of KDPG aldolase from P. putida closely resembles the structure of the homologous enzyme from Escherichia coli.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, R Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [F31GM065062,
   F31GM065062, F31GM065062, F31GM065062] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM65062] Funding Source: Medline
CR Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   DeLano W.L., 2002, PYMOL MOL GRAPHICS S
   DRAUZ K, 1995, ENZYME CATALYSIS OR
   ENTNER N, 1952, J BIOL CHEM, V196, P853
   Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MACGEE J, 1954, J BIOL CHEM, V210, P617
   Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J
   MAVRIDIS IM, 1982, J MOL BIOL, V162, P419, DOI 10.1016/0022-2836(82)90536-8
   MAVRIDIS IM, 1976, BIOCHEMISTRY-US, V15, P4410, DOI 10.1021/bi00665a010
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2
   Shelton MC, 1996, J AM CHEM SOC, V118, P2117, DOI 10.1021/ja952596+
   VANDLEN RL, 1973, J BIOL CHEM, V248, P2251
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4
   Zannetti MT, 1999, CHEM-EUR J, V5, P1882
NR 19
TC 8
Z9 8
U1 1
U2 8
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD AUG
PY 2003
VL 59
BP 1454
EP 1458
DI 10.1107/S0907444903013192
PN 8
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 704DM
UT WOS:000184322700015
PM 12876349
DA 2020-12-01
ER

PT J
AU Abad, MC
   Binderup, K
   Rios-Steiner, J
   Arni, RK
   Preiss, J
   Geiger, JH
AF Abad, MC
   Binderup, K
   Rios-Steiner, J
   Arni, RK
   Preiss, J
   Geiger, JH
TI The X-ray crystallographic structure of Escherichia coli branching
   enzyme
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PANCREATIC ALPHA-AMYLASE; MAIZE ENDOSPERM; CYCLODEXTRIN
   GLYCOSYLTRANSFERASE; ANGSTROM RESOLUTION; AMYLOLYTIC ENZYMES;
   MUTAGENESIS; SPECIFICITY; STABILITY; MECHANISM; RESIDUES
AB Branching enzyme catalyzes the formation of alpha-1,6 branch points in either glycogen or starch. We report the 2.3-Angstrom crystal structure of glycogen branching enzyme from Escherichia coli. The enzyme consists of three major domains, an NH2-terminal seven-stranded beta-sandwich domain, a COOH-terminal domain, and a central alpha/beta-barrel domain containing the enzyme active site. While the central domain is similar to that of all the other amylase family enzymes, branching enzyme shares the structure of all three domains only with isoamylase. Oligosaccharide binding was modeled or branching enzyme using the enzyme-oligosaccharide complex structures of various alpha-amylases and cyclodextrin glucanotransferase and residues were implicated in oligosaccharide binding. While most of the oligosaccharides modeled well in the branching enzyme structure, an approximate 50degrees rotation between two of the glucose units was required to avoid steric clashes with Trp(298) of branching enzyme. A similar rotation was observed in the mammalian alpha-amylase structure caused by an equivalent tryptophan residue in this structure. It appears that there are two binding modes for oligosaccharides in these structures depending on the identity and location of this aromatic residue.
C1 Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   Univ Puerto Rico, Dept Chem, Mayaguez, PR 00681 USA.
   UNESP, IBILCE, Dept Phys, BR-15054400 Sao Jose Dos Campos, SP, Brazil.
RP Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
EM preiss@pilot.msu.edu; geiger@cem.msu.edu
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Geiger, James/0000-0002-9443-4488
CR Abad MC, 2002, ACTA CRYSTALLOGR D, V58, P359, DOI 10.1107/S090744490102073X
   BABA T, 1991, BIOCHEM BIOPH RES CO, V181, P87, DOI 10.1016/S0006-291X(05)81385-3
   Bao Y, 1996, J CLIN INVEST, V97, P941, DOI 10.1172/JCI118517
   Binderup K, 1998, BIOCHEMISTRY-US, V37, P9033, DOI 10.1021/bi980199g
   Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V377, P366, DOI 10.1006/abbi.2000.1815
   Binderup K, 2000, ARCH BIOCHEM BIOPHYS, V374, P73, DOI 10.1006/abbi.1999.1580
   Binderup M, 2002, ARCH BIOCHEM BIOPHYS, V397, P279, DOI 10.1006/abbi.2001.2544
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i
   BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CHEN YT, 1995, METABOLIC MOL BASES, V1, P935
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   DIMAURO S, 1994, MYOLOGY, V2, P1554
   Funane K, 1998, J PROTEIN CHEM, V17, P579, DOI 10.1007/BF02780959
   GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269
   Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115
   Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438
   Hong SJ, 2001, ARCH BIOCHEM BIOPHYS, V386, P62, DOI 10.1006/abbi.2000.2179
   JESPERSEN HM, 1991, BIOCHEM J, V280, P51, DOI 10.1042/bj2800051
   JESPERSEN HM, 1993, J PROTEIN CHEM, V12, P791, DOI 10.1007/BF01024938
   Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992
   KLEIN C, 1991, J MOL BIOL, V217, P737, DOI 10.1016/0022-2836(91)90530-J
   Kuriki T, 1996, J PROTEIN CHEM, V15, P305, DOI 10.1007/BF01887119
   Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999
   Libessart N, 1998, ARCH BIOCHEM BIOPHYS, V360, P135, DOI 10.1006/abbi.1998.0960
   MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659
   Mikkelsen R, 2001, ARCH BIOCHEM BIOPHYS, V385, P372, DOI 10.1006/abbi.2000.2164
   NICHOLLS A, 1993, BIOPHYS J, V64, pA166
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Qian MX, 2001, BIOCHEMISTRY-US, V40, P7700, DOI 10.1021/bi0102050
   ROMEO T, 1988, GENE, V70, P363, DOI 10.1016/0378-1119(88)90208-9
   SCHRODER JM, 1993, ACTA NEUROPATHOL, V85, P419, DOI 10.1007/BF00334454
   SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233
   TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C
   TAO BY, 1989, BIOCHIM BIOPHYS ACTA, V995, P214, DOI 10.1016/0167-4838(89)90038-1
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235
   Uitdehaag JCM, 2000, BIOCHEMISTRY-US, V39, P7772, DOI 10.1021/bi000340x
NR 39
TC 88
Z9 92
U1 1
U2 28
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 1
PY 2002
VL 277
IS 44
BP 42164
EP 42170
DI 10.1074/jbc.M205746200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 610WR
UT WOS:000178985300109
PM 12196524
OA Bronze
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Nirthanan, S
   Rajaseger, G
   Polikarpov, I
   Kini, RM
   Arni, RK
AF Watanabe, L
   Nirthanan, S
   Rajaseger, G
   Polikarpov, I
   Kini, RM
   Arni, RK
TI Crystallization and preliminary X-ray analysis of bucain, a novel toxin
   from the Malayan krait Bungarus candidus
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID PROTEIN CRYSTALLOGRAPHY BEAMLINE; VENOM ALPHA-NEUROTOXINS; BLACK MAMBA
   VENOM; ACETYLCHOLINE-RECEPTORS; CALCIUM-CHANNEL; LY-6 FAMILY; ALIGNMENT;
   SEQUENCE; BLOCKER
AB Bucain is a three-finger toxin, structurally homologous to snake-venom muscarinic toxins, from the venom of the Malayan krait Bungarus candidus. These proteins have molecular masses of approximately 6000-8000 Da and encompass the potent curaremimetic neurotoxins which confer lethality to Elapidae and Hydrophidae venoms. Bucain was crystallized in two crystal forms by the hanging-drop vapour-diffusion technique in 0.1 M sodium citrate pH 5.6, 15% PEG 4000 and 0.15 M ammonium acetate. Form I crystals belong to the monoclinic system space group C2, with unit-cell parameters a = 93.73, b = 49.02, c = 74.09 Angstrom, beta = 111.32degrees, and diffract to a nominal resolution of 1.61 Angstrom. Form II crystals also belong to the space group C2, with unit-cell parameters a = 165.04, b = 49.44, c = 127.60 Angstrom, beta = 125.55degrees, and diffract to a nominal resolution of 2.78 Angstrom. The self-rotation function indicates the presence of four and eight molecules in the crystallographic asymmetric unit of the form I and form II crystals, respectively. Attempts to solve these structures by molecular-replacement methods have not been successful and a heavy-atom derivative search has been initiated.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Natl Univ Singapore, Fac Med, Singapore 117548, Singapore.
   Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 119260, Singapore.
   Lab Nacl Luz Sincrotron, Campinas, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Polikarpov, Igor/D-2575-2012; Kini,
   Manjunatha/H-8029-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Polikarpov,
   Igor/0000-0001-9496-4174; Kini, Manjunatha/0000-0002-6100-3251;
   Nirthanan, S. Niru/0000-0001-9888-8447
CR ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BILWES A, 1994, J MOL BIOL, V239, P122, DOI 10.1006/jmbi.1994.1357
   Cervenansky C., 1991, P303
   DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437
   Endo T., 1991, P165
   FLEMING TJ, 1993, J IMMUNOL, V150, P5379
   GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45
   JERUSALINSKY D, 1994, TRENDS PHARMACOL SCI, V15, P424, DOI 10.1016/0165-6147(94)90092-2
   Kuhn P, 2000, ACTA CRYSTALLOGR D, V56, P1401, DOI 10.1107/S0907444900011501
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004
   Mebs D, 1991, SNAKE TOXINS, P425
   Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2
   Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1
   Polikarpov I, 1998, NUCL INSTRUM METH A, V405, P159, DOI 10.1016/S0168-9002(97)01202-3
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x
NR 22
TC 5
Z9 6
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD OCT
PY 2002
VL 58
SI 2
BP 1879
EP 1881
DI 10.1107/S0907444902011022
PN 10
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 597YJ
UT WOS:000178248100027
PM 12351845
DA 2020-12-01
ER

PT J
AU Bortoleto, RK
   Murakami, MT
   Watanabe, L
   Soares, AM
   Arni, RK
AF Bortoleto, RK
   Murakami, MT
   Watanabe, L
   Soares, AM
   Arni, RK
TI Purification, characterization and crystallization of Jararacussin-I, a
   fibrinogen-clotting enzyme isolated from the venom of Bothrops
   jararacussu
SO TOXICON
LA English
DT Article
DE Bothrops jararacussu snake venom; thrombin-like enzyme;
   fibrinogen-clotting enzyme; purification; characterization and
   crystallization
ID EXOGENOUS HEMOSTATIC FACTORS; THROMBIN-LIKE ENZYME; AMINO-ACID-SEQUENCE;
   SNAKE-VENOM; ALPHA-FIBRINOGENASE; SERINE-PROTEASE; INVENTORY; PROTEINS
AB A fibrinogen-clotting enzyme, Jararacussin-I, was purified from the venom of Bothrops jararacussu by a combination of ion exchange chromatography using Resource 15S resin and affinity chromatography using Benzamidine Sepharose 6B resin. Jararacussin-I displays a molecular mass of 28 kDa as estimated by sodium dodecyl sulphate-PAGE and possesses an isoetectric point of 5.0. The coagulant specific activity of the enzyme was determined to be 45.8 NIH U/mg using bovine fibrinogen as the substrate and the esterase specific activity was determined to be 258.7 U/mg. The protease inhibitors, benzamidine and DTT inhibited the esterase specific activity by 72.4 and 69.7%, respectively. The optimal temperature and pH for the degradation of both chains of fibrinogen and esterase specific activity were determined to be 37 degreesC and 7.4-8.0, respectively. The enzyme was inactivated at both 4 and 75 T. Single crystals of Jararacussin-I were obtained and complete three-dimensional X-ray diffraction data was collected at the Brazilian National Synchrotron Source (LNLS) to a resolution of 2.4 Angstrom. (C) 2002 Published by Elsevier Science Ltd.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   UNAERP, Dept Biotechnol, Ribeirao Preto, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Cristovao Colombo 1165,Caixa Postal 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI Murakami, Mario T/C-2087-2012; Arni, Raghuvir K/N-9338-2018; Murakami,
   Mario T/F-5640-2016; Arni, Raghuvir K/B-2222-2013; Soares, Andreimar
   M/K-5556-2014
OI Arni, Raghuvir K/0000-0003-2460-1145; Murakami, Mario
   T/0000-0002-0405-8010; Arni, Raghuvir K/0000-0003-2460-1145; Soares,
   Andreimar/0000-0003-1032-2188
CR Aguiar AS, 1996, TOXICON, V34, P555, DOI 10.1016/0041-0101(95)00159-X
   AndriaoEscarso SH, 1997, TOXICON, V35, P1043, DOI 10.1016/S0041-0101(96)00222-X
   ARAGONORTIZ F, 1993, TOXICON, V31, P1435, DOI 10.1016/0041-0101(93)90209-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURKHART W, 1992, FEBS LETT, V297, P297, DOI 10.1016/0014-5793(92)80559-Y
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   EHRENPREIS S, 1957, J BIOL CHEM, V227, P1043
   FARID TM, 1989, BIOCHEMISTRY-US, V28, P371, DOI 10.1021/bi00427a051
   GAFFNEY P J, 1973, Biochemical Society Transactions, V1, P1208
   HALTON MWC, 1973, BIOCHEM J, V131, P799
   Henschen-Edman AH, 1999, THROMB HAEMOSTASIS, V81, P81
   HUANG QQ, 1983, TOXICON, V37, P999
   ITOH N, 1987, J BIOL CHEM, V262, P3132
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MARKLAND FS, 1991, THROMB HAEMOSTASIS, V65, P438
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Matsui T, 1998, EUR J BIOCHEM, V252, P569, DOI 10.1046/j.1432-1327.1998.2520569.x
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   NISHIDA S, 1994, BIOCHEMISTRY-US, V33, P1843, DOI 10.1021/bi00173a030
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   OUYANG C, 1992, TOXICON, V30, P945, DOI 10.1016/0041-0101(92)90040-C
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Pirkle H, 1998, THROMB HAEMOSTASIS, V79, P675
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958
   SHIEH JC, 1988, J BIOCHEM-TOKYO, V103, P596
   SHIEH TC, 1985, J BIOCHEM, V98, P713, DOI 10.1093/oxfordjournals.jbchem.a135329
   Tu AT, 1996, ADV EXP MED BIOL, V391, P37
   VESTERBERG O, 1972, BIOCHIM BIOPHYS ACTA, V257, P11, DOI 10.1016/0005-2795(72)90248-6
   WARE AG, 1949, AM J CLIN PATHOL, V19, P471
   Zaganelli GL, 1996, TOXICON, V34, P807, DOI 10.1016/0041-0101(96)00006-2
NR 32
TC 29
Z9 30
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP
PY 2002
VL 40
IS 9
BP 1307
EP 1312
AR PII S0041-0101(02)00140-X
DI 10.1016/S0041-0101(02)00140-X
PG 6
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 604EM
UT WOS:000178603500008
PM 12220716
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Rucavado, A
   Kamiguti, A
   Theakston, RDG
   Gutierrez, JM
   Arni, RK
AF Watanabe, L
   Rucavado, A
   Kamiguti, A
   Theakston, RDG
   Gutierrez, JM
   Arni, RK
TI Crystallization and preliminary diffraction data of BaP1, a haemorrhagic
   metalloproteinase from Bothrops asper snake venom
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID PROTEINS; DAMAGE
AB BaP1 is a metalloproteinase isolated from the venom of the Central American snake Bothrops asper (terciopelo). It is a 24 kDa protein consisting of a single chain which includes the metalloproteinase domain only, therefore being classified as a class P-I snake-venom metalloproteinase. BaP1 induces prominent local tissue damage, such as haemorrhage, myonecrosis, blistering, dermonecrosis and oedema. In order to elucidate its structure, BaP1 was crystallized by the hanging-drop vapour-diffusion technique in 0.1 M bicine pH 9.0, 10% PEG 20 000 and 2%(v/v) dioxane. Diffraction data were observed to a resolution of 2.7 Angstrom. Crystals belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 38.22, b = 60.17, c = 86.09 Angstrom.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Univ Liverpool, Dept Haematol, Liverpool L69 3BX, Merseyside, England.
   Univ Liverpool, Liverpool Sch Trop Med, Venom Res Unit, Liverpool L3 5QA, Merseyside, England.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, Brazil.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Gutierrez, Jose
   Maria/0000-0001-8385-3081
CR BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I
   Farsky SHP, 2000, MEDIAT INFLAMM, V9, P213, DOI 10.1080/09629350020025728
   GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x
   Gong WM, 1998, J MOL BIOL, V283, P657, DOI 10.1006/jmbi.1998.2110
   GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   HITE LA, 1994, ARCH BIOCHEM BIOPHYS, V308, P182, DOI 10.1006/abbi.1994.1026
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kumasaka T, 1996, J BIOCHEM, V119, P49, DOI 10.1093/oxfordjournals.jbchem.a021215
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   OHSAKA A, 1979, HDB EXPT PHARM, V52, P480
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rucavado A, 1998, INT J EXP PATHOL, V79, P245
   Rucavado A, 1995, EXP MOL PATHOL, V63, P186, DOI 10.1006/exmp.1995.1042
   ZHANG DC, 1994, P NATL ACAD SCI USA, V91, P8447, DOI 10.1073/pnas.91.18.8447
NR 19
TC 2
Z9 2
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD JUN
PY 2002
VL 58
SI 2
BP 1034
EP 1035
DI 10.1107/S0907444902003633
PN 6
PG 2
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 563TG
UT WOS:000176271200016
PM 12037308
OA Green Published
DA 2020-12-01
ER

PT J
AU Watanabe, L
   Vieira, DF
   Bortoleto, RK
   Arni, RK
AF Watanabe, L
   Vieira, DF
   Bortoleto, RK
   Arni, RK
TI Crystallization of bothrombin, a fibrinogen-converting serine protease
   isolated from the venom of Bothrops jararaca
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID SNAKE-VENOM; FIBRINOPEPTIDE-B; PURIFICATION; ENZYME; ACTIVATOR
AB Bothrombin, a snake-venom serine protease, specifically cleaves fibrinogen, releasing fibrinopeptide A to form non-crosslinked soft clots, aggregates platelets in the presence of exogeneous fibrinogen and activates blood coagulation factor VIII. Bothrombin shares high sequence homology with other snake-venom proteases such as batroxobin (94% identity), but only 30 and 34% identity with human alpha-thrombin and trypsin, respectively. Single crystals of bothrombin have been obtained and X-ray diffraction data have been collected at the Laboratorio Nacional de Luz Sincrotron to a resolution of 2.8 Angstrom. The crystals belong to the space group P2(1)2(1)2(1), with unit-cell parameters a = 94.81, b = 115.68, c = 155.97 Angstrom.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, Brazil.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
CR Aguiar AS, 1996, TOXICON, V34, P555, DOI 10.1016/0041-0101(95)00159-X
   ARAGONORTIZ F, 1981, TOXICON, V19, P799
   F Kornalik, 1990, HDB TOXICOLOGY, P697
   HERZIG RH, 1970, J LAB CLIN MED, V76, P451
   IWASAKI A, 1990, J BIOCHEM, V108, P822, DOI 10.1093/oxfordjournals.jbchem.a123287
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KORNALIK F, 1990, HDB TOXICOLOGY, P18
   MARKLAND FS, 1983, J TOXICOL-TOXIN REV, V2, P119, DOI 10.3109/15569548309012695
   MARRAKCHI N, 1995, BBA-GEN SUBJECTS, V1244, P147, DOI 10.1016/0304-4165(94)00216-K
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   NIEWIAROWSKI S, 1979, BIOCHEMISTRY-US, V18, P3570, DOI 10.1021/bi00583a021
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   OUYANG C, 1976, BIOCHIM BIOPHYS ACTA, V420, P298, DOI 10.1016/0005-2795(76)90321-4
   OUYANG C, 1979, TOXICON, V17, P121, DOI 10.1016/0041-0101(79)90290-3
   Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   RAWALA R, 1978, CIRCULATION, V58, P209
   SATO T, 1965, J BIOCHEM, V57, P380, DOI 10.1093/oxfordjournals.jbchem.a128092
   SCHIFFMAN S, 1969, BIOCHEMISTRY-US, V8, P1397, DOI 10.1021/bi00832a014
   SCHMAIER AH, 1980, BLOOD, V56, P1013
   SELISTRE HS, 1987, TOXICON, V25, P1135, DOI 10.1016/0041-0101(87)90131-0
NR 21
TC 8
Z9 10
U1 0
U2 1
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD JUN
PY 2002
VL 58
SI 2
BP 1036
EP 1038
DI 10.1107/S0907444902003645
PN 6
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 563TG
UT WOS:000176271200017
PM 12037309
OA Green Published
DA 2020-12-01
ER

PT J
AU Abad, MC
   Arni, RK
   Grella, DK
   Castellino, FJ
   Tulinsky, A
   Geiger, JH
AF Abad, MC
   Arni, RK
   Grella, DK
   Castellino, FJ
   Tulinsky, A
   Geiger, JH
TI The X-ray crystallographic structure of the angiogenesis inhibitor
   angiostatin
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE angiogenesis; plasminogen; coagulation; crystal structure; kringle
   domains
ID STREPTOCOCCAL SURFACE PROTEIN; HUMAN PLASMINOGEN KRINGLE-4;
   EPSILON-AMINOCAPROIC ACID; ENDOTHELIAL-CELLS; ANTIANGIOGENIC ACTIVITY;
   BINDING DETERMINANTS; TUMOR-GROWTH; DOMAIN; CANCER; ENDOSTATIN
AB Angiogenesis inhibitors have gained much public attention recently as anti-cancer agents and several are currently in clinical trials, including angiostatin (Phase I, Thomas Jefferson University Hospital, Philadelphia, PA). We report here the bowl-shaped structure of angiostatin kringles 1-3, the first multi-kringle structure to be determined. All three kringle lysine-binding sites contain a bound bicine molecule of crystallization while the former of kringle 2 and kringle 3 are cofacial. Moreover, the separation of the kringle 2 and kringle 3 lysiner binding sites is sufficient to accommodate the a-helix of the 30 residue pepticle VEK-30 found in the kringle 2/VEK-30 complex. Together the three kringles produce a central cavity suggestive of a unique domain where they may function in concert. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   UNESP, IBILCE, Dept Phys, BR-1504000 San Jose De Rio Preto, SP, Brazil.
   EntreMed Inc, Rockville, MD 20850 USA.
   Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.
   Univ Notre Dame, Wm Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.
RP Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Geiger, James/0000-0002-9443-4488
FU NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL013423, R01HL025942,
   R01HL013423, R01HL043229, R01HL043229, R01HL013423, R01HL025942,
   R37HL013423, R01HL043229, R37HL013423, R01HL013423, R01HL013423,
   R01HL025942, R01HL043229, R01HL043229, R01HL025942, R01HL013423,
   R01HL043229, R01HL013423, R37HL013423, R01HL013423, R01HL013423,
   R37HL013423, R01HL013423, R01HL043229, R01HL025942, R01HL025942,
   R01HL043229, R01HL025942, R01HL013423, R01HL013423, R01HL025942,
   R01HL013423, R01HL025942, R37HL013423, R01HL013423, R01HL043229,
   R37HL013423, R01HL013423, R37HL013423, R01HL043229, R01HL013423,
   R01HL013423, R01HL043229, R01HL043229, R01HL043229, R01HL013423,
   R01HL013423, R37HL013423, R37HL013423, R01HL025942, R01HL013423,
   R01HL013423, R37HL013423, R01HL013423, R01HL025942, R01HL025942,
   R01HL025942, R01HL013423, R01HL043229, R01HL025942, R01HL043229] Funding
   Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [HL25942, HL13423, HL43229] Funding
   Source: Medline
CR Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Burgin J, 1999, CELL MOL LIFE SCI, V55, P135, DOI 10.1007/s000180050278
   Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728
   Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e
   Feldman AL, 2000, CANCER-AM CANCER SOC, V89, P1181
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868
   Graversen JH, 2000, BIOCHEMISTRY-US, V39, P7414, DOI 10.1021/bi000155j
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Hohenester E, 1998, EMBO J, V17, P1656, DOI 10.1093/emboj/17.6.1656
   Joe YA, 1999, INT J CANCER, V82, P694, DOI 10.1002/(SICI)1097-0215(19990827)82:5<694::AID-IJC12>3.0.CO;2-C
   Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   Lee H, 2000, ARCH BIOCHEM BIOPHYS, V375, P359, DOI 10.1006/abbi.1999.1675
   MacDonald NJ, 1999, BIOCHEM BIOPH RES CO, V264, P469, DOI 10.1006/bbrc.1999.1486
   MARTZ FA, 1994, P FORAG GR, V3, P219
   Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351
   MCCANCE SG, 1994, J BIOL CHEM, V269, P32405
   Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811
   MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Otwinowski Z., 1993, DATA COLLECTION PROC, P56
   RAMAKRISHNAN V, 1991, BIOCHEMISTRY-US, V30, P3963, DOI 10.1021/bi00230a023
   Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646
   Scappaticci FA, 2001, MOL THER, V3, P186, DOI 10.1006/mthe.2000.0243
   Shepard SR, 2000, PROTEIN EXPRES PURIF, V20, P216, DOI 10.1006/prep.2000.1276
   Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200
   THORSEN S, 1981, BIOCHIM BIOPHYS ACTA, V668, P377, DOI 10.1016/0005-2795(81)90171-9
   Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247
   WINN ES, 1980, EUR J BIOCHEM, V104, P579, DOI 10.1111/j.1432-1033.1980.tb04461.x
   WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030
NR 37
TC 31
Z9 34
U1 0
U2 5
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 10
PY 2002
VL 318
IS 4
BP 1009
EP 1017
DI 10.1016/S0022-2836(02)00211-5
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 554ZT
UT WOS:000175767800008
PM 12054798
DA 2020-12-01
ER

PT J
AU Langer, K
   Tillmanns, E
   Kersten, M
   Almen, H
   Arni, RK
AF Langer, K
   Tillmanns, E
   Kersten, M
   Almen, H
   Arni, RK
TI The crystal chemistry of Mn3+ in the clino- and orthozoisite structure
   types, Ca2M33+[OH vertical bar O vertical bar SiO4 vertical bar Si2O7]:
   A structural and spectroscopic study of some natural piemontites and
   "thulites" and their synthetic equivalents
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE
LA English
DT Article
ID DISTANCES; POLYHEDRA
AB Six new structure refinements and eleven sets of polarised, single-crystal electronic absorption spectra, E parallel to X, Y and Z, in the energy range 35000-5000 cm(-1) were obtained on natural and synthetic orthozoisite-type "thulites" and clinozoisite-type piemontites: Ca-2(Al3--pMp3+) [OH\O\SiO4\Si2O7] where M3+ = Mn3+ or (Mn1--n3+Fen3+) for the synthetic or natural minerals, respectively. Electron microprobe analyses of the single crystals studied revealed substitutional degrees PM3+ = 0.13 or 0.51 in natural and synthetic "thulite", respectively, and 0.57 less than or equal to p(M3+) less than or equal to 1.17 or 0.83 less than or equal to p(M3+) less than or equal to 1.47 in the natural or synthetic piemontites, respectively.
   Manganese in "thulite" is trivalent, as it is in piemontite. In both structure types, M3+ fractionates strongly into the axially compressed [M(3)O-6] polyhedra, and does not enter the M(2) sites. Mean M(3)-O and M(l)-O distances increase in both structures, compared to the M3+-free Al end members. Such distance changes in piemontite are +0.47% and +0.53% per 0.1x(M3+), respectively, (x = site fraction). The bending angle of the Si2O7-group in cis-configuration, <Si(l)-O(9)-Si(2), decreases from 164.4degrees in clinozoisite to 147.4degrees in the most Mn3+-rich synthetic piemontite with PMn3+ = 1.47 (emp) or x(Mn3+(M3)) = 0.931 and x(Mn3+(M1)) = 0.460 (from structure refinement).
   The detailed evaluation of the changes, due to Al-->M3+ substitution, of individual bond lengths, as well as the quantitative evaluation of the intensities of the strong spin-allowed dd bands of Mn3+ in M(3), prove that in natural pieniontite the preference of Mn3+ for M(3) over M(l) is more pronounced than that of Fe3+. This is in accord with the Jahn-Teller effect of 3d(4)-configurated Mn3+. In addition, evaluation of the individual M(3)-O(i) distances with increasing x(Mn3+(M3)) in piemontite indicates that the axial compression of the [M(3)O-6] polyhedra increases.
C1 Univ Vienna, Geozentrum, Inst Mineral & Kristallog, A-1090 Vienna, Austria.
   Tech Univ Berlin, Inst Angew Geowissensch, D-10623 Berlin, Germany.
   Univ Wurzburg, Inst Mineral, D-97074 Wurzburg, Germany.
RP Tillmanns, E (corresponding author), Univ Vienna, Geozentrum, Inst Mineral & Kristallog, A-1090 Vienna, Austria.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
CR ABSWURMBACH I, 1983, J PETROL, V24, P48, DOI 10.1093/petrology/24.1.48
   ABSWURMBACH I, 1981, Z KRISTALLOGR, V155, P81, DOI 10.1524/zkri.1981.155.1-2.81
   ANASTASIOU P, 1977, CONTRIB MINERAL PETR, V60, P225, DOI 10.1007/BF01166798
   BAUR WH, 1986, SADIAN86
   BURNHAM CW, 1961, Z KRISTALLOGR, V115, P269
   BURNS RG, 1967, MINERAL MAG J M SOC, V36, P204, DOI 10.1180/minmag.1967.036.278.04
   CEMIC L, 1990, NEUES JB MINER MONAT, P49
   CHINNER GA, 1969, AM J SCI, V267, P96
   DOLLASE WA, 1969, AM MINERAL, V54, P710
   DOLLASE WA, 1968, AM MINERAL, V53, P1882
   FINGER LW, 1975, 854 US NAT BUR STAND
   FRENTRUP KR, 1981, NEUES JB MINER MONAT, P245
   Frentrup KR, 1982, HIGH PRESSURE RES GE, P247
   GABE EJ, 1973, AM MINERAL, V58, P218
   Ibers J.A., 1974, INT TABLES XRAY CRYS, VIV
   Jahn HA, 1937, PROC R SOC LON SER-A, V161, P220, DOI 10.1098/rspa.1937.0142
   KERSTEN M, 1988, Z KRISTALLOGR, V185, P111
   KESKINEN M, 1987, J METAMORPH GEOL, V5, P495, DOI 10.1111/j.1525-1314.1987.tb00398.x
   Konig E., 1977, LIGAND FIELD ENERGY
   LANGER K, 1982, PHYS CHEM MINER, V8, P143, DOI 10.1007/BF00311285
   LANGER K, 1976, Z KRISTALLOGR, V144, P434
   LANGER K, 1977, PHYS CHEM MINER, V1, P273, DOI 10.1007/BF00307568
   Langer K, 2001, Z KRISTALLOGR, V216, P87, DOI 10.1524/zkri.216.2.87.20330
   Langer K, 1988, PHYSICAL PROPERTIES, P639
   MARFUNIN AS, 1979, PHYSICS MINERALS INO
   ROBINSON K, 1971, SCIENCE, V172, P567, DOI 10.1126/science.172.3983.567
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   SHELDRICK G, 1976, PROGRAMS CRYSTAL STR
   SMITH G, 1982, PHYS CHEM MINER, V8, P138
   STRENS RGJ, 1966, MINERAL MAG J M SOC, V35, P777, DOI 10.1180/minmag.1966.035.273.15
   STRUNZ H, 1978, KLOCKMANNS LEHRBUCH, P698
   TILLMANNS E, 1984, 13 INT C CRYST HAMB
   TROGER WE, 1952, TABELLEN GESTEINSBIL
   Wilson E.B., 1955, MOL VIBRATIONS
NR 34
TC 27
Z9 27
U1 1
U2 3
PU R OLDENBOURG VERLAG
PI MUNICH
PA LEKTORAT M/N, K BERBER-NERLINGER, POSTFACH 80 13 60, D-81613 MUNICH,
   GERMANY
SN 0044-2968
J9 Z KRISTALLOGR
JI Z. Kristall.
PY 2002
VL 217
IS 11
BP 563
EP 580
DI 10.1524/zkri.217.11.563.20780
PG 18
WC Crystallography
SC Crystallography
GA 635BL
UT WOS:000180376900001
DA 2020-12-01
ER

PT J
AU Soares, AM
   Andriao-Escarso, SH
   Bortoleto, RK
   Rodrigues-Simioni, L
   Arni, RK
   Ward, RJ
   Gutierrez, JM
   Giglio, JR
AF Soares, AM
   Andriao-Escarso, SH
   Bortoleto, RK
   Rodrigues-Simioni, L
   Arni, RK
   Ward, RJ
   Gutierrez, JM
   Giglio, JR
TI Dissociation of enzymatic and pharmacological properties of piratoxins-I
   and -III, two myotoxic phospholipases A(2) from Bothrops pirajai snake
   venom
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bothrops pirajai; myotoxins; phospholipases A(2); pharmacological
   activities; chemical modifications; circular dichroism; crystal
   structure
ID AMINO-ACID-SEQUENCE; A(2) HOMOLOG; BIOCHEMICAL-CHARACTERIZATION;
   FUNCTIONAL-CHARACTERIZATION; ACCELERATED EVOLUTION;
   BIOLOGICAL-ACTIVITIES; ASPER; LYS49; ANTICOAGULANT; PROTEINS
AB Piratoxins (PrTX) I and III are phospholipases A(2) (PLA(2)s) or PLA(2) homologue myotoxins isolated from Bothrops pirajai snake venom, which also induce myonecrosis, bactericidal activity against Escherichia coli, disruption of artificial membranes, and edema. PrTX-III is a catalytically active hemolytic and anticoagulant Asp49 PLA(2), while PrTX-I is a Lys49 PLA, homologue, which is catalytically inactive on artificial substrates, but promotes blockade of neuromuscular transmission. Chemical modifications of His, Lys, Tyr, and Trp residues of PrTX-I and PrTX-III were performed, together with cleavage of the N-terminal octapeptide by CNBr and inhibition by heparin and EDTA. The lethality, bactericidal activity, myotoxicity, neuromuscular effect, edema inducing effect, catalytic and anticoagulant activities, and the liposome-disruptive activity of the modified toxins were evaluated. A complex pattern of functional differences between the modified and native toxins was observed. However, in general, chemical modifications that significantly affected the diverse pharmacological effects of the toxins did not influence catalytic or membrane disrupting activities. Analysis of structural changes by circular dichroism spectroscopy demonstrated significant changes in the secondary structure only in the case of N-terminal octapeptide cleavage. These data indicate that PrTX-I and PrTX-III possess regions other than the catalytic site, which determine their toxic and pharmacological activities. (C) 2001 Academic Press.
C1 Univ Sao Paulo, Fac Med, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Quim & Fis, BR-14049900 Ribeirao Preto, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Quim, BR-14049 Ribeirao Preto, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Farmacol, Campinas, SP, Brazil.
   Univ Estadual Paulista, IBILCE, Dept Fis Biofis, Sao Jose Do Rio Preto, SP, Brazil.
RP Giglio, JR (corresponding author), Univ Sao Paulo, Fac Med, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, Brazil.
EM jrgiglio@fmrp.usp.br
RI Ward, Richard/C-2460-2012; Soares, Andreimar M/K-5556-2014; Arni,
   Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Arni, Raghuvir K/0000-0003-2460-1145; Soares,
   Andreimar/0000-0003-1032-2188; Gutierrez, Jose Maria/0000-0001-8385-3081
CR ALVARADO J, 1988, REV BIOL TROP, V36, P563
   Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175
   Calderon L, 1998, ARCH BIOCHEM BIOPHYS, V358, P343, DOI 10.1006/abbi.1998.0853
   Canduri F, 1998, TOXICON, V36, P547, DOI 10.1016/S0041-0101(97)00120-7
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P103, DOI 10.1016/0005-2744(68)90248-9
   Dessen A, 2000, STRUCT FOLD DES, V8, pR15, DOI 10.1016/S0969-2126(00)00097-6
   DIAZ C, 1994, ARCH BIOCHEM BIOPHYS, V312, P336, DOI 10.1006/abbi.1994.1317
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1988, TOXICON, V26, P411, DOI 10.1016/0041-0101(88)90010-4
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HELENIUS A, 1977, P NATL ACAD SCI USA, V74, P529, DOI 10.1073/pnas.74.2.529
   Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lomonte B, 1999, BBA-BIOMEMBRANES, V1461, P19, DOI 10.1016/S0005-2736(99)00143-1
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   Mounier CM, 2000, EUR J BIOCHEM, V267, P4960, DOI 10.1046/j.1432-1327.2000.01523.x
   Nicolas JP, 1997, J BIOL CHEM, V272, P7173, DOI 10.1074/jbc.272.11.7173
   Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307
   Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x
   REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Rodrigues VM, 1998, COMP BIOCHEM PHYS A, V121, P215, DOI 10.1016/S1095-6433(98)10136-8
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V373, P7, DOI 10.1006/abbi.1999.1492
   Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5
   Soares AM, 2000, ARCH BIOCHEM BIOPHYS, V378, P201, DOI 10.1006/abbi.2000.1790
   SOARES AM, 2001, UNPUB INT J BIOCH CE
   SOONS KR, 1986, TOXICON, V24, P679, DOI 10.1016/0041-0101(86)90031-0
   TAKASAKI C, 1990, TOXICON, V28, P107, DOI 10.1016/0041-0101(90)90012-V
   Toyama MH, 1998, J PROTEIN CHEM, V17, P713, DOI 10.1007/BF02780974
   Toyama MH, 2000, BIOCHIMIE, V82, P245, DOI 10.1016/S0300-9084(00)00202-9
   Toyama MH, 1999, J PROTEIN CHEM, V18, P371, DOI 10.1023/A:1021051831740
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
NR 47
TC 92
Z9 95
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2001
VL 387
IS 2
BP 188
EP 196
DI 10.1006/abbi.2000.2244
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 413WG
UT WOS:000167634100003
PM 11370840
DA 2020-12-01
ER

PT J
AU Krishnan, R
   Mochalkin, I
   Arni, R
   Tulinsky, A
AF Krishnan, R
   Mochalkin, I
   Arni, R
   Tulinsky, A
TI Structure of thrombin complexed with selective non-electrophilic
   inhibitors having cyclohexyl moieties at P1
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID HUMAN ALPHA-THROMBIN; ACTIVE-SITE; BINDING-SITE; MIMETICS; DESIGN;
   REFINEMENT; ACTIVATION; POSITION; RESIDUES; PROTEINS
AB The crystal structures of five new non-electrophilic beta-strand-templated thrombin active-site inhibitors, have been determined bound to the enzyme. Four co-crystallize with hirugen and inhibitor isomorphously to produce thrombin-hirugen crystals (monoclinic, space group C2), while one co-crystallizes in the hexagonal system, space group P6(5). A 1,4-substituted cyclohexyl moiety is conserved at the P1 position of all the inhibitors, along with a fused hetero-bicyclic five- and six-membered ring that occupies the P2 site. Amino, amidino and aminoimidazole groups are attached to the cyclohexyl ring for recognition at the S1 specificity site, while benzylsulfonyl and diphenyl groups enhance the binding at the S3 subsite. The cyclohexyl groups at the P1 positions of three of the inhibitors appear to be in the energetically favored chair conformation, while the imidazole-substituted cyclohexyl rings are in a boat conformation Somewhat unexpectedly, the two cyclohexyl-aminoimidazole groups bind differently in the specificity site; the unique binding of one is heretofore unreported. The other inhibitors generally mimic arginyl binding at S1. This group of inhibitors combines the nonelectrophilicity and selectivity of DAPA-like compounds and the more optimal binding features of the S1-S3 sites of thrombin for peptidic molecules, which results in highly potent (binding constants 12 nM-16 pM, one being 1.1 mu M) and selective (ranging from 140 to 20 000 times more selective compared with trypsin) inhibitors of thrombin, The binding modes of these novel inhibitors are correlated with their binding constants, as is their selectivity, in order to provide further insight: for the design of therapeutic antithrombotic agents that inhibit thrombin directly at the active site.
C1 Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
RP Tulinsky, A (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
EM tulinsky@cem.msu.edu
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL43229] Funding Source: Medline; NATIONAL HEART,
   LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229] Funding Source: NIH RePORTER
CR BALASUBRAMANIAN BN, 1995, BIOORGAN MED CHEM, V3, P999
   BANNER DW, 1991, J BIOL CHEM, V266, P20085
   Boatman PD, 1999, J MED CHEM, V42, P1367, DOI 10.1021/jm980354p
   BODE W, 1992, PROTEIN SCI, V1, P426
   Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988
   BRANDSTETTER H, 1992, J MOL BIOL, V226, P1085, DOI 10.1016/0022-2836(92)91054-S
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   CLAESON G, 1993, BIOCHEM J, V290, P309, DOI 10.1042/bj2900309
   COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089
   ELGENDY S, 1992, TETRAHEDRON LETT, V33, P4209, DOI 10.1016/S0040-4039(00)74691-0
   ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29
   Feng DM, 1997, J MED CHEM, V40, P3726, DOI 10.1021/jm970493r
   FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144
   GAN ZR, 1994, J BIOL CHEM, V269, P1301
   HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   KAHN M, 1988, J AM CHEM SOC, V110, P1638, DOI 10.1021/ja00213a055
   KARSHIKOV A, 1992, PROTEIN SCI, V1, P727, DOI 10.1002/pro.5560010605
   Krishnan R, 1998, BIOCHEMISTRY-US, V37, P12094, DOI 10.1021/bi980840e
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAU WF, 1995, BIOORGAN MED CHEM, V3, P1039, DOI 10.1016/0968-0896(95)00100-U
   LOCHT A, 1997, EMBO J, V16, P2977
   Malikayil JA, 1997, BIOCHEMISTRY-US, V36, P1034, DOI 10.1021/bi9622231
   MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018
   MATHEWS II, 1995, ACTA CRYSTALLOGR D, V51, P550, DOI 10.1107/S0907444994013132
   Matthews JH, 1996, BIOPHYS J, V71, P2830, DOI 10.1016/S0006-3495(96)79479-1
   Mochalkin I, 1999, ACTA CRYSTALLOGR D, V55, P785, DOI 10.1107/S0907444999000359
   NAKANISHI H, 1992, P NATL ACAD SCI USA, V89, P1705, DOI 10.1073/pnas.89.5.1705
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Ogbu CO, 1998, BIOORG MED CHEM LETT, V8, P2321, DOI 10.1016/S0960-894X(98)00420-X
   SHEEHAN JP, 1994, J BIOL CHEM, V269, P32747
   SINGH J, 1987, FEBS LETT, V224, P161, DOI 10.1016/0014-5793(87)80441-6
   SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379
   St Charles R, 1999, J MED CHEM, V42, P1376, DOI 10.1021/jm980052n
   STLAURENT DR, 1995, BIOORGAN MED CHEM, V3, P1145, DOI 10.1016/0968-0896(95)00103-N
   TABERNERO L, 1995, J MOL BIOL, V246, P14, DOI 10.1006/jmbi.1994.0060
   TAPPARELLI C, 1993, J BIOL CHEM, V268, P4734
   Tucker TJ, 1997, J MED CHEM, V40, P830, DOI 10.1021/jm960762y
   VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211
   WEBER PC, 1995, BIOCHEMISTRY-US, V34, P3750, DOI 10.1021/bi00011a033
   WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008
   WU TP, 1993, PROTEIN ENG, V6, P471, DOI 10.1093/protein/6.5.471
   YE J, 1994, J BIOL CHEM, V269, P17965
   Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2
NR 46
TC 13
Z9 14
U1 0
U2 1
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD MAR
PY 2000
VL 56
BP 294
EP 303
DI 10.1107/S0907444900000068
PN 3
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 295CZ
UT WOS:000085950300006
PM 10713516
DA 2020-12-01
ER

PT J
AU Binderup, K
   Watanabe, L
   Polikarpov, I
   Preiss, J
   Arni, RK
AF Binderup, K
   Watanabe, L
   Polikarpov, I
   Preiss, J
   Arni, RK
TI Crystallization and preliminary X-ray diffraction analysis of the
   catalytic subunit of ADP-glucose pyrophosphorylase from potato tuber
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID BACTERIAL GLYCOGEN; PROTEINS
AB ADP-glucose pyrophosphorylase is the key regulatory enzyme in the biosynthesis of starch in plants and glycogen in bacteria. The enzyme from potato tuber is comprised of a regulatory subunit and a catalytic subunit and is present as a heterotetramer (alpha(2)beta(2)) The catalytic subunit from potato tuber (50 kDa) was crystallized in four different forms, two of which are suitable for structural studies. A tetragonal crystal form obtained in the presence of the substrate analog Cr-ATP diffracted to 2.2 Angstrom and belongs to space group P4(1) (or its enantiomorph), with unit-cell parameters a = b = 110.57, c = 190.14 Angstrom. A second crystal form obtained diffracted to 2.8 Angstrom and belongs to space group PZ, with unit-eel parameters a = 80.06, b = 138.84, c = 92.20 Angstrom, beta = 112.40 degrees. As this protein displays no significant homology to any currently known protein structure, a search for heavy-atom derivatives has been initiated.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Lab Nacl Luz Sincrotron, BR-13083970 Campinas, SP, Brazil.
   Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Polikarpov,
   Igor/D-2575-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Polikarpov, Igor/0000-0001-9496-4174
CR BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245
   ESPADA J, 1962, J BIOL CHEM, V237, P3577
   GHOSH HP, 1966, J BIOL CHEM, V241, P4491
   HAUGEN TH, 1976, J BIOL CHEM, V251, P7880
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JANSON CA, 1974, J BIOL CHEM, V249, P2572
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182
   MULICHAK AM, 1988, J BIOL CHEM, V263, P17237
   NAKATA PA, 1991, PLANT MOL BIOL, V17, P1089, DOI 10.1007/BF00037149
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684
   PREISS J, 1966, BIOCHEMISTRY-US, V5, P1833, DOI 10.1021/bi00870a008
   Preiss J, 1998, GENET ENG P, V20, P177
   PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223
   Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59
   SMITHWHITE BJ, 1992, J MOL EVOL, V34, P449, DOI 10.1007/BF00162999
   SOWOKINOS JR, 1982, PLANT PHYSIOL, V69, P1459, DOI 10.1104/pp.69.6.1459
NR 18
TC 6
Z9 6
U1 0
U2 3
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD FEB
PY 2000
VL 56
BP 192
EP 194
DI 10.1107/S0907444999015012
PN 2
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 288HX
UT WOS:000085557600012
PM 10666602
OA Green Published
DA 2020-12-01
ER

PT J
AU Soares, AM
   Andriao-Escarso, SH
   Angulo, Y
   Lomonte, B
   Gutierrez, JM
   Marangoni, S
   Toyama, MH
   Arni, RK
   Giglio, JR
AF Soares, AM
   Andriao-Escarso, SH
   Angulo, Y
   Lomonte, B
   Gutierrez, JM
   Marangoni, S
   Toyama, MH
   Arni, RK
   Giglio, JR
TI Structural and functional characterization of myotoxin I, a Lys49
   phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake
   venom
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bothrops moojeni; myotoxin-I; molecular association; primary structure;
   molecular modeling; chemical modification
ID AMINO-ACID-SEQUENCE; BOVINE PANCREATIC PHOSPHOLIPASE-A2; P-BROMOPHENACYL
   BROMIDE; BIOLOGICAL-ACTIVITY; PIRATOXIN-I; CRYSTAL-STRUCTURE; LYSINE-49
   PHOSPHOLIPASE-A(2); BIOCHEMICAL-CHARACTERIZATION; ASPER TERCIOPELO;
   PHENACYL-BROMIDE
AB Myotoxin-I (MjTX-I) was purified to homogeneity from the venom of Bothrops moojeni by ion-exchange chromatography on CM-Sepharose. Its molecular weight, estimated by SDS-PAGE, was 13,400 (reduced) or 26,000 (unreduced). The extinction coefficient (E-1.0 cm(1.0 mg/ml)) of MjTX-I was 1.145 at lambda = 278 nm, pH 7.0, and its isoelectric point was 8.2 at ionic strength mu = 0.1. When lyophilized and stored at 4 degrees C, dimeric, trimeric, and pentameric forms of the protein were identified by SDS-PAGE. This "heterogeneous" sample could be separated into three fractions by gel filtration on Sephadex 6-50. The fractions were analyzed by isoelectric focusing, immunoelectrophoresis, and amino acid composition, which indicated that heterogeneity was the result of different levels of self-association. Protein sequencing indicated that MjTX-I is a Lys49 myotoxin and consists of 121 amino acids (M-r = 13,669), containing a high proportion of basic and hydrophobic residues. It shares a high degree of sequence identity with other Lys49 PLA(2)-like myotoxins, but shows a significantly lower identity with catalytically active Asp49 PLA(2)s. The three-dimensional structure of MjTX-I was modeled based on the crystal structures of three highly homologous Lys49 PLA(2)-like myotoxins. This model showed that the amino acid substitutions are conservative, and mainly the beta-wing region, and the C-terminal extended random coil. MjTX-I displays local myotoxic and edema-inducing activities in mice, and is lethal by intraperitoneal injection, with an LD50 value of 8.5 +/- 0.8 mg/kg, In addition, it is cytotoxic to myoblasts/ myotubes in culture, and disrupts negatively charged liposomes. In comparison with the freshly prepared dimeric sample, the more aggregated forms showed significantly reduced myotoxic activity. However, the edema-inducing activity of MjTX-I was independent of molecular association. Phospholipase A(2) activity on egg yolk, as well as anticoagulant activity, were undetectable both in the native and in the more associated forms. His, Tyr, and Trp residues of the toxin were chemically modified by specific reagents. Although the myotoxic and lethal activities of the modified toxins were reduced by these treatments, neither its edema-inducing or Liposome-disrupting activities were significantly altered. Rabbit antibodies to native MjTX-I cross-reacted with the chemically modified forms, and both the native and modified MjTX-I preparations were recognized by antibodies against the C-terminal region 115-129 of myotoxin II from B. asper, a highly Lys49 PLA(2)-homologue with high sequencial similarity. (C) 2000 Academic Press.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Costa Rica, Inst Clodomiro Picado, Fac Microbiol, San Jose, Costa Rica.
   Univ Estadual Campinas, Dept Bioquim, Inst Biol, Campinas, SP, Brazil.
   UNESP, Dept Fis, IBILCE, Sao Jose Do Rio Preto, SP, Brazil.
RP Giglio, JR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim, BR-14049 Ribeirao Preto, SP, Brazil.
EM jrgiglio@fmrp.usp.br
RI Soares, Andreimar M/K-5556-2014; Arni, Raghuvir K/N-9338-2018; Lomonte,
   Bruno/B-8862-2019; Arni, Raghuvir K/B-2222-2013; Toyama, Marcos
   H/P-4673-2017
OI Arni, Raghuvir K/0000-0003-2460-1145; Lomonte,
   Bruno/0000-0003-2419-6469; Arni, Raghuvir K/0000-0003-2460-1145; Toyama,
   Marcos H/0000-0001-6836-3084; Soares, Andreimar/0000-0003-1032-2188;
   Gutierrez, Jose Maria/0000-0001-8385-3081
CR Arni RK, 1999, ARCH BIOCHEM BIOPHYS, V366, P177, DOI 10.1006/abbi.1999.1210
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BRUSES JL, 1993, J NEUROCHEM, V60, P1030, DOI 10.1111/j.1471-4159.1993.tb03251.x
   Calderon L, 1998, ARCH BIOCHEM BIOPHYS, V358, P343, DOI 10.1006/abbi.1998.0853
   CAMBILLAU C, 1989, PROT STRUC FUNCT GEN, V4, P63
   Campbell D. H., 1970, METHODS IMMUNOLOGY, V260
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   de Azevedo WF, 1999, TOXICON, V37, P371, DOI 10.1016/S0041-0101(98)00189-5
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   de Sousa MV, 1998, BBA-PROTEIN STRUCT M, V1384, P204, DOI 10.1016/S0167-4838(98)00023-5
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DIAZ C, 1993, TOXICON, V31, P1202, DOI 10.1016/0041-0101(93)90136-7
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   DUBOURDIEU DJ, 1987, TOXICON, V25, P333, DOI 10.1016/0041-0101(87)90262-5
   Finney D.J., 1952, STAT METHODS BIOL AS
   FLECTHER JE, 1998, TOXICON, V36, P1549
   FLECTHER JE, 1996, TOXICON, V34, P1301
   FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1991, EXP MOL PATHOL, V55, P217, DOI 10.1016/0014-4800(91)90002-F
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   HELENIUS A, 1977, P NATL ACAD SCI USA, V74, P529, DOI 10.1073/pnas.74.2.529
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1993, INFLAMMATION, V17, P93, DOI 10.1007/BF00916097
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8
   LOMONTE B, 1992, COMP BIOCHEM PHYS B, V102, P325, DOI 10.1016/0305-0491(92)90129-F
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605
   Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413
   REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0
   RENETSEDER R, 1988, J MOL BIOL, V200, P181, DOI 10.1016/0022-2836(88)90342-7
   Rodrigues VM, 1998, COMP BIOCHEM PHYS A, V121, P215, DOI 10.1016/S1095-6433(98)10136-8
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOFFONE E, 1968, BIOCHEMISTRY-US, V7, P971, DOI 10.1021/bi00843a014
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SELISTRE HS, 1990, TOXICON, V28, P261, DOI 10.1016/0041-0101(90)90062-C
   Soares A.M., 1998, Journal of Venomous Animals and Toxins, V4, P137
   Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5
   SOONS KR, 1986, TOXICON, V24, P679, DOI 10.1016/0041-0101(86)90031-0
   TAKASAKI C, 1990, TOXICON, V28, P107, DOI 10.1016/0041-0101(90)90012-V
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Toyama MH, 1998, J PROTEIN CHEM, V17, P713, DOI 10.1007/BF02780974
   Toyama MH, 1995, BIOCHEM MOL BIOL INT, V37, P1047
   VALIENTE C, 1992, TOXICON, V30, P815, DOI 10.1016/0041-0101(92)90379-J
   VESTERBERG O, 1972, BIOCHIM BIOPHYS ACTA, V257, P11, DOI 10.1016/0005-2795(72)90248-6
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
NR 68
TC 89
Z9 92
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2000
VL 373
IS 1
BP 7
EP 15
DI 10.1006/abbi.1999.1492
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 282QP
UT WOS:000085229800002
PM 10620318
DA 2020-12-01
ER

PT J
AU Arni, RK
   Padmanabhan, KP
   Tulinsky, A
AF Arni, RK
   Padmanabhan, KP
   Tulinsky, A
TI Crystallization and preliminary diffraction data of a
   platelet-aggregation inhibitor from the venom of Agkistrodon piscivorus
   piscivorus (North American water moccasin)
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID PROTEIN; RGD; ASSIGNMENTS; ECHISTATIN; PEPTIDE
AB Applaggin (Agkistrodon piscivorus piscivorus platelet-aggregation inhibitor) is a potent inhibitor of blood platelet aggregation derived from the venom of the North American water moccasin, The protein consists of 71 amino acids, is rich in cysteines, contains the sequence-recognition site of adhesion proteins at positions 50-52 (Arg-Gly-Asp) and shares high sequence homology with other snake-venom disintegrins such as echistatin, kistrin and trigramin, Single crystals of applaggin have been grown and X-ray diffraction data have been collected to a resolution of 3.2 Angstrom. The crystals belong to space group P4(1)2(1)2 (or its enantiomorph), with unit-cell dimensions a = b = 63.35, c = 74.18 Angstrom and two molecules per asymmetric unit. Molecular replacement using models constructed from the NMR structures of echistatin and kistrin has not been successful in producing a trial structure for applaggin.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
RP Tulinsky, A (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL25942] Funding Source: Medline; NATIONAL HEART,
   LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL025942, R01HL025942, R01HL025942,
   R01HL025942, R01HL025942, R01HL025942, R01HL025942, R01HL025942,
   R01HL025942, R01HL025942, R01HL025942, R01HL025942, R01HL025942,
   R01HL025942] Funding Source: NIH RePORTER
CR ADLER M, 1992, BIOCHEMISTRY-US, V31, P1031, DOI 10.1021/bi00119a011
   BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0
   Brunger A. T., 1992, X PLOR VERSION 3 1 S
   CALVETE JJ, 1991, BIOCHEMISTRY-US, V30, P5225, DOI 10.1021/bi00235a016
   CHAO BH, 1989, P NATL ACAD SCI USA, V86, P8050, DOI 10.1073/pnas.86.20.8050
   CHEN Y, 1991, BIOCHEMISTRY-US, V30, P11625, DOI 10.1021/bi00114a004
   DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471
   FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299
   HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436
   HUANG TF, 1989, BIOCHEMISTRY-US, V28, P661, DOI 10.1021/bi00428a037
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PERRY ACF, 1992, BIOCHEM J, V286, P671, DOI 10.1042/bj2860671
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003
NR 15
TC 5
Z9 5
U1 2
U2 4
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD AUG
PY 1999
VL 55
BP 1468
EP 1470
DI 10.1107/S0907444999006332
PN 8
PG 3
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 227NL
UT WOS:000082086400014
PM 10417418
OA Green Published
DA 2020-12-01
ER

PT J
AU Arni, RK
   Fontes, MRM
   Barberato, C
   Gutierrez, JM
   Diaz, C
   Ward, RJ
AF Arni, RK
   Fontes, MRM
   Barberato, C
   Gutierrez, JM
   Diaz, C
   Ward, RJ
TI Crystal structure of myotoxin II, a monomeric Lys49-Phospholipase A(2)
   homologue isolated from the venom of Cerrophidion (Bothrops) godmani
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE snake venoms; Lys49-Phospholipase A(2); myotoxins; Cerrophidion
   (Bothrops) godmani
ID AMINO-ACID-SEQUENCE; PHOSPHOLIPASE A(2); SNAKE-VENOMS; PROTEIN; CALCIUM;
   ASPARTATE-49; PURIFICATION; BINDING
AB Lys49-Phospholipase A(2) (Lys49-PLA(2)) homologues damage membranes by a Ca2+-independent mechanism which does not involve catalytic activity. With the aim of determining the structural basis for this novel activity, we have solved the crystal structure of myotoxin-II, a Lys49-PLA(2) isolated from the venom of Cerrophidion (Bothrops) godmani (godMT-II) at 2.8 Angstrom resolution by molecular replacement. The final model has been refined to a final crystallografic residual (R-factor) of 18.8% (R-free = 28.2%), with excellent stereochemistry. godMT-II is also monomeric in the crystalline state, and small-angle X-ray scattering results demonstrate that the protein is monomeric in solution under fisicochemical conditions similar to those used in the crystallographic studies. (C) 1999 Academic Press.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Dept Chem, Fac Filosof Ciencias & Letras, Ribeirao Preto, SP, Brazil.
   UNESP, Dept Phys & Biophys, Botucatu, SP, Brazil.
   Fac Associadas Sao Paola, Sao Paulo, Brazil.
   Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Fis, Caixa Postal 136, BR-15054600 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.unesp.br
RI Arni, Raghuvir K/B-2222-2013; Ward, Richard/C-2460-2012; Fontes, Marcos
   R/B-1941-2009
OI Arni, Raghuvir K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737;
   Fontes, Marcos R/0000-0002-4634-6221; Gutierrez, Jose
   Maria/0000-0001-8385-3081
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   de Sousa MV, 1998, BBA-PROTEIN STRUCT M, V1384, P204, DOI 10.1016/S0167-4838(98)00023-5
   DEAZEVEDO WF, 1997, IN PRESS PROTEIN PEP
   DEAZEVEDO WF, 1998, IN PRESS TOXICON
   Denno Deborah W., 1994, AM J CRIM L, V22, P1
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kini RM, 1997, VENOM PHOSPHOLIPASE, P1
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LIU SY, 1990, J BIOCHEM, V107, P400, DOI 10.1093/oxfordjournals.jbchem.a123057
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Rosenberg P., 1990, HDB TOXINOLOGY, P67
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   WAITE M, 1987, PHOSPHOLIPASES HDB L
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 34
TC 56
Z9 58
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 1999
VL 366
IS 2
BP 177
EP 182
DI 10.1006/abbi.1999.1210
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 206XC
UT WOS:000080904800001
PM 10356281
DA 2020-12-01
ER

PT J
AU Arni, RK
AF Arni, RK
TI Macromolecular crystallography in South America and the national
   syncrotron source for X-ray diffraction
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 UNESP, Dept Biophys, Biol Struct Grp, IBILCE, SJ Rio Preto, SP, Brazil.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 23
PY 1999
VL 13
IS 7
SU S
BP A1425
EP A1425
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 226QX
UT WOS:000082033400599
DA 2020-12-01
ER

PT J
AU Walz, FG
   Kumar, K
   Arni, RK
   Kreitman, RJ
AF Walz, FG
   Kumar, K
   Arni, RK
   Kreitman, RJ
TI 3-D structure of ribonuclease T-1 complexed with a phosphonate analog of
   GpU.
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 Kent State Univ, Kent, OH 44242 USA.
   UNESP, IBILCE, S J Do Rio Preto, SP, Brazil.
   NCI, Bethesda, MD 20892 USA.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR 23
PY 1999
VL 13
IS 7
SU S
BP A1356
EP A1356
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 226QX
UT WOS:000082033400203
DA 2020-12-01
ER

PT J
AU Arni, RK
   Watanabe, L
   Ward, RJ
   Kreitman, RJ
   Kumar, K
   Walz, FG
AF Arni, RK
   Watanabe, L
   Ward, RJ
   Kreitman, RJ
   Kumar, K
   Walz, FG
TI Three-dimensional structure of ribonuclease T-1 complexed with an
   isosteric phosphonate substrate analogue of GpU: Alternate substrate
   binding modes and catalysis
SO BIOCHEMISTRY
LA English
DT Article
ID SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; RNASE T1; 3-DIMENSIONAL
   STRUCTURE; SUBSITE INTERACTIONS; ENZYMATIC-REACTION; 1.9-A RESOLUTION;
   ACTIVE-SITE; MECHANISM; HISTIDINE-40
AB The X-ray crystal structure of a complex between ribonuclease T-1 and guanylyl(3'-6')-6'-deoxyhomouridine (GpcU) has been determined at 2.0 Angstrom resolution. This Ligand is an isosteric analogue of the minimal RNA substrate, guanylyl(3'-5')uridine (GpU), where a methylene is substituted for the uridine 5'-oxygen atom. Two protein molecules are part of the asymmetric unit and both have a GpcU bound at the active site in the same manner. The protein-protein interface reveals an extended aromatic stack involving both guanines and three enzyme phenolic groups. A third GpcU has its guanine moiety stacked on His92 at the active site on enzyme molecule A and interacts with GpcU on molecule B in a neighboring unit via hydrogen bonding between uridine ribose 2'- and 3'-OH groups. None of the uridine moieties of the three GpcU molecules in the asymmetric unit interacts directly with the protein. GpcU-active-site interactions involve extensive hydrogen bonding of the guanine moiety at the primary recognition site and of the guanosine 2'-hydroxyl group with His40 and Glu58. On the other hand, the phosphonate group is weakly bound only by a single hydrogen bond with Tyr38, unlike ligand phosphate groups of other substrate analogues and 3'-GMP, which hydrogen-bonded with three additional active-site residues. Hydrogen bonding of the guanylyl 2'-OH group and the phosphonate moiety is essentially the same as that recently observed for a novel structure of a RNase T-1-3'-GMP complex obtained immediately after in situ hydrolysis of exo-(S-p)-guanosine 2',3'-cyclophosphorothioate [Zegers et al. (1998) Nature Struct. Biol. 5, 280-283]. It is likely that GpcU at the active site represents a nonproductive binding mode for GpU [:Steyaert, J., and Engleborghs (1995) fur. J. Biochem. 233, 140-144]. The results suggest that the active site of ribonuclease T-1 is adapted for optimal tight binding of both the guanylyl 2'-OH and phosphate groups (of GpU) only in the transition state for catalytic transesterification, which is stabilized by adjacent binding of the leaving nucleoside (U) group.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 SJ Rio Preto, SP, Brazil.
   USP, FMRP, Dept Biochem, BR-14049900 Ribeirao Preto, Brazil.
   NCI, NIH, Div Basic Sci, Mol Biol Lab, Bethesda, MD 20892 USA.
   Kent State Univ, Dept Chem, Kent, OH 44242 USA.
RP Walz, FG (corresponding author), UNESP, IBILCE, Dept Phys, CEP 15054000,CP 136, BR-15054000 SJ Rio Preto, SP, Brazil.
EM FWALZ@KENT.EDU
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018; Ward,
   Richard/C-2460-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737
CR ARNI R, 1988, J BIOL CHEM, V263, P15358
   BAUDET S, 1991, J MOL BIOL, V219, P123, DOI 10.1016/0022-2836(91)90862-Z
   Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c
   Brunger A. T., 1992, X PLOR VERSION 3 1 S
   CHLADEK S, 1964, COLLECT CZECH CHEM C, V29, P214
   CORDES F, 1995, J AM CHEM SOC, V117, P10365, DOI 10.1021/ja00146a022
   GOHDA K, 1994, J BIOL CHEM, V269, P17531
   GREEN DPL, 1970, TETRAHEDRON, V26, P1031, DOI 10.1016/S0040-4020(01)98780-0
   HAYDOCK K, 1990, J AM CHEM SOC, V112, P3826, DOI 10.1021/ja00166a016
   HEYDENREICH A, 1993, EUR J BIOCHEM, V218, P1005, DOI 10.1111/j.1432-1033.1993.tb18459.x
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   Irie M., 1997, RIBONUCLEASES STRUCT, P101
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JONES GH, 1970, J AM CHEM SOC, V92, P5510, DOI 10.1021/ja00721a034
   JONES GH, 1968, J AM CHEM SOC, V90, P5337, DOI 10.1021/ja01021a086
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KOEPKE J, 1989, J MOL BIOL, V206, P475, DOI 10.1016/0022-2836(89)90495-6
   KREITMAN RJ, 1983, BIOPHYS J, V41, pA390
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LENZ A, 1991, J BIOL CHEM, V266, P7661
   LIM C, 1992, J AM CHEM SOC, V114, P7245, DOI 10.1021/ja00044a040
   McPherson A., 1982, PREPARATION ANAL PRO
   MONTGOMERY JA, 1979, J MED CHEM, V22, P109, DOI 10.1021/jm00187a024
   MOSSAKOWSKA DE, 1989, BIOCHEMISTRY-US, V28, P3843, DOI 10.1021/bi00435a033
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NONAKA T, 1993, BIOCHEMISTRY-US, V32, P11825, DOI 10.1021/bi00095a011
   PACE CN, 1991, ANGEW CHEM INT EDIT, V30, P343, DOI 10.1002/anie.199103433
   RAMMLER DH, 1962, J AM CHEM SOC, V84, P3112, DOI 10.1021/ja00875a016
   RICHARDS FM, 1973, ATLAS MOL STRUCTURE
   SHIBATA Y, 1988, FEBS LETT, V235, P237, DOI 10.1016/0014-5793(88)81270-5
   Sowa GA, 1997, J AM CHEM SOC, V119, P2319, DOI 10.1021/ja963974t
   Steyaert J, 1997, EUR J BIOCHEM, V247, P1, DOI 10.1111/j.1432-1033.1997.t01-1-00001.x
   STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025
   STEYAERT J, 1993, J MOL BIOL, V229, P770, DOI 10.1006/jmbi.1993.1078
   TRAUTWEIN K, 1991, FEBS LETT, V281, P275, DOI 10.1016/0014-5793(91)80410-5
   WALZ FG, 1973, BIOCHEMISTRY-US, V12, P4846, DOI 10.1021/bi00748a006
   WALZ FG, 1971, BIOCHEMISTRY-US, V10, P2156, DOI 10.1021/bi00787a031
   WALZ FG, 1992, BIOCHIM BIOPHYS ACTA, V1159, P327, DOI 10.1016/0167-4838(92)90063-J
   WALZ FG, 1979, ARCH BIOCHEM BIOPHYS, V195, P95, DOI 10.1016/0003-9861(79)90330-8
   Walz FG, 1997, BBA-GENE STRUCT EXPR, V1350, P183, DOI 10.1016/S0167-4781(96)00159-5
   WALZ FG, 1976, BIOCHEMISTRY-US, V15, P2837, DOI 10.1021/bi00658a021
   WALZ FG, 1976, BIOCHEMISTRY-US, V15, P4446, DOI 10.1021/bi00665a017
   WALZ FG, 1977, BIOCHEMISTRY-US, V16, P5509, DOI 10.1021/bi00644a018
   WLADOWSKI BD, 1997, J AM CHEM SOC, V120, P5488
   YAKOVLEV GI, 1993, BIOCHIM BIOPHYS ACTA, V1202, P143, DOI 10.1016/0167-4838(93)90075-3
   ZABINSKI M, 1976, ARCH BIOCHEM BIOPHYS, V175, P558, DOI 10.1016/0003-9861(76)90545-2
   ZEGERS I, 1994, PROTEIN SCI, V3, P2322, DOI 10.1002/pro.5560031217
   ZEGERS I, 1994, J BIOL CHEM, V269, P127
   Zegers I, 1998, NAT STRUCT BIOL, V5, P280, DOI 10.1038/nsb0498-280
NR 49
TC 17
Z9 18
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 23
PY 1999
VL 38
IS 8
BP 2452
EP 2461
DI 10.1021/bi982612q
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 173FW
UT WOS:000078971300025
PM 10029539
DA 2020-12-01
ER

PT J
AU de Azevedo, WF
   Ward, RJ
   Gutierrez, JM
   Arni, RK
AF de Azevedo, WF
   Ward, RJ
   Gutierrez, JM
   Arni, RK
TI Structure of a Lys49 phospholipase A(2) homologue isolated from the
   venom of Bothrops nummifer (jumping viper)
SO TOXICON
LA English
DT Article
ID CRYSTAL-STRUCTURE; MYOTOXIN-II; LYSINE-49 PHOSPHOLIPASE-A2; ASPER
   TERCIOPELO; BOVINE PANCREAS; SNAKE-VENOMS; PROTEINS; CALCIUM; BINDING;
   CRYSTALLIZATION
AB Lys49-Phospholipase A(2) (Lys49-PLA(2)) homologues damage membranes by a Ca2+-independent mechanism which does not involve catalytic activity, We have solved the structure of myotoxin-I, a Lys49-PLA(2) homologue isolated from the venom of Bothrops nummifer (jumping viper) at 2.4 Angstrom resolution using molecular replacement techniques. The final model has been refined to a final R-factor of 18.4% (R-free = 23.2%), and shows excellent geometry, The myotoxin-I from Bothrops nummifer is dimeric in the crystalline state as has been observed for other Lys49-PLA(2) homologues. In addition, a continuous electron density in the active site and substrate binding channel could be successfully modeled as a fatty-acid molecule. (C) 1999 Elsevier Science Ltd, All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, FMRP, Dept Biochem, Ribeirao Preto, Brazil.
   Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM arni@df.ibilce.u-nesp.br
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013; de Azevedo,
   Walter F/N-5585-2018
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   de Azevedo, Walter F/0000-0001-8640-357X; Gutierrez, Jose
   Maria/0000-0001-8385-3081
CR ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   deAzevedo WF, 1996, P NATL ACAD SCI USA, V93, P2735, DOI 10.1073/pnas.93.7.2735
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTERREZ JM, 1997, VENOM PHOSPHOLIASE A, P321
   GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   HITCHCOCK PB, 1974, P NATL ACAD SCI USA, V71, P3036, DOI 10.1073/pnas.71.8.3036
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7
   JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LUGTIGHEID RB, 1993, EUR J BIOCHEM, V216, P519, DOI 10.1111/j.1432-1033.1993.tb18170.x
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   Mancin AC, 1997, BIOCHEM MOL BIOL INT, V42, P1171
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   OHSAKA A, 1979, SNAKE VENOMS, P480
   OWNBY CL, 1982, RATTLESNAKE VENOMS T, P163
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Rosenberg P., 1990, HDB TOXINOLOGY, P67
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   TOMOO K, 1994, PROTEINS, V19, P330, DOI 10.1002/prot.340190408
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   WAITE M, 1987, PHOSPHOLIPASES HDB L
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 48
TC 38
Z9 38
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD FEB
PY 1999
VL 37
IS 2
BP 371
EP 384
DI 10.1016/S0041-0101(98)00189-5
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 163ZP
UT WOS:000078437400010
PM 10078866
DA 2020-12-01
ER

PT J
AU Ward, RJ
   De Azevedo, WF
   Arni, RK
AF Ward, RJ
   De Azevedo, WF
   Arni, RK
TI At the interface: Crystal structures of phospholipases A(2)
SO TOXICON
LA English
DT Article; Proceedings Paper
CT 12th World Congress on Animal, Plant and Microbial Toxins
CY SEP 21-26, 1997
CL CUERNAVACA, MEXICO
ID BOTHROPS SNAKE-VENOMS; ENZYMATIC-ACTIVITY; PHARMACOLOGICAL PROPERTIES;
   SEQUENCE-ANALYSIS; MYOTOXIN-II; LYSINE-49 PHOSPHOLIPASE-A2; CHEMICAL
   MODIFICATION; PLATELET-AGGREGATION; NAJA-NIGRICOLLIS; FUNCTIONAL ROLES
AB The protein content of many snake venoms often includes one or more phospholipases A(2) (PLA(2)). In recent years a growing number of venoms from snakes of Agkistrodon, Bothrops and Trimeresurus species have been shown to contain a catalytically inactive PLA(2)-homologue in which the highly conserved aspartic acid at position 49 (Asp49) is substituted by lysine (Lys49). Although demonstrating little or no catalytic activity, these Lys49-PLA(2)s disrupt membranes by a Ca2+-independent mechanism of action. In addition, this family of PLA(2)s demonstrates myotoxic and cytolytic pharmacological activities, however the structural bases underlying these functional properties are poorly understood. Through the application of X-ray crystallography in combination with biophysical and bioinformatics techniques, we are studying structure/function relationships of Lys49-PLA(2)s. We here present results of a systematic X-ray crystallographic and amino acid sequence analysis study of Lys49-PLA(2)s and propose a model to explain the Ca2+ independent membrane damaging activity. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Josep Do Rio Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, Caixa Postal 136, BR-15054000 Sao Josep Do Rio Preto, SP, Brazil.
RI de Azevedo, Walter F/N-5585-2018; Ward, Richard/C-2460-2012; Arni,
   Raghuvir K/B-2222-2013
OI de Azevedo, Walter F/0000-0001-8640-357X; Ward,
   Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BABU AS, 1994, TOXICON, V32, P749, DOI 10.1016/0041-0101(94)90344-1
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   Chang LS, 1996, J PROTEIN CHEM, V15, P473, DOI 10.1007/BF01886855
   CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82
   CONDREA E, 1981, TOXICON, V19, P705, DOI 10.1016/0041-0101(81)90108-2
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   DeAraujo HSS, 1996, TOXICON, V34, P1237, DOI 10.1016/S0041-0101(96)00111-0
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DEAZEVEDO WF, 1998, UNPUB ARCH BIOCH BIO
   DEAZEVEDO WF, 1997, IN PRESS TOXICON
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P10576, DOI 10.1021/bi00158a021
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Harris J.B., 1991, P91
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG HC, 1984, TOXICON, V22, P359, DOI 10.1016/0041-0101(84)90080-1
   JAIN MK, 1982, BIOCHIM BIOPHYS ACTA, V688, P341, DOI 10.1016/0005-2736(82)90345-5
   JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9
   JOHNSON EK, 1993, TOXICON, V31, P243, DOI 10.1016/0041-0101(93)90143-7
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1992, TOXICON, V30, P239, DOI 10.1016/0041-0101(92)90866-4
   Mancin AC, 1997, BIOCHEM MOL BIOL INT, V42, P1171
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MEBS D, 1986, TOXICON, V24, P1001, DOI 10.1016/0041-0101(86)90006-1
   MOLLIER P, 1989, EUR J BIOCHEM, V185, P263, DOI 10.1111/j.1432-1033.1989.tb15111.x
   OGAWA T, 1992, P NATL ACAD SCI USA, V89, P8557, DOI 10.1073/pnas.89.18.8557
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1439, DOI 10.1021/bi00704a019
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   ROSENBERG P, 1983, BIOCHEM PHARMACOL, V32, P3525, DOI 10.1016/0006-2952(83)90298-8
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   TAKASAKI C, 1990, TOXICON, V28, P319, DOI 10.1016/0041-0101(90)90067-H
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VANSCHARRENBURG GJM, 1982, BIOCHEMISTRY-US, V21, P1345, DOI 10.1021/bi00535a037
   Ward RJ, 1998, PROTEIN ENG, V11, P285, DOI 10.1093/protein/11.4.285
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 60
TC 45
Z9 45
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD NOV
PY 1998
VL 36
IS 11
BP 1623
EP 1633
DI 10.1016/S0041-0101(98)00155-X
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 123NF
UT WOS:000076130700020
PM 9792179
DA 2020-12-01
ER

PT J
AU Canduri, F
   Teodoro, LGVL
   Lorenzi, CCB
   Gomes, RAS
   Fontes, MRM
   Arni, RK
   de Azevedo, WF
AF Canduri, F
   Teodoro, LGVL
   Lorenzi, CCB
   Gomes, RAS
   Fontes, MRM
   Arni, RK
   de Azevedo, WF
TI Crystallization, preliminary X-ray analysis and Patterson search of a
   new aspartic protease isolated from human urine
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
DE aspartic protease; crystallography; drug design; synchrotron; X-ray
   analysis
ID RHIZOPUS-CHINENSIS; ACID PROTEASES; PROTEINASES; PENICILLOPEPSIN;
   RESOLUTION; EVOLUTION; HOMOLOGY; PEPSIN
AB Aspartic protease (EC 3.4.23) make up a widely distributed class of enzymes in animals, plants, microbes and, viruses. In animals these enzymes perform diverse functions, which range from digestion of food proteins to very specific regulatory roles. In contrast the information about the well-characterized aspartic proteases, very little is known about the corresponding enzyme in urine. A new aspartic protease isolated from human urine has been crystallized and X-ray diffraction data collected to 2.45 Angstrom resolution using a synchrotron radiation source. Crystals belong to the space group P2(1)2(1)2(1) The cell parameters obtained were a=50.99, b=75.56 and c=89.90 Angstrom. Preliminary analysis revealed the presence of one molecule in the asymmetric unit. The structure was determined using the molecular replacement technique and is currently being refined using simulated annealing and conjugate gradient protocols.
C1 UNESP, Inst Biociencias Letras & Ciencias Exatas, Dept Fis, BR-15054000 Sao Jose Do Rio Prieto, SP, Brazil.
   FMTM Uberaba, Fac Med Triangulo Mineiro, Dept Bioquim Celular & Biofis, BR-38015050 Uberlandia, MG, Brazil.
   UNESP, IB, Dept Fis & Biofis, Botucatu, SP, Brazil.
RP de Azevedo, WF (corresponding author), UNESP, Inst Biociencias Letras & Ciencias Exatas, Dept Fis, BR-15054000 Sao Jose Do Rio Prieto, SP, Brazil.
RI Canduri, Fernanda/K-7120-2013; Arni, Raghuvir K/N-9338-2018; de Azevedo,
   Walter F/N-5585-2018; Arni, Raghuvir K/B-2222-2013; Fontes, Marcos
   R/B-1941-2009
OI Arni, Raghuvir K/0000-0003-2460-1145; de Azevedo, Walter
   F/0000-0001-8640-357X; Arni, Raghuvir K/0000-0003-2460-1145; Fontes,
   Marcos R/0000-0002-4634-6221; Gomes, Roseli/0000-0002-5984-0712
CR ANDREEVA NS, 1985, ASPARTIC PROTEINASES, P137
   BOTT R, 1982, BIOCHEMISTRY-US, V21, P6956, DOI 10.1021/bi00269a052
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   DUNN BM, 1986, BIOCHEM J, V237, P899, DOI 10.1042/bj2370899
   Filippova IY, 1996, ANAL BIOCHEM, V234, P113, DOI 10.1006/abio.1996.0062
   FRUTON JS, 1976, ADV ENZYMOL RAMB, V44, P1
   GEWIRTH D, 1995, HKL MANUAL
   HARA K, 1993, J INVEST DERMATOL, V100, P394, DOI 10.1111/1523-1747.ep12472009
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   HSU IN, 1977, NATURE, V266, P140, DOI 10.1038/266140a0
   HSU IN, 1977, ACID PROTEASES STRUC, P61
   JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   MATHEWS BW, 1968, J MOL BIOL, V33, P491
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PEARL L, 1984, FEBS LETT, V174, P96, DOI 10.1016/0014-5793(84)81085-6
   SUBRAMANIAN E, 1977, P NATL ACAD SCI USA, V74, P556, DOI 10.1073/pnas.74.2.556
   TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0
   TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106
NR 19
TC 3
Z9 3
U1 0
U2 1
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE, NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD OCT
PY 1998
VL 46
IS 2
BP 355
EP 363
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 133DW
UT WOS:000076672000015
PM 9801803
DA 2020-12-01
ER

PT J
AU De Azevedo, WF
   Ward, RJ
   Canduri, F
   Soares, A
   Giglio, JR
   Arni, RK
AF De Azevedo, WF
   Ward, RJ
   Canduri, F
   Soares, A
   Giglio, JR
   Arni, RK
TI Crystal structure of piratoxin-I: A calcium-independent, myotoxic
   phospholipase A(2)-homologue from Bothrops pirajai venom
SO TOXICON
LA English
DT Article
ID ASPER SNAKE-VENOM; PANCREATIC PHOSPHOLIPASE-A2; LYSINE-49
   PHOSPHOLIPASE-A2; MEMBRANE LEAKAGE; A(2); PROTEIN; RESOLUTION;
   FRACTIONATION; TERCIOPELO; LIPOSOMES
AB The crystal structure of Piratoxin-I (PrTX-I) a Lys49 homologue isolated from the venom of Bothrops pirajai has been determined and refined at 2.8 Angstrom to a crystallographic residual of 19.7% (R-free = 29.7%). Amino-acid sequence differences between catalytically active phospholipases and PrTX-I in the putative Ca2+-binding loop, specifically the substitutions Tyr28-->Asn, Gly32-->Leu and Asp49-->Lys, result in an altered conformation of this loop, The analysis of the position of the E-amino group of Lys49 in the PrTX-I structure indicates that it fills the site normally occupied by the calcium ion in the catalytically active phospholipases, In contrast to the homologous monomeric Lys49 variant from Agkistrodon piscivorus piscivorus (App), PrTX-I is present as a dimer in the crystalline state, as observed in the structures of myotoxin II from Bothrops asper and Bothropstoxin I from Bothrops jararacussu. The two molecules in the asymmetric unit in the crystal structure of PrTX-I are related by a nearly perfect two-fold symmetry axis, yet the dimeric structure is radically different from the dimeric structure of the phospholipase from Crotalus atrox. In the C. atrox structure the dimer interface occludes the active sites, whereas in the PrTX-I structure they are exposed to solvent, (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   USP, FMRP, Dept Biochem, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Phys, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI de Azevedo, Walter F/N-5585-2018; Ward, Richard/C-2460-2012; Canduri,
   Fernanda/K-7120-2013; Arni, Raghuvir K/B-2222-2013
OI de Azevedo, Walter F/0000-0001-8640-357X; Ward,
   Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Soares, Andreimar/0000-0003-1032-2188
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   CANDURI F, 1997, IN PRESS TOXICON
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   *CCP4, 1979, SUIT PROGR PROT CRYS
   CHO WW, 1988, J BIOL CHEM, V263, P11237
   CORDELLAMIELE E, 1990, J BIOL CHEM, V265, P17180
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DEAZEVEDO WF, 1997, UNPUB ARCH BIOCH BIO
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GIOTTO MTD, 1997, IN PRESS PROT STRUCT
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   GUTIERREZ JM, 1984, TOXICON, V22, P115, DOI 10.1016/0041-0101(84)90144-2
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q
   JAIN MK, 1995, METHOD ENZYMOL, V249, P567
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7
   JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SELISTRE HS, 1990, TOXICON, V28, P261, DOI 10.1016/0041-0101(90)90062-C
   TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   WAITE M, 1987, PHOSPHOLIPASES HDB L
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
NR 52
TC 33
Z9 34
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD OCT
PY 1998
VL 36
IS 10
BP 1395
EP 1406
DI 10.1016/S0041-0101(98)00017-8
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 108JX
UT WOS:000075263700008
PM 9723838
DA 2020-12-01
ER

PT J
AU Krishnan, R
   Zhang, E
   Hakansson, K
   Arni, RK
   Tulinsky, A
   Lim-Wilby, MSL
   Levy, OE
   Semple, JE
   Brunck, TK
AF Krishnan, R
   Zhang, E
   Hakansson, K
   Arni, RK
   Tulinsky, A
   Lim-Wilby, MSL
   Levy, OE
   Semple, JE
   Brunck, TK
TI Highly selective mechanism-based thrombin inhibitors: Structures of
   thrombin and trypsin inhibited with rigid peptidyl aldehydes
SO BIOCHEMISTRY
LA English
DT Article
ID HUMAN ALPHA-THROMBIN; ACTIVE-SITE GEOMETRY; BOVINE BETA-TRYPSIN; NA+
   BINDING-SITE; ANTICOAGULANT-THERAPY; CRYSTAL-STRUCTURES; MOLECULAR
   DESIGN; SLOW-BINDING; COMPLEXES; POTENT
AB The crystal structures of three highly potent and selective low-molecular weight rigid peptidyl aldehyde inhibitors complexed with thrombin have been determined and refined to R values 0.152-0.170 at 1.8-2.1 Angstrom resolution. Since the selectivity of two of the inhibitors was >1600 with respect to trypsin, the structures of trypsin-inhibited complexes of these inhibitors were also determined (R = 0.142-0.157 at 1.9-2.1 Angstrom resolution). The selectivity appears to reside in the inability of a benzenesulfonamide group to bind at the equivalent of the D-enantiomorphic S3 site of thrombin, which may be related to the lack of a 60-insertion loop in trypsin. All the inhibitors have a novel lactam moiety at the P3 position, while the two with greatest trypsin selectivity have a guanidinopiperidyl group at the P1 position that binds in the Si specificity site. Differences in the binding constants of these inhibitors are correlated with their interactions with thrombin and trypsin. The kinetics of inhibition vary from slow to fast with thrombin and are fast in all cases with trypsin. The kinetics are examined in terms of the slow formation of a stable transition-state complex in a two-step mechanism. The structures of both thrombin and trypsin complexes show similar well-defined transition states in the S1 site and at the electrophilic carbon atom and Ser1950G. The trypsin structures, however, suggest that the first step in a two-step kinetic mechanism may involve formation of a weak transition-state complex, rather than binding dominated by the P2-P4 positions.
C1 Michigan State Univ, Dept Chem, E Lansing, MI 48823 USA.
   Corvas Int Inc, San Diego, CA 92121 USA.
RP Tulinsky, A (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48823 USA.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL 43229] Funding Source: Medline; NATIONAL HEART,
   LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL043229] Funding Source: NIH RePORTER
CR BALASUBRAMANIAN BN, 1995, BIOORGAN MED CHEM, V3, P999
   BARTUNIK HD, 1989, J MOL BIOL, V210, P813, DOI 10.1016/0022-2836(89)90110-1
   BODE W, 1992, PROTEIN SCI, V1, P426
   COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3
   DAS J, 1995, BIOORGAN MED CHEM, V3, P999, DOI 10.1016/0968-0896(95)00104-O
   DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089
   FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144
   FLAVIN DF, 1982, VET HUM TOXICOL, V24, P25
   Ganesh V, 1996, PROTEIN SCI, V5, P825
   GEISE HJ, 1971, J MOL STRUCT, V9, P447, DOI 10.1016/0022-2860(71)87034-5
   HAKANSSON K, 1995, BIOORGAN MED CHEM, V3, P1009, DOI 10.1016/0968-0896(95)00096-Y
   HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252
   HILPERT K, 1994, J MED CHEM, V37, P3889, DOI 10.1021/jm00049a008
   HIRSH J, 1994, CIRCULATION, V89, P1449, DOI 10.1161/01.CIR.89.3.1449
   HIRSH J, 1994, CIRCULATION, V89, P1469, DOI 10.1161/01.CIR.89.3.1469
   Krishnan R, 1996, PROTEIN SCI, V5, P422
   Levy OE, 1996, J MED CHEM, V39, P4527, DOI 10.1021/jm960607j
   Lewis SD, 1998, J BIOL CHEM, V273, P4843, DOI 10.1074/jbc.273.9.4843
   Malikayil JA, 1997, BIOCHEMISTRY-US, V36, P1034, DOI 10.1021/bi9622231
   MARTIN PD, 1992, J BIOL CHEM, V267, P7911
   MATHEWS TD, 1994, NEW STATESMAN SOC, V7, P33
   Matthews JH, 1996, BIOPHYS J, V71, P2830, DOI 10.1016/S0006-3495(96)79479-1
   MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8
   Obst U, 1997, CHEM BIOL, V4, P287, DOI 10.1016/S1074-5521(97)90072-7
   RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P111
   Ripka WC, 1997, ANNU REP MED CHEM, V32, P71, DOI 10.1016/S0065-7743(08)61466-9
   SCHLECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157
   SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005
   Semple JE, 1996, J MED CHEM, V39, P4531, DOI 10.1021/jm960572n
   SKRZYPCZAKJANKUN E, 1989, J MOL BIOL, V206, P755, DOI 10.1016/0022-2836(89)90582-2
   SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379
   STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x
   TAPPARELLI C, 1993, TRENDS PHARMACOL SCI, V14, P366, DOI 10.1016/0165-6147(93)90095-2
   VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211
   WEBER PC, 1995, BIOCHEMISTRY-US, V34, P3750, DOI 10.1021/bi00011a033
   Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2
NR 36
TC 49
Z9 49
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD SEP 1
PY 1998
VL 37
IS 35
BP 12094
EP 12103
DI 10.1021/bi980840e
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 116XQ
UT WOS:000075750700012
PM 9724521
DA 2020-12-01
ER

PT J
AU Canduri, F
   Ward, RJ
   de Azevedo, WF
   Gomes, RAS
   Arni, RK
AF Canduri, F
   Ward, RJ
   de Azevedo, WF
   Gomes, RAS
   Arni, RK
TI Purification and partial characterization of cathepsin D from porcine
   (Sus scrofa) liver using affinity chromatography
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
DE cathepsin D; aspartic protease; lysosomal enzyme; affinity
   chromatography; pepstatin A
ID CRYSTAL-STRUCTURES; RESOLUTION; ENZYME
AB Cathepsin D, a lysosomal aspartic protease, has been purified from porcine liver using a combination of pepstatin-A agarose and Affi-Gel Blue affinity chromatography, followed by size-exclusion chromatography. The purified protein consists of two polypeptide chains of 15 and 30 kDa, and has an isoelectric point of 6.8. Porcine liver cathepsin D has maximum activity at pH 2.5-3.0 as determined by its activity against hemoglobin, with a K-cat of 14.3 s(-1) and a k(cat)/K-M of 2.70 x 10(6) s(-1) M-1 as determined by the hydrolysis of a fluorogenic peptide substrate.
C1 UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
   Fac Med Triangulo Mineiro, Dept Bioquim Celular & Biofis, BR-38015050 Uberaba, MG, Brazil.
RP Ward, RJ (corresponding author), UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose do Rio Preto, SP, Brazil.
RI de Azevedo, Walter F/N-5585-2018; Canduri, Fernanda/K-7120-2013; Ward,
   Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013
OI de Azevedo, Walter F/0000-0001-8640-357X; Ward,
   Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Gomes, Roseli/0000-0002-5984-0712
CR ANDREEVA NS, 1984, J BIOL CHEM, V259, P1353
   ANSON ML, 1939, J GEL PHYSL, V23, P695
   BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796
   BARRET AJ, 1977, PROTEINASES MAMMALIA, P5209
   BARRETT AJ, 1970, BIOCHEM J, V117, P601, DOI 10.1042/bj1170601
   BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001
   BOTT R, 1982, BIOCHEMISTRY-US, V21, P6956, DOI 10.1021/bi00269a052
   CUNNINGHAM M, 1976, J BIOL CHEM, V251, P4528
   Filippova IY, 1996, ANAL BIOCHEM, V234, P113, DOI 10.1006/abio.1996.0062
   GULNIK S, 1992, J MOL BIOL, V227, P265, DOI 10.1016/0022-2836(92)90696-H
   KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x
   RIGHETTI PG, 1990, GEL ELECTROPHORESIS, P149
   ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522
   SPYRATOS F, 1989, LANCET, V2, P1115
   Voet D, 1990, BIOCHEMISTRY
   VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167
NR 19
TC 7
Z9 8
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE, NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD JUL
PY 1998
VL 45
IS 4
BP 797
EP 803
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 109BD
UT WOS:000075300600019
PM 9713704
DA 2020-12-01
ER

PT J
AU de Azevedo, WF
   Fontes, MRM
   Ward, RJ
   Lombardi, FR
   Cintra, ACO
   Giglio, JR
   Arni, RK
AF de Azevedo, WF
   Fontes, MRM
   Ward, RJ
   Lombardi, FR
   Cintra, ACO
   Giglio, JR
   Arni, RK
TI Crystallization and preliminary X-ray analysis of S-III-SPIII, a
   phospholipase A2 isolated from the venom of Bothrops jararacussu.
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID SNAKE-VENOM; ASPER VENOM; CROTOXIN; A(2)
AB Large single crystals have been obtained of S-III-SPIII, a phospholipase A(2) from the venom of Bothrops jararacussu. The crystals belong to the orthorhombic system space group C222, and diffract X-rays to a resolution of 1.9 Angstrom. Preliminary analysis reveals the presence of one molecule in the crystallographic asymmetric unit. The crystal structure is currently being determined using molecular replacement techniques.
C1 UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Rio Preto, SP, Brazil.
   UNESP, IB, Dept Fis & Biofis, Botucatu, SP, Brazil.
   USP, Fac Med Ribeirao Preto, Dept Bioquim, BR-14049900 Ribeirao Preto, SP, Brazil.
RI de Azevedo, Walter F/N-5585-2018; Fontes, Marcos R/B-1941-2009; Ward,
   Richard/C-2460-2012; Cintra, Adelia/K-6034-2013; Arni, Raghuvir
   K/B-2222-2013
OI de Azevedo, Walter F/0000-0001-8640-357X; Fontes, Marcos
   R/0000-0002-4634-6221; Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir
   K/0000-0003-2460-1145
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DEAZEVEDO WF, 1998, IN PRESS TOXICON
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7
   GIOTTI MTD, IN PRESS PROTEINS ST
   GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG HC, 1984, TOXICON, V22, P359, DOI 10.1016/0041-0101(84)90080-1
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 20
TC 2
Z9 2
U1 0
U2 0
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD JUN
PY 1998
VL 5
IS 3
BP 181
EP 184
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ZQ903
UT WOS:000073914600011
DA 2020-12-01
ER

PT J
AU de Sousa, MV
   Morhy, L
   Arni, RK
   Ward, RJ
   Diaz, C
   Gutierrez, JM
AF de Sousa, MV
   Morhy, L
   Arni, RK
   Ward, RJ
   Diaz, C
   Gutierrez, JM
TI Amino acid sequence of a myotoxic Lys49-phospholipase A(2) homologue
   from the venom of Cerrophidion (Bothrops) godmani
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
LA English
DT Article
DE amino acid; myotoxic; venom
ID AGKISTRODON-PISCIVORUS-PISCIVORUS; PHOSPHOLIPASE A(2); PANCREATIC
   PHOSPHOLIPASE-A2; LYSINE-49 PHOSPHOLIPASE-A2; SNAKE-VENOMS; ASPER;
   PROTEIN; CALCIUM; PURIFICATION; BINDING
AB The complete amino acid sequence of myotoxin II (godMT-II), a myotoxic phospholipase A( 2 )(PLA(2)) homologue from the venom of the Central American crotaline snake Cerrophidion (Bothrops) godmani, was determined by direct protein sequencing methods. GodMT-II is a class II PLA, showing a Lys instead of Asp at position 49. An additional substitution in the calcium binding loop region (Asn instead of Tyr at position 28) suggests the lack of enzymatic activity observed in this toxin is due to loss of its ability to bind the co-factor Ca2+, since the residues involved in forming the catalytic network of PLA(2)s (His-48, Tyr-52 and Asp-99) an conserved in godMT-II. This myotoxin shows highest sequence homology with other Lys-49 PLA(2)s from Bothrops, Agkistrodon and Trimeresurus species, suggesting that they constitute a conserved family of proteins, yet in contrast presents lower homology with Bothrops asper myotoxin III, a catalytically-active PLA(2). The C-terminal region of godMT-II, which is rich in cationic and hydrophobic residues, shares high sequence homology to the corresponding region in the myotoxin II from B. asper, which has been proposed to play an important role in the Ca2+-independent membrane damaging activity. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
   UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
   Univ Brasilia, Dept Biol Celular, Ctr Brasileiro Sequenciamento Prot, BR-70910900 Brasilia, DF, Brazil.
RP Gutierrez, JM (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.
EM jgutierr@cariari.ucr.ac.cr
RI de Sousa, Marcelo Valle/H-1838-2016; Arni, Raghuvir K/B-2222-2013; Ward,
   Richard/C-2460-2012
OI de Sousa, Marcelo Valle/0000-0002-2871-4430; Arni, Raghuvir
   K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737; Gutierrez,
   Jose Maria/0000-0001-8385-3081
CR AITKEN JA, 1989, PROTEIN SEQUENCE PRA, P43
   ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   CAMPBELL JA, 1992, OCC PAP MUS TEXAS TU, V153, P1
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTIERREZ JM, 1989, TOXICON, V27, P735, DOI 10.1016/0041-0101(89)90040-8
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Harris J.B., 1991, P91
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   LIU SY, 1990, J BIOCHEM, V107, P400, DOI 10.1093/oxfordjournals.jbchem.a123057
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   Rosenberg P., 1990, HDB TOXINOLOGY, P67
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Traub P, 1971, METHOD ENZYMOL, V20, P391
   VANDENBERGH CJ, 1988, EUR J BIOCHEM, V176, P353
   WARD RJ, 1995, GENE, V156, P305, DOI 10.1016/0378-1119(95)00099-R
   Wilson K.J., 1989, PROTEIN SEQUENCING P, P1
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 34
TC 26
Z9 27
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4838
J9 BBA-PROTEIN STRUCT M
JI Biochim. Biophys. Acta-Protein Struct. Molec. Enzym.
PD MAY 19
PY 1998
VL 1384
IS 2
BP 204
EP 208
DI 10.1016/S0167-4838(98)00023-5
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ZV313
UT WOS:000074292100003
PM 9659381
DA 2020-12-01
ER

PT J
AU Lombardi, FR
   Fontes, MRM
   Souza, GMO
   Coelho, LCBB
   Arni, RK
   de Azevedo, WF
AF Lombardi, FR
   Fontes, MRM
   Souza, GMO
   Coelho, LCBB
   Arni, RK
   de Azevedo, WF
TI Crystallization and preliminary x-ray analysis of Parkia pendula lectin
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID PROTEINS
AB Lectins are proteins important in various biological processes such as infection, cell differentiation and metastasis. The Parkia pendula lectin has been crystallized using the hanging-drop vapour diffusion method. X-ray diffraction data were collected using a Rigaku RU300 rotating anode generator and R-AXIS IV diffractometer. The cell parameters for P. pendula lectin are a=93.7 Angstrom b=161.1 Angstrom, c=80.0 Angstrom and space group C222. The maximum resolution was of 2.98 Angstrom. These data showed a R-sym=12.8%.
C1 UNESP, Inst Biociencias Letras & Ciencias Exatas, Dept Fis, BR-15054000 Sao Paulo, Brazil.
   UNESP, IB, Dept Fis & Biofis, Botucatu, SP, Brazil.
   Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil.
RI Fontes, Marcos R/B-1941-2009; de Azevedo, Walter F/N-5585-2018; Arni,
   Raghuvir K/B-2222-2013
OI Fontes, Marcos R/0000-0002-4634-6221; de Azevedo, Walter
   F/0000-0001-8640-357X; Arni, Raghuvir K/0000-0003-2460-1145
CR ARAR C, 1995, J BIOL CHEM, V270, P3551, DOI 10.1074/jbc.270.8.3551
   BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039
   DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cellbio.9.1.237
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   MACPHERSON A, 1982, PREPARATION ANAL PRO
   NAISMITH JH, 1994, ACTA CRYSTALLOGR D, V50, P847, DOI 10.1107/S0907444994005287
   OHTANI K, 1980, J BIOCHEM, V87, P407, DOI 10.1093/oxfordjournals.jbchem.a132761
   SHARON N, 1993, TRENDS BIOCHEM SCI, V18, P221, DOI 10.1016/0968-0004(93)90193-Q
   SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581
   YOUNG NM, 1992, J MOL BIOL, V228, P924, DOI 10.1016/0022-2836(92)90875-K
NR 11
TC 2
Z9 2
U1 0
U2 0
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD APR
PY 1998
VL 5
IS 2
BP 117
EP 120
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ZE091
UT WOS:000072756800010
DA 2020-12-01
ER

PT J
AU de Azevedo, WF
   Ward, RJ
   Gutierrez, JM
   Diaz-Oreiro, C
   Arni, RK
AF de Azevedo, WF
   Ward, RJ
   Gutierrez, JM
   Diaz-Oreiro, C
   Arni, RK
TI Crystallization and preliminary X-ray diffraction analysis of a
   Lys49-PLA(2) homologue from Cerrophidion godmani venom.
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID BOTHROPS SNAKE-VENOMS; PHOSPHOLIPASE A(2); MYOTOXINS; VIPER
AB Lys49-phospholipase A(2) (Lys49-PLA(2)) homologues damage membranes by a Ca2+-independent mechanism which does not involve catalytic activity. The myotoxic Lys-49 phospholipase myotoxin II from Cerrophidion (Bothrops) godmani has been crystallized, and X-ray diffraction data were collected to 2.8 Angstrom resolution. Preliminary analysis reveals the presence of one molecule in the asymmetric unit.
C1 UNESP, IBILCE, Dept Phys, BR-15054000 Sao Jose Rio Preto, Brazil.
   Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica.
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013; de Azevedo,
   Walter F/N-5585-2018
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   de Azevedo, Walter F/0000-0001-8640-357X; Gutierrez, Jose
   Maria/0000-0001-8385-3081
CR ARNI RK, 1995, TOXICON, V33, P383, DOI 10.1016/0041-0101(94)00156-3
   ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   CANDURI F, 1998, IN PRESS TOXICON
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DEAZEVEDO WF, 1998, IN PRESS TOXICON
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   MATTHEWS BW, 1977, PROTEINS, V3, P404
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Treharne AC, 1997, TOXICON, V35, P613, DOI 10.1016/S0041-0101(96)00162-6
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
NR 21
TC 1
Z9 1
U1 0
U2 1
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD APR
PY 1998
VL 5
IS 2
BP 121
EP 126
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ZE091
UT WOS:000072756800011
DA 2020-12-01
ER

PT J
AU Ward, RJ
   Alves, AR
   Neto, JR
   Arni, RK
   Casari, G
AF Ward, RJ
   Alves, AR
   Neto, JR
   Arni, RK
   Casari, G
TI A SequenceSpace analysis of Lys49 phospholipases A(2): clues towards
   identification of residues involved in a novel mechanism of membrane
   damage and in myotoxicity
SO PROTEIN ENGINEERING
LA English
DT Article
DE Lys49; membrane damage; myotoxicity; phospholipase A(2); sequence
   analysis
ID AMINO-ACID-SEQUENCE; ASPER SNAKE-VENOM; TRIMERESURUS-FLAVOVIRIDIS
   PHOSPHOLIPASE-A2; AGKISTRODON-HALYS-BLOMHOFFII; BRAIN
   SYNAPTIC-MEMBRANES; VIPER VIPERA-AMMODYTES; BOTHROPS-ASPER; TOXIC
   PHOSPHOLIPASE-A2; LYSINE-49 PHOSPHOLIPASE-A2; PANCREATIC
   PHOSPHOLIPASE-A2
AB 'SequenceSpace' analysis is a novel approach which has been used to identify unique amino acids within a subfamily of phospholipases A(2) (PLA(2)) in which the highly conserved active site residue Asp49 is substituted by Lys (Lys49-PLA(2)s). Although Lys49-PLA(2)s do not bind the catalytic co-factor Ca2+ and possess extremely low catalytic activity, they demonstrate a Ca2+-independent membrane damaging activity through a poorly understood mechanism, which does not involve lipid hydrolysis. Additionally, Lys49-PLA(2)s possess combined myotoxic, oedema forming and cardiotoxic pharmacological activities, however the structural basis of these varied functions is largely unknown. Using the 'SequenceSpace' analysis we have identified nine residues highly unique to the Lys49-PLA(2) sub-family, which are grouped in three amino acid clusters in the active site, hydrophobic substrate binding channel and homodimer interface regions. These three highly specific residue clusters may have relevance for the Ca2+-independent membrane damaging activity. Of a further 15 less stringently conserved residues, nine are located in two additional clusters which are well isolated from the active site region, The less strictly conserved clusters have been used in predictive sequence searches to correlate amino acid patterns in other venom PLA(2)s with their pharmacological activities, and moths for presynaptic and combined toxicities are proposed.
C1 EMBL, D-96012 Heidelberg, Germany.
   UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
RP Ward, RJ (corresponding author), Univ Sao Paulo, FMRP, Dept Biochem, Avenida Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Ward, Richard/C-2460-2012; Neto, Joao Ruggiero/C-7716-2012; Arni,
   Raghuvir K/B-2222-2013
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145
CR AIRD SD, 1990, TOXICON, V28, P669, DOI 10.1016/0041-0101(90)90255-6
   AIRD SD, 1986, ARCH BIOCHEM BIOPHYS, V249, P296, DOI 10.1016/0003-9861(86)90005-6
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BABU AS, 1994, TOXICON, V32, P749, DOI 10.1016/0041-0101(94)90344-1
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CHEN YC, 1987, TOXICON, V25, P401, DOI 10.1016/0041-0101(87)90073-0
   CHWETZOFF S, 1990, FEBS LETT, V261, P226, DOI 10.1016/0014-5793(90)80559-2
   da Silva Giotto MT, 1998, PROTEINS, V30, P442, DOI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
   DASILVA AMM, 1995, J MOL EVOL, V41, P174, DOI 10.1007/BF00170670
   DeAraujo HSS, 1996, TOXICON, V34, P1237, DOI 10.1016/S0041-0101(96)00111-0
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   deAzevedo WF, 1997, PROTEIN PEPTIDE LETT, V4, P329
   DEAZEVEDO WF, 1998, IN PRESS TOXICON
   DENG LL, 1991, TOXICON, V29, P973
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3
   Dixon RW, 1996, J NEUROPATH EXP NEUR, V55, P1230, DOI 10.1097/00005072-199612000-00006
   DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P10576, DOI 10.1021/bi00158a021
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FORST S, 1986, BIOCHEMISTRY-US, V25, P4309, DOI 10.1021/bi00363a020
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342
   FUKAGAWA T, 1992, TOXICON, V30, P1331, DOI 10.1016/0041-0101(92)90510-C
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   GOWDA TV, 1993, TOXICON, V31, P1267, DOI 10.1016/0041-0101(93)90400-D
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Harris J.B., 1991, P91
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   JOUBERT FJ, 1981, H-S Z PHYSIOL CHEM, V362, P997, DOI 10.1515/bchm2.1981.362.2.997
   JOUBERT FJ, 1980, EUR J BIOCHEM, V112, P493
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   KINI RM, 1987, J BIOL CHEM, V262, P14402
   KINI RM, 1986, TOXICON, V24, P895
   KINI RM, 1986, TOXICON, V24, P527, DOI 10.1016/0041-0101(86)90173-X
   KONDO K, 1989, J BIOCHEM-TOKYO, V105, P196, DOI 10.1093/oxfordjournals.jbchem.a122639
   KRIZAJ I, 1993, BIOCHIM BIOPHYS ACTA, V1157, P81, DOI 10.1016/0304-4165(93)90081-I
   KRIZAJ I, 1995, TOXICON, V33, P437, DOI 10.1016/0041-0101(94)00182-8
   LAMBEAU G, 1990, J BIOL CHEM, V265, P9526
   LAMBEAU G, 1989, J BIOL CHEM, V264, P11503
   LAMBEAU G, 1991, FEBS LETT, V293, P29, DOI 10.1016/0014-5793(91)81145-X
   LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534
   LAMBEAU G, 1991, NEUROCHEM RES, V16, P651, DOI 10.1007/BF00965551
   LAMONTE B, 1982, TOXICON, V30, P239
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LIND P, 1981, TOXICON, V19, P11, DOI 10.1016/0041-0101(81)90113-6
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   LIU CS, 1990, TOXICON, V28, P1457, DOI 10.1016/0041-0101(90)90159-5
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MANCHEVA I, 1984, H-S Z PHYSIOL CHEM, V365, P885, DOI 10.1515/bchm2.1984.365.2.885
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A
   Melo PA, 1996, TOXICON, V34, P653, DOI 10.1016/0041-0101(96)00015-3
   NISHIDA S, 1982, BIOCHEM J, V207, P589, DOI 10.1042/bj2070589
   ODA N, 1990, J BIOCHEM-TOKYO, V108, P816, DOI 10.1093/oxfordjournals.jbchem.a123286
   OGAWA T, 1992, P NATL ACAD SCI USA, V89, P8557, DOI 10.1073/pnas.89.18.8557
   PEARSON JA, 1993, BIOCHIM BIOPHYS ACTA, V1161, P223, DOI 10.1016/0167-4838(93)90217-F
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455, DOI 10.1021/bi00704a021
   PUNGERCAR J, 1990, NUCLEIC ACIDS RES, V18, P4601, DOI 10.1093/nar/18.15.4601
   PUNGERCAR J, 1991, TOXICON, V29, P269, DOI 10.1016/0041-0101(91)90112-5
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RANDOLPH A, 1982, J BIOL CHEM, V257, P2155
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   TOMOO K, 1989, J BIOL CHEM, V264, P3636
   TSAI IH, 1987, BIOCHIM BIOPHYS ACTA, V916, P94, DOI 10.1016/0167-4838(87)90215-9
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021
   VILJOEN CC, 1982, TOXICON, V20, P715, DOI 10.1016/0041-0101(82)90120-9
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   WANG YM, 1992, EUR J BIOCHEM, V209, P635, DOI 10.1111/j.1432-1033.1992.tb17330.x
   WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0
   YATES SL, 1990, TOXICON, V28, P939, DOI 10.1016/0041-0101(90)90023-Z
   YEN CH, 1991, BIOCHEMISTRY-US, V30, P11473, DOI 10.1021/bi00112a015
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
   Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3
NR 94
TC 58
Z9 58
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0269-2139
J9 PROTEIN ENG
JI Protein Eng.
PD APR
PY 1998
VL 11
IS 4
BP 285
EP 294
DI 10.1093/protein/11.4.285
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA ZV496
UT WOS:000074310400005
PM 9680190
OA Bronze
DA 2020-12-01
ER

PT J
AU Bortoleto, RK
   de Oliveira, AHC
   Ruller, R
   Arni, RK
   Ward, RJ
AF Bortoleto, RK
   de Oliveira, AHC
   Ruller, R
   Arni, RK
   Ward, RJ
TI Tertiary structural changes of the alpha-hemolysin from Staphylococcus
   aureus on association with liposome membranes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE alpha-hemolysin; alpha-toxin; Staphylococcus aureus; pore-forming;
   liposome membrane; unfolded intermediate
ID PORE-FORMING PROTEIN; TRANSMEMBRANE PORE; TOXIN PORE; CHANNEL;
   OLIGOMERIZATION; MECHANISM; SEQUENCE; RESIDUES; SWITCH
AB The interaction of alpha-hemolysin (also called alpha-toxin) from Staphylococcus aureus with mixed egg-yolk phosphatidylcholine/cholesterol liposomes has been investigated using the intrinsic tryptophan fluorescence emission (ITFE) signal. The ITFE intensity of alpha-hemolysin, which was obtained using a novel purification protocol, showed a triphasic increase on incubation with liposomes at low protein/lipid ratios. The first, rapid phase results in an increase in ITFE of 10%, which reflects rapid conformation changes in the alpha-hemolysin on association with the liposome membrane, The second phase of the ITFE increase is associated with a red shift from 334 to 339 nm in the maximum emission wavelength, suggesting the transition to a partially unfolded intermediate in the oligomerization process. The third phase of the ITFE intensity change demonstrates a temporal correlation with the appearance of SDS-stable oligomers. The results demonstrate the feasibility of identification of intermediate protein conformations in complex membrane-associated processes by manipulation of the liposomal membrane composition. (C) 1998 Academic Press.
C1 UNESP, IBILCE, Dept Phys, Biol Struct Grp, BR-15054600 Sao Jose Rio Preto, SP, Brazil.
RP Ward, RJ (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM rjward@fmrp.usp.br
RI de Oliveira, Arthur Henrique Cavalcante/A-1797-2013; Ward,
   Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013; Ruller,
   ROBERTO/D-1260-2014
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Ruller, Roberto/0000-0001-7501-5176; Ruller, ROBERTO/0000-0002-5087-9493
CR BARLETT GR, 1959, J BIOL CHEM, V234, P466
   BERNHEIMER AW, 1974, BIOCHIM BIOPHYS ACTA, V344, P27, DOI 10.1016/0304-4157(74)90007-0
   BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475
   BHAKDI S, 1987, REV PHYSIOL BIOCH P, V107, P147, DOI 10.1007/BFb0027646
   BHAKDI S, 1991, MICROBIOL REV, V55, P147
   FAIRWEATHER N, 1983, INFECT IMMUN, V41, P1112, DOI 10.1128/IAI.41.3.1112-1117.1983
   FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83
   GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828
   GRAY GS, 1984, INFECT IMMUN, V46, P615, DOI 10.1128/IAI.46.2.615-618.1984
   HILDEBRAND A, 1991, J BIOL CHEM, V266, P17195
   IKIGAI H, 1987, J BIOL CHEM, V262, P2150
   IKIGAI H, 1985, BIOCHEM BIOPH RES CO, V130, P175, DOI 10.1016/0006-291X(85)90398-5
   JURSCH R, 1994, INFECT IMMUN, V62, P2249, DOI 10.1128/IAI.62.6.2249-2256.1994
   KRASILNIKOV OV, 1988, GEN PHYSIOL BIOPHYS, V7, P467
   KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIND I, 1987, ANAL BIOCHEM, V164, P84, DOI 10.1016/0003-2697(87)90371-X
   MENESTRINA G, 1986, J MEMBRANE BIOL, V90, P177, DOI 10.1007/BF01869935
   PALMER M, 1993, J BIOL CHEM, V268, P11959
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194
   THELESTAM M, 1988, TOXICON, V26, P51, DOI 10.1016/0041-0101(88)90137-7
   TOBKES N, 1985, BIOCHEMISTRY-US, V24, P1915, DOI 10.1021/bi00329a017
   TOKUNAGA H, 1992, BIOCHIM BIOPHYS ACTA, V1105, P125, DOI 10.1016/0005-2736(92)90170-Q
   Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x
   VALEVA A, 1995, BBA-BIOMEMBRANES, V1236, P213, DOI 10.1016/0005-2736(95)00060-G
   VecseySemjen B, 1996, J BIOL CHEM, V271, P8655, DOI 10.1074/jbc.271.15.8655
   WALKER B, 1992, J BIOL CHEM, V267, P21782
   WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1
   WALKER B, 1994, PROTEIN ENG, V7, P655, DOI 10.1093/protein/7.5.655
   WARD RJ, 1992, J STRUCT BIOL, V109, P129, DOI 10.1016/1047-8477(92)90044-B
   WARD RJ, 1994, BIOCHEMISTRY-US, V33, P7477, DOI 10.1021/bi00189a056
NR 32
TC 19
Z9 21
U1 0
U2 6
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 1998
VL 351
IS 1
BP 47
EP 52
DI 10.1006/abbi.1997.0550
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA YZ944
UT WOS:000072310900007
PM 9500849
DA 2020-12-01
ER

PT J
AU da Silva Giotto, MT
   Garratt, RC
   Oliva, G
   Mascarenhas, YP
   Giglio, JR
   Cintra, ACO
   de Azevedo, WF
   Arni, RK
   Ward, RJ
AF da Silva Giotto, MT
   Garratt, RC
   Oliva, G
   Mascarenhas, YP
   Giglio, JR
   Cintra, ACO
   de Azevedo, WF
   Arni, RK
   Ward, RJ
TI Crystallographic and spectroscopic characterization of a molecular
   hinge: Conformational changes in bothropstoxin I, a dimeric Lys49
   phospholipase A2 homologue
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE venom toxin; protein-membrane interaction; X-ray diffraction;
   spectroscopy; quaternary structural change
ID ASPER SNAKE-VENOM; MYOTOXIN-II; INTERFACIAL CATALYSIS; LYSINE-49
   PHOSPHOLIPASE-A2; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; MEMBRANE
   LEAKAGE; A(2); TERCIOPELO; PROTEINS
AB Bothropstoxin I(BthTX-I) from the venom of Bothrops jararacussu is a myotoxic phospholipase A2 (PLA2) homologue which, although catalytically inactive due to an Asp49-->Lys substitution, disrupts the integrity of lipid membranes by a Ca2+-independent mechanism, The crystal structures of two dimeric farms of BthLTX-I which diffract X-rays eo resolutions of 3.1 and 2.1 Angstrom have been determined, The monomers in both structures are related by an almost perfect twofold axis of rotation and the dimer interfaces are defined by contacts between the N-terminal alpha-helical regions and the tips of the beta-wings of partner monomers. Significant differences in the relative orientation of the monomers in the two crystal forms results in "open" and "closed" dimer conformations, Spectroscopic Investigations of BthTX-I in solution have correlated these conformational differences with changes in the intrinsic fluorescence emission of the single tryptophan residues located at the dimer interface, The possible relevance of this structural transition in the Ca2+-independent membrane damaging activity is discussed. (C) 1998 Wiley-Liss, Inc.
C1 Univ Sao Paulo, FMRP, Dept Biochem, Fac Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, IFSC, Inst Phys, Sao Carlos, SP, Brazil.
   UNESP, IBILCE, Dept Phys, Sao Jose Do Rio Preto, SP, Brazil.
RP Ward, RJ (corresponding author), Univ Sao Paulo, FMRP, Dept Biochem, Fac Med, Avenida Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM rward@fmrp.usp.br
RI Oliva, Glaucius/B-9059-2012; Arni, Raghuvir K/B-2222-2013; Mascarenhas,
   Yvonne/E-5926-2012; garratt, richard c/F-6921-2011; de Azevedo, Walter
   F/N-5585-2018; Cintra, Adelia/K-6034-2013; Ward, Richard/C-2460-2012;
   Mascarenhas, Yvonne P/L-6914-2015
OI Arni, Raghuvir K/0000-0003-2460-1145; de Azevedo, Walter
   F/0000-0001-8640-357X; Ward, Richard/0000-0003-1136-5737; Mascarenhas,
   Yvonne P/0000-0003-1918-114X
CR ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   BRUNGER A, 1992, TXPLOR V3 0 MANUAL
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   BRUNIE S, 1985, J BIOL CHEM, V249, P3827
   BRUSES JL, 1993, J NEUROCHEM, V60, P1030, DOI 10.1111/j.1471-4159.1993.tb03251.x
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   GIOTTO MTD, 1996, THESIS U SAO PAULO
   GUTIERREZ JM, 1986, COMP BIOCHEM PHYS C, V84, P159, DOI 10.1016/0742-8413(86)90183-0
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019
   JAIN MK, 1982, BIOCHIM BIOPHYS ACTA, V688, P341, DOI 10.1016/0005-2736(82)90345-5
   JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9
   JAIN MK, 1995, METHOD ENZYMOL, V249, P567
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R
   LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015
   LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   Rosenberg P., 1986, NATURAL TOXINS ANIMA, P129
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   Swindells J F, 1958, 440 NAT BUR STAND
   THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VELAPOLDI PA, 1972, NATL BUREAU STANDARD, V260
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   WAITE M, 1987, HDB LIPID RES, V5
   WARD RJ, 1995, GENE, V156, P305, DOI 10.1016/0378-1119(95)00099-R
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 57
TC 94
Z9 94
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD MAR 1
PY 1998
VL 30
IS 4
BP 442
EP 454
DI 10.1002/(SICI)1097-0134(19980301)30:4<442::AID-PROT11>3.0.CO;2-I
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ZA664
UT WOS:000072388700011
PM 9533628
DA 2020-12-01
ER

PT J
AU Soares, AM
   Rodrigues, VM
   Homsi-Brandeburgo, MI
   Toyama, MH
   Lombardi, FR
   Arni, RK
   Giglio, JR
AF Soares, AM
   Rodrigues, VM
   Homsi-Brandeburgo, MI
   Toyama, MH
   Lombardi, FR
   Arni, RK
   Giglio, JR
TI A rapid procedure for the isolation of the Lys-49 myotoxin II from
   Bothrops moojeni (caissaca) venom: Biochemical characterization,
   crystallization, myotoxic and edematogenic activity
SO TOXICON
LA English
DT Article
ID PIRAJAI SNAKE-VENOM; PHOSPHOLIPASE A(2); ASPER TERCIOPELO; PIRATOXIN-I;
   PROTEINS; ATROX; FRACTIONATION; CLEAVAGE; CALCIUM; HOMOLOG
AB A, M. Soares, V, M, Rodrigues, M. I. Homsi-Brandeburgo, M. H. Toyama, F, R, Lombardi, K. Arni and J. R, Giglio. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: Biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon 36, 503-514, 1998.-Bothrops moojeni snake venom was fractionated on a CM-Sepharose column which was previously equilibrated with 0.05 M ammonium bicarbonate buffer at pH 8.0 and subsequently eluted with an ammonium bicarbonate concentration gradient from 0.05 to 0.5 M at constant pH (8.0) and temperature (25 degrees C). The fraction which eluted last (M-VI) showed, after direct lyophilization, a single band by polyacrylamide gel electrophoresis (PAGE) and SDS-PAGE, indicating an approximate M,. of 14 000 and 77 000, in the presence and absence of dithiothreitol, respectively. Its amino acid composition revealed a high level of hydrophobic and basic amino acids as well as 13 half-cystine residues. Its isoelectric point and extinction coefficient (E-1.0cm(1.0mg/ml) at 278 nm and pH 7.0) were 8.2 and 1.170, respectively. M-VI was devoid of phospholipase A(2) (PLA(2)) activity on egg yolk, as well as of hemorrhagic, anticoagulant and coagulant activities, but could induce drastic necrosis on skeletal muscle fibres as well as rapid and transient edema on the rat paw. Its N-terminal sequence: SLFELGKMILQETGKNPAKSYGVYGCNCGVGGRGKPKDATDRCCYVHKCCYK.... revealed high homology with other Lys 49 PLA(2)-like myotoxins from other bothropic venoms. Orthorhombic crystals of M-VI? which diffracted to a maximal resolution of 1.6 Angstrom. were obtained and indicated the presence of a dimer in the asymmetrical unit. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Univ Sao Paulo, Fac Med, Dept Bioquim, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Fed Uberlandia, Dept Genet & Bioquim, BR-38400 Uberlandia, MG, Brazil.
   Univ Campinas, Inst Biol, Dept Bioquim, Campinas, SP, Brazil.
   Univ Estadual Paulista, IBILCE, Dept Fis, Sao Jose Do Rio Preto, SP, Brazil.
RP Giglio, JR (corresponding author), Univ Sao Paulo, Fac Med, Dept Bioquim, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Soares, Andreimar M/K-5556-2014; Toyama, Marcos H/P-4673-2017; Arni,
   Raghuvir K/B-2222-2013; rodrigues, veridiana/A-3662-2013
OI Toyama, Marcos H/0000-0001-6836-3084; Arni, Raghuvir
   K/0000-0003-2460-1145; rodrigues, veridiana/0000-0002-3386-9197; Soares,
   Andreimar/0000-0003-1032-2188
CR ALVARADO J, 1988, REV BIOL TROP, V36, P563
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   ASSAKURA MT, 1992, COMP BIOCHEM PHYS B, V102, P727, DOI 10.1016/0305-0491(92)90071-X
   BOSCH HVD, 1980, BIOCHIM BIOPHYS ACTA, V604, P191
   DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P103, DOI 10.1016/0005-2744(68)90248-9
   DIAZ C, 1994, ARCH BIOCHEM BIOPHYS, V312, P336, DOI 10.1006/abbi.1994.1317
   Diaz Cecilia, 1995, Natural Toxins, V3, P26, DOI 10.1002/nt.2620030107
   DUCRIX A, 1992, CRYSTALLIZATION NUCL
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Gray W R, 1972, Methods Enzymol, V25, P121, DOI 10.1016/S0076-6879(72)25010-8
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HIGASHI T, 1990, PROCESS PROGRAM INDE
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KINI RM, 1986, TOXICON, V24, P895
   KINI RM, 1986, TOXICON, V24, P527, DOI 10.1016/0041-0101(86)90173-X
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   NIKAI T, 1984, ARCH BIOCHEM BIOPHYS, V231, P309, DOI 10.1016/0003-9861(84)90393-X
   REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0
   SAMPAIO SV, 1983, TOXICON, V21, P265, DOI 10.1016/0041-0101(83)90011-9
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SELISTRE HS, 1987, TOXICON, V25, P1135, DOI 10.1016/0041-0101(87)90131-0
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   Toyama MH, 1995, BIOCHEM MOL BIOL INT, V37, P1047
   VESTERBERG O, 1972, BIOCHIM BIOPHYS ACTA, V257, P11, DOI 10.1016/0005-2795(72)90248-6
NR 34
TC 100
Z9 105
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR
PY 1998
VL 36
IS 3
BP 503
EP 514
DI 10.1016/S0041-0101(97)00133-5
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA ZW709
UT WOS:000074439600008
PM 9637370
DA 2020-12-01
ER

PT J
AU Canduri, F
   Mancuso, LC
   Soares, AM
   Giglio, JR
   Ward, RJ
   Arni, RK
AF Canduri, F
   Mancuso, LC
   Soares, AM
   Giglio, JR
   Ward, RJ
   Arni, RK
TI Crystallization of piratoxin I, a myotoxic LYS49-phospholipase A(2)
   homologue isolated from the venom of Bothrops pirajai
SO TOXICON
LA English
DT Article
ID PHOSPHOLIPASE-LIKE MYOTOXINS; SNAKE-VENOM; LYSINE-49 PHOSPHOLIPASE-A2;
   PISCIVORUS-PISCIVORUS; ENZYMATIC-ACTIVITY; MEMBRANE LEAKAGE; ASPER
   VENOM; FRACTIONATION; CROTOXIN; PROTEIN
AB Fernanda Canduri, Lit C. Mancuso, Andreimar M. Soares, Jose R. Giglio, Richard J. Ward and Raghuvir K. Arni. Crystallization of piratoxin I, a myotoxic Lys49-phospholipase A(2) homologue isolated from the venom of Bothrops pirajai. Toxicon 36, 547-551, 1998.-Large single crystals of piratoxin I, a Lys49-PLA(2) homologue with low enzymatic activity, have been obtained. The crystals belong to the orthorhombic system space group p2(1)2(1)2(1) and diffract X-raps to a resolution of 2.8 Angstrom. Preliminary analysis reveals the presence of two molecules in the crystallographic asymmetric unit. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 UNESP, IBILCE, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   USP, Fac Med Ribeirao Preto, Dept Bioquim, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Arni, RK (corresponding author), UNESP, IBILCE, Dept Fis, Caixa Postal 136, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RI Canduri, Fernanda/K-7120-2013; Arni, Raghuvir K/N-9338-2018; Arni,
   Raghuvir K/B-2222-2013; Soares, Andreimar M/K-5556-2014; Ward,
   Richard/C-2460-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737; Soares,
   Andreimar/0000-0003-1032-2188
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82
   DASILVAGIOTTO MT, 1997, UNPUB PROTEINS STRUC
   DIAZ C, 1992, ARCH BIOCHEM BIOPHYS, V298, P135, DOI 10.1016/0003-9861(92)90104-5
   DIAZ C, 1993, TOXICON, V31, P1202, DOI 10.1016/0041-0101(93)90136-7
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG HC, 1984, TOXICON, V22, P359, DOI 10.1016/0041-0101(84)90080-1
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   McPherson A., 1982, PREPARATION ANAL PRO
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 30
TC 5
Z9 5
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR
PY 1998
VL 36
IS 3
BP 547
EP 551
DI 10.1016/S0041-0101(97)00120-7
PG 5
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA ZW709
UT WOS:000074439600012
PM 9637374
DA 2020-12-01
ER

PT J
AU deAzevedo, WF
   Ward, RJ
   Lombardi, FR
   Giglio, JR
   Soares, AM
   Fontes, MRM
   Arni, RK
AF deAzevedo, WF
   Ward, RJ
   Lombardi, FR
   Giglio, JR
   Soares, AM
   Fontes, MRM
   Arni, RK
TI Crystal structure of myotoxin-II: A myotoxic phospholipase A2 -
   Homologue from Bothrops moojeni venom.
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID SNAKE-VENOMS; MEMBRANE LEAKAGE; A(2); FRACTIONATION; LIPOSOMES; PROTEINS
AB The crystal structure of Myotoxin-II (MjTX-II), a Lys49 PLA(2)-homologue from Bothrops moojeni venom has been determined and refined at 2.0 Angstrom to a crystallographic residual of 19.7% (R-free = 28.1%). MjTX-II is a dimer in the crystal, with the monomers in the asymmetric unit related by a two-fold symmetry axis running through the dimer interface. The dimers of MjTX-II and the Lys49 PLA(2) from B. asper venom are similar, however the relative orientations of the monomers suggests a flexible dimer interface, which serves as a hinge between the two molecules.
C1 UNIV NACL ESTADUAL SAO PAULO,IBIL,DEPT PHYS,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
   UNIV SAO PAULO,FMRP,DEPT BIOCHEM,BR-1449900 RIBEIRAO PRET,SP,BRAZIL.
   UNIV ESTADUAL PAULISTA JULIO MESQUITA FILHO,DEPT BIOPHYS,BOTUCATU,SP,BRAZIL.
RI Ward, Richard/C-2460-2012; Soares, Andreimar M/K-5556-2014; Fontes,
   Marcos R/B-1941-2009; Arni, Raghuvir K/B-2222-2013; de Azevedo, Walter
   F/N-5585-2018
OI Ward, Richard/0000-0003-1136-5737; Fontes, Marcos R/0000-0002-4634-6221;
   Arni, Raghuvir K/0000-0003-2460-1145; de Azevedo, Walter
   F/0000-0001-8640-357X
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   *CCP4, 4 SERC UK
   CORDELLAMIELE E, 1990, J BIOL CHEM, V265, P17180
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   JAIN MK, 1993, BIOCHEMISTRY-US, V32, P11838, DOI 10.1021/bi00095a012
   JAIN MK, 1995, METHOD ENZYMOL, V249, P567
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LOMONTE B, 1990, TOXICON, V28, P1137, DOI 10.1016/0041-0101(90)90114-M
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MANCUSO LC, 1995, TOXICON, V33, P615, DOI 10.1016/0041-0101(95)00012-B
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PARSEGIAN VA, 1994, ADV CHEM SER, V235, P177
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SOARES AM, 1997, UNPUB TOXICON
   TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   WAITE M, 1987, PHOSPHOLIPASES HDB L
NR 37
TC 33
Z9 34
U1 0
U2 1
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD OCT
PY 1997
VL 4
IS 5
BP 329
EP 334
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YA771
UT WOS:A1997YA77100007
DA 2020-12-01
ER

PT J
AU Smarra, ALS
   Arni, RK
   DeAzevedo, WF
   Colombo, MF
   BonillaRodriguez, GO
AF Smarra, ALS
   Arni, RK
   DeAzevedo, WF
   Colombo, MF
   BonillaRodriguez, GO
TI Crystallization and X-ray diffraction data analysis of oxyhemoglobin-I
   from the catfish Liposarcus anisitsi (PISCES)
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID HUMAN HEMOGLOBIN
AB Hemoglobin remains, despite the enormous amount of research involving this molecule, as a prototype for allosteric models and new conformations. Functional studies carried out on Hemoglobin-I from the South-American Catfish Liposarcus anisitsi [1] suggest the existence of conformational states beyond those already described for human hemoglobin, which could be confirmed crystallographically. The present: work represents the initial steps towards that goal.
C1 UNIV NACL ESTADUAL SAO PAULO,DEPT FIS,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
   UNIV NACL ESTADUAL SAO PAULO,DEPT QUIM & GEOCIENCIAS,INST BIOCIENCIAS LETRAS & CIENCIAS EXATAS,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
RI Colombo, Marcio F/K-5229-2013; Bonilla-Rodriguez, Gustavo
   Orlando/C-5968-2012; Bonilla-Rodriguez, Gustavo Orlando/B-9948-2011;
   Arni, Raghuvir K/B-2222-2013; de Azevedo, Walter F/N-5585-2018
OI Colombo, Marcio F/0000-0003-3035-3926; Bonilla-Rodriguez, Gustavo
   Orlando/0000-0001-9902-2557; Bonilla-Rodriguez, Gustavo
   Orlando/0000-0001-9902-2557; Arni, Raghuvir K/0000-0003-2460-1145; de
   Azevedo, Walter F/0000-0001-8640-357X
CR HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   MASALA B, 1992, COMP BIOCHEM PHYS B, V102, P779, DOI 10.1016/0305-0491(92)90079-7
   McPherson A., 1982, PREPARATION ANAL PRO
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Mylvaganam SE, 1996, NAT STRUCT BIOL, V3, P275, DOI 10.1038/nsb0396-275
   Riggs A., 1981, Methods in Enzymology, V76, P5
   SILVA MM, 1992, J BIOL CHEM, V267, P17248
   SMARRA ALS, 1997, UNPUB
   SMITH FR, 1991, PROTEINS, V10, P81, DOI 10.1002/prot.340100202
NR 10
TC 8
Z9 8
U1 0
U2 1
PU BENTHAM SCIENCE PUBL BV
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD OCT
PY 1997
VL 4
IS 5
BP 349
EP 354
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA YA771
UT WOS:A1997YA77100010
DA 2020-12-01
ER

PT J
AU Arni, RK
   Watanabe, L
   Fontes, M
   Burdette, DS
   Zeikus, JG
AF Arni, RK
   Watanabe, L
   Fontes, M
   Burdette, DS
   Zeikus, JG
TI Crystallization of the secondary alcohol dehydrogenase from
   Thermoanaerobacter ethanolicus 39E.
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
ID ORGANIC-SYNTHESIS; PURIFICATION; REDUCTION; BROCKII
AB The secondary alcohol dehydrogenase from the thermophile Thermoanaerobacter ethanolicus 39E has been crystallized at 40 degrees C by vapour difussion using polyethelene glycol as a precipitant. The orthorhombic crystals belong to the space group P 2(1)2(1)2 with cell constants of a=170.0 Angstrom, b=125.7 Angstrom and c=80.5 Angstrom. A native X-ray diffraction data set has been collected to 2.7 Angstrom resolution.
C1 UNESP,IBILCE,DEPT PHYS,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
   UNIV ESTADUAL PAULISTA JULIO MESQUITA FILHO,DEPT BIOPHYS,BOTUCATU,SP,BRAZIL.
   MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824.
   MICHIGAN BIOTECHNOL INST,LANSING,MI.
RI Arni, Raghuvir K/B-2222-2013; Fontes, Marcos R/B-1941-2009
OI Arni, Raghuvir K/0000-0003-2460-1145; Fontes, Marcos
   R/0000-0002-4634-6221
CR BOHNM G, 1994, INT J PEPT PROT RES, V43, P97
   BRADSHAW CW, 1992, J ORG CHEM, V57, P1526, DOI 10.1021/jo00031a036
   BRADSHAW CW, 1992, J ORG CHEM, V57, P1533
   BRANDEN CI, 1975, ENZYMES, V11, P103
   BRYANT FO, 1988, APPL ENVIRON MICROB, V54, P460, DOI 10.1128/AEM.54.2.460-465.1988
   BURDETTE D, 1994, BIOCHEM J, V302, P163, DOI 10.1042/bj3020163
   Burdette DS, 1996, BIOCHEM J, V316, P115, DOI 10.1042/bj3160115
   HUMMEL W, 1990, APPL MICROBIOL BIOT, V34, P15, DOI 10.1007/BF00170916
   HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382
   ISMAIEL AA, 1993, J BACTERIOL, V175, P5097, DOI 10.1128/JB.175.16.5097-5105.1993
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KEINAN E, 1987, ANN NY ACAD SCI, V501, P130, DOI 10.1111/j.1749-6632.1987.tb45698.x
   KEINAN E, 1986, J AM CHEM SOC, V108, P162, DOI 10.1021/ja00261a026
   KEINAN E, 1990, BIOCATALYSIS, V4, P1
   KORKHIN Y, 1996, ACTA CRYSTALLOGR D, V52, P887
   STCLAIR NL, 1992, J AM CHEM SOC, V114, P7314, DOI 10.1021/ja00044a064
   STEINBUCHEL A, 1984, EUR J BIOCHEM, V141, P555, DOI 10.1111/j.1432-1033.1984.tb08229.x
   Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1
   WHITE S, 1993, BIOCHEMISTRY-US, V32, P12955, DOI 10.1021/bi00211a002
   ZEIKUS JG, 1981, ARCH MICROBIOL, V128, P365
   ZHANG ZM, 1993, J MOL BIOL, V230, P353, DOI 10.1006/jmbi.1993.1149
NR 21
TC 2
Z9 2
U1 0
U2 0
PU BENTHAM SCIENCE PUBL BV
PI SCHIPHOL
PA PO BOX 75676, 1118 ZS SCHIPHOL, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD DEC
PY 1996
VL 3
IS 6
BP 423
EP 426
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA VW062
UT WOS:A1996VW06200010
DA 2020-12-01
ER

PT J
AU Arni, RK
   Ward, RJ
AF Arni, RK
   Ward, RJ
TI Phospholipase A(2) - A structural review
SO TOXICON
LA English
DT Article
ID AMINO-ACID-SEQUENCE; PORCINE PANCREATIC PHOSPHOLIPASE-A2; COBRA-VENOM
   PHOSPHOLIPASE-A2; BOTHROPS-ASPER TERCIOPELO; TRANSITION-STATE ANALOG;
   SNAKE-VENOM; CRYSTAL-STRUCTURE; MYOTOXIN-II; TOXIC PHOSPHOLIPASE-A2;
   ACTIVE-SITE
AB Phospholipases A(2) (PLA(2)) are widely distributed in nature and are well characterized proteins with respect to their catalytic and pharmacological activities, A wealth of structural information has recently become available both from X-ray diffraction and NMR studies, and although a detailed model of the catalytic mechanism of PLA(2) has been proposed, the structural bases of other aspects of PLA(2) function, such as interfacial activation and venom PLA(2) pharmacological activities, are still under debate. An appreciation of the PLA(2) protein structure will yield new insights with regard to these activities, The salient structural features of the class I, II and III PLA(2) are discussed with respect to their functional roles. Copyright (C) 1996 Published by Elsevier Science Ltd
RP Arni, RK (corresponding author), UNESP, IBILCE, DEPT PHYS, CP 136, BR-15054000 Sao Jose Do Rio Preto, SP, BRAZIL.
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145
CR ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   BELTRANABREGO JR, 1993, 2 C IB BIOF CIUD PUE, V4, P48
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   BETZEL C, 1993, J MOL BIOL, V231, P498, DOI 10.1006/jmbi.1993.1297
   BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x
   BOTES DP, 1974, J BIOL CHEM, V249, P3827
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CHWETZOFF S, 1989, J BIOL CHEM, V264, P13289
   CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E
   CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82
   CORDELLAMIELE E, 1990, J BIOL CHEM, V265, P17180
   DEMARET JP, 1990, PROTEIN ENG, V4, P171, DOI 10.1093/protein/4.2.171
   DEMARET JP, 1990, PROTEIN ENG, V4, P163, DOI 10.1093/protein/4.2.163
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DIJKSTRA BW, 1981, NATURE, V289, P604, DOI 10.1038/289604a0
   DREYER F, 1990, REV PHYSIOL BIOCH P, V115, P93
   DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x
   DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P10576, DOI 10.1021/bi00158a021
   FLETCHER JE, 1981, TOXICOL APPL PHARM, V59, P375, DOI 10.1016/0041-008X(81)90209-X
   FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342
   *GCG, 1994, PROGR MAN WISC PACK
   GELB MH, 1994, FASEB J, V8, P916
   GERRARD JM, 1993, BIOCHEM CELL BIOL, V71, P432, DOI 10.1139/o93-064
   Glaser K B, 1995, Adv Pharmacol, V32, P31, DOI 10.1016/S1054-3589(08)61011-X
   GLASER KB, 1993, TRENDS PHARMACOL SCI, V14, P92, DOI 10.1016/0165-6147(93)90071-Q
   GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Harris J.B., 1991, P91
   HAZLETT TL, 1985, BIOCHEMISTRY-US, V24, P6152, DOI 10.1021/bi00343a018
   HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG HC, 1984, TOXICON, V22, P359, DOI 10.1016/0041-0101(84)90080-1
   ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897
   JAIN MK, 1995, METHOD ENZYMOL, V249, P567
   JOHANSEN B, 1992, BIOCHEM BIOPH RES CO, V187, P544, DOI 10.1016/S0006-291X(05)81528-1
   JOUBERT FJ, 1983, H-S Z PHYSIOL CHEM, V364, P1717, DOI 10.1515/bchm2.1983.364.2.1717
   KILBY PM, 1995, BIOCHEM J, V305, P935, DOI 10.1042/bj3050935
   KINI RM, 1987, J BIOL CHEM, V262, P14402
   KINI RM, 1986, TOXICON, V24, P895
   KRIZAJ I, 1991, EUR J BIOCHEM, V202, P1165, DOI 10.1111/j.1432-1033.1991.tb16485.x
   KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R
   KUIPERS OP, 1989, SCIENCE, V244, P82, DOI 10.1126/science.2704992
   KUIPERS OP, 1990, PROTEIN ENG, V3, P599, DOI 10.1093/protein/3.7.599
   KUIPERS OP, 1989, PROTEIN ENG, V2, P467, DOI 10.1093/protein/2.6.467
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LAMBEAU G, 1995, J BIOL CHEM, V270, P5534, DOI 10.1074/jbc.270.10.5534
   LAMBEAU G, 1994, J BIOL CHEM, V269, P1575
   LAMBEAU G, 1991, NEUROCHEM RES, V16, P651, DOI 10.1007/BF00965551
   LI YS, 1994, BIOCHEMISTRY-US, V33, P14714, DOI 10.1021/bi00253a009
   LIU CS, 1991, BIOCHIM BIOPHYS ACTA, V1077, P362, DOI 10.1016/0167-4838(91)90552-B
   LLORET S, 1993, TOXICON, V31, P949, DOI 10.1016/0041-0101(93)90254-G
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   LOMONTE B, 1994, TOXICON, V32, P1359, DOI 10.1016/0041-0101(94)90408-1
   MALIWAL BP, 1994, BIOCHEMISTRY-US, V33, P4509, DOI 10.1021/bi00181a010
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MEBS D, 1986, TOXICON, V24, P161, DOI 10.1016/0041-0101(86)90118-2
   MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X
   NOEL JP, 1991, BIOCHEMISTRY-US, V30, P11801, DOI 10.1021/bi00115a010
   PEARSON JA, 1993, BIOCHIM BIOPHYS ACTA, V1161, P223, DOI 10.1016/0167-4838(93)90217-F
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   PETERS AR, 1992, BIOCHEMISTRY-US, V31, P10024, DOI 10.1021/bi00156a023
   PLESNIAK LA, 1995, BIOCHEMISTRY-US, V34, P4943, DOI 10.1021/bi00015a005
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   SHARP JD, 1991, J BIOL CHEM, V266, P14850
   SIDDIQI AR, 1991, FEBS LETT, V278, P14, DOI 10.1016/0014-5793(91)80072-B
   SIMPSON LL, 1993, TOXICON, V31, P13, DOI 10.1016/0041-0101(93)90352-J
   SLOTBOOM AJ, 1975, BIOCHEMISTRY-US, V14, P5394, DOI 10.1021/bi00696a002
   Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527
   THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0
   TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041
   TSAI IH, 1987, BIOCHIM BIOPHYS ACTA, V916, P94, DOI 10.1016/0167-4838(87)90215-9
   TZENG MC, 1995, J BIOL CHEM, V270, P2120, DOI 10.1074/jbc.270.5.2120
   VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538
   VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021
   WAITE M, 1988, PHOSPHOLIPASES HDB L
   WARD RJ, 1995, GENE, V156, P305, DOI 10.1016/0378-1119(95)00099-R
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024
   YUAN YP, 1993, THROMB RES, V70, P471, DOI 10.1016/0049-3848(93)90089-7
NR 90
TC 305
Z9 316
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD AUG
PY 1996
VL 34
IS 8
BP 827
EP 841
DI 10.1016/0041-0101(96)00036-0
PG 15
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA VH836
UT WOS:A1996VH83600002
PM 8875770
DA 2020-12-01
ER

PT J
AU Bortoleto, RK
   Ward, RJ
   Giglio, JR
   Cintra, ACO
   Arni, RK
AF Bortoleto, RK
   Ward, RJ
   Giglio, JR
   Cintra, ACO
   Arni, RK
TI Crystallization of bothropstoxin II isolated from the venom of Bothrops
   jararacussu
SO TOXICON
LA English
DT Article
ID AMINO-ACID-SEQUENCE; PHOSPHOLIPASE-A2; SNAKE; MYOTOXINS; MUSCLE
AB A myotoxic phospholipase A(2), bothropstoxin II, which exhibits low hydrolytic activity, was crystallized and X-ray diffraction data were collected to a resolution of 2.2 Angstrom. Preliminary analysis reveals the presence of three molecules in the asymmetric unit. Copyright (C) 1996 Elsevier Science Ltd.
C1 UNIV ESTADUAL PAULISTA,DEPT FIS,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
   UNIV SAO PAULO,DEPT BIOQUIM,BR-14049 RIBEIRAO PRET,BRAZIL.
RI Arni, Raghuvir K/B-2222-2013; Ward, Richard/C-2460-2012; Cintra,
   Adelia/K-6034-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737;
   
CR ARNI RK, 1995, TOXICON, V33, P383, DOI 10.1016/0041-0101(94)00156-3
   ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1995, ACTA CRYSTALLOGR D, V51, P311, DOI 10.1107/S0907444994011455
   CARTER CW, 1979, J BIOL CHEM, V254, P2219
   CHWETZOFF S, 1989, J BIOL CHEM, V264, P13289
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   CONDREA E, 1982, THROMB HAEMOSTASIS, V45, P82
   GUTIERREZ JM, 1991, EXP MOL PATHOL, V55, P217, DOI 10.1016/0014-4800(91)90002-F
   GUTIERREZ JM, 1984, TOXICON, V18, P603
   HARRIS JB, 1985, PHARMACOL THERAPEUT, V31, P79, DOI 10.1016/0163-7258(85)90038-5
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   KINI RM, 1987, J BIOL CHEM, V262, P14402
   KINI RM, 1986, TOXICON, V24, P895
   KINI RM, 1986, TOXICON, V24, P527, DOI 10.1016/0041-0101(86)90173-X
   McPherson A., 1982, PREPARATION ANAL PRO
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   PEDERSEN JZ, 1994, BBA-BIOMEMBRANES, V1190, P177, DOI 10.1016/0005-2736(94)90049-3
   PEDERSEN JZ, 1995, BIOCHEMISTRY-US, V34, P4670, DOI 10.1021/bi00014a021
   PEREIRA MF, 1995, 24 REUN AN SOC BRAS, P176
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   WARD RJ, 1995, GENE, V156, P305, DOI 10.1016/0378-1119(95)00099-R
NR 24
TC 3
Z9 4
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAY
PY 1996
VL 34
IS 5
BP 614
EP 617
DI 10.1016/0041-0101(95)00143-3
PG 4
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA UN926
UT WOS:A1996UN92600014
PM 8783457
DA 2020-12-01
ER

PT J
AU Zhang, E
   Arni, RK
   Levy, OE
   Tulinsky, A
AF Zhang, E.
   Arni, R. K.
   Levy, O. E.
   Tulinsky, A.
TI STEREOCHEMICAL CONSIDERATIONS IN DRUG DESIGN: THE CRYSTAL STRUCTURES OF
   HUMAN alpha-THROMBIN COMPLEXED WITH TWO TRIPEPTIDYL ALDEHYDE INHIBITORS
   AT 2.1 angstrom RESOLUTION.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
C1 [Zhang, E.; Arni, R. K.; Tulinsky, A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   [Levy, O. E.] Corvas Int Inc, San Diego, CA 92121 USA.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 1996
VL 52
SU S
MA PS04.12.38
BP C209
EP C209
DI 10.1107/S0108767396091015
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VA8NX
UT WOS:000410483200033
OA Bronze
DA 2020-12-01
ER

PT J
AU ARNI, RK
   WARD, RJ
   GUTIERREZ, JM
   TULINSKY, A
AF ARNI, RK
   WARD, RJ
   GUTIERREZ, JM
   TULINSKY, A
TI STRUCTURE OF A CALCIUM-INDEPENDENT PHOSPHOLIPASE-LIKE MYOTOXIC PROTEIN
   FROM BOTHROPS-ASPER VENOM
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID AMINO-ACID-SEQUENCE; PORCINE PANCREATIC PHOSPHOLIPASE-A2;
   CRYSTAL-STRUCTURE; LYSINE-49 PHOSPHOLIPASE-A2; PISCIVORUS-PISCIVORUS;
   CROTALUS-ADAMANTEUS; SNAKE-VENOM; RESOLUTION; TERCIOPELO; A2
AB Myotoxin II, a myotoxic calcium-independent phospholipase-like protein isolated from the venom of Bothrops asper, possesses no detectable phospholipase activity. The crystal structure has been determined and refined at 2.8 Angstrom to an R factor of 16.5% (F>3 sigma) with excellent stereochemistry. Amino-acid differences between catalytically active phospholipases and myotoxin LI in the Ca2+-binding region, specifically the substitutions Tyr28-->Asn, Gly32-->Leu and Asp49-->Lys, result in an altered local conformation. The key difference is that the epsilon-amino group of Lys49 fills the site normally occupied by the calcium ion in catalytically active phospholipases. In contrast to the homologous monomeric Lys49 variant from Agkistrodon piscivorus piscivorus, myotoxin II is present as a dimer both in solution and in the crystalline state. The two molecules in the asymmetric unit are related by a nearly perfect twofold axis, yet the dimer is radically different from the dimer formed by the phospholipase from Crotalus atrox. Whereas in C. atrox the dimer interface occludes the active sites, in myotoxin II they are exposed to solvent.
C1 UNIV COSTA RICA,INST CLODOMIRO PICADO,SAN JOSE,COSTA RICA.
   MICHIGAN STATE UNIV,DEPT CHEM,E LANSING,MI 48824.
RP ARNI, RK (corresponding author), IBILCE,UNEXSP,DEPT PHYS,CXP 136,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   Gutierrez, Jose Maria/0000-0001-8385-3081
CR ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   BERG CJ, 1989, J CELL BIOCHEM, V39, P379
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   BRUNGER AT, 1988, CRYSTALLOGRAPHIC COM, V4
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   CHO WW, 1988, J BIOL CHEM, V263, P11237
   CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172
   Dennis E.A., 1983, ENZYMES, P307
   DHILLON DS, 1987, BIOCHEM PHARMACOL, V36, P1723, DOI 10.1016/0006-2952(87)90059-1
   DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4
   DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3
   DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x
   FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   FREEMONT DH, 1993, P NATL ACAD SCI USA, V90, P342
   GUTIERREZ JM, 1984, TOXICON, V22, P115, DOI 10.1016/0041-0101(84)90144-2
   HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   HOMSIBRANDEBURG.MI, 1988, TOXICON, V26, P615
   HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   KINI RM, 1986, TOXICON, V24, P895
   KUIPERS OP, 1990, PROTEIN ENG, V4, P199, DOI 10.1093/protein/4.2.199
   LATTMAN EE, 1972, ACTA CRYSTALLOGR B, V26, P1854
   LIU SY, 1990, J BIOCHEM, V107, P400, DOI 10.1093/oxfordjournals.jbchem.a123057
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   MARAGANORE JM, 1987, J PROTEIN CHEM, V6, P173
   MARAGANORE JM, 1984, J BIOL CHEM, V261, P13839
   RAMACHANDRAN GN, 1965, ADV PROTEIN CHEM, V23, P283
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SHEN BW, 1975, J AM CHEM SOC, V97, P1205, DOI 10.1021/ja00838a040
   TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041
   VANDEENEN LLM, 1964, ADV LIPID RES, V2, P167
   WAITE M, 1987, PHOSPHOLIPASES, P155
   WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0
   WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 41
TC 117
Z9 117
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD MAY 1
PY 1995
VL 51
BP 311
EP 317
DI 10.1107/S0907444994011455
PN 3
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA RB205
UT WOS:A1995RB20500007
PM 15299297
OA Green Published
DA 2020-12-01
ER

PT J
AU WARD, RJ
   MONESI, N
   ARNI, RK
   LARSON, RE
   PACOLARSON, ML
AF WARD, RJ
   MONESI, N
   ARNI, RK
   LARSON, RE
   PACOLARSON, ML
TI SEQUENCE OF A CDNA-ENCODING BOTHROPSTOXIN-I, A MYOTOXIN FROM THE VENOM
   OF BOTHROPS-JARARACUSSU
SO GENE
LA English
DT Note
DE PHOSPHOLIPASE; LYS(49); CA2+-INDEPENDENT; MEMBRANE DAMAGING; SNAKE TOXIN
ID ASPER TERCIOPELO; PHOSPHOLIPASE-A2
AB With the aim of further understanding the structure/function relationships in the membrane-damaging activity of the Lys(49) phospholipase A(2) (Lys(49)-PLA(2)) sub-family, we used PCR (polymerase chain reaction) on total venom gland cDNAs from Bothrops jararacussu with degenerate oligodeoxyribonucleotides encoding the N- and C-termini of myotoxin II, a Lys(49)-PLA(2) from Bothrops asper. A 350-bp cDNA coding for bothropstoxin I (BtxtxI) was amplified. Sequencing of the amplified fragment shows that BtxtxI has a Lys(49), and comparison with the known structure of myotoxin II showed that the amino acids involved in the formation of a novel dimeric structure in this protein were also conserved.
C1 UNIV SAO PAULO,DEPT MORFOL,RIBEIRAO PRET,SP,BRAZIL.
   UNIV SAO PAULO,DEPT BIOQUIM,RIBEIRAO PRET,SP,BRAZIL.
RP WARD, RJ (corresponding author), UNIV NACL ESTADUAL SAO PAULO,IBILCE,DEPT FIS,RUA CRISTOVAO COLOMBO 2265,S JOSE RIO PR,SP,BRAZIL.
RI Paco-Larson, Maria L/I-8613-2012; Arni, Raghuvir K/B-2222-2013; Ward,
   Richard/C-2460-2012
OI Arni, Raghuvir K/0000-0003-2460-1145; Ward, Richard/0000-0003-1136-5737
CR ARNI RK, 1995, TOXICON, V32
   ARNI RK, 1995, IN PRESS ACTA CRYS D
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   HOMSIBRANDEBURG.MI, 1988, TOXICON, V26, P615
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   RENETSEDER R, 1985, J BIOL CHEM, V260, P1627
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
NR 8
TC 24
Z9 25
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
J9 GENE
JI Gene
PD APR 24
PY 1995
VL 156
IS 2
BP 305
EP 306
DI 10.1016/0378-1119(95)00099-R
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA QW708
UT WOS:A1995QW70800024
PM 7758974
DA 2020-12-01
ER

PT J
AU ARNI, RK
   WARD, RJ
   CINTRA, ACO
   GIGLIO, JR
AF ARNI, RK
   WARD, RJ
   CINTRA, ACO
   GIGLIO, JR
TI CRYSTALLIZATION AND PRELIMINARY DIFFRACTION DATA OF BOTHROPSTOXIN-I
   ISOLATED FROM THE VENOM OF BOTHROPS-JARARACUSSU
SO TOXICON
LA English
DT Note
ID AMINO-ACID-SEQUENCE; ASPER TERCIOPELO; LYSINE-49 PHOSPHOLIPASE-A2;
   PISCIVORUS-PISCIVORUS; MYOTOXIN-II; CALCIUM
AB The myotoxic Lys-49 phospholipase bothropstoxin I was crystallized, and X-ray diffraction data were collected to 3.5 Angstrom resolution. Preliminary analysis reveals the presence of four molecules in the asymmetric unit.
C1 UNIV SAO PAULO,FAC MED,DEPT BIOQUIM,BR-14049900 RIBEIRAO PRET,SP,BRAZIL.
RP ARNI, RK (corresponding author), UNIV ESTADUAL PAULISTA,DEPT FIS,CAIXA POSTAL 136,BR-15054000 S JOSE RIO PR,SP,BRAZIL.
RI Ward, Richard/C-2460-2012; Arni, Raghuvir K/B-2222-2013; Cintra,
   Adelia/K-6034-2013
OI Ward, Richard/0000-0003-1136-5737; Arni, Raghuvir K/0000-0003-2460-1145;
   
CR ARNI RK, 1993, TOXICON, V31, P1061, DOI 10.1016/0041-0101(93)90264-J
   ARNI RK, 1994, UNPUB ACTA CRYSTAL D
   CARTER CW, 1979, J BIOL CHEM, V254, P2219
   CINTRA ACO, 1993, J PROTEIN CHEM, V12, P57, DOI 10.1007/BF01024915
   DIAZ C, 1991, BIOCHIM BIOPHYS ACTA, V1070, P455, DOI 10.1016/0005-2736(91)90086-N
   FEIGL F, 1954, SPOT TESTS, V1
   Feigl F, 1954, SPOT TESTS, VII
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   HOLLAND DR, 1990, J BIOL CHEM, P17649
   HOMSIBRANDEBURG.MI, 1988, TOXICON, V26, P615
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   MATTHEWS BW, 1977, PROTEINS, V3, P404
   McPherson A., 1982, PREPARATION ANAL PRO
   RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404
   VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91
NR 20
TC 13
Z9 14
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR
PY 1995
VL 33
IS 3
BP 383
EP 386
DI 10.1016/0041-0101(94)00156-3
PG 4
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA QU466
UT WOS:A1995QU46600011
PM 7638878
DA 2020-12-01
ER

PT J
AU ARNI, RK
   PADMANABHAN, K
   PADMANABHAN, KP
   WU, TP
   TULINSKY, A
AF ARNI, RK
   PADMANABHAN, K
   PADMANABHAN, KP
   WU, TP
   TULINSKY, A
TI STRUCTURE OF THE NONCOVALENT COMPLEX OF PROTHROMBIN KRINGLE-2 WITH
   PPACK-THROMBIN
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Article
DE FRAGMENT 2; THROMBIN COMPLEX; PROTHROMBIN KRINGLE 2; ALPHA-THROMBIN
ID HUMAN ALPHA-THROMBIN; HUMAN PLASMINOGEN KRINGLE-4; BLOOD-COAGULATION;
   CRYSTAL-STRUCTURE; ACTIVE-SITE; FRAGMENT 2; BINDING; DOMAIN; RESOLUTION;
   ACID
AB Prothrombin fragment 2 (the second kringle) has been co-crystallized with PPACK (D-Phe-Pro-Arg)-thrombin and the structure of the non-covalent complex has been determined and refined (R=0.16) at 3.2 Angstrom resolution using X-ray crystallographic methods. The kringles interact with thrombin at a site that has previously been proposed to be the heparin binding region. The latter is a highly electropositive surface near the C-terminal helix of thrombin abundant in arginine and lysine residues. These form salt bridges with acidic side chains of kringle 2. Somewhat unexpectedly, the negative groups of the kringle correspond to an enlarged anionic center of the lysine binding site of lysine binding kringles such as plasminogen KI and K4 and TPA K2. The anionic motif is DGDEE in prothrombin kringle 2. The corresponding cationic center of the lysine binding site region has an unfavorable Arg71Phe substitution but Lys35 is conserved. However, the folding of fragment 2 is different from that of prothrombin kringle I and other kringles: the second outer loop possesses a distorted two-turn helix and the hairpin P-turn of the second inner loop pivots at V64 and D70 by 60 degrees. The Lys35 is located on a turn of the helix, which causes it to project into solvent space in the fragment 2-thrombin complex, thereby devastating the cationic center of the lysine binding site. Since fragment 2 has not been reported to bind lysine, it most likely has a different inherent folding conformation for the second outer loop, while the movement of the V64-D70 p-turn is most likely a conformational change accompanying complexation, both of which reveal a new heretofore unsuspected flexibility in kringles. The fragment 2-thrombin complex is the first cassette module-catalytic domain interaction determined for a multi-domain blood protein and only the second domain-domain interaction to be described among such proteins, the other being Ca+2 prothrombin fragment 1 (Gla-domain and kringle I). It has been possible to propose a reasonable model for the four domain prothrombin structure using these two double domain structures.
C1 MICHIGAN STATE UNIV, DEPT CHEM, E LANSING, MI 48824 USA.
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL43229, HL25942] Funding Source: Medline; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [R01HL025942, R01HL043229,
   R01HL043229, R01HL043229, R01HL025942, R01HL025942, R01HL025942,
   R01HL025942, R01HL043229, R01HL025942, R01HL025942, R01HL043229,
   R01HL025942, R01HL025942, R01HL043229, R01HL043229, R01HL043229,
   R01HL043229, R01HL025942, R01HL043229, R01HL043229, R01HL043229,
   R01HL025942, R01HL025942, R01HL043229, R01HL025942, R01HL025942,
   R01HL043229, R01HL043229] Funding Source: NIH RePORTER
CR BAJAJ SP, 1975, J BIOL CHEM, V250, P2150
   BLOOM JW, 1978, BIOCHEMISTRY-US, V17, P4430, DOI 10.1021/bi00614a012
   BODE W, 1992, PROTEIN SCI, V1, P426
   BYEON IJL, 1991, J MOL BIOL, V222, P1035, DOI 10.1016/0022-2836(91)90592-T
   CHURCH FC, 1989, J BIOL CHEM, V264, P18419
   DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037
   ESMON CT, 1974, J BIOL CHEM, V249, P7791
   HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953
   JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876
   KARSHIKOV A, 1992, PROTEIN SCI, V1, P727, DOI 10.1002/pro.5560010605
   LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x
   LI X, 1992, BIOCHEMISTRY-US, V31, P9562, DOI 10.1021/bi00155a008
   LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007
   Magnusson S, 1975, PROTEASES BIOL CONTR, V2, P123
   MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0
   MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029
   MYRMEL KH, 1976, BIOCHEMISTRY-US, V15, P1767, DOI 10.1021/bi00653a027
   NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648
   NELSESTUEN GL, 1984, MET IONS BIOL SYST, V17, P353
   OSTERBERG R, 1980, BIOCHEMISTRY-US, V19, P2283
   PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441
   PARK CH, 1986, BIOCHEMISTRY-US, V25, P3977, DOI 10.1021/bi00362a001
   PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5
   PRENDERGAST FG, 1977, J BIOL CHEM, V252, P840
   QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004
   RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926
   SESHADRI TP, 1991, J MOL BIOL, V220, P481, DOI 10.1016/0022-2836(91)90025-2
   SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016
   STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730
   STEPHENS RW, 1992, BIOCHEMISTRY-US, V31, P7572, DOI 10.1021/bi00148a019
   TULINSKY A, 1988, J MOL BIOL, V202, P885, DOI 10.1016/0022-2836(88)90565-7
   TULINSKY A, 1991, THROMB HAEMOSTASIS, V66, P16
   TULINSKY A, 1988, PROTEINS, V3, P85, DOI 10.1002/prot.340030203
   TULINSKY A, 1993, PROTEINS, V14, P305
   WALKER FJ, 1979, J BIOL CHEM, V254, P5618
   WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030
   ZHANG L, 1993, IN PRESS J BIOL CHEM
NR 37
TC 28
Z9 29
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
EI 1873-2941
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PY 1994
VL 67-8
SI SI
BP 59
EP 66
DI 10.1016/0009-3084(94)90124-4
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA NB029
UT WOS:A1994NB02900007
PM 8187245
DA 2020-12-01
ER

PT J
AU ARNI, RK
   GOISSIS, G
   MASCARENHAS, YP
   MARTINS, VCA
   KAVOUNIS, CA
AF ARNI, RK
   GOISSIS, G
   MASCARENHAS, YP
   MARTINS, VCA
   KAVOUNIS, CA
TI THE CRYSTAL-STRUCTURE OF 5-BROMO-7-NITROINDOLINE
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE
LA English
DT Article
DE CRYSTAL STRUCTURE
AB The crystal structure of the title compound, BrC8H7N2O2, (BNI hereafter) has been determined from three - dimensional X-ray diffraction data. The structure is orthorhombic, P2(1)2(1)2(1), with a = 4.077(1) angstrom, b = 8.072(1) angstrom, c = 26.282(4) angstrom, V = 864.9(5) angstrom3 and Z = 4. The structure was solved by direct methods and refined by full-matrix least-squares calculations to a final residual of 0.039 for 631 observed reflections [I greater-than-or-equal-to 3sigma(I)].
   The molecule consists of an indole ring with a Br atom bound at position 5 and a nitro group at position 7. The least-squares planes of the six and five membered rings form an angle of 4.1(4) degrees. Br is coplanar with the six membered ring, since it deviates from that by 0.089(16) angstrom, and the N atom from the nitro group coincides with the plane of the five membered ring, since it deviates from that by 0.059(24) angstrom. All bond distances and angles show no significant deviation from standard values.
C1 ARISTOTELIAN UNIV THESSALONIKI,APPL PHYS LAB,GR-54006 THESSALONIKI,GREECE.
   DEPT PHYS,S JOSE RIO PR,SP,BRAZIL.
   INST FIS & QUIM,BR-13560 SAO CALOS,SP,BRAZIL.
RI Martins, Virginia C. A./H-5832-2012; Arni, Raghuvir K/B-2222-2013;
   Mascarenhas, Yvonne/E-5926-2012; Mascarenhas, Yvonne P/L-6914-2015
OI Martins, Virginia C. A./0000-0001-7565-9641; Arni, Raghuvir
   K/0000-0003-2460-1145; Mascarenhas, Yvonne P/0000-0003-1918-114X
CR AMIT B, 1976, J AM CHEM SOC, V98, P843, DOI 10.1021/ja00419a038
   AMIT B, 1976, J CHEM SOC PERK T 1, P57, DOI 10.1039/p19760000057
   CHANDRAKANTHA TN, 1991, ACTA CRYSTALLOGR C, V47, P995, DOI 10.1107/S0108270190009453
   GALL WG, 1955, J ORG CHEM, V20, P1538, DOI 10.1021/jo01128a012
   JOHNSON CK, 1965, ORNL379 REP
   SHELDRICK GM, 1976, SHELX PROGRAM CRYSTA
   SHELDRICK GM, 1985, SHELXS86 CRYSTALLOGR, V3, P175
   WATSON WH, 1989, ACTA CRYSTALLOGR C, V45, P1322, DOI 10.1107/S0108270189001150
   1979, STRUCTURE DETERMINAT
NR 9
TC 0
Z9 0
U1 0
U2 1
PU R OLDENBOURG VERLAG
PI MUNICH 80
PA ROSENHEIMER STR 145 POSTFACH 801360, W-8000 MUNICH 80, GERMANY
SN 0044-2968
J9 Z KRISTALLOGR
JI Z. Kristall.
PY 1994
VL 209
IS 6
BP 499
EP 501
PG 3
WC Crystallography
SC Crystallography
GA NU334
UT WOS:A1994NU33400006
DA 2020-12-01
ER

PT J
AU FROHLICH, R
   ARNI, RK
   BOZOPOULOS, A
   KAVOUNIS, CA
AF FROHLICH, R
   ARNI, RK
   BOZOPOULOS, A
   KAVOUNIS, CA
TI THE CRYSTAL-STRUCTURE OF BENZOYL-HISTIDINE MONOHYDRATE
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE
LA English
DT Article
DE CRYSTAL STRUCTURE
AB The crystal structure of benzoyl-histidine monohydrate (BYLH hereafter), C-13H-12N-3O-3. H2O was determined from three dimensional data of 3012 independent reflections measured on a Enraf-Nonius (CAD4) single crystal diffractometer.  The compound crystallizes in the orthorhombic space group P2(1)2(1)2(1) with cell dimensions alpha = 7.102(1) angstrom, b = 13.783(3) angstrom, c = 14.160(4) angstrom, V = 1385.92 angstrom-3, F.W. = 277.28, F(000) = 584 Q(calc) = 1.32 g cm-3 and Z = 4.
   The structure was solved with direct methods.  All positional and anisotropic thermal parameters were refined by full-matrix least-squares calculations.  The final reliability factor was R = 0.040, while the weighted one was Rw = 0.034.  The H atoms found in the difference Fourier map were refined isotropically.
   The compound consists of a histidine molecule bound to a benzoyl group.  There is also a cocrystallized water molecule stabilized through a hydrogen bridge.
   The 5-membered ring of the histidine has its tautomeric form, after the transfer of the H atom from the N(delta) to the N(epsilon) atom of the ring.  There is an sp2 conformation around C6 while the conformation around C3 is that of sp3.  The histidine ring forms with the benzene ring a dihedral angle of 109.8(1)-degree.
   All angle values and bond distances agree very well with the expected values in the literature.
C1 ARISTOTELIAN UNIV THESSALONIKI,APPL PHYS LAB,GR-54006 THESSALONIKI,GREECE.
   ENRAF NONIUS GMBH,W-5650 SOLINGEN,GERMANY.
   UNESP IBILCE,DEPT PHYS,BR-15054000 S JOSE RIO,SP,BRAZIL.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
CR DONOHUE J, 1964, ACTA CRYSTALLOGR, V17, P1178, DOI 10.1107/S0365110X64003048
   FAIR CK, 1990, MOLEN INTERACTIVE ST
   Gabe E. J., 1985, CRYSTALLOGRAPHIC COM, V3, P167
NR 3
TC 0
Z9 0
U1 0
U2 1
PU R OLDENBOURG VERLAG
PI MUNICH 80
PA ROSENHEIMER STR 145 POSTFACH 801360, W-8000 MUNICH 80, GERMANY
SN 0044-2968
J9 Z KRISTALLOGR
JI Z. Kristall.
PY 1994
VL 209
IS 10
BP 816
EP 817
DI 10.1524/zkri.1994.209.10.816
PG 2
WC Crystallography
SC Crystallography
GA PP348
UT WOS:A1994PP34800009
DA 2020-12-01
ER

PT J
AU ARNI, RK
   GUTIERREZ, JM
AF ARNI, RK
   GUTIERREZ, JM
TI CRYSTALLIZATION AND PRELIMINARY DIFFRACTION DATA OF 2 MYOTOXINS ISOLATED
   FROM THE VENOMS OF BOTHROPS-ASPER (TERCIOPELO) AND BOTHROPS-NUMMIFER
   (JUMPING VIPER)
SO TOXICON
LA English
DT Note
ID FLAVOVIRIDIS HABU SNAKE; AMINO-ACID-SEQUENCE; LYSINE-49
   PHOSPHOLIPASE-A2; CRYSTAL-STRUCTURE; RESOLUTION; A2; PURIFICATION
AB Two myotoxins isolated from B. asper (myotoxin II) and B. nummifer (myotoxin I) snake venoms have been crystallized and their diffraction properties are described. These myotoxins are phospholipase A2 variants which lack enzymatic activity; B. asper myotoxin II is a lysine-49 phospholipase. Crystals were obtained at room temperature by standard hanging-drop vapour diffusion methods. Crystals diffracted to a resolution of 2.8 and 2.3 angstrom, respectively.
C1 UNIV COSTA RICA,FAC MICROBIOL,INST CLODOMIRO PICADO,SAN JOSE,COSTA RICA.
   UNIV ESTADUAL PAULISTA,INST BIOCIENCIAS,DEPT FIS,BR-15054 S JOSE RIO P,SP,BRAZIL.
RI Arni, Raghuvir K/B-2222-2013; Arni, Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Gutierrez, Jose Maria/0000-0001-8385-3081
CR ACHARI A, 1985, J BIOL CHEM, V260, P9385
   BRUNIE S, 1985, J BIOL CHEM, V260, P9742
   DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4
   DIJKSTRA BW, 1982, ACTA CRYSTALLOGR B, V38, P793, DOI 10.1107/S0567740882004099
   FINZEL BC, 1991, ACTA CRYSTALLOGR B, V47, P814, DOI 10.1107/S0108768191004226
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211
   GUTIERREZ JM, 1989, TOXICON, V27, P735, DOI 10.1016/0041-0101(89)90040-8
   GUTIERREZ JM, 1986, TOXICON, V24, P885, DOI 10.1016/0041-0101(86)90089-9
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   KANNAN KK, 1977, TOXICON, V15, P435, DOI 10.1016/0041-0101(77)90122-2
   KWONG PD, 1989, J BIOL CHEM, V264, P19349
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU SY, 1990, J BIOCHEM, V107, P400, DOI 10.1093/oxfordjournals.jbchem.a123057
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839
   McPherson A., 1982, PREPARATION ANAL PRO
   OHSAKA A, 1979, SNAKE VENOMS, P480
   OWNBY CL, 1982, RATTLESNAKE VENOMS T, P163
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070
   SCOTT DL, 1991, TOXICON, V29, P1517, DOI 10.1016/0041-0101(91)90009-G
   SHINODA Y, 1990, J BIOCHEM-TOKYO, V107, P84, DOI 10.1093/oxfordjournals.jbchem.a123017
   Traub P, 1971, METHOD ENZYMOL, V20, P391
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
NR 26
TC 17
Z9 17
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PD AUG
PY 1993
VL 31
IS 8
BP 1061
EP 1064
DI 10.1016/0041-0101(93)90264-J
PG 4
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA LT845
UT WOS:A1993LT84500013
PM 8212044
DA 2020-12-01
ER

PT J
AU ARNI, RK
   PADMANABHAN, K
   PADMANABHAN, KP
   WU, TP
   TULINSKY, A
AF ARNI, RK
   PADMANABHAN, K
   PADMANABHAN, KP
   WU, TP
   TULINSKY, A
TI STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN
   FRAGMENT-2 WITH HUMAN PPACK-THROMBIN
SO BIOCHEMISTRY
LA English
DT Article
ID HUMAN ALPHA-THROMBIN; HUMAN PLASMINOGEN KRINGLE-4; PROTEIN STRUCTURES;
   REFINED STRUCTURE; BINDING-SITES; ACID; ACTIVATION; RESOLUTION;
   TRANSITIONS; ASSOCIATION
AB Both human and bovine prothrombin fragment 2 (the second kringle) have been cocrystallized separately with human PPACK (D-Phe-Pro-Arg)-thrombin, and the structures of these noncovalent complexes have been determined and refined (R = 0.155 and 0.157, respectively) at 3.3-angstrom resolution using X-ray crystallographic methods. The kringles interact with thrombin at a site that has previously been proposed to be the heparin binding region. The latter is a highly electropositive surface near the C-terminal helix of thrombin abundant in arginine and lysine residues. These form salt bridges with acidic side chains of kringle 2. Somewhat unexpectedly, the negative groups of the kringle correspond to an enlarged anionic center of the lysine binding site of lysine binding kringles such as plasminogens K1 and K4 and TPA K2. The anionic motif is DGDEE in prothrombin kringle 2. The corresponding cationic center of the lysine binding site region has an unfavorable Arg70Asp substitution, but Lys35 is conserved. However, the folding of fragment 2 is different from that of prothrombin kringle 1 and other kringles: the second outer loop possesses a distorted two-turn helix, and the hairpin beta-turn of the second inner loop pivots at Val64 and Asp70 by 60-degrees. Lys35 is located on a turn of the helix, which causes it to project into solvent space in the fragment 2-thrombin complex, thereby devastating any vestige of the cationic center of the lysine binding site. Since fragment 2 has not been reported to bind lysine, it most likely has a different inherent folding conformation for the second outer loop, as has also been observed to be the case with TPA K2 and the urokinase kringle. The movement of the Val64-Asp70 beta-turn is most likely a conformational change accompanying complexation, which reveals a new heretofore unsuspected flexibility in kringles. The fragment 2-thrombin complex is only the second cassette module-catalytic domain structure to be determined for a multidomain blood protein and only the third domain-domain interaction to be described among such proteins, the others being factor Xa without a Gla domain and Ca2+ prothrombin fragment 1 with a Gla domain and a kringle.
C1 MICHIGAN STATE UNIV, DEPT CHEM, E LANSING, MI 48824 USA.
RI Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL 43229, HL 25942] Funding Source: Medline; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [R01HL043229, R01HL025942,
   R01HL043229, R01HL025942, R01HL043229, R01HL043229, R01HL025942,
   R01HL025942, R01HL043229, R01HL025942, R01HL043229, R01HL025942,
   R01HL043229, R01HL043229, R01HL043229, R01HL043229, R01HL025942,
   R01HL025942, R01HL043229, R01HL043229, R01HL043229, R01HL025942,
   R01HL025942, R01HL043229, R01HL025942, R01HL043229, R01HL025942,
   R01HL025942, R01HL025942] Funding Source: NIH RePORTER
CR BAJAJ SP, 1975, J BIOL CHEM, V250, P2150
   BLOOM JW, 1978, BIOCHEMISTRY-US, V17, P4430, DOI 10.1021/bi00614a012
   BOCK PE, 1992, J BIOL CHEM, V267, P14974
   BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x
   BODE W, 1992, PROTEIN SCI, V1, P426
   BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633
   BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458
   BRUNGER AT, 1990, X PLOR MANUAL VERSIO
   BYEON IJL, 1991, J MOL BIOL, V222, P1035, DOI 10.1016/0022-2836(91)90592-T
   CARTER CW, 1979, J BIOL CHEM, V254, P2219
   CHURCH FC, 1989, J BIOL CHEM, V264, P18419
   DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037
   DOMBROSE FA, 1979, J BIOL CHEM, V254, P5027
   ELION J, 1986, BIOREGULATORY FUNCTG, V2, P16
   ESMON CT, 1974, J BIOL CHEM, V249, P7791
   FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x
   FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144
   FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299
   HEWETTEMMETT D, 1974, THROMB RES, V5, P421, DOI 10.1016/0049-3848(74)90178-9
   HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436
   JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876
   KARSHIKOV A, 1992, PROTEIN SCI, V1, P727, DOI 10.1002/pro.5560010605
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x
   LI X, 1992, BIOCHEMISTRY-US, V31, P9562, DOI 10.1021/bi00155a008
   LIU LW, 1991, J BIOL CHEM, V266, P23632
   Magnusson S., 1975, PROTEASES BIOL CONTR, P123
   MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0
   MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0
   MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029
   MYRMEL KH, 1976, BIOCHEMISTRY-US, V15, P1767, DOI 10.1021/bi00653a027
   NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648
   NESHEIM ME, 1980, REGULATION COAGULATI, P145
   PADMANABHAN K, 1993, IN PRESS J MOL BIOL
   PARK CH, 1986, BIOCHEMISTRY-US, V25, P3977, DOI 10.1021/bi00362a001
   PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5
   PRENDERGAST FG, 1977, J BIOL CHEM, V252, P840
   QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004
   RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926
   RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5
   SESHADRI TP, 1991, J MOL BIOL, V220, P481, DOI 10.1016/0022-2836(91)90025-2
   SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379
   SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016
   STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730
   STEPHENS RW, 1992, BIOCHEMISTRY-US, V31, P7572, DOI 10.1021/bi00148a019
   TREXLER M, 1982, J BIOL CHEM, V257, P7401
   TULINSKY A, 1988, J MOL BIOL, V202, P885, DOI 10.1016/0022-2836(88)90565-7
   TULINSKY A, 1991, THROMB HAEMOSTASIS, V66, P16
   TULINSKY A, 1988, PROTEINS, V3, P85, DOI 10.1002/prot.340030203
   TULINSKY A, 1993, IN PRESS BLOOD COAGU
   VALI Z, 1984, J BIOL CHEM, V259, P3690
   WALKER FJ, 1979, J BIOL CHEM, V254, P5618
   WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030
NR 53
TC 106
Z9 106
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 11
PY 1993
VL 32
IS 18
BP 4727
EP 4737
DI 10.1021/bi00069a006
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LB647
UT WOS:A1993LB64700006
PM 8387813
DA 2020-12-01
ER

PT J
AU ARNI, RK
   MARTINS, VCA
   MASCARENHAS, YP
   GOISSIS, G
   KAVOUNIS, CA
AF ARNI, RK
   MARTINS, VCA
   MASCARENHAS, YP
   GOISSIS, G
   KAVOUNIS, CA
TI THE CRYSTAL-STRUCTURE OF 1-(N(A)-TRIFLUORACETYLALANYL)-INDOLINE
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE
LA English
DT Article
DE CRYSTAL STRUCTURE; C13H13N2F3O2
AB The crystal structure of the title compound, C13H13N2F3O2, (NTFAAI hereafter) has been determined from three-dimensional X-ray diffraction data. The structure is monoclinic, C2, with a = 19.023(5), b = 7.574(2), c = 10.405(2), angstrom, beta = 114.17(2)-degrees, V = 1368(1) angstrom3 and Z = 4.
   The structure was solved by direct methods and refined by full-matrix least-squares calculations to a final residual of 0.051 for 1030 observed reflections [I greater-than-or-equal-to 3sigma(I)]. The molecule comprises an indole ring bound to a trifluoracetyl group via an alanine. Both the six- and five-membered rings are coplanar to a very good approximation, since they form a dihedral angle of 1.6(2) degrees. The trifluorocarbon group is tetrahedrally coordinated with the two carbonyl oxygens located on their peptide plane. All bond distances and angles demonstrate no significant deviations from standard values.
C1 ARISTOTELIAN UNIV THESSALONIKI,APPL PHYS LAB,THESSALONIKI,GREECE.
RP ARNI, RK (corresponding author), UNIV SAO PAULO,INST FIS & QUIM SAO CARLOS,BR-36913560 SAO CARLOS,SP,BRAZIL.
RI Arni, Raghuvir K/N-9338-2018; Arni, Raghuvir K/B-2222-2013; Martins,
   Virginia C. A./H-5832-2012; Mascarenhas, Yvonne/E-5926-2012;
   Mascarenhas, Yvonne P/L-6914-2015
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145; Martins, Virginia C. A./0000-0001-7565-9641;
   Mascarenhas, Yvonne P/0000-0003-1918-114X
CR CHANDRAKANTHA TN, 1991, ACTA CRYSTALLOGR C, V47, P995, DOI 10.1107/S0108270190009453
   JOHNSON CK, ORNL379 REP
   KRUMDIECK CL, 1969, BIOCHEMISTRY-US, V8, P1568, DOI 10.1021/bi00832a036
   Pope M T, 1983, HETEROPOLY ISOPOLY O
   ROTTLETT JS, 1965, COMPUTING METHODS CR, P25
   SHELDRICK GM, 1976, SHELX PROGRAM CRYSTA
   WATSON WH, 1989, ACTA CRYSTALLOGR C, V45, P1322, DOI 10.1107/S0108270189001150
   WEYGAND F, 1952, ANGEW CHEM-GER EDIT, V64, P136, DOI 10.1002/ange.19520640505
   1979, SDP STRUCTURE DETERM
NR 9
TC 0
Z9 0
U1 0
U2 1
PU R OLDENBOURG VERLAG
PI MUNICH 80
PA ROSENHEIMER STR 145 POSTFACH 801360, W-8000 MUNICH 80, GERMANY
SN 0044-2968
J9 Z KRISTALLOGR
JI Z. Kristall.
PY 1993
VL 208
BP 175
EP 180
DI 10.1524/zkri.1993.208.Part-2.175
PN 2
PG 6
WC Crystallography
SC Crystallography
GA MR721
UT WOS:A1993MR72100002
DA 2020-12-01
ER

PT J
AU BIEBER, F
   BRACHVOGEL, V
   ARNI, R
   FUSEK, M
   METCALF, P
AF BIEBER, F
   BRACHVOGEL, V
   ARNI, R
   FUSEK, M
   METCALF, P
TI CRYSTALLIZATION AND INITIAL CRYSTALLOGRAPHIC RESULTS FOR PEPSTATIN-A
   INHIBITED BOVINE CATHEPSIN-D
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Note
DE CATHEPSIN-D; PEPSTATIN; ASPARTIC PROTEASE; LYSOSOMAL TARGETING; CRYSTAL
ID RAY-DIFFRACTION DATA; ASPARTIC PROTEINASES; DETECTOR
C1 EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,POSTFACH 10-2209,W-6900 HEIDELBERG,GERMANY.
RI Fusek, Martin/AAG-7725-2019; Arni, Raghuvir K/B-2222-2013; Arni,
   Raghuvir K/N-9338-2018
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145
CR BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365
   BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7
   BLUM M, 1987, J APPL CRYSTALLOGR, V20, P235, DOI 10.1107/S0021889887086783
   BOTT R, 1982, BIOCHEMISTRY-US, V21, P6956, DOI 10.1021/bi00269a052
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633
   DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201
   FUSEK M, 1992, J MOL BIOL, V226, P555, DOI 10.1016/0022-2836(92)90968-P
   GOPALAN P, 1987, CAN J PHYSIOL PHARM, V65, P124, DOI 10.1139/y87-025
   GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0
   HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507
   HUANG JS, 1979, J BIOL CHEM, V254, P1405
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   JUPP RA, 1990, BIOCHEM J, V265, P871, DOI 10.1042/bj2650871
   KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903
   KENESSEY A, 1989, J NEUROSCI RES, V23, P454, DOI 10.1002/jnr.490230412
   KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411
   MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x
   TANDON AK, 1990, NEW ENGL J MED, V322, P297, DOI 10.1056/NEJM199002013220504
NR 19
TC 4
Z9 4
U1 0
U2 2
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 20
PY 1992
VL 227
IS 4
BP 1265
EP 1268
DI 10.1016/0022-2836(92)90539-V
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JW721
UT WOS:A1992JW72100027
PM 1433300
DA 2020-12-01
ER

PT J
AU ARNI, RK
   PAL, GP
   RAVICHANDRAN, KG
   TULINSKY, A
   WALZ, FG
   METCALF, P
AF ARNI, RK
   PAL, GP
   RAVICHANDRAN, KG
   TULINSKY, A
   WALZ, FG
   METCALF, P
TI 3-DIMENSIONAL STRUCTURE OF GLN25-RIBONUCLEASE-T1 AT 1.84-(A)CAP
   RESOLUTION - STRUCTURAL VARIATIONS AT THE BASE RECOGNITION AND CATALYTIC
   SITES
SO BIOCHEMISTRY
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; X-RAY; ACID COMPLEX; CONFORMATIONAL
   STABILITY; HISTIDINE-RESIDUES; CRYSTAL-STRUCTURE; 1.9-A RESOLUTION; FREE
   ENZYME; RIBONUCLEASE-T1; MUTANT
AB The structure of the Gln25 variant of ribonuclease T1 (RNase T1) crystallized at pH 7 and at high ionic strength has been solved by molecular replacement using the coordinates of the LyS25-RNase T1/2'-guanylic acid (2'GMP) complex at pH 5 [Arni et al. (1988) J. Biol. Chem. 263, 15358-15368] and refined by energy minimization and stereochemically restrained least-squares minimization to a crystallographic R-factor of 14.4% at 1.84-angstrom resolution. The asymmetric unit contains three molecules, and the final model consists of 2302 protein atoms, 3 sulfates (at the catalytic sites), and 179 solvent water molecules. The estimated root mean square (rms) error in the coordinates is 0.15 angstrom, and the rms deviation from ideality is 0.018 angstrom for bond lengths and 1.8-degrees for bond angles. Significant differences are observed between the three molecules in the asymmetric unit at the base recognition and catalytic sites.
C1 MICHIGAN STATE UNIV,DEPT CHEM,E LANSING,MI 48824.
   KENT STATE UNIV,DEPT CHEM,KENT,OH 44242.
RP ARNI, RK (corresponding author), EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,POSTFACH 102209,W-6900 HEIDELBERG,GERMANY.
RI Arni, Raghuvir K/N-9338-2018; Metcalf, Peter/B-4598-2011; Arni, Raghuvir
   K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145; Arni, Raghuvir
   K/0000-0003-2460-1145
CR ARNI R, 1987, ACTA CRYSTALLOGR B, V43, P548, DOI 10.1107/S0108768187097337
   ARNI R, 1988, J BIOL CHEM, V263, P15358
   AXELSEN PH, 1989, BIOPHYS J, V56, P43, DOI 10.1016/S0006-3495(89)82651-7
   BLUM M, 1987, J APPL CRYSTALLOGR, V20, P235, DOI 10.1107/S0021889887086783
   BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458
   CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172
   Crowther RA, 1972, MOL REPLACEMENT METH, P173
   EGAMI F, 1969, MOL BIOL BIOCH BIOPH, V6, P1
   FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299
   HAKOSHIMA T, 1990, J BIOCHEM-TOKYO, V108, P695, DOI 10.1093/oxfordjournals.jbchem.a123265
   HAKOSHIMA T, 1990, J MOL BIOL, V216, P497, DOI 10.1016/0022-2836(90)90374-U
   HEINEMANN U, 1982, NATURE, V299, P27, DOI 10.1038/299027a0
   Heinemann U., 1989, PROTEIN NUCLEIC ACID, P111
   HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG
   HILL C, 1983, TRENDS BIOCHEM SCI, V8, P364, DOI 10.1016/0968-0004(83)90363-8
   HOFFMANN E, 1988, EUR J BIOCHEM, V177, P539, DOI 10.1111/j.1432-1033.1988.tb14406.x
   HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436
   IIDA S, 1969, BIOCHEMISTRY-US, V27, P3242
   JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P8250, DOI 10.1021/bi00488a008
   KOEPKE J, 1989, J MOL BIOL, V206, P475, DOI 10.1016/0022-2836(89)90495-6
   KOSTREWA D, 1989, BIOCHEMISTRY-US, V28, P7592, DOI 10.1021/bi00445a014
   LATTMAN EE, 1970, ACTA CRYSTALL B-STRU, VB 26, P1854, DOI 10.1107/S0567740870004995
   LENZ A, 1991, J BIOL CHEM, V266, P7661
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   MACKERELL AD, 1988, BIOCHEMISTRY-US, V27, P4547, DOI 10.1021/bi00412a049
   MACKERELL AD, 1987, BIOPHYS CHEM, V26, P247, DOI 10.1016/0301-4622(87)80027-3
   MACKERELL AD, 1991, BIOCHIM BIOPHYS ACTA, V1073, P357, DOI 10.1016/0304-4165(91)90143-5
   MACKERELL AD, 1989, PROTEINS, V6, P20, DOI 10.1002/prot.340060103
   MALIN R, 1991, J BIOL CHEM, V266, P4848
   MARTIN PD, 1980, J MOL BIOL, V136, P95, DOI 10.1016/0022-2836(80)90368-X
   MCNUTT M, 1990, BIOCHEMISTRY-US, V29, P7572, DOI 10.1021/bi00485a005
   NISHIKAWA S, 1987, BIOCHEMISTRY-US, V26, P8620, DOI 10.1021/bi00400a019
   OSTERMAN HL, 1978, BIOCHEMISTRY-US, V17, P4124, DOI 10.1021/bi00613a003
   PACE CN, 1986, J MOL BIOL, V188, P477, DOI 10.1016/0022-2836(86)90169-5
   PACE CN, 1988, BIOCHEMISTRY-US, V27, P3242, DOI 10.1021/bi00409a018
   PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5
   RAVICHANDRAN V, 1981, INT J PEPT PROT RES, V18, P121
   SATO K, 1957, J BIOCHEM-TOKYO, V44, P753, DOI 10.1093/oxfordjournals.jbchem.a126717
   SCHIMADA I, 1990, BIOCHEMISTRY-US, V29, P757
   SEVCIK J, 1991, ACTA CRYSTALLOGR B, V47, P240, DOI 10.1107/S0108768190009569
   SHIRLEY BA, 1989, J BIOL CHEM, V264, P11621
   STEYAERT J, 1990, BIOCHEMISTRY-US, V29, P9064, DOI 10.1021/bi00490a025
   STEYAERT J, 1991, BIOCHEMISTRY-US, V30, P494, DOI 10.1021/bi00216a027
   SUGIO S, 1988, J BIOCHEM-TOKYO, V103, P354, DOI 10.1093/oxfordjournals.jbchem.a122274
   TAKAHASHI K, 1971, J BIOCHEM, V70, P945, DOI 10.1093/oxfordjournals.jbchem.a129724
   TAKAHASHI K, 1985, J BIOCHEM-TOKYO, V98, P815, DOI 10.1093/oxfordjournals.jbchem.a135339
   Takahashi K., 1982, ENZYMES, V15, p435 468
   WALZ FG, 1979, ARCH BIOCHEM BIOPHYS, V195, P95, DOI 10.1016/0003-9861(79)90330-8
   WALZ FG, 1990, J BIOL CHEM, V265, P7127
   WALZ FG, 1976, BIOCHEMISTRY-US, V15, P2837, DOI 10.1021/bi00658a021
NR 54
TC 7
Z9 7
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAR 31
PY 1992
VL 31
IS 12
BP 3126
EP 3135
DI 10.1021/bi00127a013
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HL679
UT WOS:A1992HL67900013
PM 1554699
DA 2020-12-01
ER

PT J
AU ARNI, R
   HEINEMANN, U
   TOKUOKA, R
   SAENGER, W
AF ARNI, R
   HEINEMANN, U
   TOKUOKA, R
   SAENGER, W
TI 3-DIMENSIONAL STRUCTURE OF THE RIBONUCLEASE T1-STAR-2'-GMP COMPLEX AT
   1.9-A RESOLUTION
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 FREE UNIV BERLIN,INST KRISTALLOG,D-1000 BERLIN 33,FED REP GER.
RI Heinemann, Udo/S-3379-2016; Arni, Raghuvir K/B-2222-2013; Heinemann,
   Udo/AAH-4766-2019
OI Heinemann, Udo/0000-0002-8191-3850; Arni, Raghuvir
   K/0000-0003-2460-1145; Heinemann, Udo/0000-0002-8191-3850
CR ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043
   ARATA Y, 1979, BIOCHEMISTRY-US, V18, P18, DOI 10.1021/bi00568a003
   ARNI R, 1987, ACTA CRYSTALLOGR B, V43, P548, DOI 10.1107/S0108768187097337
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Blackburn P, 1982, ENZYMES, V15, P317
   CAMPBELL MK, 1976, BIOCHEM BIOPH RES CO, V72, P1014, DOI 10.1016/S0006-291X(76)80233-1
   DELEEUW HPM, 1980, ISRAEL J CHEM, V20, P108
   ECKSTEIN F, 1972, BIOCHEMISTRY-US, V11, P3507, DOI 10.1021/bi00769a002
   EFTINK M, 1983, BIOPHYS J, V43, P323, DOI 10.1016/S0006-3495(83)84356-2
   Egami F, 1980, Mol Biol Biochem Biophys, V32, P250
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   FULLING R, 1978, FEBS LETT, V88, P279, DOI 10.1016/0014-5793(78)80193-8
   HARTLEY RW, 1980, J MOL EVOL, V15, P355, DOI 10.1007/BF01733142
   HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459
   HEINEMANN U, 1980, EUR J BIOCHEM, V109, P109, DOI 10.1111/j.1432-1033.1980.tb04774.x
   HEINEMANN U, 1982, NATURE, V299, P27, DOI 10.1038/299027a0
   HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252
   HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG
   HERSHBERGER MV, 1980, BIOCHEMISTRY-US, V19, P2204, DOI 10.1021/bi00551a032
   HILL C, 1983, TRENDS BIOCHEM SCI, V8, P364, DOI 10.1016/0968-0004(83)90363-8
   IIDA S, 1969, BIOCHEMISTRY-US, V8, P3897, DOI 10.1021/bi00838a003
   INAGAKI F, 1985, BIOCHEMISTRY-US, V24, P1013, DOI 10.1021/bi00325a031
   INAGAKI F, 1981, J BIOCHEM-TOKYO, V89, P1185
   JAMES DR, 1985, BIOCHEMISTRY-US, V24, P5517, DOI 10.1021/bi00341a036
   JONES AT, 1978, J APPL CRYSTALLOGR, V11, P268
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KYOGOKU Y, 1982, J BIOCHEM-TOKYO, V91, P675, DOI 10.1093/oxfordjournals.jbchem.a133740
   LAKOWICZ JR, 1983, BIOCHEMISTRY-US, V22, P1741, DOI 10.1021/bi00277a001
   LESK AM, 1982, SCIENCE, V216, P539, DOI 10.1126/science.7071602
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   MACKERELL AD, 1987, BIOPHYS CHEM, V26, P247, DOI 10.1016/0301-4622(87)80027-3
   MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6
   NAGAI H, 1985, FEBS LETT, V189, P167, DOI 10.1016/0014-5793(85)81017-6
   NISHIKAWA S, 1986, BIOCHEM BIOPH RES CO, V138, P789, DOI 10.1016/S0006-291X(86)80566-6
   OSHIMA T, 1971, J BIOCHEM-TOKYO, V70, P197, DOI 10.1093/oxfordjournals.jbchem.a129621
   PONGS O, 1970, BIOCHEMISTRY-US, V9, P2316, DOI 10.1021/bi00813a015
   QUAAS R, 1988, EUR J BIOCH, V773, P617
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3
   RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574
   RUTERJANS H, 1987, METABOLISM ENZYMOLOG, V6, P81
   SAENGER W, 1984, PRINCIPLES NUCLEIC A
   SEELA F, 1982, BIOCHEMISTRY-US, V21, P4338, DOI 10.1021/bi00261a024
   SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0
   SUGIO S, 1985, FEBS LETT, V183, P115, DOI 10.1016/0014-5793(85)80966-2
   SUGIO S, 1985, FEBS LETT, V181, P129, DOI 10.1016/0014-5793(85)81127-3
   TAKAHASH.K, 1967, J BIOL CHEM, V242, P4682
   TAKAHASHI K, 1972, J BIOCHEM, V72, P1469, DOI 10.1093/oxfordjournals.jbchem.a130039
   TAKAHASHI K, 1971, J BIOCHEM, V70, P945, DOI 10.1093/oxfordjournals.jbchem.a129724
   TAKAHASHI K, 1970, J BIOCHEM, V67, P833, DOI 10.1093/oxfordjournals.jbchem.a129315
   TAKAHASHI K, 1976, J BIOCHEM-TOKYO, V80, P1267, DOI 10.1093/oxfordjournals.jbchem.a131398
   TAKAHASHI K, 1985, J BIOCHEM-TOKYO, V98, P815, DOI 10.1093/oxfordjournals.jbchem.a135339
   TAKAHASHI K, 1970, J BIOCHEM, V68, P659, DOI 10.1093/oxfordjournals.jbchem.a129399
   Takahashi K., 1982, ENZYMES, V15, p435 468
   USHER DA, 1969, P NATL ACAD SCI USA, V62, P661, DOI 10.1073/pnas.62.3.661
   VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006
   WALZ FG, 1977, BIOCHEMISTRY-US, V16, P4568, DOI 10.1021/bi00640a005
   WALZ FG, 1976, BIOCHEMISTRY-US, V15, P4446, DOI 10.1021/bi00665a017
   WALZ FG, 1977, BIOCHEMISTRY-US, V16, P5509, DOI 10.1021/bi00644a018
   WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0
   WLODAWER A, 1985, BIOL MACROMOL, V2, P393
   YOSHIDA H, 1983, BIOCHEM BIOPH RES CO, V114, P88, DOI 10.1016/0006-291X(83)91597-8
NR 62
TC 173
Z9 174
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 25
PY 1988
VL 263
IS 30
BP 15358
EP 15368
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA Q5806
UT WOS:A1988Q580600023
PM 2844811
DA 2020-12-01
ER

PT J
AU ARNI, R
   HEINEMANN, U
   MASLOWSKA, M
   TOKUOKA, R
   SAENGER, W
AF ARNI, R
   HEINEMANN, U
   MASLOWSKA, M
   TOKUOKA, R
   SAENGER, W
TI RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL-STRUCTURE OF THE
   RIBONUCLEASE T1-STAR2'-GUANYLIC ACID COMPLEX AT 1.9 A RESOLUTION
SO ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE
LA English
DT Article
RP ARNI, R (corresponding author), FREE UNIV BERLIN,INST KRISTALLOG,TAKUSTR 6,D-1000 BERLIN 33,FED REP GER.
RI Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019; Arni, Raghuvir
   K/B-2222-2013
OI Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850;
   Arni, Raghuvir K/0000-0003-2460-1145
CR AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618
   ARNI R, 1987, UNPUB
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   BLOW DM, 1959, ACTA CRYSTALLOGR, V12, P794, DOI 10.1107/S0365110X59002274
   COLMAN PM, 1972, J MOL BIOL, V70, P701, DOI 10.1016/0022-2836(72)90569-4
   Egami F, 1980, Mol Biol Biochem Biophys, V32, P250
   FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144
   FUJINAGA M, 1985, J MOL BIOL, V183, P479
   FULLING R, 1978, FEBS LETT, V88, P279, DOI 10.1016/0014-5793(78)80193-8
   HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459
   HEINEMANN U, 1980, EUR J BIOCHEM, V109, P109, DOI 10.1111/j.1432-1033.1980.tb04774.x
   HEINEMANN U, 1982, NATURE, V299, P27, DOI 10.1038/299027a0
   HEINEMANN U, 1982, THESIS U GOTTINGEN F
   HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252
   HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG
   HILL C, 1983, TRENDS BIOCHEM SCI, V8, P364, DOI 10.1016/0968-0004(83)90363-8
   IKEHARA M, 1986, P NATL ACAD SCI USA, V83, P4695, DOI 10.1073/pnas.83.13.4695
   JONES AT, 1978, J APPL CRYSTALLOGR, V11, P268
   KATTI SK, 1981, ACTA CRYSTALLOGR B, V37, P1825, DOI 10.1107/S0567740881007346
   KRATZIN H, 1987, COMMUNICATION
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   MACHIN PA, 1983, DARESBURY LABORATORY, V10, P3
   PONNUSWAMY PK, 1976, J THEOR BIOL, V60, P481, DOI 10.1016/0022-5193(76)90076-X
   QUAAS R, 1987, BIOPHOSPHATES THEIR, P345
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   RAVICHANDRAN V, 1981, INT J PEPT PROT RES, V18, P121
   SUGIO S, 1985, FEBS LETT, V183, P115, DOI 10.1016/0014-5793(85)80966-2
   SUGIO S, 1985, FEBS LETT, V181, P129, DOI 10.1016/0014-5793(85)81127-3
   TAKAHASHI K, 1971, J BIOCHEM, V70, P945, DOI 10.1093/oxfordjournals.jbchem.a129724
   TAKAHASHI K, 1985, J BIOCHEM-TOKYO, V98, P815, DOI 10.1093/oxfordjournals.jbchem.a135339
   Takahashi K., 1982, ENZYMES, V15, p435 468
   Wilson AJC, 1942, NATURE, V150, P151, DOI 10.1038/150152a0
   WLODAWER A, 1986, ACTA CRYSTALLOGR B, V42, P379, DOI 10.1107/S0108768186098063
NR 33
TC 44
Z9 44
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0108-7681
J9 ACTA CRYSTALLOGR B
JI Acta Crystallogr. Sect. B-Struct. Commun.
PD DEC 1
PY 1987
VL 43
BP 548
EP 554
DI 10.1107/S0108768187097337
PN 6
PG 7
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA L1751
UT WOS:A1987L175100012
DA 2020-12-01
ER

PT J
AU ARNI, R
   HEINEMANN, U
   SAENGER, W
AF ARNI, R
   HEINEMANN, U
   SAENGER, W
TI STRUCTURE AND FUNCTION OF THE ENZYME RIBONUCLEASE-T1
SO FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE
LA German
DT Article
RP ARNI, R (corresponding author), FREE UNIV BERLIN,INST KRISTALLOG,TAKUSTR 6,D-1000 BERLIN 33,FED REP GER.
RI Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019; Arni, Raghuvir
   K/B-2222-2013
OI Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850;
   Arni, Raghuvir K/0000-0003-2460-1145
CR ARNI R, 1987, THESIS TU BERLIN
   HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459
   HEINEMANN U, 1982, NATURE, V299, P27, DOI 10.1038/299027a0
   HILL C, 1983, TRENDS BIOCHEM SCI, V8, P364, DOI 10.1016/0968-0004(83)90363-8
   QUAAS R, 1986, IN PRESS PHOSPHOROUS
   SUGIO S, 1985, FEBS LETT, V183, P115, DOI 10.1016/0014-5793(85)80966-2
NR 6
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0016-1152
J9 FRESEN Z ANAL CHEM
PY 1987
VL 327
IS 1
BP 67
EP 68
DI 10.1007/BF00474576
PG 2
WC Chemistry, Analytical
SC Chemistry
GA H2040
UT WOS:A1987H204000067
DA 2020-12-01
ER

PT J
AU ARNI, R
   LANGER, K
   TILLMANNS, E
AF ARNI, R
   LANGER, K
   TILLMANNS, E
TI MN-3+ IN GARNETS .3. ABSENCE OF JAHN-TELLER DISTORTION IN SYNTHETIC
   MN-3+-BEARING GARNET
SO PHYSICS AND CHEMISTRY OF MINERALS
LA English
DT Article
C1 UNIV MAINZ,INST GEOWISSENSCH,D-6500 MAINZ,FED REP GER.
   TECH UNIV BERLIN,INST MINERAL & KRISTALLOG,D-1000 BERLIN,FED REP GER.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
CR BAUR WH, 1969, SADIAN 69
   DRAGER M, 1971, ACTA CHEM SCAND, V25, P761, DOI 10.3891/acta.chem.scand.25-0761
   FINGER LW, 1975, NBS854 TECHN NOT
   FRENTRUP KR, 1981, NEUES JB MINER MONAT, P245
   FURSENKO BA, 1982, DOKL AKAD NAUK SSSR, V268, P421
   Ibers J.A., 1974, INT TABLES XRAY CRYS, VIV
   Jahn HA, 1937, PROC R SOC LON SER-A, V161, P220, DOI 10.1098/rspa.1937.0142
   LANGER K, 1984, NEUES JB MINER ABH, V149, P129
   LATTARD D, 1983, CONTRIB MINERAL PETR, V84, P199, DOI 10.1007/BF00371286
   NISHIZAWA H, 1975, AM MINERAL, V60, P84
   NOVAK GA, 1971, AM MINERAL, V56, P791
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Sheldrick G. M., 1976, SHELX 76 PROGRAM CRY
   Stout G. H., 1968, XRAY STRUCTURE DETER
   STRENS RGJ, 1966, MINERAL MAG J M SOC, V35, P777, DOI 10.1180/minmag.1966.035.273.15
   STRENS RGJ, 1965, MINERAL MAG J M SOC, V35, P547, DOI 10.1180/minmag.1965.035.271.12
NR 16
TC 5
Z9 5
U1 0
U2 4
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0342-1791
J9 PHYS CHEM MINER
JI Phys. Chem. Miner.
PY 1985
VL 12
IS 5
BP 279
EP 282
DI 10.1007/BF00310340
PG 4
WC Materials Science, Multidisciplinary; Mineralogy
SC Materials Science; Mineralogy
GA ASC73
UT WOS:A1985ASC7300004
DA 2020-12-01
ER

PT J
AU TILLMANNS, E
   LANGER, K
   ARNI, R
   ABRAHAM, K
AF TILLMANNS, E
   LANGER, K
   ARNI, R
   ABRAHAM, K
TI CRYSTAL-STRUCTURE REFINEMENTS OF COEXISTING THULITE AND PIEMONTITE,
   CA2AL3-PMP-3+ [OH/O/SIO4/SI2O7] (M-3+=MN-3++FE-3+)
SO ACTA CRYSTALLOGRAPHICA SECTION A
LA English
DT Meeting Abstract
C1 UNIV MAINZ,D-6500 MAINZ,FED REP GER.
   TECH UNIV BERLIN,D-1000 BERLIN 12,FED REP GER.
   RUHR UNIV BOCHUM,D-4630 BOCHUM,FED REP GER.
RI Arni, Raghuvir K/B-2222-2013
OI Arni, Raghuvir K/0000-0003-2460-1145
CR BURNS RG, 1967, MINERAL MAG J M SOC, V36, P204, DOI 10.1180/minmag.1967.036.278.04
   DOLLASE WA, 1968, AM MINERAL, V53, P1882
   FINGER, 1975, NBS854 TECH NOT
   LANGER, 1976, Z KRIST, V144, P334
NR 4
TC 1
Z9 1
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0108-7673
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 1984
VL 40
SU S
BP C258
EP C258
DI 10.1107/S0108767384092278
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA TK545
UT WOS:A1984TK54500753
DA 2020-12-01
ER

EF